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ABSTRACT
Using multi-scale molecular dynamics (MD) simulations, we systematically study the influences of nanoparticle (NP) properties (including size, shape, elasticity and surface functionality) on the endocytosis process. Furthermore, we use MD simulations to help design
new liposome-like and pH-responsive NPs.
The endocytosis of elastic NPs is first investigated. With a new developed elastic NP
model, we investigate NPs with different sizes, shapes, and stiffness. Our simulations provide
clear evidence that the membrane wrapping efficiency of NPs is a result of competition
between receptor diffusion kinetics and thermodynamic driving force. We further suggest
that conflicting experimental observations on the endocytosis efficiency of elastic NPs should
be caused by their different mechanical properties.
We then explore the endocytosis of PEGylated liposomes and PEGylated bicelles. Comparing PEGylated rigid NPs and liposomes, we find that the mobile PEG polymers on
liposome aggregate. This aggregation induces a large energy barrier and suppresses the
membrane wrapping of PEGylated liposomes. Comparing PEGylated liposomes and PEGylated bicelles, we find that the aggregation of PEG polymers makes the bicelles more
energetic favorable. We confirm that interplay between ligand mobility and NP geometry
can significantly change the influence of NP geometry on the endocytosis.
A core-polyethylene glycol-lipid shell (CPLS) NP is proposed with a lipid bilayer self-

Zhiqiang Shen, Ph.D.
University of Connecticut, 2020

assembled at the surface of a PEGylated inorganic core. Due to the lipid surface, CPLS NPs
inherit the biocompatibility of liposomes. Furthermore, they also have better properties
than liposomes, including well-controlled size distribution and high mechanical stability.
This self-assembly method can be generalized to fabricate liposome-like NPs incorporating
different polymers.
We finally study the stability of pH-responsive AuNPs and their interactions with lipid
bilayers. Free energy analysis reveals that an energy barrier before the appearance of
the hydrophobic driving force is critical to AuNPs’ stability. For interactions with lipid
bilayers, the lipids are extracted by the AuNPs. The extracted lipids cause dehydration
and disruption of the bilayers when multiple AuNPs exist.
In this dissertation, our simulations provide a detailed mechanistic understanding for
the endocytosis of NPs. Furthermore, we prove that MD simulations serve as a powerful
tool to help design new NP platforms.
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Chapter 1

Introduction
1.1

Introduction of Drug Delivery

Nanomaterials have been recognized as emerging materials in the design of drug delivery vehicles 1–4 . Due to the sequestration in the reticulo-endothelial system (RES) organs 5 , degradation by serum protein absorption 6 , macrophage internalization 7 and many other factors,
the freely administrated drug molecules cannot be efficiently delivered into the diseased cells.
To overcome these biological barriers, nanomaterials have been found to be able to carry
these drug molecules and effectively deliver them into the tumor cells 8–10 . Langer and
co-workers have developed a biodegradable long-circulating polymeric nanospheres based
on amphiphilic copolymers 8 . When the polyethylene glycol-poly(lacticco- glycolic acid)
(PEG-PLGA) copolymers are immersed into the water, their hydrophobic parts (PLGA)
will self-assembled together to form a hydrophobic core region and minimize their interactions with water molecules. In the mean time, the hydrophobic drug molecules can also be
enveloped into this core region with 45% weight ratio. Due to the hydrophilic properties
of PEG polymers, adsorption of serum proteins haven blocked by these polymer brushes.
Thus, the synthesized nanosphere has been found to exhibit long circulation time within
1

blood flow and less accumulation in the liver of mice 8 . The above example demonstrates
that nanomaterials have a great potential in the design of targeted drug delivery platform.

A

B

C

D

Figure 1.1: Schematic of the nanoparticle-mediated drug delivery process. (A) Solution containing
nanoparticle delivery platforms is injected into a patient’s circulatory system. (B) In the microvasculature, nanoparticles are segregated from red blood cells, increasing their interaction with the endothelium, eventually leading to their removal from circulation. (C) Nanoparticles diffusion through
the extracellular matrix, eventually adsorbing onto the surface of a target cell. The nanoparticles
are then endocytosed from the lipid membrane. (D) The endosome containing the drug-delivery
complex ruptures, releasing the therapeutic agents into the cytoplasm. When released from the
endosome, the nanoparticle cargo maybe dissociated due to the local pH environment change.

As described above, the initial concept of drug delivery is to use nanoparticles (NPs)
as vehicles to protect drug molecules and deliver them into targeted diseased sites. To
realize this kind of ultimate goal, NPs have to experience a tough “journey” inside the
human body, as given in Fig.1.1. First, the intravenously administrated NPs with loaded
drug molecules need to circulate within the bloodstream. Blood is composed of blood
cells in blood plasma, which contain thousands of different serum proteins. Red blood
cells (RBCs) account for approximately 35-45% of blood by volume. Under shear flow,
RBCs tend to migrate away from vessel walls, creating a “cell-free layer” near the wall.
2

In contrast, NPs which are much smaller than the RBCs, prefer to migrate into the “cellfree layer” 11,12 . Endothelial cells line together to form a monolayer, which forms the inner
surface of vessel walls. By entering the “cell-free layer”, NPs have a great probability of
interacting with these endothelial cells. Endothelial cells near tumors are discontinues,
forming gaps between cells of a few hundred nanometers. It is unclear right now, by which
pathway the NPs extravasate and enter the tumor cellular matrix. The current view is
that NPs are able to penetrate through these gaps and be retained in tumors because of
the pressure created by poor lymphatic drainage, which is well known as the enhanced
permeability and retention (EPR) effect 13–15 . However, different arguments suggest that
NPs could also extravasate via a transendothelial cell pathway 16 . After extravasation, NPs
confront the heterogeneous tumor microenvironment, including non-malignant cells and
extracellular matrix components (like collagen, fibronectin). For successfully delivery, NPs
have to diffuse through the extracellular matrix and reach the targeted tumor cells. The
interaction between NPs and the cell membrane is heavily influenced by the functionalization
of the carrier surface, the local molecular composition of the membrane, and extracellular
environmental variables such as pH and salt concentration 17 . NPs firstly adsorb onto the
membrane and are then wrapped by the cell membrane and endocytosed. The endosomes
containing the NP-drug complexes can then either evolve into lysosomes, which can degrade
the drug molecules during this the process, or they can rupture, releasing their contents
into the cytoplasm.
The whole NP-mediated drug delivery process could be classified into three main stages:
(I) NPs circulate within the bloodstream, called the blood circulation stage; (II) The extravasated NPs navigate and diffuse through the tumor extracellular matrix, called the
extracellular matrix diffusion stage; (III) NPs are internalized by tumor cells and release
their encapsulated drug molecules, called the cellular uptake and drug releasing stage. Although the whole drug delivery process looks simple, there are also several biological barriers
that obstruct this process. For instance, the majority of administrated NPs are cleared up
3

by the mononuclear phagocyte system (MPS) . The MPS consists of dendritic cells, blood
monocytes, and tissue-resident macrophages in the liver, spleen, and lymph nodes that are
responsible for clearing, processing, and degrading foreign materials from circulation. After
injection, various kinds of serum proteins in the bloodstream are adsorbed to NPs’ surfaces, forming layers of proteins known as a protein “corona”. This protein corona alters
the chemical identities of NPs. Furthermore, many of these proteins act as opsonins that
initiate the phagocytes of the MPS, resulting in the clearance of NPs 18 . Therefore, during
the blood circulation stage, to increase the chance of NP extravasation through the EPR
effect, the problem of serum protein adsorption must be addressed in NP design to prolong
blood circulation time. It has also been reported that the osmotic pressure in a tumor
is usually higher than in normal tissue 19–21 . This kind of interstitial fluid pressure (IFP)
is uniformly distributed. Specifically, the value of hydrostatic pressure decreases from the
tumor center to the periphery. This indicates that during the extracellular matrix diffusion
stage, NPs have to diffuse against the pressure gradient, which reduces the number of NPs
that are able to reach the tumor cells 19,22 . Additionally, even after entering tumor cells,
drug molecules may not be released. For NPs internalized by the endocytosis pathway, the
vesicles wrapped around NPs will eventually evolve into endosomes and lysosomes, which
are characterized by an acidic environment with a pH value of around 5. This when combined with the degradative enzymes found inside endosomes/lysosomes, can easily cause
drug molecules to degrade and lose their function.

1.2

Design of Nanoparticles for Drug Delivery

In view of these complex biological barriers, the key problem in NP-mediated drug delivery
is understanding how to design them properly. The physiochemical properties of NPs, such
as size, shape, stiffness and surface functionality (4S parameters), play important roles in the
biological responses, affecting their biological clearance and distribution 23–26 . On the other

4

hand, with advancements in nanotechnology, size, shape, stiffness (composition), and surface
properties of nanomaterials can be precisely controlled during chemical synthesis. Therefore,
NPs can be modified in various ways to overcome their biological barriers, extending their
circulation time and increasing the accumulation of drug molecules in tumor cells 13,14 .

1.2.1

Size Effect

During the blood circulation process, the leaky gaps between endothelial cells act as an
upper limit for the size of NPs. If NPs cannot enter these gaps they cannot take advantage
of the EPR effect and passively accumulate in tumor tissue. Furthermore, NPs smaller
than 10 nm will be cleaned from the blood stream through the kidney or from the tumor
via extravasation 27 . However, NPs larger than 200 nm are at risk of being filtered out by
the liver or spleen or are destroyed by bone marrow. Charoenphol et al 28 . studied the NP
size effect by using spheres with diameters ranging from 0.5 to 10 µm in the blood. The
margination propensity of NPs was found to increase with the sphere diameter. Recently,
Lee et al. 29 explored the NP size effect through combined in vivo and in silico studies,
by using spherical polystyrene NPs with diameters of 10–1000 nm. The results of their
simulations and experiments confirm that larger NPs (greater than 500 nm) can migrate
into the ‘cell-free layer’, while smaller NPs (less than 200 nm) are mostly trapped between
RBCs in the core region. On the other hand, during the cellular uptake process, both
experimental and theoretical research has demonstrated that for ligand-receptor mediated
endocytosis the optimal size of NPs are within the range of 30 to 50 nm. For NPs above
50 nm, a large number of receptors is needed to fully envelope their surfaces. Thus, the
efficiency of receptor-mediated endocytosis is limited by the redistribution of receptors on
the surface via diffusion. While, if the NP is too small, the quantity of ligands on surface
is not enough to overcome the energy barriers of membrane bending, which prevents the
internalization of small NPs 30,31 .

5

1.2.2

Shape Effect

NPs can be made into different geometrical shapes, such as spheres, rods, cubes and discs.
In relation to blood circulation time, it has been discovered that thin discoidal NPs exhibit
a larger lateral drift velocity (migration rate) than that of other NPs under the influence of
hydrodynamic forces 11,12 . These results indicate that thin discoidal NPs are more likely to
interact with the vascular wall. Some of the theoretical, in vitro and in vivo experimental
results have revealed that thin discoidal particles can more firmly adhere to the lateral
walls under shear flow when compared to spherical and slender cylindrical particles 32–34 .
The thin discoidal NPs are observed to offer a larger surface of adhesion and a smaller cross
section, leading to lower hydrodynamic forces and larger adhesive interaction. During the
endocytosis process, shaped NPs express complex behaviors; their form affects their final
efficacy. For instance, in their experiments, Gratton et al. 35 revealed that rod shaped NPs
larger than 100 nm have advantages during the endocytosis process. Spherical NPs have
been found to be more efficient than rods, when they are under the size of 100 nm 36,37 .
However, simulation results indicate that spherical NPs are the most likely carriers to be
accepted by diseased cells. The membrane bending energy is the primary reason for why
non-spherical NPs are less efficient for delivery into diseased cells 38,39 .

1.2.3

Stiffness Effect

Recently, mechanical properties like stiffness have been recognized as another important
factor that determines the density of NPs in drug delivery 40 . The deformability (stiffness)
of particles and its effect on transportation in blood circulation has been noted by the
DeSimone group 41 . They adopted the PRINT approach, which is similar to the hydrogeltemplate strategy, to demonstrate that deformable microparticles (5 µm) with concave
shapes can circulate longer than their rigid counterparts 41 . In their simulations, Kumar
and Graham 42 modelled a dilute suspension of elastic capsules under simple shear flow.
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They found that stiff particles (such as WBCs) tend to marginate, while soft (‘floppy’)
particles (such as RBCs) accumulate near the center of the channel 42 . However, conflicting
results have been reported for NPs during the cellular uptake process. Focusing on the
polyethylene glycol (PEG)-based hydrogel nanoparticles of uniform size (200 nm) with
elastic moduli ranging from 0.255 to 3000 kPa, Anselmo et al. 43 discovered that harder
NPs are more readily internalized by 4T1 cancer cells than the softer ones. In contrast, Liu
et al. 44 concluded that for poly(2-hydroxyethyl methacrylate) (HEMA) hydrogel particles,
softer NPs were internalized more quickly by HepG2 cells. In theory, Xin et al. 45–47 reported
that during endocytosis, a soft NP encounters a very large membrane bending energy due
to deformation. Thus, a soft NP is more energetically difficult than harder NPs. However,
for the diffusion of receptors on membrane surfaces, a softer NP has a greater probability
of recruiting more receptors to its large contact area. Thus, soft NPs are more efficiently
wrapped by membranes than harder NPs.

1.2.4

Surface Properties

Among the 4S parameters, surface functionalization has been considered the most important. For instance, bare inorganic NPs, such as Au or Ag NPs, can easily aggregate together
in water, as they are hydrophobic. More importantly, when they are injected into the blood
flow, the surfaces of inorganic NPs become bound by serum proteins due to electrostatic
interactions. Thus, these particles become visible to immune cells (i.e. macrophage) and
are eventually removed through phagocytosis. To overcome these issues, biocompatible
and hydrophilic PEG polymers have been widely used to decorate the surface of inorganic
NPs. With a high grafting density, tethered PEG polymers form a brush on the surface of
these NPs 48,49 , thus, they can be well-dispersed in water. The PEG chains also dramatically reduce the absorption of serum proteins 50,51 . Therefore, PEGylated NPs demonstrate
prolonged circulation time and high accumulation in tumor sites in vivo due to the EPR
effect 49,52 .
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The evolution of drug delivering NPs can be classified into three “generations” 23,53 .
Research on the first-generation of NPs focuses on the basic surface chemistry of NPs, mainly
their surface charges, to improve their biocompatibility and reduce toxicity. These NPs are
tested for their toxicity and efficiency during cellular uptake 36,54 . However, because first
generation nanoparticles do not consider the interactions between NPs and serum proteins,
they are quickly removed by immune cells. In comparison, the second generation of NPs are
usually functionalized with bio-compatible polymers such as PEG. Under the protection of
a the tethered polymer layer, these particles exhibit a prolonged blood half-life time, which
in turn helps them accumulate at tumor sites through the EPR effect 55,56 .Recently a third
generation of NPs with environmentally-responsive polymers has been adopted. These NPs
do not rely on the EPR effect. Local biological, physical or chemical cues are used instead
to trigger property changes on tethered polymers and maximize their drug delivery efficacy.
For example, the pH value of a tumor site (about 5 6) is relatively lower than that of normal
tissue (about 7.4). By taking advantage of this acidic environment, the PEG surface shell
could be removed by a pH-triggered effect to reveal a positively-charged inorganic NP core,
facilitating the nonspecific cellular uptake of the drug-filled NPs 57 . Through the design of
these “smart” polymers, the selectivity of NP-based drug carriers could be further enhanced.

1.3

Motivation and Dissertation Organization

In views of the difficulties and problems in the nanoparticle-mediated drug delivery process, we try to investigate relating problems with the help of multiscale molecular dynamics
(MD) simulations. Particularly, we will explore the influences of 4S parameters and interplay of nanoparticle properties on the cellular uptake process. In addition, we will utilize
the advantages of MD simulation to help design new nanoparticles. The entire dissertation
is organized as follows: Chapter 2 and Chapter 3 will focus on the cellular uptake of elastic
nanoparticles. Chapter 2 will develop an elastic nanoparticle model with well-controlled
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mechanical properties. Chapter 3 will investigate the cellular uptake process of elastic
nanoparticles with different sizes, shapes, and stiffness. It is found in Chapter 3 that the
membrane wrapping efficiency NPs during endocytosis is a result of competition between
receptor diffusion kinetics and thermodynamic driving force. Chapter 4 and Chapter 5 will
focus on the cellular uptake of PEGylated liposomes and PEGylated bicelles. In Chapter 4, it is found that the mobility of decorated PEG polymers on the liposome surfaces
suppresses the cellular uptake of PEGylated liposomes. Due to the mobility of PEG polymers, PEGylated bicelles are found more energetic favorable than PEGylated liposomes
during cellular uptake process in Chapter 5. Chapter 6, Chapter 7 and Chapter 8 will
focus on the design of new liposome-like nanoparticles of core-polyethylene glycol-lipid shell
(CPLS) nanoparticles. In Chapter 6, it is found that a CPLS nanoparticle can be fabricated through self-assembly process. The self-assembled CPLS nanoparticles are proposed
to have well-controlled size and good stability to overcome the disadvantages of liposomes.
In Chapter 7, the self-assembled CPLS nanoparticles are systematically compared with the
liposome in the shear flow. The CPLS nanoparticles are proved more mechanical stable
due to the existence of PEGylated core. In Chapter 8, the template mediated self-assembly
method of CPLS nanoparticles will be extended as a general protocol to design liposomelike nanoparticles incorporated with polymers in different stiffness. Chapter 9 will focus
on smart nanoparticles of pH-responsive monolayer-protected gold nanoparticles. The last
chapter will give a summary in this dissertation.
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Chapter 2

Understanding Receptor-Mediated
Endocytosis of Elastic
Nanoparticles through Coarse
Grained Molecular Dynamic
Simulation
2.1

Abstract

For nanoparticle (NP)–based drug delivery platforms, the elasticity of NPs has significant
influence on their blood circulation time and cellular uptake efficiency. However, due to
the complexity of endocytosis process and inconsistency in the definition of elasticity for
NPs in experiments, the understanding about the receptor-mediated endocytosis process of
elastic NPs is still limited. In this work, we developed a coarse-grained molecular dynamics
(CGMD) model for elastic NPs. The energy change of elastic NPs can be precisely controlled
by the bond, area, volume and bending potentials of this CGMD model. To represent
liposomes with different elasticities, we systematically varied the bending rigidity of elastic
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NPs in CGMD simulations. Additionally, we changed the radius of elastic NPs to explore
the potential size effect. Through virtual nano-indentation tests, we found that the effective
stiffness of elastic NPs was determined by their bending rigidity and size. Afterwards, we
investigated the receptor-mediated endocytosis process of elastic NPs with different sizes
and bending rigidities. We found that the membrane wrapping of soft NPs was faster than
stiff ones at early stage, due to the NP deformation induced large contact area between
the NP and membrane. However, because of the large energy penalties induced by the
NP deformation, the membrane wrapping speed of soft NPs slows down during the late
stage. Eventually, the soft NPs are less efficient than stiff ones during the membrane
wrapping process. Through systematic CGMD simulations, we found a scaling law between
the cellular uptake efficiency and phenomenal bending rigidity of elastic NPs, which agrees
reasonably well with experimental observations. Furthermore, we observed that membrane
wrapping efficiencies of soft and stiff NPs with large size were close to each other, due to
the stronger ligand-receptor binding force and smaller difference in stiffness of elastic NPs.
Our computational model provides an effective tool to investigate the receptor-mediated
endocytosis of elastic NPs with well controlled mechanical properties. This study can also
be applied to guide the design of NP-based drug carriers with high efficacy, by utilizing
their elastic properties

2.2

Introduction

Nanoparticle (NP)-based drug delivery is attractive in research fields for its promising
potential to selectively and precisely deliver therapeutics or imaging agents to diseased
sites. 2,3,16,23 . For this purpose, NPs are engineered to carry drug molecules or imaging
agents, protect and delivery them to target tissues or organs. During this process, NPs
act as a medium and protector for encapsulated drug molecules to interact with local biological surroundings, such as proteins, immune cells, endothelial cells and tumor cells.
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Therefore, the properties of NPs play significant roles in determining their final biological
fate 23,24,58 . Specifically, the “4S” NP parameters, such as size, shape, surface functionality
and stiffness are the most important design parameters for NP-mediated drug carriers 23,59 .
For instance, NPs with radii of 30-50 nm are demonstrated to be the optimal size during
cellular uptake process 30,31,60 . However, comparing to the widely studied size, shape and
surface functionality effects, the influence of NP elasticity (stiffness) has received relative
less attention 40,59,61 .
Recently, the NP elasticity has been recognized to significantly affect both their blood
circulation time and cellular uptake 40 . On one hand, NPs with better capability of deformation are more difficult to be internalized by macrophages and other immune cells during
blood circulation 40,41 . NPs are internalized by the immune cells through the phagocytosis
pathway 23,40 . It has been reported that the soft NPs are unfavorable to the actin filament
organization during the phagocytosis process. 62 For example, by focusing on the interaction
between J774 macrophages and polyethylene glycol (PEG) based hydrogel NPs, Anselmo
et.al 43 found that the number of internalized NPs with bulk modulus 3000 kPa is near 4fold higher than their counterparts with bulk modulus 10 kPa during the same time period.
Therefore, the elasticity of NPs can be leveraged to design NPs with increased blood circulation time, as shown by DeSimone and co-workers 41 . On the other hand, the elasticity
of NPs plays a complicated role during cellular uptake process of tumor cells. Different
from that of immune cells, the internalization of NPs into tumor cells is regulated by the
receptor-mediated endocytosis process 23 . For instance, Liu et.al 44 investigated the cellular
uptake process of poly(2-hydroxyethyl methacrylate)(HEMA) hydrogel particles by using
HepG2 cell line. The elasticity of hydrogel NPs is characterized by the compressive modulus
of bulk hydrogel. They reported that NPs with modulus of 15-50 kPa are more efficient to
be internalized by HepG2 cells than NPs with modulus of 75-160 kPa. Yet, Takechi-Haraya
et.al 63 explored the cellular uptake efficiency of liposomes by HeLa cells. They found that
liposomes with large bending rigidity (15 × 10−19 J) had a higher cellular uptake efficiency
12

than those with small bending rigidity (2 × 10−19 J). These conflicting experimental observations might be induced by different experimental conditions. However, the reasons
behind these conflicting phenomena are not clear so far 40 .
The complexity of endocytosis process is one of the reasons limiting our fundamental
understandings. Endocytosis is one of essential processes for cells to internalize molecules
or macromolecules, which is also a primary route exploited by engineering NPs 23,60,61 . Depending on proteins and lipids involved, endocytosis could be sub-classified in several other
mechanisms, such as macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated
endocytosis and calthrin/caveolae independent endocytosis 64,65 . All of these pathways
share the same steps in ligand-dependent binding, membrane budding and pinching off.
Particularly, the endocytosis process is initiated and driven by the ligand-receptor binding.
The ligand (L) and receptor (R) reaction process could be conceptually separated into two
steps 66 :
d+

r+

d−

r−

−
*
L+R−
)
−
− LR −
)*
−C

(2.1)

where d+ and d− are the rate of formation and dissolution of encounter complex LR, respectively. The encounter complex (LR) is used to describe the state that ligand and receptor
are close to each other, but they have not yet reacted and bound together. r+ and r− are
the rate of breaking and forming of the bound state (C) from LR, respectively. Therefore, in
the first step, the ligand and receptor diffuse to encounter each other, the efficiency of which
is diffusion limited. Whereas, in the second step, the chemical reaction between ligand and
receptor occurs, the efficiency of which is determined by the energy barrier between bound
and unbound states. Both of these two steps could affect the efficiency of ligand-receptor
binding, which eventually determines the cellular uptake efficiency. For example, assuming
the second step as an irreversible process, Gao et.al 31 found that for the NPs with large
size, more receptors are needed to bind ligands decorated on NP surface. Therefore, the
recruiting of receptors takes a long diffusion time. Hence, membrane wrapping efficiency of
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large size NPs is greatly limited by the receptor diffusion.
The inconsistency in the different definitions of elasticity for NPs is another factor that
hides behind the conflicting experimental results on cellular uptake efficiency 40 . Young’s
modulus 67 , bending rigidity 63 , stiffness 68,69 , bulk modulus 44 are used to describe the elasticity of NPs 40 during the cellular uptake process. However, these physical parameters are
totally different from a mechanical point of view. For instance, the stiffness is defined as as
a property of material to resist external force, which is a structural property that depends
on the geometry of NPs. Whereas, the Young’s modulus is defined as the ability to resist
stress, which is an intrinsic material property. Therefore, direct comparison between experimental results is not appropriate, without considering these aspects. On the contrary,
theoretical and computational studies that can clearly define the physical parameters of
NPs are of great interests to clarify the conflicting experimental observations.
Theoretically, Yi et al. systematically investigated the membrane wrapping process of
elastic NPs 45,46 The membrane wrapping process was modeled by the interaction between a
planar membrane and an elastic vesicle 45,46 . The elastic vesicles were assumed to have constant area during membrane wrapping. Moreover, the elasticity of vesicles was controlled by
its bending rigidity. The authors explored the membrane wrapping process from both thermodynamic and kinetic perspectives. To analyze the energy landscape, the ligand-receptor
interaction was considered as direct adhesion between vesicle and membrane. The authors
found that soft vesicles with small bending rigidity deformed and spread on the membrane
at the early wrapping stage. Therefore, at this stage, the membrane does not significantly
bend due to the deformation of soft vesicle. While, at the late wrapping stage, the membrane
has to experience a rapid defamation to fully wrap the soft vesicle. This abrupt change in
deformation requires a large adhesion energy to overcome the corresponding elastic energy
barrier from membrane bending. Therefore, the soft vesicles are energetically unfavorable
during the membrane wrapping process. To investigate the kinetics of receptor-mediated
membrane wrapping, the authors further considered the ligand-receptor binding during the
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wrapping process. The receptors in membrane initially freely diffuse on the membrane. Additionally, the receptors were assumed to bind instantly and irreversibly to ligands on NP
surface. Due to their larger contact area with membrane, soft vesicles have better chance to
encounter and interact with receptors than stiff vesicles. Therefore, soft vesicles are more
efficiently to be fully wrapped because of the diffusion limited efficiency in the first step of
ligand-receptor reaction (cf. Eq.2.1). However, how the deformation and energy change of
soft vesicles will affect the second step in Eq.2.1 is not clear yet, which is too complicated
for theoretical studies.
Molecular dynamic (MD) simulations have been successfully adopted to explore molecular details during receptor-mediated membrane wrapping process for NPs 70–74 . For example, Li et al. 70 used polymeric NP, liposome and solid NP to represent NPs with increasing
hardness in MD simulations. They found that the solid NP was more efficient than polymeric NP and liposome during membrane wrapping process. However, it is difficult to
directly quantify the mechanical properties of polymeric NP, liposome and solid NP in their
simulations. Therefore, these simulation results are not easy to be directly compared with
experimental studies, which have various bending rigidities or stiffnesses of NPs. Thus, it
remains challenge to computationally quantify how the bending rigidities or stiffnesses of
NPs will affect their internalization.
To overcome above challenge, we developed a coarse-grained molecular dynamics (CGMD)
model for elastic NPs. The energy change of elastic NPs can be precisely controlled by the
bond, area, volume and bending potentials of this CGMD model. To represent liposomes
with different rigidities 63,75 , we systematically varied the bending rigidity of elastic NPs in
CGMD simulations. In addition, we also changed the radius of elastic NPs to explore the
potential size effect. We found that the membrane wrapping of soft NPs was faster than
stiff ones at early stage, due to the NP deformation induced large contact area between
the NP and membrane. However, because of the large energy penalties induced by the NP
deformation, the membrane wrapping speed of soft NPs slows down during the late stage.
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Eventually, the soft NPs are less efficient than stiff ones during the membrane wrapping process. Through systematic CGMD simulations, we found a scaling law between the cellular
uptake efficiency and phenomenal bending rigidity of elastic NPs, which agrees reasonably
well experimental observations 63 . Our computational model provides an effective tool to
investigate the receptor-mediated endocytosis of elastic NPs with well controlled mechanical
properties. This study can also be applied to guide the design of NP-based drug carriers
with high efficacy, by utilizing their elastic properties.

2.3
2.3.1

Computational Model and Method
Model of lipid molecule

A solvent-free lipid model developed by Deserno et al. 76 is adopted in our CGMD simulation
to build the planar lipid bilayer. In this model, a lipid molecule is mimicked by three
connected beads, as given in Fig. 2.1. The bead colored in cyan represents the hydrophilic
lipid head group. The two ice-blue beads represent the hydrophobic tail group. The size of
these beads is determined by a Weeks-Chandler-Andersen (WCA) potential:

Vrep (r, b) =




4[(b/r)12 − (b/r)6 + 1 ],
4

r ≤ rc



0,

r > rc

(2.2)

where bhead,bead = bhead,tail = 0.95σ and btail,tail = σ.  and σ define the basic units of
energy and length in our CGMD simulations, respectively. An attractive interaction exists
between tail beads to reflect the hydrophobic effect of tail group:

Vcos =





−,





r < rc

2
− cos [π(r − rc )/2wc ],





0,
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rc ≤ r ≤ rc + wc
r > rc + wc

(2.3)

Ligand
NP matrix

Nanoparticle

Lipid

Receptor

Membrane
Figure 2.1: Computational models of elastic nanoparticle (NP) and membrane. The elastic NP is
represented by a spherical thin elastic shell, which consists of interactive beads (yellow) locating at
the vertex points of triangles. The yellow beads are connected by harmonic bonds. The red beads
represent ligands, which are evenly distributed on NP surface. A single lipid molecule is represented
by one head bead (colored in cyan) and two tail beads (colored in ice-blue). The receptor molecule
shares the same configuration with lipid. While the head bead receptor (colored in blue) acts as an
active site, which can specifically bind with ligands on NP surface. The snapshots for elastic NP
and membrane are rendered by Visual Molecular Dynamics (VMD) software ? .

where, rc = 21/6 σ, and wc = 1.7σ. A bead is connected with its nearest neighbor by a finite
extensible nonlinear elastic (FENE) bond:
1
2
Vbond (r) = kbond r∞
log[1 − (r/r∞ )2 ]
2
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(2.4)

where kbond = 30/σ 2 and r∞ = 1.5σ. To ensure the straightness of lipid, a harmonic spring
potential is applied between the head bead and the second tail bead:
1
Vbend = kbend (r − 4σ)2
2

(2.5)

where kbend = 10/σ 2 . Under controls of these potentials, lipid molecules can self assemble
into a planar membrane or vesicle with fluid stage bilayer structure under the temperature
of T = 1.1/kB 59,76 , where kB is the Boltzmann constant. This solvent free lipid model has
been widely used to explore the interaction between membrane and NPs 39,71,73,77–80 .

2.3.2

Model of elastic nanoparticle

Inspired by the concept to model red blood cells through CGMD simulations 81–85 , an elastic
NP in our simulations is modeled by a spherical thin shell, consisting of interactive beads.
These beads on the thin shell locate on a set of vertex points xi , i ∈ 1...Nv . These vertex
¯
points are connected by Ns edges, forming Nt triangles on the shell. The potential energy
of an elastic NP is defined as:

V (xi ) = Varea + Vvolume + Vin−plane + Vbending

(2.6)

The in-plane energy Vin−plane mimics the elastic networks, which consists of harmonic
springs:
Vin−plane = Σj∈1...Ns [ks (lj − lj0 )2 ]

(2.7)

where ks = 5/σ 2 is the spring constant, lj is the length of spring. lj0 is the equilibrium
length for individual springs.
The area potential Varea is expressed as below:

Varea =

kd (Aj − A0 )2
ka (A − AT 0 )2
+ Σj∈1...Nt
2AT 0
2A0
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(2.8)

where ka = 0.1/σ 2 and kd = 0.08/σ 2 are the global area and local area constraints
coefficients, respectively. A and AT 0 are the total area and equilibrium total area, respectively. Aj and A0 are the area of each triangle and its equilibrium area, respectively. Note
that the area potential consists of two parts, the first part is to control the total area of
elastic NP. While the second part is to constrain the local area of each triangle.
The in-plane stretching modulus K of the NP shell can be derived as 82,83

K = ka + kd +

√

3ks

(2.9)

Therefore, the in-plane stretching modulus of the elastic NP shell is K = 8.84/σ 2 , which
is around 40% of the membrane stretching modulus.
The volume potential Vvolume is expressed as:

Vvolume =

kv (V − VK0 )2
2VK0

(2.10)

where kv = 1.0/σ 3 is the volume constraint coefficient. V and VK0 are the volume of an
elastic NP and its equilibrium value, respectively.
The expression of bending potential Vbending is given by:

Vbending = Σj∈1...Ns kbend [1 − cos(θj − θj0 )]

(2.11)

where kbend is the bending constant, θj is the dihedral angle between two adjacent triangles
that share the edge j. θj0 is the equilibrium dihedral angle. The bending constant kbend is
directly related to the macroscopic bending rigidity kb of an elastic NP based on Helfrich
√
model 82 . The relation is expressed as kb = 3kbend /2. Note that the macroscopic bending
rigidity kb is used to capture the energy change only associated with curvature variation.
While the membrane bending in nano-indentation tests also results in local in-plane deformation. It indicates that the bending deformation gives rise to energy changes associated
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with both curvature variation and in-plane compressing/stretching of elastic shell. Therefore, to differentiate between macroscopic bending rigidity kb in our CGMD simulations
and bending rigidity based on nano-indentation tests, we name kb as ‘bending rigidity’ in
this study. While the one based on nano-indentation test is coined as ‘phenomenal bending
rigidity’.

2.3.3

Ligand-receptor interaction

A certain number of beads on NP surface are selected as ligands, which are evenly distributed on NP surface (cf. Fig. 2.1). Lipids in planar membrane are randomly chosen
as receptors. The receptors in planar membrane share the same configuration as lipids.
Whereas, their heads can specifically interact with ligands on NP surface. In CGMD simulations, to study the membrane wrapping process of NPs, the specific ligand-receptor
interaction is usually represented by pair-wise interactions 39,73 . Under the pair-wise interactions, ligands on NP surface could interact with multiple receptors simultaneously. This
unreasonable multi-bindings could induce local aggregation of receptors and provide extremely large binding energy during the membrane wrapping process, which is inconsistent
with the ligand-receptor binding in biology. To avoid this problem, the ligand-receptor
interaction in our CGMD simulations is modeled by a bond interaction. A ligand could
only bind with one receptor in planar membrane over the same time period. The breaking
and forming of the ligand-receptor bond is considered as a stochastic Monte Carlo (MC)
process. Particularly, a Morse potential 86 is applied to represent the ligand and receptor
bond:
Vmorse (r) = D0 [1 − exp(−α(r − r0 ))]2 − D0

(2.12)

where D0 = 30 is the potential well depth, r is the distance between ligand and receptor,
r0 = 1.0σ is the equilibrium distance and α = 0.5σ −1 determines the width of potential.
During the ligand-receptor interaction process, a ligand has a probability of 0.5 to interact
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Table 2.1: Computational models for elastic NPs in CGMD simulations. The vertex point Nv is
the same as total bead number of NPs. The bead density on NP surface is fixed around 1.0σ −2 .
The triangle edges (Ns ) are the edges connecting vertex points, forming Nt triangles. The ligand
density is fixed around 0.1σ −2 . Thus, the total number of ligands NL is given by product of ligand
density and surface area.

Radius
R = 10 σ
R = 15 σ
R = 20 σ
R = 25 σ

Nv
2552
5756
10136
16064

Ns
1278
2880
5070
8034

Nt
3828
8634
15204
24096

NL
148
333
539
927

with the receptor at a distance of 3.4 σ, at which their interactive energy is around −15.
This interactive energy increases with the bond length. If the distance between ligand and
receptor is larger than the value of 4.0 σ, the bounded ligand-receptor will break. Therefore,
the specific binding and attractive energy preference of ligand-receptor interaction could be
reflected during this MC process.

2.3.4

Simulation protocol

The bending rigidities of elastic NPs are taken as kb = 0.1, 1, 10, 100, covering four different
orders of magnitude. In addition, to explore the size effect of elastic NPs during membrane
wrapping process, four different sets of NPs with radii of r = 10, 15, 20 and 25σ are considered in our simulations, as summarized in Tab. 2.1. The bead density on NP surface is
fixed at 1.0σ −2 , which is comparable to the lipid area density in planar membrane. To build
a stress-free NP, all the equilibrium parameters, including lj0 , A0 , AT 0 , AK0 and θj0 are
taken as their initial values in NP potentials 83 . During the membrane wrapping process, the
ligand area density on NP surface is around 0.1/σ −2 , which is comparable to the ligand area
density in real biological systems 87 . A lipid bilayer with size of 200 × 200σ 2 in xy plane is
firstly fully relaxed and equilibrated. Then, about 20% of lipids in membrane are randomly
selected as receptors. Note that the total number of receptors in the membrane is 14260,
which is much larger than that of ligands on NP surfaces. Because of this large number of
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receptors and one-to-one ligand-receptor interaction, there are always free receptors near
the ligands within the contact region between NP and membrane. The simulation time
needed for receptors to diffuse towards and encounter ligands is negligible. Therefore, the
influence of receptor diffusion on ligand and receptor interaction in Eq.2.1 can be ignored.
In our simulation, the unit mass is m for all the beads and is set to be unity. The
p
time step in simulation is ∆t = 0.005τ , with τ = /(mσ 2 ). The temperature of the lipid
membrane is controlled at 1.1 /kB by a Langevin thermostat. To rule out the possible
influence of thermal fluctuation on elastic NPs, the temperature of NP is controlled at
0.001/kB . The membrane tension is maintained at 0, by controlling the xy in-plane pressure
through a modified Berendsen method 39,88 . The velocity-verlet integration algorithm is
adopt for the time integration. All simulations are performed with LAMMPS 89 . The
physical length and time corresponding to our simulations could be obtained by comparing
the membrane thickness and diffusion coefficient between computational and experimental
values. The membrane thickness in simulation is dHH = 4.55σ. Considering the typical
membrane thickness in experiments is about 4 nm 90,91 , we have the basic length unit
in simulation is about σ ≈ 0.88 nm. The lateral diffusion coefficient of lipid in CGMD
simulation is D = 3.47×10−2 σ 2 /τ . By mapping the typical diffusion coefficient of membrane
in experiments about 5µm2 /s 92 , the basic time unit in simulation is τ = 5.38 ns.
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2.4

Results and Discussion

2.4.1

A

Calibration of mechanical properties for model membrane
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Figure 2.2: (A) Out-of-plane fluctuation spectrum of a planar membrane as a function of the wave
number q. (B) Relation between membrane tension and lipid area.

The bending rigidity of the planar membrane can be extracted from the membrane fluctuation spectrum 76,93 . According to the membrane profile function h(x, y) of a planar
membrane, its Fourier transform could be expressed as:

h(q) =

l
Σn h(r) exp(iq · r)
L

(2.13)

where L is the lateral side length of the planar membrane. l is the membrane patch
length, when we divide the membrane into small patches to capture profile function h(x, y).
q=

2π
L (nx , ny )

is the wave vector. q is the norm of wave vector. Based on the equipartition

theorem, the power spectrum is given as 94,95 :

< |h(q)|2 >=

kB T
2
l [κq 4 + Σq 2 ]

(2.14)

where κ and Σ are the bending rigidity and membrane tension, respectively. Then, the
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bending rigidity of membrane can be obtained by fitting the measured fluctuation spectrum
to Eq.2.14 76,94,96,97 .
For this numerical study, we built a flat square membrane in the xy plane with 7200
lipids. The membrane is relaxed by 2 × 104 τ time steps. The membrane lateral tension is
maintained at zero. And temperature of membrane is controlled at T = 1.1/kB . Afterwards, the membrane is further relaxed with 1 × 105 τ time steps for fluctuation analysis. To
measure the out-of-plane fluctuation, the membrane is divided into a 32×32 grid. Therefore,
the patch length l = L/32. The average vertical displacement of each patch is calculated
to get h(x, y). Then we calculate the values of fluctuation spectra by 2 dimensional Fourier
transform in MATLAB. By fitting the numerical data to Eq.2.14, we can get the membrane
bending rigidity κ = 13.636kB T , which is κ = 15, if we convert the unit to . This bending
rigidity of model membrane lies within the experimental range (10 ∼ 50kB T ) 98,99 .
The stretching modules of membrane KMEM could be calculated by measuring the relation between membrane tension and its projected area as below 97,100 :

Σ = KMEM [A − A0 ]/A0

(2.15)

where A is the lipid area, which is defined as project in-plane area of each lipid molecule.
A0 is lipid area at zero surface tension. In our simulation, we measured relation between
membrane tension and lipid area, as shown in Fig. 2.2.B. In addition, the lipid area at
zero surface tension is 1.132σ 2 . Therefore, the stretching modulus of membrane is around
22/σ 2 .

2.4.2

Calibration of mechanical properties for elastic nanoparticles

Mechanical properties of elastic NPs are firstly calibrated through a nano-indentation test.
In experiments, the bottom of NPs or liposomes is usually fixed on a substrate during the
nano-indentation test 67,75,101,102 . To mimic this situation, an elastic NP is initially placed
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Figure 2.3: Nano-indentation tests on elastic nanoparticles (NPs). (A) Snapshots of elastic NPs
at different deformations (indentation depths). The radius of elastic NP is R = 10σ with bending
rigidity kb = 1. (B) Force-deformation curves for NPs with radius R = 10σ and bending rigidity
kb = 0.11, 10 and 100. (C) Relations between bending rigidity and stiffness of elastic NPs with
different radii. (D) Relation between phenomenal bending rigidity kbphen and bending rigidity kb of
elastic nanoparticles.

above a planar rigid substrate with a distance of 1.0σ (cf. Fig. 2.3.A). The thickness of
substrate is about 4σ. These substrate beads are arranged in a FCC lattice with lattice
parameter Lc = 1.0σ. In addition, six beads on the bottom of NP are fixed during the
nano-indentation process. The interaction between beads of NPs and substrate is governed
by the WCA interaction given in Eq. 2.2, with b = 0.95σ. During the nano-indentation
test, a virtual spherical indenter is placed on top of NP with distance of 2.0σ. The indenter
interacts with beads of NPs through a harmonic potential VIndent (r) = 100(r − Rindent )2 ,
where Rindent is the radius of indenter. r is the distance from the NP bead to the center of
the indenter. Similar to the nano-indentation test for liposomes in experiments, the force
experienced by indenter and NP deformation will be extracted in our simulations to analyze
the stiffness of elastic NPs. Specifically, during the simulations, the indenter moves towards
NPs with a velocity of 0.01σ/τ , which is small enough not to affect the force-deformation
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curve. The size of indenter might also affect force-deformation curve 101,102 . Therefore, three
different indenters are considered. The radii of indenters are 0.5 ,1.0 and 1.5 times of the
radius R of specific NPs. Within this range, we find that the force-deformation curves are
only slightly affected by the indenter radius Rindent . In the following, the results measured
during the nano-indentation tests with indenter radius Rindent = 1.5R will be presented.
During the nano-indentation test, the shape of elastic NP gradually changes from spherical to apple-like shape. Upon the approaching of indenter, pronounced deformation appears at the top and bottom of NPs, resulting in a high curvature in the contact regions (cf.
Fig. 2.3.A). The corresponding force-deformation curves for NPs with radius of R = 10σ are
given in Fig. 2.3.B. For NPs with bending rigidity kb < 100, the indentation force firstly
increases linearly with the NP deformation. Then, a super-linear relation follows up when
the deformation becomes larger. For NP with bending rigidity kb = 100, the indentation
force has a linear relationship during the whole nano-indentation process. The linear and
super-liner relation between force and deformation measured in our simulations are similar
to the experimental indentation tests on liposomes 101–103 . This force-deformation relationship also indicates that our NP model has similar mechanical properties of liposomes.
The slope of the force-deformation curves is defined as the stiffness of elastic NPs. In our
simulations, the stiffness of each NP is obtained by taking the slope in force-deformation
curves before the NP deformation d = 6σ. As shown in Fig. 2.3.C, the stiffness of NP
monotonically increases with its bending rigidity kb . For NPs with radius of R = 10σ,
the stiffness increases from 1.8/σ 2 under kb = 0.1 to 11/σ 2 under kb = 100. While,
it is noteworthy that under the same bending rigidity kb , the stiffness of NP decreases
with the increment of NP radius. For instance, under the bending rigidity of kb = 100,
the stiffness of NP with R = 25σ is only 64% of that of NP with R = 10σ. Therefore, the
bending rigidity and size of NP are coupled together to determine its stiffness. This relation
between stiffness and bending rigidity is in consistent with previous results that the effective
2 , where
stiffness of liposome decreases with its size increasing, following a relation of κlip /Rlip
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κlip and Rlip are the bending rigidity and radius of liposome, respectively 98,99 . The larger
NPs with different bending rigidities have smaller difference in stiffness values than that of
smaller NPs (cf. Fig. 2.3.C).
To explore the relation between bending rigidity kb and phenomenal bending rigidity
obtained by indentation test, the phenomenal bending rigidity of each NP in our simulations
is obtained by following the formula 104 : kbphen =

√

3k
√stiff Rh ,
48 1−ν 2

where kstiff is the stiffness

measured in Fig. 2.3.C. R and h are the radius and thickness of NPs, respectively. Here, we
take h = σ as the effective thickness of NP shell. ν is Poisson ratio, for which we take the
value of 0.5 as that given in experiments 63 . As illustrated in Fig. 2.3.D, the phenomenal
bending rigidity kbphen increases with the increment of bending rigidity kb .

2.4.3

Receptor-mediated membrane wrapping process of elastic nanoparticles
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Figure 2.4: Snapshots of elastic NPs (R = 10σ) during membrane wrapping process: (A) bending
rigidity of kb = 0.1 and (B) bending rigidity of kb = 100. The color scheme is the same as Fig. 2.1.

After inspecting mechanical properties of elastic NPs, we further investigate the mem-
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brane wrapping process of NPs with different bending rigidities. We start from the NPs
with radius of R = 10σ and bending rigidities of kb = 0.1 and kb = 100. As illustrated in
Fig. 2.4, both of NPs are initially placed above the membrane with a distance of 3σ. For NP
with kb = 100, it behaves like a rigid NP and barely deforms during the whole wrapping
process. The membrane wrapping process for stiff NP with kb = 100 can be divided into
sub-processes as: NP adhesion (t < 500τ ), membrane bending (500τ < t < 10000τ ), membrane necking (1000τ < t = 30000τ ) and pinching off (30000τ < t < 40000τ ). However, for
soft NP with kb = 0.1, the deformation of NP is significantly different. Due to the ligandreceptor binding, the NP adheres and spreads on membrane surface, at t = 500τ . While,
because of low bending energy cost for soft NP, it almost deforms into a hemisphere with a
flattened bottom. In this way, the soft NP could maximize its contact area with membrane
to establish more ligand-receptor binding. With more bounded ligands and receptors involved, the membrane starts to bend and wrap around the soft NP. At t = 10000τ , the soft
NP deforms into a cone-like shape with relative sharp tip and curved cap. At t = 40000τ ,
the membrane starts necking and the NP deforms into an ellipsoidal shape. After being
fully wrapped (t = 69800τ ), the soft NP returns to its original spherical shape. This spherical, hemispherical, cone-like, ellipsoidal and spherical shape transformations of soft NP are
similar to the deformations of soft vesicle observed in previous theoretical and computational studies 45,105 . More importantly, by comparing the wrapping time of these two NPs in
Fig. 2.4, we find that the NP with large bending rigidity kb = 100 is already fully wrapped
and pinched off at t = 40000τ . While the NP with small bending rigidity kb = 0.1 can not
be fully wrapped until t = 69800τ . It suggests that the soft NP is less efficient during the
membrane wrapping process, comparing to stiff ones.
To explore the potential size effect, we investigate the membrane wrapping process of
larger elastic NPs with radius of R = 25σ. The bending rigidities of NPs are still fixed
at kb = 0.1 and kb = 100, respectively. As shown in Fig. 2.5, the soft NP (kb = 0.1)
also experiences large deformations as that of smaller soft NPs. Whereas, comparing to the
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Figure 2.5: Snapshots of elastic NPs (R = 25σ) during membrane wrapping process: (A) bending
rigidity of kb = 0.1 and (B) bending rigidity of kb = 100. The color scheme is the same as Fig. 2.1.

small stiff NP (R = 10σ and kb = 100), slightly deformation can be observed for large stiff
NP (R = 25σ and kb = 100). This deformation might be induced by the smaller stiffness
of large NPs with the same bending rigidity (cf. Fig. 2.3C). It is worthy to note that these
two large NPs are almost fully wrapped and pinched off at the same time, regardless of
their bending rigidity difference.
We further compare membrane wrapping process of elastic NPs with four different bending rigidities kb = 0.1, kb = 1, kb = 10 and kb = 100. The deformations of NP and
membrane under the wrapping ratios of f = 0.4, 0.7 and 0.9 are presented in Fig. 2.6. The
wrapping ratio of NP is defined as the ratio of NP bead number within wrapped part over
total NP bead number. For NPs with radius of R = 10σ in Fig. 2.6.A, under the same
wrapping ratio, the deformations of NPs with different bending rigidities are totally different from each other. At the wrapping ratio f = 0.4, the NP with kb = 0.1 deforms into a
hemisphere with its flattened bottom adhering to the membrane. The curvature in the front
edge of the hemisphere shape is extremely large, due to the low cost of NP bending energy.
When the bending rigidity of NP increases, the contact bottoms of NPs (kb = 1, 10σ) bends
slightly, which is accompanied with the bending of membrane. In the meantime, the curvature of the front edge becomes smaller. In comparison, when the bending rigidity of NP
increases to kb = 100, NP hardly deforms at the wrapping ratio of f = 0.4. By contrast,
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Figure 2.6: Snapshots for deformation of elastic NPs with different bending rigidities. (A) Comparison of configurations for membrane wrapping of NPs with radius R = 10σ and bending rigidities
kb = 0.1, 1.0, 10, 100 under different wrapping ratios f . (B) Comparison of configurations for membrane wrapping of NPs with radius R = 25σ and bending rigidities kb = 0.1, 1.0, 10, 100 under
different wrapping ratios f . The ligands on NP surface are not shown for clarity. The membrane is
made semi-transparent to highlight deformations of NPs.

the membrane bends and wraps around the bottom of NP to maximum the contact area.
At the wrapping ratio of f = 0.7, the wrapped part of soft NPs (kb = 0.1, 1) deforms into
a cone-like shape, which has a high curvature near the tip of cone and edges of wrapped
area. The corresponding bending energy cost in these high curvature regions increase dramatically with the increment of bending rigidity. For NP with bending rigidity kb = 100,
the cone-like shape can not be observed at the wrapping ratio of f = 0.7. At the wrapping
ratio of f = 0.9, the soft NPs (kb = 0.1, 1) deform into an ellipsoid like shape, which
experiences high curvature at edges of wrapped NP surface. While these high curvature
regions disappear for NPs with larger bending rigidity (kb = 10, 100).
The deformations of NPs with larger radius R = 25σ under different wrapping ratios
are illustrated in Fig. 2.6.B. The soft NPs (kb = 0.1, 1) also experience large deformation
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during the wrapping process. However, because of the reduced difference in stiffness for
these large NPs (R = 25σ), they experience more similar deformations between soft and
stiff NPs at the same wrapping ratio. At the wrapping ratio of f = 0.4, the edges of wrapped
NP surfaces are all bent. Moreover, at f = 0.7 and f = 0.9, the difference in deformations
of NPs only exists at the connecting region between wrapped and unwrapped parts. All of
these also contribute to the similar membrane profiles.
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Figure 2.7: Evolution of membrane wrapping ratio: (A) elastic NPs with radius of R = 10σ and
(B) elastic NPs with radius of R = 25σ. The insets are the wrapping ratio near the end of membrane
wrapping process.

2.4.4

Comparison of membrane wrapping efficiency for elastic nanoparticles

We further compare membrane wrapping efficiency of elastic NPs, which is directly related
to their cellular uptake efficiency in experiments. The evolution of wrapping ratio is measured in Fig. 2.7. For NP with radius of R = 10σ in Fig.2.7.A, the whole wrapping process
could be divided into two stages: (1) the early stage for t < 3 × 103 τ ; (2) the late stage
for t > 3 × 103 τ . At the early stage, the soft NPs with small bending rigidity deform and
spread to achieve a large contact area, which accompanies with larger driving force from
ligand-receptor binding. Thus, the wrapping ratio of soft NPs is larger than that of stiff
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NPs at this early stage. However, as the increment of bounded ligands, the membrane itself
bends and wraps around NPs. The advantage of spreading for soft NPs gradually disappears. At the late stage, for soft NPs, the increment of wrapping ratio slows down when
the wrapping ratios of all NPs are around f = 0.6. Finally, the NP with bending rigidity
kb = 100 is the first one to be fully wrapped, which is followed by the NPs with rigidities
of kb = 10, 1 and 0.1 (cf. insert of Fig. 2.7.A). Therefore, the stiff NP with larger bending
rigidity is more efficient to be fully internalized.
For NPs with large radius R = 25σ in Fig 2.7.B, the wrapping ratios of soft NPs are
still larger than their stiff counterparts at the beginning of membrane wrapping process.
However, due to the similar deformation behaviors between different NPs (cf. Fig. 2.6.B),
the difference in wrapping ratio of large NPs is not as pronounced as that of small NPs
(R = 10σ) at the early stage of membrane wrapping. At the end, all of NPs are almost
fully wrapped by the membrane simultaneously. In short, we can conclude that for small
NPs (R = 10σ), the soft NP with smaller bending rigidity is less efficient than stiff NP with
All simulation data
larger bending
rigidity during the membrane wrapping process. Whereas, for large NPs
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efficiency between simulations and experiments. The experimental data is directly extracted from
Ref. 63 .

To systematically investigate the size effect of elastic NPs, we further perform simu-
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lations for NPs with radii R = 15σ and 20σ. Four different bending rigidities of kb =
0.1, 1, 10, 100 are taken for each size. The deformation and wrapping ratio evolution for
these NPs are given in Fig.A.1 and Fig.A.1 in section A.1 of supplementary materials. Moreover, to directly compare the membrane wrapping efficiency of elastic NPs, we measure the
wrapping time for elastic NPs in Fig. 2.8.A. The wrapping time for elastic NP is defined
as the total simulation time needed to reach wrapping ratio of 1.0. For NPs with radius of
R = 10σ, the wrapping time dramatically decreases from 7 × 104 τ at the bending rigidity of
kb = 0.1 to 4 × 104 τ at the bending rigidity of kb = 100. For NPs with radii of R = 15 and
, 20σ, the wrapping time also monotonically decreases with the bending rigidity increasing.
Whereas, the slope of decreasing for wrapping time becomes much smaller. When the radius of NP is about R = 25σ, the wrapping time is almost the same for all of the NPs with
different bending rigidities. Therefore, with the increment of NP radius, the influence of
bending rigidity on wrapping efficiency becomes smaller. Note that due to the increment
of ligand number in large NPs and exclusion of receptor diffusion effect, the wrapping time
for larger NPs is shorter than NPs with smaller size.
In experiments, it is impossible to directly measure the wrapping or cellular uptake time
for an individual NP. Instead, counting the number of NPs that internalized by cells during
certain time period is the way to characterize the endocytosis or cellular uptake efficiency.
Following the similar idea, we take the wrapping efficiency as the reciprocal of wrapping
time (cf. Fig.2.8.B). Takechi-Haraya et al. 63 have systematically investigated influence
of phenomenal bending rigidities of liposomes with similar radius (about 100 nm) on their
cellular uptake efficiency by HeLa cells in experiments. Taking the cellular uptake efficiency
of HSPC/PEG-DSPE liposome as a reference, they found that the relatively cellular uptake
efficiency of liposomes increases with the increment of phenomenal bending rigidity. For
comparison, we take the wrapping efficiency of stiff NPs (kb = 100) for each size as reference
to exclude the size effect. The relative wrapping efficiency in our simulations is calculated
as the ratio between wrapping efficiency of each NP over the stiffest NP (kb = 100) with
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the same size. Then we plot the relative cellular uptake efficiency from experiments and
membrane wrapping efficiency from our simulations against phenomenal bending rigidity in
Fig. 2.8.C. Interestingly, we find that our simulation results agree well with that given by
experiments. In particular, if we fit our simulation data with a linear function, the slope of
relative efficiency in simulation almost shares the same value as that of experiments. Note
that the slope of experimental data is directly extracted from the experimental study 63 . In
addition, for direct comparison, we scale the phenomenal bending rigidity of elastic NPs in
our simulations to the same range as that of liposomes in experiment. Nevertheless, it does
affect the scaling law between relative wrapping efficiency and phenomenal bending rigidity.
This agreement between simulations and experiments further validates the elastic NP model
and methodology of our simulations. Additionally, the previous theoretical work 45 also
predicted that the cellular uptake efficiency of elastic vesicles will increase as the ratio of
the liposomal bending modulus to cellular membrane bending modulus increasing, which
has been further confirmed by our CGMD simulations.

2.4.5

Free energy analysis for membrane wrapping process of elastic
nanoparticles

To further understand physical mechanisms behind the difference wrapping efficiencies for
elastic NPs, we analyze the free energy changes. During the membrane wrapping process,
the free energy change of the NP-membrane system consists of three major parts: (1)
ligand-receptor binding ∆ELR , providing the main driving force for adhesion and membrane
wrapping of NPs; (2) elastic energy change ∆ENP associated with NP deformation; and (3)
elastic energy change ∆EMEM due to membrane bending and/or stretching. Note that the
possible free energy changes induced by the membrane fluctuation and translational entropy
loss of receptors are much smaller than above energy barriers 60,106,107 . Therefore, we ignore
these entropy contributions to simplify our free energy analysis. The free energy gained by
each ligand-receptor binding is around −30. Taking the elastic NP with radius of R = 10σ
34

as an example, there are 148 ligands on the surface of NP, which could provide energy of
−4440 in total. In the following, we will mainly focus on the elastic energy changes from
NP and membrane.
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Figure 2.9: Free energy analysis during the membrane wrapping process of elastic nanoparticles.
(A) The relation between ligand-receptor binding ratio with wrapping ratio. (B) The relation between elastic energy change of NPs and wrapping ratio. (C) The relation between elastic energy
change of membrane and wrapping ratio. (D) The relation between total elastic energy barrier (from
NP and membrane) and wrapping ratio.

The ligand-receptor binding provides the driving force to overcome the energy barriers
induced by the deformation of elastic NPs and membrane. The ligand-receptor binding
ratios for NP (R = 10σ) with bending rigidities of kb = 0.1, 1, 10, and 100 are measured in
Fig. 2.9.A. Here the ligand-receptor binding ratio is defined as the ratio of bounded ligands
over the total number of ligands. Due to the evenly distribution of ligands on NP surface,
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the ligand-receptor binding ratio linearly increases with the wrapping ratio. Furthermore,
the curves for different NPs are almost the same, indicating that under the same wrapping
ratio, the driving forces of all the elastic NPs are the same. Therefore, the energy barriers
induced by the deformations of elastic NPs and membrane are the key factors determining
the final membrane wrapping efficiency of NPs.
The pronounced deformation of elastic NPs (cf. Fig. 2.6) leads to their elastic energy
change. As shown in Fig. 2.9.B, the elastic energy change of each NP is measured in our
simulations. For stiff NPs with large bending rigidities of kb = 10 and 100, their elastic
energy changes firstly increase before the wrapping ratio of f = 0.4, after which ∆ENP
reaches a plateau value around 200 and 150, respectively. For soft NPs with bending
rigidities of kb = 0.1 and 1, before the wrapping ratio f = 0.6, because of the deformation
from spherical shape to cone-like and ellipsoidal-like shapes, ∆ENP increases to 300 and
250 respectively, which is 1.5 times larger than that of stiff NPs (kb = 10, 100). While
after the wrapping ratio of f = 0.6, ∆ENP of soft NP decreases due to the transformation
from ellipsoidal-like to spherical shapes. It is also interesting to point out that after being
fully wrapped (f = 1.0), the ∆ENP of all NPs are not zero in our simulations. This
nonzero ∆ENP is mainly contributed by the elastic energy changes associated with area
and curvature. Due to the confinement of membrane at f = 1.0, the NP surface area has
been reduced, which also accompanies with the changed surface curvature.
Then we evaluate the elastic energy change of membrane ∆EMEM during the wrapping
process. The ∆EMEM directly obtained in CGMD simulations experiences a large fluctuation due to a large number of lipid molecules and thermal fluctuation. Therefore, we adopt
another strategy to estimate ∆EMEM . Particularly, we capture the configuration of membrane under certain wrapping ratio. Then, the middle plane of membrane is obtained based
on the position of each lipid molecule. After that, we try to fit the cross-sectional profile of
membrane middle plane with a polynomial function. The membrane energy is calculated
based on the rotational symmetry assumption. The degree of polynomial function under
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each wrapping ratio is obtained by considering two factors: (1) the conformity between
membrane profile at cross-section and the fitting curve; (2) the conformity between membrane elastic energy of wrapping a rigid NP in simulation and the value predicted by theory.
The membrane elastic energy of wrapping a rigid NP can be directly calculated in theory
due to the zero membrane tension. ∆EMEM = 8πκf 0 108 , where f 0 is ratio of wrapped NP
area over its total area, which is similar as the wrapping ratio in our simulation. As given
in Fig. 2.9.C, the membrane elastic energy of wrapping a rigid NP estimated by the fitting
function is almost the same with the one given in theory. After getting the degree of polynomial function at certain wrapping ratio for rigid NP, all other membrane elastic energies
are calculated by following the same fitting function at the same wrapping ratio. The error
bar in Fig. 2.9.C is calculated by averaging the membrane elastic energies under different
rotational degrees of cross-section. As illustrated in Fig. 2.9.C, due to the flattened contact
area of soft NPs, under small wrapping ratio, the ∆EMEM of soft NP is smaller than that of
stiff NP. With the increment of wrapping ratio, the wrapped part of membrane bends and
finally forms a sphere around NP. Therefore, the ∆EMEM of soft NPs gradually increases
and finally reaches the same value as NP with large bending rigidity, 8πκ.
The total energy barrier (∆ENP + ∆EMEM ) during the wrapping process is given in
Fig. 2.9.D. Before the wrapping ratio of f = 0.5, the total energy barrier ∆ENP + ∆EMEM
for soft NPs (kb = 0.1, 1) are smaller than that of stiff NPs (kb = 10, 100). This smaller
energy barrier for soft NPs might explain their faster membrane wrapping at the early stage.
However, after f > 0.5, ∆ENP + ∆EMEM for soft NP sharply increases and becomes larger
than that of stiff NP. This sharply increased energy barrier for soft NPs might be the reason
that the membrane wrapping of soft NPs slows down at the late stage (cf. Fig. 2.7.A).
The ligand-receptor binding ratio and elastic energy change of NPs with radius of R =
25σ are measured in Fig.A.3 of supplementary materials. Similarly, the ligand-receptor
binding ratios of all the NPs linearly increase with the wrapping ratio and overlap with
each other. While comparing to smaller NPs, there are more ligands on NP surface, which
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can provide much larger driving force for membrane wrapping. Moreover, due to smaller
difference in NP deformation, difference in ∆ENP for NPs becomes smaller, which further
accompanies with the similar membrane profile of different NPs. All these factors combined
together might be the reason that the wrapping efficiency of large NPs (R = 25σ) with
different bending rigidities is comparable to each other.
Compared to smaller NPs, there are more ligands on for NPs with radius of R =
25σ, which can provide much larger driving force for membrane wrapping. Moreover, the
difference in deformation for large NPs is smallar, which further accompanies with the
similar membrane profile of different NPs. All these factors combined together might be
the reason that the wrapping efficiency of large NPs (R = 25σ) with different bending
rigidities is comparable to each other.

2.5

Concluding Remarks

In summary, we explore the receptor-mediated endocytosis of elastic NPs through CGMD
simulations. The mechanical properties of elastic NPs can be precisely controlled by the
in-plane, area, volume and bending potentials. Nano-indentation tests further confirm that
the stiffness of elastic NPs is determined by their size and bending rigidity. The stiffness
of elastic NPs monotonically increases with bending rigidity kb under given size. For large
bending rigidity (kb = 100), the stiffness of elastic NPs can be dramatically reduced by
the increment of NP radius from 10σ to 25σ. Based on above elastic NP model, we further
explore the receptor-mediated endocytosis of elastic NPs. The soft NPs are found to be
able to adhere and spread on membrane surface at early stage, due to the small bending
energy cost. Thus, the soft NPs are being wrapped faster than stiff ones at the beginning
of membrane wrapping. However, due to their large elastic energy change, the membrane
wrapping of soft NPs gradually slows down. Eventually, the wrapping time for stiff NPs
is much shorter than soft ones. Through systematic CGMD simulations, we find a scaling
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law between the cellular uptake efficiency and phenomenal bending rigidity of elastic NPs,
which agrees reasonably well with experimental results on liposomes with different bending
rigidities 63 . Nevertheless, for large NPs with different bending rigidities, the wrapping
efficiency of NPs becomes comparable, due to the large ligand-receptor binding strength
and small different in their stiffness. Our simulation results provide better understandings
on the endocytic kinetics of elastic NPs, which can help us to design more efficiency NPbased drug carriers by utilizing their elastic properties.
Here we should emphasize that due to the computational cost and limit, we assume
that the receptors in cell membrane are excessive, which has been widely used in previous
CGMD simulations 39,70,73,79 . Therefore, the receptor diffusion-limited endocytosis has been
excluded from present study. To overcome this issue, a highly coarse-grained and oneparticle-thick membrane model 87 could be adopted to further explore the endocytic kinetics
of elastic NPs, by simultaneously considering the ligand-receptor binding and diffusion of
receptors to contact region between NP and membrane.
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Chapter 3

Membrane Wrapping Efficiency of
Elastic Nanoparticles during
Endocytosis: Size and Shape
Matter
3.1

Abstract

Using coarse-grained molecular dynamics simulations, we systematically investigate the
receptor-mediated endocytosis of elastic nanoparticles (NPs) with different sizes, ranging
from 25 nm to 100 nm, and shapes, including sphere-like, oblate-like and prolate-like. Simulation results provide clear evidence that the membrane wrapping efficiency of NPs during
endocytosis is a result of competition between receptor diffusion kinetics and thermodynamic driving force. The receptor diffusion kinetics refer to the kinetics of receptor recruitment that are affected by the contact edge length between the NP and membrane. The
thermodynamic driving force represents the amount of required free energy to drive NPs
into a cell. Under volume constraint of elastic NP, the soft spherical NPs are found to have
similar contact edge lengths as rigid ones and to less efficiently be fully wrapped due to
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their elastic deformation. Moreover, the difference in wrapping efficiency between soft and
rigid spherical NPs increases with their sizes, due to the increment of their elastic energy
change. Furthermore, because of its prominent large contact edge length, the oblate ellipsoid is found to be the least sensitive geometry to the variation in NP’s elasticity among the
spherical, prolate and oblate shapes during the membrane wrapping. In addition, simulation results indicate that conflicting experimental observations on the efficiency of cellular
uptake of elastic NPs could be caused by their different mechanical properties. Our simulations provide a detailed mechanistic understanding about the influence of NPs’ size, shape
and elasticity on their membrane wrapping efficiency, which serves as a rational guidance
for the design of NP-based drug carriers.

3.2

Introduction

Receptor-mediated endocytosis is not only an essential process for cells to internalize molecules,
macromolecules and viruses, but also a primary route exploited in drug delivery 23,60,61 . The
ultimate goal of targeted drug delivery is to protect drug molecules and selectively deliver
them to tumor sites by precisely controlling physicochemical properties (for example, size,
shape, elasticity and surface chemistry) of engineered nanoparticles (NPs). Although hundreds of different NPs have been proposed and synthesized in labs, few NPs have been
further used in clinical tests and approved by the US Food and Drug Administration
(FDA) 16,109,110 . Besides, most of NPs in clinical trials are spherical 111 . If we look into
the nature, viruses can smartly take advantages of their elastic and geometric properties
during their interaction with cells. For instance, human immunodeficiency virus (HIV) can
regulate its elasticity at different life stages 112 : the immature HIV that needs to bud off
the host is 14-fold stiffer than the mature HIV which becomes softer to enter the host cell.
Moreover, an abundance of viral shapes persist in nature. HIV is spherical, Ebola virus
is filamentous 113 , and tobacco mosaic virus exhibits a rod-like shape 111 . In comparison
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with the proliferation of viruses in nature, one of the important reasons leading to the gap
between the huge number of NPs in labs and their poor performance in clinical applications
is the lack of mechanistic understanding of the relation between NP properties and their
biological activities.
The complexity of the endocytosis process is one of the major reasons that limits our understanding. Endocytosis may refer to several different mechanisms including: macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated endocytosis, calthrin/caveolae independent endocytosis and phagocytosis 64,65 . Although the specific proteins and lipids
involved in these pathways are different, they share some similarities in ligand-receptor
binding and membrane wrapping. Particularly, during the receptor-mediated endocytosis
of engineered NPs, receptors in the cell membrane freely diffuse to encounter and bind ligands decorated on NPs. The formation of ligand-receptor bonds provides a driving force
for the membrane to wrap around NPs. Therefore, both receptor diffusion kinetics and
thermodynamic driving force are of great importance to determine endocytosis efficiency.
On the other hand, the inconsistency of experimental conditions in different labs could be
another reason that limits our understanding. Owing to large potential variables, such as
NP materials, geometry, mechanical properties and cell lines, it is difficult to make a direct
comparison between different experiments and draw a solid conclusion. Furthermore, these
variables might be coupled together to influence the experimental results.
Despite the amount of effort that has been devoted to understanding the effects of NP’s
geometry on the cellular uptake process, no solid conclusions have been drawn yet 111 , and
results are inconsistent between experiments. For example, Florez et al. 114 and Zhang et
al. 115 reported that ellipsoidal (including oblate-like and prolate-like) NPs were easier to
bind, but more difficult to be internalized by HeLa cells compared with spherical NPs.
However, Sharma et al. 116 found that the internalization efficiency of NPs by macrophages
is ranked as follows: oblate NPs > spherical NPs > prolate NPs. On the other hand,
computational studies based on energy minimization 117,118 and molecular dynamic (MD)
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simulations 78,119 discovered that the oblate and prolate NPs were less favorable to be fully
wrapped by the membrane than spherical NPs due to their relatively larger energy barriers.
However, by assuming the direct adhesion between the membrane and NPs during energy
minimization and much larger receptor and ligand densities in MD simulations than those
in biological systems, the true receptor diffusion kinetics cannot be reflected by these works.
Richards et al. 120 considered the receptor diffusion process in theory and found that with
their flat sides towards the membrane plane, oblate and prolate NPs are more efficiently
wrapped by the cell membrane than their spherical counterparts. In their work, orientation
of oblate and prolate NPs is fixed during the membrane wrapping process. However, this
artificial orientational constraint might induce significantly unphysical effects on the energy
barrier as well as the membrane wrapping efficiency for anisotropic NPs 38,87,121–123 .
The elasticity of NPs has recently attracted increasing attention for its significant role
during blood circulation 43,62,124 , penetration in solid tumors 63,125 and tumor cellular uptake 40,126 . Nevertheless, conflicting experimental results have been reported in terms of
the relation between cellular uptake efficiency and NPs’ elasticity. For instance, by tuning the lipid composition in liposomes, Takechi-Haray et al. 63 found that liposomes with
larger bending rigidity exhibited a higher rate of internalization by HeLa cells than those
with smaller bending rigidity. A similar relationship was obtained by Shi et al. 67,80 in
their investigation on the stiffness effect of core–shell poly(lactic-co-glycolic acid) (PLGA)lipid NPs on the internalization efficiency by HeLa cells. However, by changing the layer
numbers, Sun et al. 68 found that hyaluronic acid (HA) layer-by-layer (LBL) capsules with
smaller stiffness had a higher uptake rate by HeLa cells compared to the HA LBL capsules
with larger stiffness. Hartmann et al. 69 also found that softer polymer LBL capsules were
transported to lysosomes inside HeLa cells faster than their rigid counterparts. The physical
mechanisms behind these conflicting experimental results remain unknown. Both theoretical works based on the energy minimization 45,127 and MD simulations 70 found that softer
NPs were energetically less favorable to be fully wrapped during the membrane wrapping
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process. However, as aforementioned, the conditions used in these works cannot reflect the
receptor diffusion kinetics. When considering the receptor diffusion, Yi et al. 46 discovered
that due to the larger contact edge length, softer NPs had a larger chance to interact with
the diffusive receptors. As a result, softer NPs are more efficiently fully wrapped by the
cell membrane. Nevertheless, fundamental questions, such as how to relate free energy barriers to the membrane wrapping kinetics and how to relate theoretical understandings to
experimental results, remain to be answered.
With these gaps between experimental results and current understanding on the influence of NPs’ geometry and elasticity in mind, we developed a coarse-grained molecular dynamics (CGMD) model for elastic NPs to systematically investigate the receptor-mediated
membrane wrapping of elastic NPs with different sizes and shapes. In our simulations, ligand and receptor densities are set as comparable to experimental values. The elastic NP is
modeled by a thin elastic shell (Fig. 3.1A). Its elasticity can be systematically changed by
tuning its bending constant. The settings in our simulations allow us to capture both the
receptor diffusion kinetics and free energy changes during the membrane wrapping process.
Our simulations provide clear evidence that the efficiency of the membrane wrapping of NPs
during receptor-mediated endocytosis is a result of competition between receptor diffusion
kinetics and thermodynamic driving force. The receptor diffusion kinetics refer to the kinetics of receptor recruitment that are affected by the length of the contact edge between
the NP and cell membrane, as well as receptor diffusion flux. The thermodynamic driving
force represents the amount of required free energy to drive NPs into the cell. Under the
constraint of volume change, soft spherical NPs are found to have a similar contact edge
length as their rigid counterparts. However, soft spherical NPs need to recruit more receptors to overcome larger energy barriers induced by their elastic deformation. Therefore,
soft spherical NPs are less efficiently fully wrapped. Moreover, the difference in wrapping
efficiency between soft and rigid NPs increases with their sizes, induced by the increment of
their elastic energy change. Among spherical, oblate and prolate NPs, the oblate ellipsoid
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is the least sensitive geometry to the variation of NP elasticity during membrane wrapping
process due to its large contact edge length. More importantly, in our simulations, both
spherical and non-spherical soft NPs remain at a high energy state when fully wrapped and
cannot return to their initial stress-free state as assumed in previous theoretical studies 45,46 .
In addition, simulation results indicate that the conflicting experimental observations on the
efficiency of wrapping elastic NPs could be induced by the different mechanical properties
of NPs. The elastic NPs with and without volume constraint can lead to inefficient and
efficient cell uptake, respectively, in comparison with their rigid counterparts. Our simulations might be able to explain the conflicting experimental results and provide theoretical
guidance on the rational design of NPs for targeted drug delivery.
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Figure 3.1: Computational models of elastic nanoparticles (NPs) and the cell membrane. (A) The
elastic NP is represented by a thin elastic shell, which consists of interactive beads (yellow) located
at the vertex points of triangles. The yellow beads are connected by harmonic bonds. The red beads
represent ligands, which are evenly distributed on the NP surface. (B) A single lipid molecule is
represented by one single spherical bead (colored in cyan) in our computational model. Receptors
(colored in blue) in the membrane can specifically interact with ligands on the NP surface. (C-G)
Models of the elastic oblate, prolate, cubic, disc-like and rod-like NPs.
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3.3

Results

3.3.1

Internalization of Spherical Nanoparticles
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Figure 3.2: Membrane wrapping of rigid spherical NPs. (A) Membrane wrapping of a spherical
rigid NP of radius R = 75 nm. (B) The receptor density distribution in the cell membrane corresponding to snapshots in (A). The color bar represents receptor density in a unit of nm−2 . (C)
Wrapping ratio evolution at different NP radii. (D) Wrapping time as a function of the NP radius.
The theoretical results for spherical rigid NPs are taken from Ref. 46 . (E) Size-dependent cell uptake of rigid spherical NPs. The experimental data are taken from Ref. 30 . Each simulation point
in (D) and (E) is obtained by averaging five independent simulations. The error bar is small and
comparable to the symbol size.

Size effect in cellular uptake of spherical rigid NPs. To correctly capture the
receptor-mediated membrane wrapping process, we need to firstly confirm that our simulation model can reproduce the receptor diffusion kinetics. In terms of the receptor diffusion,
a well-known phenomenon is the effect of NP size on membrane wrapping time 31,46,128 .
When the size of NP is larger than its optimal value, the larger NPs need to recruit more
receptors to be fully wrapped, and the diffusion of receptors to the contact region between
NP and cell membrane is time consuming. Therefore, the larger NPs require more time to be
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fully wrapped if their sizes exceed the optimal value 31,129 . To investigate this size effect, we
firstly investigate the membrane wrapping process of rigid spherical NPs with radii ranging
from 25 nm to 100 nm. The ligand density on these NPs is fixed as 9.44 × 10−3 /nm2 . The
receptor density in the cell membrane is set as 6.08×10−4 /nm2 . Both of the densities in our
model are comparable to the experimental values 130,131 . Corresponding to this low receptor
density, the one-bead solvent-free lipid model 132 is adopted to provide a large membrane
patch of (875 × 875) nm2 (Fig. 3.1B). The membrane tension is controlled at zero in all
simulations. The membrane bending rigidity is 24 kB T , where kB and T are the Boltzmann
constant and temperature, respectively.
The snapshots in Fig. 3.2A show the typical membrane wrapping process of a rigid
spherical NP with radius R = 75 nm. The spherical NP is wrapped by the membrane
gradually from the bottom to top of the NP, accompanied by the bending deformation of
the membrane. During this process, we inspect the receptor distribution evolution as shown
in Fig. 3.2B. The receptors gradually aggregate in the contact region between the NP and
cell membrane. Importantly, as assumed in the theory 31,46 , there exists a receptor depletion
region in the near vicinity of the binding region, which is associated with the receptor
diffusion flux. The membrane wrapping process and receptor distribution evolution for
other sizes of rigid spherical NP are similar. The evolution of the wrapping ratio f for each
spherical NP is recorded in Fig. 3.2C. Here f is defined as the ratio of the wrapped area to
the total NP surface area. Our simulations indicate that R = 30 nm could be the optimum
NP size with the smallest wrapping time tw (defined as the time required for a successful
NP internalization). The wrapping time for NPs of R = 75 nm and 100 nm is much larger
than that at R = 30 nm. On the other hand, due to the limited ligands on the surface of
the NP of R = 25 nm, the driving force provided by ligand-receptor binding is not large
enough to overcome the energy barrier induced by the membrane bending deformation 60 .
Thus, the NP of R = 25 nm is trapped in the membrane and cannot be fully wrapped
(Fig.?? in supplementary materials).
47

To compare our simulations with theoretical predictions, we normalize the wrapping
time in both simulations and theory by the wrapping time of rigid NP with R = 100 nm in
simulations and theory, respectively. As shown in Fig. 3.2D, our simulation results are in
excellent agreement with theoretical predictions provided by Yi and Gao 46 . The choice of
the reference NP size does not change the trend in these curves. Experimentally, Chithrani
et al. 30 studied the uptake of transferrin-coated gold NPs by HeLa cells. They found that
the number of NPs internalized per cell is non-monotonically dependent on the NP size. To
correlate our simulation results with this experiment, we try to calculate the number Nc of
NPs internalized by a cell. The Nc can be estimated as 133 Nc = ωNg ∆tob , where ω = 1/tw
is the wrapping efficiency (wrapping rate), defined as the reciprocal of the wrapping time tw ;
Ng the number of NPs adjacent to the cell; ∆tob the observation time. To compare with the
above experiments, we choose a value of Ng ∆tob such that the maximum uptake number Nc
estimated from simulations has the same value as the one in the experiments. The results are
given in Fig. 3.2E, where the effective size of NP Rexp in the experiments is shifted to Rexp +
9.3 to account for the size of transferrin receptor’s ectodomain 133,134 . Our simulation results
again agree well with experimental results. The deviation between the simulations and
experiments at Rexp = 20 nm is due to the cooperative cell uptake observed in experiments
for NPs of such a small size 30 . Our computational model can reproduce and confirm the
theoretical prediction 31 and experimental observation 30 on the size-dependent cell uptake of
spherical rigid NPs. Moreover, the membrane wrapping process in our simulations is highly
related to the internalization efficiency in experiments. In other words, our computational
model can correctly capture the receptor diffusion kinetics during endocytosis, which has
been ignored due to the ultra-high density of receptors in previous simulations 73,135–137 .
Inefficient cellular uptake of spherical elastic NPs. With the above model at
hand, we further explore the influence of elasticity on the membrane wrapping of spherical
NPs. Corresponding to the rigid case in Fig. 3.2A, the wrapping process of a soft spherical
NP with R = 75 nm and bending constant kbend = 0.1 is studied first. Here kbend can
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Figure 3.3: Membrane wrapping of soft spherical NPs. (A) Membrane wrapping of soft spherical
NP with the bending constant kbend = 0.1 and radius R = 75 nm. (B) Wrapping ratio evolution
for rigid (kbend = ∞) and soft (kbend = 0.1) spherical NPs with identical radii R = 75 nm. (C)
Wrapping time for rigid and soft spherical NPs of different radii.

be directly mapped to the macroscopic bending rigidity of a soft NP 82–84 . As shown in
Fig. 3.3A, the soft NP deforms during the wrapping process. The mean curvature at
the contact edge between the wrapped and unwrapped regions is significantly increased
(see Fig.A.7 in supplementary materials). As the wrapping ratio increases, the contact
edge moves gradually to the top of the NP, and eventually the soft NP is fully wrapped
at the time t = 10875 µs. As shown in Fig. 3.3B, the soft NP is much slower to be
fully wrapped than the rigid NP. To further explore the interplay between the size and
elasticity of spherical NPs, we systematically investigate soft NPs (kbend = 0.1) of different
radii and compare them with rigid NPs in Fig. 3.3C. There are two key phenomena we
can observe from this comparison. First, the minimum size of spherical NPs that can be
fully wrapped by the cell membrane is increased to R = 30 nm for soft NPs compared
to R = 27.5 nm for rigid spherical NPs (cf. Fig.A.5.C in supplementary materials). This
shift of limited size boundary is in agreement with the theoretical prediction 46 due to an
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additional energy barrier induced by the deformation of soft NP. Second, all soft NPs are
less efficiently wrapped than rigid ones, and the difference between them increases as the
NP radius increases. It is noteworthy that this trend in our simulations seems to conflict
with the theory 46 , where the soft NPs are predicted to be more efficient. The reason for
this will be discussed in the following parts.
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Figure 3.4: Free energy analysis of membrane wrapping process for spherical NPs. Comparison of
(A) contact radius, (B) NP elastic energy change, (C) membrane energy change, (D) energy barrier
change and (E) bound receptor numbers between rigid and soft (kbend = 0.1) spherical NPs at
R = 75 nm. (F) Comparison of the energy barrier change between soft NPs with different radii.

Large energy barrier leads to inefficient wrapping of elastic NPs. As we
described above, the receptor-mediated membrane wrapping process can be divided into two
sub-steps: (1) the receptors diffuse to contact region between the NP and cell membrane and
encounter ligands on the NP surface; (2) the binding of ligands and receptors to overcome the
energy barrier induced by the membrane wrapping. The first step is a pure diffusion limited
process that is related to the receptor recruiting speed. This recruiting speed is determined
by the receptor diffusion flux and the length of the contact edge between the membrane
and NP. The second step is a thermodynamic process that is driven by ligand-receptor
binding. The number of receptors needed to achieve a certain wrapping ratio is determined
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by the binding strength of individual ligand-receptor bonds and the corresponding free
energy barriers. The wrapping time tw depends on both the receptor recruiting speed and
the number of receptors required to form ligand-receptor bonds. Therefore, the wrapping
efficiency (or wrapping rate) is the result of competition between the kinetics of receptor
recruitment and the amount of required driving force. In this part, we will analyze the
difference between rigid and soft spherical NPs in these two aspects. In our simulations, the
receptor diffusion flux is the same for all cases with fixed ligand density on the NP surface
and initial receptor density in the membrane 46,122 . To estimate the contact edge length,
we calculate the minimum contact circular radius in the membrane plane that can enclose
the interface between wrapped and unwrapped regions of a NP. As shown in Fig. 3.4A, the
contact radius RC of a rigid spherical NP of radius R0 = 75 nm firstly increases to its radius
value and then decreases to zero as the wrapping ratio increases. Moreover, the contact
radius of the soft NP is almost the same as that of the rigid NP at each wrapping ratio.
Therefore, the receptor recruiting speed should not be the reason for the slower membrane
wrapping progress of soft NPs.
The average individual ligand-receptor binding strength in our simulations is around 10.
The increment of the wrapping ratio f is associated with overcoming of the corresponding
energy barriers induced by the interplay among the NP, membrane and receptors. The
total energy barrier ∆EBarrier during the membrane wrapping process is composed of three
parts: (1) NP’s elastic energy change ∆ENP ; (2) membrane energy change ∆EMem ; (3)
the entropy loss of receptors. Compared to the first two parts, the receptor entropy loss is
negligible 60,106,107 .
The elastic energy change of a rigid NP is zero at all wrapping stages. As we demonstrated in our previous work 136 , the elastic energy change of a soft NP ∆ENP is induced by
the variations in its area, volume and curvature. These contributions to the energy change
can be recorded in our computational model. As shown in Fig. 3.4B, ∆ENP of a soft NP
increases with the increment of the wrapping ratio until f = 0.8, after which it decreases
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slightly, ending with a value around 50 at f = 1. Note that the elastic energy change of a
soft NP is not zero when fully wrapped. Particularly, as shown in Fig.A.8 of supplementary
materials, the surface area of a soft NP varies during the membrane wrapping process, and
its volume is slightly decreasing. Additionally, the mean curvature distribution of the soft
NP at f = 1 is not uniform as the initial stage as shown in Fig.A.7 of supplementary materials. These results suggest that the soft NP can not return to its initial stress-free state at
the full wrapping stage f = 1. The deformed non-spherical shape of soft NPs is maintained
and stable till the end of our simulations, once they are enclosed by the cell membrane. We
would like to emphasize that this non-zero energy state for fully wrapped soft spherical NPs
is quite different from the stress-free state assumed in the previous theoretical works 45,46 .
This non-zero energy state can be further understood by comparing to a vesicle adhering
on a planar cell membrane. The in-plane stress in the contact region between vesicle and
membrane is compressive 138,139 . It suggests that the wrapped region of a soft NP should
be always under compression before fully wrapped. Thus, it is reasonable that the soft NP
is under compression and stays at a non-zero energy state after being fully wrapped, which
can be stabilized by the ligand-receptor binding.
For a membrane at zero tension, its bending energy far away from the contact region
with the NP is zero, following the minimal catenoid shape surface 87,140,141 . Therefore, the
membrane energy change in our simulations is only contributed to by the bending energy
increment. This membrane bending calculation is non-trivial in simulations. Due to the
large degrees of freedom and thermal fluctuation, the membrane energy directly recorded in
the simulations has large variations and is not useful. Therefore, third party methods, such
as membrane configuration estimation through theory 142–144 and a force-directed free energy
calculation 71,78 , are usually applied. However, these methods might not be effective for soft
NPs as it is difficult to obtain a soft NP in theoretical analysis that shares the exact same
mechanical properties as the one in simulations. On the other hand, the guiding force during
free energy calculation might cause additional unrelated deformations for soft NPs. Here
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we use another approach to compute the membrane bending energy. The membrane in the
contact region adheres to the NP surface, and they share the same curvature, as we show in
the snapshots (Figs. 3.2 and 3.3). Therefore, we can utilize the configuration in the wrapped
part of a NP to calculate the corresponding membrane bending energy 46,87 , particularly,
based on the triangulation information 83,84 . As shown in Fig. 3.4C, this method can
correctly capture the membrane bending energy. The membrane bending energy ∆EMem
for the rigid NP linearly increases with the wrapping ratio f and reaches a value 8πκ at
the fully wrapped stage (f = 1), in accord with theoretical prediction 108 . Here κ is the
membrane bending modulus. In comparison, the ∆EMem for the soft NP is also linearly
proportional to f , but ends with a value around 17πκ as the soft NP at f = 1 stays at a
non-perfect spherical shape. Please refer to the supplementary materials for Chapter 3 for
details about the membrane energy calculation.
The total energy barriers ∆EBarrier of rigid and soft NPs are given in Fig. 3.4D with
∆EBarrier of soft NP much larger than that of rigid NP at each f . Therefore, the soft
NP needs to recruit more receptors to overcome a larger energy barrier at each stage after
f = 0.4 (Fig. 3.3B). Due to the similar receptor recruiting speed as we mentioned above,
the soft NP needs to wait longer than the rigid NP to encounter and bind extra receptors.
That is also the reason that the soft NP is slower to be fully wrapped (cf. Fig.3.3B). We
further calculate energy barriers of soft NPs with different sizes in Fig.3.4F. It is found
that the energy barrier of a soft NP is increasing with the increment of the NP size. In
comparison, the energy barriers of rigid NPs with different sizes are the same. This can
explain how the wrapping time difference between rigid and soft NPs is increasing with
their radii, as shown in Fig. 3.3C. In summary because of their similar contact edge length
and larger energy barriers in membrane wrapping, soft spherical NPs require more time to
be fully wrapped than their rigid counterparts.
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Figure 3.5: Membrane wrapping of rigid oblate and prolate NPs. (A-B) Snapshots of membrane
wrapping process of rigid oblate and prolate NPs. (C-D) Wrapping ratio and orientation angle
evolution for rigid oblate and prolate NPs. (E) Functions of orientation angle against the wrapping
ratio for rigid oblate and prolate NPs.

3.3.2

Internalization of Nonspherical Nanoparticles

Large contact edge length results in fast internalization of oblate rigid NPs.
We proceed to investigate the membrane wrapping process of rigid oblate and prolate NPs.
Their initial configurations are generated based on the function (x2 + y 2 )/a2 + (z/b)2 = 1.
The surface areas of both oblate and prolate NPs are controlled at the same value as
the spherical NP of radius R = 75 nm. The aspect ratios b/a are set as 1/3 and 3 for
oblate and prolate NPs, respectively. Initially, the oblate and prolate NPs are placed above
the membrane with their minor and major axes perpendicular to the membrane plane,
respectively. Note that the oblate and prolate NPs are symmetric in the membrane plane.
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We call this entry angle as the tip-first entry mode for the oblate and prolate NPs.
As shown in Fig.3.5, the membrane wrapping process for the rigid oblate NP can be
divided into three different stages. In the first stage (t < 500 µs), due to the large contact
area, half of the oblate NP is immediately wrapped by the membrane, and the wrapping
ratio quickly increases to f = 0.4 (Fig. 3.5C). In the second stage (500 µs < t < 2000 µs),
f increases slowly because of the highly curved edge of the oblate NP, which simultaneously
rotates slowly to adjust its orientation with respect to the membrane (Fig. 3.5D). In the
third stage (t > 2000 µs), one side of the oblate NP edge starts to be wrapped by the
membrane. At the same time, the wrapping ratio and orientation angle begin to increase at
a faster rate than in the second stage. The oblate NP is fully wrapped at t = 7250 µs (Fig.
3.5A). Compared to the oblate NP, the prolate NP is gradually wrapped by the membrane
(Fig. 3.5B) with a slower wrapping rate than that of the oblate NP during the entire
wrapping process (Fig. 3.5C). This result in our simulations seems to conflict with the theory
that the prolate NP is more energetically favorable to be wrapped than the oblate NP with
reciprocal aspect ratio 117 . Additionally, the prolate NP just slightly changes its orientation
before t = 6000 µs (f = 0.8) (cf. Fig.3.5D), and is almost perpendicular to the membrane
during the whole process. In Fig.3.5E, we obtain the function of orientation angle against
wrapping ratio for both oblate and prolate NPs. For the oblate NP, its orientation angle
would not change until f = 0.4, after which the orientation angle increases dramatically
to 25◦ . This orientation variation feature of wrapping oblate NP in our simulations is
consistent with the theory that can capture the orientation kinetics of ellipsoidal NPs 122 .
For the prolate NP, its small orientation variation in our simulations is consistent with the
theory that at zero membrane tension, one-dimensional NPs prefer a perpendicular entry
angle 39,122,140 .
A key question we need to answer for the rigid oblate and prolate NP with reciprocal
aspect ratios is why the energetically unfavorable oblate NP is more efficiently wrapped
by the membrane than the prolate NP. We further analyze the corresponding contact edge
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Figure 3.6: Free energy analysis for the membrane wrapping of rigid oblate and prolate NPs.
Comparison of (A) contact edge length, (B) membrane energy barrier, and (C) bound receptor
number between rigid oblate and prolate NPs. The dashed curves in (B) are obtained from the
membrane energy by wrapping the same NPs but at a fixed entry angle in theory. See Fig.A.9 in
supplementary materials for more details.

length and energy barrier as we did for the spherical NPs. For easier comparison, the
contact radii of the oblate and prolate NPs are divided by the corresponding spherical radius
R0 = 75 nm. As shown in Fig. 3.6A, the contact radius of the oblate NP is significantly
larger than that of the prolate NP between f = 0.1 and 0.9. This means that the oblate NP
has a much larger chance to encounter receptors, which provides a higher receptor recruiting
speed. On the other hand, as predicted in the theory 117 , the oblate NP needs to overcome
a larger membrane energy barrier than the prolate NP after the wrapping ratio of f = 0.5.
Correspondingly, the oblate NP needs to recruit more receptors as f > 0.5 (Fig. 3.6C).
As a conclusion, though the oblate NP needs to overcome a larger energy barrier than the
prolate NP during the membrane wrapping process, the oblate NP is still more efficiently
fully wrapped as it has a significantly larger contact edge length. In addition, we compare
the membrane energy barrier with the one having fixed entry angle in theory. As shown in
Fig.3.6B, the orientation adjustment of the oblate NP in simulations after f = 0.4 is driven
by the lower membrane energy barrier. While the membrane energy barrier of the prolate
NP is almost the same as the one in theory with a fixed angle. Please refer to Fig.A.9 in
supplementary materials for details of theoretical calculation.
Interplay between geometry and elasticity in cellular uptake of nonspherical
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Figure 3.7: Membrane wrapping of oblate and prolate soft NPs with the bending constant kbend =
3. Membrane wrapping process of an oblate (A) and a prolate (B) soft NP. (C-E) Comparisons of the
wrapping ratio, contact radius and energy barrier for rigid and soft oblate NPs. (F-H) Comparisons
of the wrapping ratio, contact radius and energy barrier for rigid and soft prolate NPs.

elastic NPs. We further investigate the wrapping of soft oblate and prolate NPs with the
same initial configurations as rigid ones. The bending constant for both oblate and prolate
NPs in this part is kbend = 3. Both soft oblate and prolate NPs follow the similar wrapping
pathways as their rigid counterparts. As shown in Fig. 3.7A, the soft oblate NP deforms
significantly near the contact edge between the NP and membrane. Specifically, its mean
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curvature distribution in Fig.A.10 of supplementary materials indicates that the contact
edge has a large mean curvature value. Moreover, the mean curvature of the highly curved
edges of soft NPs firstly increases and then decreases until fully wrapped. As shown in Fig.
3.7 C-E for the comparison between soft and rigid oblate NPs, it is interesting to find that
their wrapping ratio evolutions are almost the same before f = 0.9. After that, the soft
oblate NP undergoes a slower wrapping. Additionally, the contact radii of soft and rigid
NPs are similar at all wrapping ratios (Fig. 3.7D). However, the energy barrier of the soft
oblate NP is much larger than that of the rigid NP (Fig. 3.7E). Particularly, accompanying
with the deformation, its energy barrier quickly increases to 275 after f = 0.4. For the soft
prolate NP, it also deforms and has a large mean curvature at the contact edge (Fig. 3.7B
and Fig. A.10.B of supplementary materials ). As shown in Fig. 3.7F, the wrapping of the
soft prolate NP is slower than that of the rigid NP after f = 0.4. Similar to the oblate NPs,
the evolution of the contact radii for soft and rigid prolate NPs are almost the same (Fig.
3.7G). The soft prolate NP needs to overcome a larger energy barrier during wrapping than
the rigid one, and this energy barrier dramatically increases after f = 0.8, reaching 300 at
the end. Moreover, the energy barriers values in the wrapping process of soft prolate and
oblate NPs are on the same order (around 300). Important to note is that the non-zero
energy states of fully wrapped oblate and prolate NPs suggest that soft nonspherical NPs
also cannot return to their initial stress-free states. It is also interesting to see that the
deformation of soft NPs promotes the orientation change for both oblate and prolate NPs
(Fig.A.11 of supplementary materials). Please refer to the supplementary materials for
details about mean curvature and orientation change during membrane wrapping process
of oblate and prolate NPs.
One question we have is why the energy barrier increment during the wrapping of the
soft oblate NP is not reflected on its wrapping efficiency before f = 0.9. We speculate
that it might be related to the difference in the contact edge lengths between oblate and
prolate NPs. For the oblate NPs, between f = 0.4 and 0.9, the minimum contact radius
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RC /R0 is 0.8. The receptor recruiting speed of oblate NP is large enough to recruit extra
receptors to overcome the corresponding energy barrier increment before f = 0.9. After
f = 0.9, the contact radius quickly decreases to 0. Therefore, the membrane wrapping is
sensitive to the energy barrier increment. The soft oblate NP needs to wait a longer time
to recruit extra receptors, and the evolution of its wrapping ratio becomes slower than the
rigid one. In comparison, for the prolate NPs, the maximum contact radius RC /R0 during
the entire membrane wrapping process is 0.8. Given the similar energy barrier increment as
soft oblate NPs, the energy barrier dominates the membrane wrapping process for prolate
NPs. Thus, the prolate NP is more sensitive to this energy barrier increment during the
entire wrapping process. In short, the energy barrier increment of soft NPs has different
effects on the wrapping process of oblate and prolate NPs. Owing to the large contact
edge length of oblate NPs, their wrapping efficiency is not sensitive to the increment of
energy barrier in the first wrapping stage, while the wrapping of soft oblate NP only slows
down in the late stage. In comparison, for the prolate NPs, because of their much smaller
contact edge length, the wrapping process of soft prolate NPs would be more sensitive to
the increment of the energy barrier during the whole process.
To understand the interplay between the geometry and elasticity of NPs on their membrane wrapping efficiency, we systematically study spherical, oblate and prolate NPs with
a series of bending constants, ranging from kbend = 1 to kbend = 200. The wrapping time
of these NPs is plotted against the bending constant kbend for different NP geometries in
Fig.3.8. Here the tip-first entry mode is adopted for non-spherical NPs. There are three
interesting phenomena we can learn from Fig.3.8: (1) under the same bending constant, NP
geometry plays a significant role. The membrane wrapping efficiency for different geometries is ranked as: oblate NPs > spherical NPs > prolate NPs; (2) under the same geometry,
the wrapping time of NPs decreases with the bending constant increases. Furthermore, the
wrapping time follows a scaling law against the bending constant. Interestingly, a similar
scaling relation between the bending rigidity and cellular uptake efficiency is found for li59
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Figure 3.8: Wrapping time as a function of bending constant for oblate, prolate and spherical
NPs.

posomes in experiments 63 ; (3) for the scaling relation, the slope for oblate NPs is much
smaller than that for spherical and prolate NPs. This indicates that the oblate shape is
the least sensitive geometry to the bending constant change. In correspondence with these
interesting results, the analyses about the contact edge length and energy barrier are given
in Fig. A.12 of supplementary materials. Under the same bending constant, the oblate
NPs have the largest contact edge lengths, followed by spherical and prolate NPs. This
large contact edge length for oblate NP makes oblate shape the most efficient geometry
during membrane wrapping, as being observed in experiments 145 . Furthermore, under the
same geometry, NPs with different bending constants have similar contact edge lengths.
The energy barrier of NPs with the same geometry decreases as bending constant increases,
leading to the scaling law between the bending constant and membrane wrapping time.
Moreover, because of the significantly large contact edge length, soft oblate NPs have a
high receptor recruiting speed to bind extra receptors for overcoming the increased energy
barrier. Therefore, the oblate NPs are less sensitive to the variation of the bending constant.
For non-spherical NPs, due to their anisotropic properties, the initial entry angle of both
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oblate and prolate NPs affects their contact edge lengths and energy barriers 87,118,121,123 .
To explore the influence of entry angle, we further study the membrane wrapping process
of oblate and prolate NPs with their minor and major axes parallel to the membrane plane,
respectively. We call this entry scenario as the side-first entry mode. Interestingly, with
the side-first entry mode, the wrapping efficiency of NPs with the same bending constant
is ranked as: prolate > spherical > oblate. This ranking sequence is totally reversed compared to the non-spherical NPs with tip-first entry mode. Additionally, we investigate the
membrane wrapping process of soft disc-like, rod-like and cubic NPs, due to their wide
applications. 146–148 It is interesting to find that NPs of the same geometric category (onedimensional shape: rod-like and prolate NPs; two-dimensional shape: disc-like and oblate
NPs; three-dimensional shape: cubic and spherical NPs) share a similar membrane wrapping pathway and wrapping efficiency. Please refer to the supplementary materials for the
effect of the entry angle and other non-spherical NPs.

3.3.3

Discussion

Larger receptor diffusion flux leads to more efficient membrane wrapping. Our
simulation results provide clear evidence that the membrane wrapping efficiency (or wrapping rate) is a result of competition between the receptor diffusion kinetics and thermodynamic driving force. The receptor diffusion kinetics, referring to the kinetics of recruitment
of receptors to the binding site, are related to the receptor diffusion flux and contact edge
length. The thermodynamic driving force, representing the amount of free energy required
to drive the NPs into the cell, is determined by energy barriers during membrane wrapping
of NPs. The receptor diffusion flux and individual ligand-receptor binding strength are
kept the same for all the simulations above. To further confirm our conclusion, we have
performed additional simulations to understand the influence of receptor diffusion flux on
the membrane wrapping efficiency of a rigid spherical NP with radius R = 75 nm. The
receptor diffusion flux is determined by the receptor density gradient according to the Fick’s
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first law. Note that the receptor density gradient is affected by the receptor density, due
to the existence of the receptor depletion region in the near vicinity of the contact region
between the NP and membrane. Here we have systematically varied the receptor densities in the cell membrane. With the same spherical rigid NPs, the energy barrier at each
wrapping ratio should be the same for all cases. As given in Fig.A.16 in supplementary materials, at the same wrapping ratio of f = 0.5 and identical contact edge length, the slope
of unbounded receptor density near the NP is dramatically increasing with the increment
of the receptor density in the cell membrane. The corresponding receptor diffusion flux is
almost linearly dependent on the receptor density. Therefore, the rigid NP should be more
quickly wrapped by the membrane with a higher receptor density, which is observed in our
simulations (Fig. A.16.B in supplementary materials). The relation between the wrapping
time and membrane receptor density is given in Fig. A.16.D in supplementary materials.
As the receptor density increases, the wrapping time dramatically decreases if the receptor
density is smaller than 24.32 × 10−4 /nm2 , after which it levels off. The saturation of the
wrapping time should be induced by the limited available unbounded ligands on the NP
surface. At these high receptor densities, the influence of receptor diffusion kinetics on the
wrapping efficiency has been eliminated, leading to a fast membrane wrapping of the rigid
NP.
Different mechanical properties lead to conflicting results on efficiency of
elastic NPs. In experiments, different elastic NPs have been synthesized, including liposomes, hybrid polymer-lipid NPs, layer-by-layer (LBL) capsules, and hydrogel NPs 40 .
Modulation of their elasticity can be achieved by changing the phospholipid components
(liposomes) 63,101 , the materials of core (hybrid polymer-lipid NPs) 63 , the layer number or
thickness (LBL capsules) 68,149 and the cross-linking density (hydrogel NPs) 43,44 . Conflicting
results have been reported about the relation between cell internalization rate and particle
elasticity. As shown in Table.3.1, we summarize experimental results about the influence
of NPs’ elasticity on their uptake by cancer cells. The softer lipid based NPs show lower
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internalization rates compared to their rigid counterparts. But the softer LBL capsules are
more efficiently internalized. The hydrogel NPs give controversial results. Although the different experimental conditions might contribute to the conflicting results, our simulations
might also provide a basic understanding behind these results. As we mentioned before,
the membrane wrapping efficiency is determined by both contact edge length and energy
barrier (or thermodynamic driving force). The softer NPs are proven to need to overcome a
larger energy barrier because of their deformation in both theories and simulations. But the
contact edge length difference between soft and rigid NPs is determined by their mechanical
properties. Specifically, in theory, by removing the volume constraint and fixing the total
area, the contact edge length of soft spherical NP in Yi and Gao’s work is 20% larger than
that of the rigid counterpart 46 . However, in our simulations, both the total volume and area
of elastic NPs are controlled by the potential functions. Thus, the soft spherical NP has a
similar contact edge as their rigid counterpart. Because of this difference, the soft NPs in
Yi and Gao’s work are faster than the rigid NPs to be fully wrapped 46 . While, in our simulations, soft NPs are less efficient. In experiments, the LBL capsules are hollow particles
after removing the template. These particles can easily change their volumes during cellular
uptake, leading to large contact lengths and high efficiencies of internalization 68,149 . On the
other hand, for the lipid based NPs, due to the hydrophobicity of lipid bilayer, the interior
water molecules are difficult to penetrate through the bilayer. Therefore, lipid based NPs
can be considered as incompressible with constant volume, similar to the elastic NPs model
in present study, which have lower cellular uptake efficiency for softer NPs 63,101 . Therefore,
our works provide an insightful explanation for these conflicting experimental results.
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Table 3.1: Experimental results about soft and rigid nanoparticles during cancer cell uptake.
Particle types

Shape

Size

Mechanical properties

Cell types

Refs

sphere

200 nm

Bulk modulus:

41T cancer

43

HeLa

67,80

HeLa

63

HeLa

68

HeLa

69

SUM159 cancer

150

HepG2

44

More efficient rigid NPs
PEG* hygrogel

10 kPa–3000 kPa
PLGA* -lipid

sphere

100/40 nm

Young’s modulus:
800 MPa–1200 MPa

PEGylated liposome

sphere

100 nm

Bending rigidity:
(2–14)×10−19 J

More efficient soft NPs
HA* LbL capsule

sphere

2400 nm

Stiffness:
7.5 N/m–28 N/m

DextS/PLArg*

and

sphere

2500 nm

PSS/PAH* LbL capsule
TA/PVPON LbL capsule

0.25 N/m–10 N/m
sphere

2000 nm

sphere

Young’s modulus:
4.3 MPa–104 MPa

/cube
HEMA hygrogel

Stiffness:

1100 nm

Bulk modulus:
15 kPa–156 kPa

* Abbreviations:

PEG, poly-(ethylene glycol); HA, Hyaluronic acid; DextS, dextran sulfatesodium salt; PLArg,

poly-l-arginine hydrochloride; PSS, poly(sodium 4-styrenesulfonate); PHA, poly(allylaminehydrochloride);
TA/PVPON, tannic acid/poly(N-vinylpyrrolidone); HEMA, poly(2-hydroxyethyl methacrylate).

3.4

Conclusions

In this work, we have systematically investigated the receptor-mediated membrane wrapping process of elastic NPs with different sizes and shapes using CGMD simulations. The
elasticity of NPs can be well controlled by the bending constant in our model. The membrane wrapping efficiency of elastic NPs is found to be governed by the receptor recruitment
speed and free energy barriers. The receptor recruitment speed is determined by the receptor diffusion flux and contact edge length between the NP and membrane. The free energy
barriers are mainly determined by the free energy changes of NPs and membrane. For spherical NPs, under the control of volume constraint, the contact edge lengths of soft and rigid
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NPs are found to be similar. Comparatively, soft spherical NPs have significantly higher
energy barriers due to their ability to deform. Due to the increased energy barriers, soft
spherical NPs need to recruit more receptors to provide the driving force for the membrane
wrapping. Therefore, they are less efficiently fully wrapped than rigid ones. Furthermore,
the free energy barrier for membrane wrapping of soft spherical NPs is increasing with their
size under the same bending constant. As a result, the difference in the wrapping efficiency
between soft and rigid spherical NPs increases with their size.
For non-spherical oblate and prolate NPs, the rigid oblate NP needs to overcome a larger
energy barrier compared to the rigid prolate NP. However, the oblate NP has a significantly
large contact edge length which enables it to be fully wrapped faster than the prolate NP.
More importantly, due to the prominent large contact edge length, the wrapping efficiency
of the soft oblate NP is the least sensitive to the bending constant variation among the
geometries of spherical, prolate and oblate shapes. Under the same bending constant, the
wrapping efficiency is ranked as oblate NP > spherical NP > prolate NP for the tip-first
entry mode. However, this ranking sequence is totally reversed when the entry angle of
oblate and prolate NPs is changed to the side-first entry mode. It is worthy to note that
according to our simulations, both the soft spherical and non-spherical NPs remain at a
high energy state when fully wrapped and cannot return to their initial stress-free state.
These simulations provide a way to understand the conflicting experimental results in terms
of the influence of NP geometry and elasticity on their endocytosis efficiency. This work
might provide a theoretical guidance for the NP design in targeted drug delivery.
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3.5
3.5.1

Model and Methods
Lipid Membrane and Elastic Nanoparticles

In the one-bead lipid model, each lipid molecule is represented by a single spherical bead
containing both the translational and rotational degrees of freedom. The interactive force
between beads depends on their relative distance and orientation. This one-bead lipid
model can correctly reproduce both dynamic and mechanical properties of the lipid membrane 96,132,151 . The membrane temperature is set to T = 0.18/kB during the membrane
wrapping process, at which the membrane maintains its fluid state 132 . In the elastic NP
model, the beads on the NP shell locate on a set of evenly distributed vertex points xi ,
¯
i ∈ 1, ..., Nv . These vertex points are connected by Ns edges, forming Nt triangles on the
shell. The elasticity of NP can be controlled by the area Varea , volume Vvolume , in-plane
Vin−plane and bending Vbending potentials. The total potential energy of an elastic NP is
defined as
V (xi ) = Varea + Vvolume + Vin−plane + Vbending .
¯
In our simulations, the elasticity of NP is controlled by tuning the bending constant kbend
in the potential Vbending . The bending constant kbend is directly related to the macroscopic
bending rigidity of an elastic NP based on Helfrich model 82,83 . For instance, the macroscopic
√
bending rigidity κb of spherical elastic NPs can be expressed as 82 κb = 3kbend /2. Therefore, with the bending constant kbend = 0.1–200, their corresponding macroscopic bending
rigidities are around κb ≈ 0.48 kB T –956 kB T , which covers the range of bending rigidities
for liquid disordered state liposome and solid ordered state PEGylated liposome 63,99,101 .
To model NPs of different shapes, the initial configurations of elastic shells are constructed
according to different geometrical functions. Particularly, the rod-like and disc-like NPs
are built based on the function [(x2 + y 2 )/a2 ]3 + (z/b)6 = 1. The aspect ratio of them is
defined as b/a. The cubic NPs are built based on the function x6 + y 6 + z 6 = a6 . To obtain
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the stable NPs, the triangularization of vertex points on the defined surface is of great importance 82,83 . During the triangularization process, Nv vertex points are firstly randomly
distributed on the surface, and each connected edge is assigned a spring force based on its
current edge length. These spring constants all have the same value. These Nv points are
then free to move on the defined surfaces until all the spring forces on all connected edges
have the same spring force value. Using this method we can construct stress-free NPs of
different shapes 152 . Please refer to the supplementary materials and Chpater 2 for more
details about lipid and NP models, respectively.

3.5.2

Ligand-Receptor Interaction

The ligands are evenly distributed on the NP surface. Certain lipids in the membrane are
initially randomly selected as receptors that can specifically interact with ligands on the NP
surface. Therefore, the diffusion constant of receptors has the same value as that of lipids.
As the area of the cell membrane is much larger than that of the NP, the receptor density
in the region of cell membrane far away from the NP is constant during the endocytosis. To
capture this feature, the boundary of the membrane serves as a receptor reservoir. Particularly, if one receptor in the membrane is already bound to a ligand, a lipid near the boundary
will be correspondingly changed into a receptor. In this way, we can reproduce the constant
receptor density boundary condition in simulations as is adopted in theory 31 . In CGMD
simulations, to study the membrane wrapping process of NPs, the specific ligand-receptor
interaction is usually represented by pair-wise interactions 39,73,153 . Under the pair-wise
interactions, ligands on NP surface could interact with multiple receptors simultaneously.
This unreasonable multi-binding behavior could induce local aggregation of receptors and
provide extremely large binding energy during the membrane wrapping process, which is inconsistent with the ligand-receptor binding in biological system. To avoid this problem, the
ligand-receptor interaction in our CGMD simulations is modeled by a bond-like interaction.
With this model, a ligand can only bind with one receptor in a planar membrane at one time.
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This ligand-receptor interaction is governed by the potential as Vlr (r) = 72[( σr )1.6 − ( σr )0.8 ]
at r < rclr , where rclr = 15σ is the cutoff distance, beyond which the ligand-receptor bond
will break. The average ligand-receptor binding strength is around 10 or 50 kB T . This
strength is within the range of ligand-receptor binding energy from literature 154–156 .

3.5.3

Simulation Protocol

In our simulations, the mass m for each bead is set to be unity value, and the time step is
p
∆t = 0.005τ with τ = /(mσ 2 ). The membrane tension is controlled by regulating the
xy in-plane pressure through a modified Berendsen method 39,88 . The velocity-verlet integration algorithm is adopted for the time integration. The Nose-Hoover thermostat is used
to maintain the temperature of the lipid bilayer, which is suggested for the one-bead lipid
model 132 . Considering the missing solvent degrees of freedom in the solvent free model,
the temperature of NPs is controlled using the Langevin thermostat and maintained at
0.001/kB to rule out the possible influence of thermal fluctuation on the mechanical behaviors of elastic NPs. The physical length and time scales corresponding to our simulations
could be obtained by comparing the membrane thickness and diffusion coefficient between
computational and experimental values. The typical membrane thickness in experiments
is about 5 nm 91,157 . As the thickness of the membrane in our simulations is around 2σ,
we have the basic length unit σ ≈ 2.5 nm. The typical diffusion coefficient of the lipid
molecules in the membrane is about 5 µm2 /s 92 in experiments. By mapping the lateral
diffusion coefficient of lipids D = 0.2σ 2 /τ in CGMD simulations with the experimental
value, the basic time unit in simulations is determined as τ = 0.25 µs. All simulations are
performed with LAMMPS 89 . Please refer to the supplementary materials for more details
about the properties of the lipid membrane.
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Chapter 4

Aggregation of Polyethylene Glycol
Polymers Suppresses
Receptor-Mediated Endocytosis of
PEGylated Liposomes
4.1

Abstract

PEGylated liposome, composed of an aqueous core and a fluid state lipid bilayer shell, is
one of the few Food and Drug Administration (FDA) approved drug delivery platforms. To
prevent absorption of serum proteins, the surface of a liposome is decorated by hydrophilic
and bio-compatible polyethylene glycol (PEG) polymers, which can significantly extend
the blood circulation time of liposomes. In this work, with the help of dissipative particle
dynamics (DPD) simulations, we explore how the tethered PEG polymers will affect the
membrane wrapping process of PEGylated liposomes during endocytosis. Specifically, we
compare the membrane wrapping process of a PEGylated rigid nanoparticle (NP) with
a PEGylated liposome under identical conditions. Due to the mobility of grafted PEG
polymers on the liposome’s surface, the complete wrapping of a PEGylated liposome can
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be dramatically delayed and blocked, in comparison with a PEGylated rigid NP. For the first
time, we observe aggregation of PEG polymers in the contact region between a PEGylated
liposome and the membrane, which in turn leads to a ligand-free region on the surface of
the liposome during endocytosis. Subsequently, the partially wrapped PEGylated liposome
can be bounced back to a less wrapped state. Through free energy analysis, we find that
the aggregation of PEG polymers during the membrane wrapping process of a PEGylated
liposome introduces a dramatic free energy penalty about ∼ 800 kB T , which is almost
twice that of the PEGylated rigid NP. Here kB and T are the Boltzmann constant and
temperature, respectively. Such a large energy barrier and existence of ligand-free region on
the surface of PEGlylated liposomes prevents their membrane wrapping, thereby reducing
the chance of internalization by tumor cells. Therefore, our DPD simulation results provide a
possible explanation for the inefficient cellular uptake of PEGylated liposomes. In addition,
we suggest that by increasing the repulsive interactions between grafted PEG polymers it
might be possible to limit their aggregation, and in turn, facilitate the internalization of
PEGylated liposome. The current study provides fundamental insights into the endocytosis
of PEGylated liposomes, which could help to design this platform with high efficacy for drug
delivery.

4.2

Introduction

Nanoparticles (NPs)-based drug delivery has been an attractive research area in recent
years 2,3,16,23 . These engineered NPs carry drug molecules or imaging agents, protect and
deliver them to target tissues or organs. Thus, the NP-based drug carriers are able to selectively detect and destroy tumor cells 158,159 . Although the concept of NPs-based nanomedicine
is very promising, there are limited numbers of NPs translated to clinical applications 16 .
Once injected into human body, the administrated NPs immediately confront with both
physical and biological barriers 23 . For instance, serum proteins in the blood flow can
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quickly interact and be absorbed on the surface of NPs. These absorbed proteins act
as opsonins that initiate phagocytes of the mononuclear phagocyte system (MPS), resulting in the clearance of most NPs 16,23,50 . Therefore, properties of NPs, such as size, shape,
stiffness and surface, could greatly affect their interactions with surrounding environment
and determine their fate during the drug delivery process 24,58,160 . Doxil is one of the few
Food and Drug Administration (FDA) approved NPs for drug delivery 110 , which is doxorubicin encapsulated in a long-circulating stealth liposome. The liposome is formed by
a phospholipid bilayer, which encloses an aqueous core inside (see Fig. 4.1). The bilayer
could either be in fluid or gel state depending on lipid compositions and environmental temperature. In addition, to reduce absorption of serum proteins, PEGylated lipids, such as
1, 2-Distearoyl-sn-glycero-3-phosphoethanolamine-Poly(ethylene glycol) (DSPE-PEG), are
incorporated into the bilayer, forming a polyethylene glycol (PEG) polymer brush on its
surface. Furthermore, targeting moieties 161 , such as peptides 162,163 or antibodies 164 , are
conjugated on the free ends of PEG polymers to enable selective targeting by interacting
with specific over-expressed receptors on the cell surface. Though being successful among
its counterparts, the efficacy of PEGylated liposomes is still limited by the releasing of encapsulated drug molecules. Once entering tumor sites, PEGylated liposomes stay outside
of tumor cells without internalization 49,110 . As a result, drug molecules need to be firstly
released from liposome to the tumor ex-cellular interstitial fluid and then diffuse into the
tumor cells 165,166 . Therefore, due to the existence of a trans-membrane barrier, the amount
of drug molecules taken up by tumor cells might be dramatically reduced. To resolve this
issue, it is crucial to study the interaction between PEGylated liposomes and tumor cells.
Endocytosis is one of the fundamental processes for cells to internalize molecules or
macromolecules, which is also a primary route exploited by engineering NPs 23,60,61 . Depending on proteins and lipids involved, endocytosis could be sub-classified in several other
mechanisms, such as macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated
endocytosis and calthrin/caveolae independent endocytosis. All of these mechanisms share
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the same steps in ligand-dependent binding, membrane budding and pinching off 46,64,65 .
Note that the typical endocytoic pathway of NPs consists of the following four steps 46,64 :
(1) specific binding of ligands on NP surface to receptors over-expressed on cell membrane;
(2) membrane wrapping around the NP and formation of a membrane-bound NP carrier;
(3) pinching-off of the membrane-bound NP carrier to form an early stage endosome in
cytoplasm; (4) endosomal release of the NP during the late stage of endosome. The current
study mainly focuses on the first two steps, related to the membrane wrapping of NPs,
which is the critical and necessary conditions for NPs to be internalized. The last two steps
related to the endosomal release of NPs remain beyond the scope of the present study.
Fundamental understandings about endocytosis could provide a guideline for rational
design of NP-mediated drug delivery. For example, during the endocytosis process, receptors in the cell membrane diffuse and rearrange to interact with ligands decorated on a
NP surface. Since the membrane wrapping of large sized NPs requires the recruitment of
a large number of receptors, the efficiency of endocytosis is limited by the receptor diffusivity in the cell membrane 31,129 . On the contrary, due to the limited number of available
ligands, small sized NPs are unable to overcome the energy barrier due to the membrane
bending penalty 31,129 . Considering the balance of receptor diffusion and ligand-receptor
binding, a radius around 30-50 nm had been suggested as a most efficient size for spherical
NPs 31,128,167 , in good agreement with experimental observations 23,30 . In addition, soft NPs
like liposomes are deformable during endocytosis. When approaching the tumor cell, soft
NPs can deform to increase their contact area with the cell membrane, resulting in a high
curvature area in the contact region. This large deformation of NPs leads to a high energy
barrier that blocks the membrane wrapping of soft NPs during endocytosis 45 . Therefore,
rigid NPs were suggested to offer a higher chance of internalization 45,80 . Apart from their
size and stiffness, both the shape and surface properties of NPs are also found to play important roles during the membrane wrapping process 72,87,123 , which can dramatically affect
the cellular uptake efficiency.
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Figure 4.1: Molecular structures of computational models: (A) PEGylated rigid NP, (B) PEGylated liposome, (C) Lipid and PEG polymer models for both types of PEGylated NPs. Lipid heads
and tails in a liposome are colored in light blue and ice blue, respectively. The PEG polymers are
colored in blue. The ligands (targeting moieties) conjugated on distal ends of PEG polymers are
represented by red beads. (D) Lipid membrane with over-expressed receptors. Lipid heads and tails
in the membrane are colored in green and gray, respectively. The molecular structure of receptors
are the same as for lipids in simulations. The bead colored in tan on the head of the receptor is the
active site to specifically bind with a ligand.

Compared with PEGylated gold NPs, the PEG polymers in PEGylated liposomes are
able to rearrange their positions and configurations during endocytosis due to the fluid
nature of the lipid bilayer. For instance, by using a molecular mean-field theory, Szleifer
and co-workers investigated the interaction between a PEGylated micelle and a planer
surface (mimicking the surface of tumor cell) 168 . When the PEGylated micelle approaches
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the planer surface, the polymer chains can migrate from the confined gap region between
the micelle and planer surface to the unconfined regions. Such a movement can dramatically
reduce the polymer segment density in the confined region, leading to the reduction of energy
penalty induced by restricted configurations and increased excluded volume interactions in
the confined regions. Furthermore, when conjugated with targeting moieties (ligands),
polymer chains can migrate to the gap boundaries to promote ligand-receptor binding and
to reduce the polymers energy penalty 169 . The mobility of polymer chains can therfore
promote the adhesion of PEGylated micelles on a cell surface, compared to the PEGylated
rigid (gold) NPs. In addition, through computational modeling, Gorfe et al. suggested
that the rearrangement of polymers on lipid-polymer hybrid (LPH) NPs could benefit the
adhesion of LPH on membrane surfaces 170 . However, considering the endocytosis, the
situation is more complicated due to the wrapping and deformation of the membrane.
The re-distribution of polymers is not only determined by the ligand-receptor binding and
polymer energy penalty, but also the free energy change associated with the deformation
of the membrane. Therefore, the problem related to how the PEG mobility will affect the
endocytosis of PEGylated liposomes remains largely unexplored.
In this work, with the help of large-scale molecular dynamics simulations, we reveal the
physical details about the endocytosis of PEGylated liposomes. Specifically, we explore
how the PEG mobility affects the membrane wrapping process during endocytosis. To
understand the influence of PEG mobility in a better way, we also study the receptormediated endocytosis of PEGylated rigid (gold) NPs, where the tethers of PEG polymers
are fixed on the NP surface. As shown in Fig. 4.1, the PEGylated rigid NP consists of a solid
core and tethered PEG polymers. In comparison, the PEGylated liposome is composed of
an aqueous core and a fluid state lipid bilayer shell. To control the mobility of grafted PEG
polymers during simulations, the rigid NP is mimicked by treating the lipids and water beads
in liposome as a single rigid body in our simulations. Therefore, the PEGylated rigid NP
and liposome share the same size and surface chemistry. The only differences between them
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are the mobility of grafted PEG polymers and deformability of the liposome. Under the
same conditions, we find that the PEGylated liposome is more difficult to be fully wrapped
by the membrane during endocytosis, compared to its rigid counterparts. In particular, we
observe aggregation of PEG polymers in the contact region between the PEGylated liposome
and the membrane, which in turn leaves a ligand-free region on the surface of the liposome.
Due to this ligand-free region, ligand-receptor binding does not occur during the late stage
of membrane wrapping for PEGylated liposomes. Furthermore, the PEGylated liposome
can be bounced back to a less wrapped state, by reducing the free energy penalty due to
membrane bending. Through a free energy analysis, we find that the free energy change
of PEG polymers during membrane wrapping plays the most important role. Specifically,
the aggregation of PEG polymers during endocytosis of PEGylated liposomes introduces
a dramatic free energy penalty (∼ 800kB T ), which is more than twice of the membrane
bending energy. Such a large energy barrier and existence of ligand-free region on the
surface of PEGylated liposomes prevent their membrane wrapping, thereby reducing the
chance of its internalization by tumor cells. Our simulation results thus provide a possible
explanation for the inefficient cellular uptake of PEGylated liposomes. In addition, we
suggest that by increasing the repulsive interactions between PEG polymers or ligands one
might be able to limit the polymer aggregation, and in turn, facilitate the internalization
of a PEGylated liposome.

4.3

Results and Discussion

The dissipative particle dynamics (DPD) method is adopted in our molecular dynamics
simulations to investigate the membrane wrapping of PEGylated NPs during endocytosis,
which has been proven to be an efficient and accurate way in our previous studies 72,123,153 .
In this model, each lipid molecule contains one lipid head group and two lipid tails. A PEG
polymer is modeled by a linear chain, as shown in Fig. 4.1. Each PEG polymer has N = 30

75

monomers (molecular weight around 1000 Da). To prepare the PEGylated liposome, a
liposome is firstly formulated through self-assembly by lipids. Lipid molecules in the outer
leaflet of the liposome are then randomly selected for grafting PEG polymers on their head
bead. Afterwards, the PEGylated liposome is further relaxed for 105 τ , at the temperature
of T = 1, where τ is the basic time unit in DPD simulations. Two differently sized liposomes
with 800 and 1701 lipids are prepared with radii around 7 r0 and 15 r0 , respectively. Here
r0 is the length unit in the DPD simulations. The planar membrane bilayer is fully relaxed
in the simulation box of size (70 × 70 × 100) r03 . The stretch modulus and bending rigidity of
the membrane is around KA ≈ 17.42 kB T /r02 and κ ≈ 6 kB T , respectively. The membrane
tension is maintained constant during the membrane wrapping process via the N -varied
DPD method 70,72,123,171,172 . The physical length and time scales, corresponding to τ and r0
in simulations, could be obtained by the relations r0 ≈ 0.9 nm and τ = 11.8 ns, considering
the thickness of the cell membrane and diffusion coefficient of lipids. Details about the DPD
model and simulation procedures are given in supplementary materials for Chapter 4.

4.3.1

Aggregation of PEG polymers during membrane wrapping of PEGylated liposome

We first investigate the membrane wrapping of PEGylated rigid NPs and liposomes with
size of r = 7 r0 under same conditions, as shown in Fig. 4.2. 20% of lipids (800 lipids
in total) in both the rigid NP and liposome are PEGylated. The membrane tension is
controlled at −0.38 kB T /r02 (1kB T /r02 corresponds to 5 mN/m). At startup (t = 0), both
the PEGylated rigid NP and liposome are placed above the planar membrane at distance
3r0 . For the PEGylated rigid NP, the membrane wrapping process can be divided into
three stages: membrane bending stage (0 < t < 10000τ ), membrane protruding stage
(10000τ < t < 80000τ ) and equilibrium stage (t > 80000τ ). At the membrane bending
stage, due to the thermal fluctuation and flexibility of PEG polymers, the targeting moieties
(ligands) conjugated on distal ends of PEG polymers can interact and bind with receptors
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Figure 4.2: Representative snapshots for membrane wrapping processes of (A) PEGylated rigid
NP and (B) PEGylated liposome with size of r = 7 r0 . The membrane tension in both cases is
controlled at −0.38 kB T /r02 . Water beads are not shown for clarity. The color scheme is the same
as that given in Fig. 4.1.

in the planar membrane, resulting in adhesion of the NP at time t = 1000τ , Then, driven by
the ligand-receptor binding, the planar membrane start bending and wrapping around the
PEGylated rigid NP. With the simulation time running, more and more receptors diffuse
into the membrane bending region and bind with ligands on the free ends of tethered PEG
polymers. The energy released by the ligand-receptor binding provides the major driving
force to overcome the energy barriers during the membrane bending. At time t = 40000τ ,
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most of the PEGylated rigid NP is wrapped by the membrane, and the membrane starts
to protrude and wrap the PEGylated rigid NP from the top (t = 50000τ ). The lower
part of the membrane only bends slowly and weakly, compared with its performance at the
membrane bending stage. Afterwards, the PEGylated rigid NP is slightly pulled upwards
and located around the center of membrane to reduce the bending energy penalty from
the lower membrane part. At time t = 80000τ , the PEGylated rigid NP is fully wrapping
by the membrane. A similar membrane wrapping pathway has been observed in previous
studies on PEGylated rigid NPs 72,123 , hydrophilic NPs decorated by ligands only (without
PEGylation) 173,174 and liposome-like NPs 70,153 .
At the early stage of membrane wrapping, both PEGylated rigid NP and liposome
demonstrate similar behaviors. However, at the late stage, their behaviors are completely
different. As shown in Fig. 4.2, at time t = 50000τ , we observe the aggregation of PEG
polymers into the membrane wrapping region, due to the strong ligand-receptor binding in
this area. This difference is more pronounced at t = 10000τ , when the unwrapped part of
the liposome almost becomes a PEG polymer free region. The majority of PEG polymers
aggregates within the contact region between liposome and membrane. Later on, rather
than being fully wrapped by the membrane, the PEGylated liposome is gradually bounced
back on the surface of the planer membrane and returns to the previous membrane bending
state (t = 40000τ ), although most of the ligands on PEG polymers bind to receptors in the
planar membrane. Therefore, the membrane wrapping process for the PEGylated liposome
can be divided into: membrane bending stage (0 < t < 50000τ ) and liposome bouncing
back stage (50000τ < t < 100000τ ).
To further quantitatively understand above different behaviors between PEGylated rigid
NP and liposome, we calculate the wrapping ratio, ligand-receptor binding ratio and asphericity of NPs, as given in Fig. 4.3. The wrapping ratio, defined as the the ratio between
the membrane’s wrapped surface area to the total surface area of NPs, can be used to
quantify the endocytosis efficiency. The ligand-receptor binding ratio, defined as the ratio
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Figure 4.3: Comparison of (A) wrapping ratio, (B) ligand-receptor binding ratio and (C) asphericity between PEGylated rigid NP and liposome during the membrane wrapping process. In (A), the
wrapping ratio is defined as the ratio between the wrapped surface area of a NP and its total surface
area. In (B), the ligand-receptor binding ratio is defined as the ratio between the numbers of bound
and total ligands. The scattered points are the data obtained during simulations. The solid lines
are obtained by fitting the data by an exponential growth function y = A + B exp(−kτ ). In (C),
the asphericity is defined by λ2z − (λ2x + λ2y )/2, where λ2x , λ2y and λ2z are the principal moments of
the gyration tensor (λ2x ≤ λ2y ≤ λ2z ) for a NP.

between bounded ligands to the total number of ligands on NP surfaces, directly reflects the
ligand-receptor binding during the membrane wrapping process. The asphericity of NPs,
given by λ2z − (λ2x + λ2y )/2, is used to capture the deformation of NPs. Here λ2x , λ2y and λ2z
are the principal moments of the gyration tensor (λ2x ≤ λ2y ≤ λ2z ) of a liposome. A large
asphericity value indicates a pronounced anisotropic shape 142 . As shown in Fig. 4.3, the
wrapping ratio of PEGylated rigid NP monotonically increases with the simulation time.
By contrast, due to the ‘bouncing back’ phenomenon, the wrapping ratio of PEGylated liposome decreases after reaching a plateau value around 0.6. Different from the wrapping ratio,
the ligand-receptor binding ratio of PEGylated liposome increases more sharply than that
of the PEGylated rigid NP. If we consider the ligand-receptor binding as a chemical reaction
and fit the simulation results by an exponential growth function y = A + B exp(−kτ ) 169 ,
the mean lifetime 1/k, needed to achieve the equilibrium of ligand-receptor interaction, for
the PEGylated liposome (1/k = 2.8 × 103 τ ) is only half of that of the PEGylated rigid
NP (1/k = 6.2 × 103 τ ). This observation signifies that the mobility and aggregation of
PEG polymers in the PEGylated liposome can significantly promote the ligand-receptor
binding during endocytosis, consistent with previous studies 168,169 . In addition, due to the
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deformable nature of liposome, the asphericity of the PEGylated liposome varies with simulation time during the membrane wrapping process. At the initial stage of wrapping, the
liposome deforms dramatically to maximize the contact area, leading to a highly anisotropic
shape. After t = 10000τ , with the increment of the wrapping ratio, the asphericity decreases
to reduce the energy cost from the liposome deformation 45 . It is worthy to note that during
the ‘bouncing back’ stage (t > 50000τ ), the changes of the asphericity are almost symmetric to their early stage behavior. The maximum asphericity value during the membrane
wrapping process is about ∼ 8r02 .
Note that both PEGylated rigid NP and liposome are considered under identical conditions, such as same size and surface property. Therefore, we believe that the above difference between ‘fully wrapped’ and ‘bouncing back’ of PEGylated rigid NP and liposome
respectively should be induced by the aggregation of PEG polymer during the membrane
wrapping process. During binding between ligands and receptors, PEG polymers are under
stretched conditions because of the restricted configurational space 72,175 . Moreover, the
PEG polymers on the edge of the contact region between liposome and membrane should
be more stretched than the ones in the central part 176,177 . As the PEG polymers are movable in the PEGylated liposome, they prefer to migrate to the center of the contact region,
to reduce the stretching energy penalty of PEG polymers and to assist recruiting free ligands at the edges. Due to the aggregation of PEG polymers, the unwrapped surface of
liposome becomes a ligand free region. Thus, ligand-receptor binding cannot be provided
for further wrapping of this ligand free region during the late stage of membrane wrapping.
This inhomogeneous ligand distribution on the liposome is unfavorable for the endocytosis
of NPs 74 .
To further confirm the above phenomenon and rule out possible effects potentially steming from the NP size and membrane tension, we explore the membrane wrapping process of
a 20 mol% PEGylated liposome with 1701 lipids in total (radius r = 15 r0 ) and 340 PEGylated lipids (340/1701=20%). The membrane tension during the endocytosis is maintained
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at 0.08 kB T /r02 . The whole membrane wrapping process is similar to that of the small sized
PEGylated liposome( cf. Fig.A.20 and Fig.A.21 in supplementary materials). Again, the
PEG polymers aggregate in the contact region between liposome and membrane, accompanied by a ligand free region from the unwrapped surface. The half-wrapped liposome
then regresses to an ‘adhesive’ state, rather than being fully wrapped. On the contrary, the
PEGylated rigid NP with identical size and PEGylation can be fully wrapping, as given in
Fig.A.20 of supplementary materials. All of these observations confirm that the aggregation
of PEG polymers could be a common problem for the endocytosis of PEGylated liposomes.
Considering the computational cost of the large size PEGylated liposomes, we still use the
small size liposome with r = 7 r0 for a detailed study in the following parts.

4.3.2

Influence of PEG molar ratio and membrane tension

The molar ratio of PEGylated lipids is one of key design parameters for PEGylated liposomes; in experiments it ranges from 10% to 50% 49 . In particular, the targeting moieties
are conjugated on the free ends of PEG polymers. Thus, the total number of PEG polymers
or molar ratio of PEGylated lipids also determines the overall strength of ligand-receptor
binding during the the wrapping process. Additionally, the diffusion coefficient of ligand on
liposome surface decreases with the increasing of PEG molar ratio as we given in Fig.A.18
in the supplementary materials. On the other hand, cells could actively adjust their membrane tension through various mechanisms 60 . For instance, maglinan cells could change
their membrane tension from 0.01 to 10 mN/m 178 . Therefore, in this part, we explore
how the membrane wrapping of PEGylated liposomes will be affected by the membrane
tension and the molar ratio of PEGylated lipids. First, we fix the membrane tension to
be −0.38kB T /r02 , as the same as the one in Fig. 4.2. Then, we increase the molar ratio
of PEGylated lipids from 20% to 40%. As presented in Fig. 4.4, the PEGylated liposome can be fully wrapped by the membrane, in comparison with the 20% PEGylated
liposome. During this process, although the PEG polymers aggregate within the contact
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Figure 4.4: Endocytosis process of 40 mol% PEGylated liposome (radius r = 7 r0 ). (A) Snapshots
of PEGylated liposome under a membrane tension of −0.38kB T /r02 (compression). (B) Snapshots
of the PEGylated liposome under membrane tension of 0.08kB T /r02 (tension). The molar ratio of
the PEGylated lipid for (A) and (B) is 40%. (C), (D) and (E) offer, respectively, a comparison of
wrapping ratio, ligand-receptor binding ratio and asphericity between these two cases.
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region (10000τ < t < 50000τ ), the area of the ligand-free region is much smaller due to
the increased number of PEG polymers. After t = 60000τ , the membrane lipids near the
contact region protrude and start to spread over the ligand free region. Note that, after
being fully wrapped by cell membrane, the PEG polymers are redistributed and become
homogeneously distributed on the surface of the liposome at t = 70000τ .
Upon further increasing the membrane tension from −0.38kB T /r02 to 0.08kB T /r02 , the
40 mol% PEGylated liposome cannot be fully wrapped and demonstrates the ‘bouncing
back’ phenomenon after time t = 60000τ , as given in Fig. 4.4.B. To further understand this
difference, we calculate the wrapping ratio, ligand-receptor binding ratio and asphericity
of these two cases. As evidenced in Fig. 4.4.B, the increase of membrane tension creates
a higher energy penalty, dramatically reduces the membrane wrapping of PEGylated liposome, and promotes the aggregation of PEG polymers (t = 40000τ ). Therefore, under
large membrane tension, a bigger ligand-free region has been observed on the surface of
PEGylated liposome, although the ligand-receptor bindings for these two cases are almost
the same (see Fig.4.4.D). In addition, we find that the asphericity of the liposomes is not
significantly affected by the membrane tension, as given in Fig. 4.4.E. Therefore, we can
conclude that the increment of membrane tension leads to a higher energy barrier and more
aggregation of PEG polymers during endocytosis, resulting in the partially wrapped state
of the PEGylated liposome.
To further understand the influence of PEG mobility, we systematically vary the molar
ratio of PEGylated lipids from 10% to 40%, and the membrane tension from -0.75 kB T /r02
to 1.0 kB T /r02 . The phase diagrams for different wrapping states of PEGylated rigid NP
and liposome are given in Fig. 4.5. Note that all the distal ends of PEG polymers are
conjugated with targeting moieties (ligands) in our simulations. There is a threshold PEG
molar ratio value VPEG for both PEGylated rigid NP and liposome, below which the ligandreceptor interaction is not strong enough to overcome energy barriers during membrane
wrapping. On the other hand, there is also a membrane tension upper bound value VTen ,
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Figure 4.5: Phase diagram for the membrane wrapping of (A) PEGylated rigid NPs and (B)
PEGylated liposomes under the influences of membrane lateral tension and PEG molar ratio. The
red dots represent the cases of being fully membrane wrapped. The blue squares are the cases of
being partially membrane wrapped during endocytosis.

above which the energy penalty from membrane is too large that prevents the endocytosis.
These two boundary values divide the whole phase diagram into two regions: fully wrapped
and partially wrapped regions. As we notice in Fig. 4.5, the area of fully wrapped region
for PEGylated liposome is dramatically smaller than that of PEGylated rigid NP. The fully
wrapping state of PEGylated liposome can only be achieved under the high PEG molar ratio
and low membrane tension. This difference further highlights the important role played by
the PEG mobility, which will be further analyzed in the next part.

4.3.3

Free energy analysis for membrane wrapping of PEGylated liposome

To provide a detailed understanding on the important role played by the PEG mobility,
we carry out a free energy analysis of the membrane wrapping process of the PEGylated
liposome. As evidenced from the simulation results (cf. Fig. 4.2), the total free energy
change of the system consists of (i) the ligand-receptor binding ∆FLR ; (ii) deformation
of liposome ∆FLIP ; (iii) bending and stretching of cell membrane ∆FMEM ; and (iv) the
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configurational entropy change of PEG polymers ∆FPEG . Note that the possible free energy
changes induced by the membrane fluctuation and translational entropy loss of receptors
(and solvent molecules) are much smaller than the above energy barriers 106,107 . We ignore
their contributions to simplify this free energy analysis. Therefore, the total free energy
during the membrane wrapping process could be expressed as

∆F = ∆FLR + ∆FLIP + ∆FMEM + ∆FPEG

(4.1)

If ∆F < 0, the driving force from the ligand-receptor binding is large enough to overcome
all the barriers. And the membrane could achieve fully wrapping around PEGylated NPs.
Otherwise, the wrapping process might be blocked. In this part, taking the example in
Fig. 4.2 (20 mol% PEGylated lipid, membrane tension −0.38kB T /r02 ), we attempt to analyze all of these energy changes of PEGylated liposome and compare them with those of
PEGylated rigid NP. First of all, the individual binding strength between the ligand and
receptor in our DPD simulations is about ∼ 6.8 kB T . Thus, the maximum energy gained
through ligand-receptor binding is around ∆FLR ≈ −1088 kB T , considering the total number of targeting moieties is 160. The estimations about ∆FLIP , ∆FMEM , and ∆FPEG are
discussed in the following.

Liposome bending energy
The liposome deforms during the wrapping process of PEGylated liposomes (cf. Fig 4.3.C
and Fig. 4.4.E). The significant shape change in the deformed liposome indicates the energy
change ∆FLIP of the liposome. During the endocytosis process, the area of liposome is
usually assumed to be constant 70,179 . In addition, for an initially relaxed liposome in our
simulations, the energy change associated with the pressure difference between interior and
outside of the liposome could be very small and is neglected 45 . The major contribution
to ∆FLIP should therefore consist of the bending energy change that relates to curvature
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Figure 4.6: Free energy changes of liposome and membrane. (A) The evolution of bending energy
change of the liposome in the course of time. (B) The free energy change of the membrane versus
wrapping ratio. Lines with different colors, such as blue, green and red, represent spherical, oblate
and prolate particles, respectively. (C) Illustration of the membrane wrapping geometry and parameters in the theoretical model. θ is the wrapping angle, s denotes arc length, φ is the angle tangent
to the membrane profile, z is the axis of rotational symmetry. The red line represents the wrapped
part of the cell membrane. The blue line denotes the free part of the cell membrane. (D) The figure
on the top left is a schematic of a spherical NP (blue line) with identical size of PEGylated liposome,
an oblate (green line, a/b > 1) and a prolate (red line, a/b < 1) ellipsoids with asphericity value of 8.
The remaining three drawings show the membrane shapes for spherical, oblate and prolate ellipsoid
NPs with wrapping ratios of 0.10, 0.34, 0.65 and 0.80.

variations of the deformed liposome. To estimate this bending energy change, we fit the
shape of the liposome at each time step by an ellipsoid 179 . Based on the fitted shape, the
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bending energy of the liposome can be obtained according to the Helfrich’s theory 95,180
Z
ELIP =
S

2
κLIP 1
cLIP + c2LIP dS
2

(4.2)

where κLIP is the bending rigidity of the liposome; c1LIP and c2LIP are principal curvatures of
the fitted ellipsoid surface. As illustrated in Fig. 4.6.A, the bending energy change of the
liposome follows the trend of its asphericity change. The maximum value of the bending
energy change for the liposome is smaller than 20 kB T . We hence conclude that ∆FLIP < 20
kB T . Since the rigid NP cannot deform during the wrapping process, there is no energy
contribution by the core of the PEGylated rigid NPs.

Membrane bending and tension energy
The cell membrane bends to wrap PEGylated NPs and might be stretched or compressed
for the excess surface induced by this wrapped membrane. The energy change of the
membrane EMTen consists of two parts 141,181,182 : (i) membrane bending energy EMBend
and (ii) membrane tension energy EMTen , given by

EMEM = EMBend + EMTen

(4.3)

To estimate the membrane elastic energy in our simulations, a theoretical model is here
developed. To this end we assume that a planar membrane wraps around a solid NP (cf.
Fig. 4.6.C), which is rotational symmetric with respect to the z axis. Moreover, to evaluate
the influence of liposome deformation, three different NPs (Fig. 4.6.D) are considered: (I) a
spherical NP with radius of r; (II) an oblate ellipsoid NP; (III) a prolate ellipsoid NP. The
shape function of both oblate and prolate ellipsoids is defined by (x2 + y 2 )/a + z 2 /b = 1,
where a and b are the length of major and minor axes of the ellipsoidal particles. All of
the three particles share the same volume under the control of relation r = (a2 b)1/3 . In
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particular, the specific values of r, a and b are taken as: (I) r = 7 r0 for the spherical
NP, which has a same radius as liposome; (II) a = 7.198 r0 , b = 6.619 r0 for the oblate
ellipsoidal NP; (III) a = 6.817 r0 , b = 7.380 r0 for the prolate ellipsoidal NP. Under these
conditions, the asphericity values of both oblate and prolate ellipsoids are 8 r02 , which is the
maximum value of the deformed liposome during the membrane process (cf. Fig. 4.3.C). It
is noteworthy in Fig. 4.6.D that the deformation of the liposome is actually small during
the whole wrapping process. By comparing the wrapping processes of these three NPs, we
should be able to estimate the upper and lower boundaries of membrane energy change for
both the PEGylated rigid NP and the liposome.
Within this model, we consider a symmetric membrane and assume no topological
change during the whole membrane wrapping process. The bending and tension energies of
the planar membrane are then expressed as
Z

κ(c1 + c2 )2 ds,

EMBend =
S

(4.4)

EMTen = σ∆S
where κ is the bending rigidity of the membrane; c1 and c2 are the principle curvatures,
σ denotes the membrane tension, and ∆S the excess area induced by the wrapping of
membrane. Subject to a given wrapping ratio, the whole membrane can be divided into
two parts 141 (cf. Fig. 4.6C): the wrapping and free parts. The geometry of the membrane
in the wrapping part is determined by the shape of NP 141 . Therefore, both the membrane
bending and tension energies are readily calculated according to the prescribed shape of
NPs within the wrapping region. To obtain the elastic energy of the free part, we assume
the tangent angle φ(s2 ) has a Fourier series form with respect to the profile of arch length
in the free part s2 181,182 . The profile of the free part, and the corresponding membrane
elastic energy at given wrapping ratio are obtained by searching parameters in the Fourier
series with minimum membrane energy. More details about the theoretical approach are
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given in the supplementary materials for Chapter 4.
The membrane energy change ∆FMEM along with the wrapping ratio for all three cases
is given in Fig. 4.6.B. At the first stage of the wrapping process, ∆FMEM increases with
increasing wrapping ratio, reaching its peak value at around 25 kB T . At this stage, the
membrane energy change is dominated by the bending energy cost. At a later stage, the
tension energy will dominate the whole membrane energy, because of the negative membrane
tension and large excess area of lipids. Therefore, ∆FMEM decreases to a negative value
around -80 kB T . In addition, due to the deformation of the liposome (cf. Fig. 4.6.D),
∆FMEM can be slightly affected. In short, we could conclude that ∆FMEM < 25 kB T for
both the PEGylated rigid NP and liposome. It is also interesting to see the pronounced
reduction of membrane energy after a wrapping ratio of 0.5, which might be able to explain
why the 20 mol% PEGylated rigid NP and 40 mol% PEGylated liposome can be fully
wrapped after the saturation of ligand-receptor binding under the membrane tension of
−0.38kB T /r02 .

PEG polymers energy change
The PEG polymers on the PEGylated liposome diffuse and rearrange their configurations
and locations to facilitate the binding between targeting moieties on the free ends and receptors in the membrane. During this process, the free energy change of PEG polymers
has three contributions 72,123,168 : (i) elastic free energy change ∆Fel representing the configurational entropy loss of each polymer; (ii) interaction free energy change ∆Fint denoting
the change of interaction energy between different polymer chains; (iii) translational free
energy change ∆Ftrans reflecting the translational entropy loss of polymer chains:

∆FPEG = ∆Fel + ∆Fint + ∆Ftrans

(4.5)

Based on our previous works 72,123 , these free energy changes of PEG polymers can be
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Figure 4.7: Cross-sectional views of PEG polymer volume fraction distribution during the membrane wrapping process: (A) PEGylated rigid NP and (B) PEGylated liposome.

estimated by feeding the self-consistent mean field (SCF) theory with the information about
PEG polymers configurations and local volume fractions from DPD simulations. According
to SCF theory 72,123 , the elastic part Fel of a single PEG chain is linearly proportional to
2 i of a polymer normal to the tethered surface, F /k T =
the mean squared extension hree
el B
2 i/R2 , where R represents the equilibrium span of an unconstrained PEG polymer
(3/2)hree
0
0
2 i/e using the available hr 2 (N )i values
with polymerization degree N . We employ R02 = hree
ee

for a single PEG chain in water 72,123 . Within the SCF, the mean interaction free energy
per chain Fint is quantified through the spatially inhomogeneous volume fraction φ of PEG
R
monomers, Fint /kB T = fm (φ)d3 r, where fm = (φ2 + φ3 )/v for PEG 72 , and v = 0.0633
nm3 denotes the excluded volume of a PEG monomer; the integral extends over the mean
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volume of a single chain. In addition, the translational free energy Ftrans is directly related
to the variable distribution of PEG tethering points on the surface. We use the volume
R
fraction to estimate this contribution, Ftrans /kB T = (N v)−1 φ ln(φ)d3 r. If the tethering
points are immobile this purely entropic term is absent. Note that the intrinsic relaxation
time of a PEG polymer with polymerization degree N = 30 is about 100 ps 183–186 , while
a time step ∆t in our DPD simulations corresponds to about 118 ps. It means that the
PEG polymers are able to relax themselves on a time scale that is short compared with
the total simulation time, the equilibrium SCF approach can be considered applicable,
and we can extract ∆FPEG in the course of time. In the following, we will monitor both
the volume fraction distribution φ and the mean end-to-end distance of PEG polymers
P
Ree = M −1 M
i=1 ree,i (M is the total number of PEG polymers) in the simulations. By
applying the information about φ and Ree on to the Fel , Fint and Ftrans formulas above, we
can directly get the corresponding free energy changes.
The local volume fraction distribution of PEG polymers changes along with the rearrangement of polymer chains during membrane wrapping. The PEG volume fraction
distribution is given in Fig. 4.7 for both PEGylated rigid NP and liposome. For the PEGylated rigid NP, the volume fraction of PEG chains in the wrapped region of NP is increased
(t = 5000 − 10000τ ) compared to its initial state. Within the wrapped region, the occupied space of PEG polymers is reduced due to the confinement from the rigid NP core and
membrane. One the other hand, we observe highly concentrated PEG polymer segments
at time t = 40000 − 100000τ , induced by the aggregation of bounded receptors 142 . For
the PEGylated liposome, apart from these two phenomena, the aggregation of mobile PEG
polymers on the liposome further contributes to a highly inhomogeneous volume fraction
distribution (t = 5000, 10000τ in Fig. 4.7.B). This inhomogeneity is more pronounced for the
PEGylated liposome during the ‘bouncing back’ stage (t = 50000−100000τ in Fig. 4.7.B, in
comparison to the PEGylated rigid NP. All these observations confirm that the mobility of
PEG polymers on PEGylated liposome facilitates their aggregation during the membrane
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Figure 4.8: Comparison of mean end-to-end distance and free energy changes of PEG polymers
between a PEGylated rigid NP and a liposome in the course of time: (A) mean end-to-end distance
Ree , (B) elastic free energy change ∆Fel , (C) translational and interaction free energies change
∆Fint + ∆Ftrans , and (D) total free energy change ∆FPEG of PEG polymers.

wrapping process, which creates additional energy barriers.
The mean end-to-end distance Ree of the PEG polymers also changes along with the
ligand-receptor binding. As illustrated in Fig. 4.8.A, the value of Ree for both the PEGylated rigid NP and liposome increases rapidly at the initial stage because of stretching of
individual PEG polymers during ligand-receptor binding. However, the Ree of PEGylated
liposome exceeds the one of the PEGylated rigid NP due to the PEG mobility facilitated
ligand-receptor binding. Interestingly, after the ‘bouncing back’ of the PEGylated liposome,
its Ree value decreases and converges to that of of PEGylated rigid NP.
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The corresponding free energy changes from PEG polymers during membrane wrapping
are illustrated in Fig. 4.8. The features of the free energy profiles are different at the membrane bending stage (0 < t < 50000τ ) and liposome ‘bouncing back’ stage (t > 50000τ ) for
the PEGylated liposome. At the membrane bending stage, both ∆Fel and ∆Fint + ∆Ftrans
of the PEGylated liposome increase rapidly, reaching values of 400 kB T and 300 kB T , respectively. Over the same time period, these energy penalties from the PEGylated rigid
NP also increase, but reach smaller values of 300 kB T and 150 kB T respectively. These
differences should be attributed to the aggregation induced inhomogeneous distribution of
PEG volume fractions and the large end-to-end distance value. At the liposome ‘bouncing
back’ stage, the elastic energy ∆Fel of PEGylated liposome decreases and becomes comparable to that of the PEGylated rigid NP, while its interaction and translational free energy
∆Fint + ∆Ftrans further increases. This competition between ∆Fel and ∆Fint + ∆Ftrans
leads to the increment of the total PEG polymer energy penalty and reaches a plateau at
the end. In comparison, over the same time period, the PEG free energy changes of the
PEGlyated rigid NP almost keep unchanged after saturation of the ligand-receptor binding
(Fig. 4.8.D). In summary, we obtain ∆FPEG ' 800 kB T for the PEGylated liposome and
∆FPEG ' 450 kB T for the PEGylated rigid NP.
To sum up the above free energy analysis results, we have calculated separate contribution to the energy barriers: (1) For the PEGylated liposome, ∆FLIP < 20 kB T ,
∆FMEM < 25 kB T and ∆FPEG ' 800kB T ; (2) For the PEGylated rigid NP, ∆FLIP = 0,
∆FMEM < 25 kB T and ∆FPEG ' 450kB T . In light of these findings, the energy barrier
from PEG polymers is the main factor prohibiting the endocytosis of a PEGylated rigid
NP and liposome. More importantly, the PEG mobility-induced aggregation further increases the value of ∆FPEG ' 800kB T , in comparison with that of the PEGylated rigid
NP ∆FPEG ' 450kB T . Such a large energy barrier ∆FPEG induced by the aggregation of
PEG polymers, and the appearance of a ligand-free region on the liposome surface are the
main reasons that the PEGylated liposome is more easily trapped during the membrane
93

wrapping process.
To further confirm the important role played by the PEG aggregation, we treat the
water beads inside the liposome as a single rigid body to prevent the deformation of the
liposome during membrane wrapping. The tethered PEG polymers are still able to diffuse
on the liposome’s surface. All other conditions remain the same as for the case depicted in
Fig. 4.2. As shown in the supplementary materials Fig.A.22, the membrane wrapping process of this PEGylated liposome with a rigid core follows the similar behavior of PEGylated
liposome. The PEG polymers aggregate within the contact region between the liposome and
membrane, leading to a trapped and partially wrapped state of the PEGylated liposome.
Besides, the wrapping ratio and ligand-receptor binding ratio of this case are very similar
to that of the PEGylated liposome, indicating that the deformation of the liposome plays a
negligible role during membrane wrapping. However, the asphericity value of the liposome
stays constant since the interior water beads are treated as a single rigid body.

4.3.4

Correlation with theoretical and experimental observations

Our DPD simulation results suggest that the mobility of polymers on the PEGylated liposome can induce their aggregation within the contact region during the membrane wrapping
process. Such an aggregation can lead to an inhomogeneous distribution of PEG polymers
and targeting moieties (ligands) on their free ends. Although the mobility of PEG polymers
and their flexibility can promote the ligand-receptor binding and adhesion of PEGylated
NPs at the early stage of the membrane wrapping process, the aggregation of PEG polymers also results in a higher energy barrier and ligand-free region on the liposome surface.
Both of these factors give rise to the inefficient cellular uptake of PEGylated liposomes, in
comparison with PEGylated rigid NPs. In fact, the ligand distribution on the NP surface
is also an important design parameter. Both theoretical and computational studies suggest
that the inhomogeneous distribution of ligands on a NP surface can prohibit the endocytosis of NPs 74,187 . For instance, Schubertova et al. explored the influence of the ligand
94

distribution on the cellular uptake efficiency of rigid NPs through coarse-grained molecular
simulations 74 . The simulation results reveal that the NPs with homogeneous ligand distributions demonstrate fast membrane wrapping and cellular uptake, while the diffusion of
ligands on the NP surface can delay and block the uptake of NPs, due to the ligand-free NP
surface. Moreover, a recent theoretical work by Lorenzo et al. 188 argues that the mobility
of ligands on the NP surface can accumulate and impede the endocytosis. They propose
that the increment of steric force between ligands can prevent their aggregation and facilitate the endocytosis of NPs with movable ligands. However, the influence of tethered PEG
polymers was not considered in these works, thus ignoring the large energy barrier induced
by the aggregation of PEG polymers.
In experiments, a large number of studies demonstrate that conjugated targeting moieties on distal ends of PEG polymers can effectively facilitate the internalization of PEGylated rigid (gold) NPs 189–191 . However, there are evidences showing that decorating ligands
on the free ends of the liposome’s PEG polymers might not enough to efficiently deliver the
encapsulated drug molecules into tumor cells. For instance, Goren et al. 192 demonstrate that
the adhesion of a ligand (anti-erbB2-2) conjugated PEGylated liposome on N-87 cell surfaces (erbB-2-positive human gasteric carcinoma) can be significantly improved, compared
to a plain PEGylated liposome. However, no improvement in cytotoxicity against N-87 cells
can be observed, which indicates that the conjugation of ligands can barely improve the internalization of PEGylated liposome. On the other hand, utilizing receptor-specific peptides
as ligands, Stefanick et al. 163,193 showed that the number of peptide-conjugated PEGylated
liposome internalized by H929 and MM.1S multiple myeloma cells cannot be increased compared with a plain PEGylated liposome. However, increasing the hydrophilicity between
peptides can dramatically improve the internalization of the peptide-conjugated PEGylated
liposome. All these experimental observations can be explained by our simulation results:
the mobility of PEG polymers and conjugated targeting moieties can promote the binding
and adhesion of PEGylated liposomes on cell surfaces, but impede the membrane wrapping
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due to the large energy penalty induced by the PEG polymer aggregation. Therefore, increasing the repulsive interactions between PEG polymers or targeting moieties can reduce
their aggregation and facilitate the endocytosis.

4.4

Conclusions

In this work, we performed large scale DPD simulations to understand the influence of PEG
polymer mobility during the endocytosis of PEGylated liposomes. Comparing between the
membrane wrapping processes of a PEGylated rigid NP and a liposome under identical
conditions, we find that the PEGylated liposome gets only partially wrapped, while the
PEGylated rigid NP can be fully wrapped by cell membrane. During the membrane wrapping process, the mobility of PEG polymers enables them to diffuse on the liposome surface
and to rearrange themselves to promote the ligand-receptor binding and adhesion of the
PEGylated liposome. However, the aggregation of PEG polymers also occurs within the
contact region between the liposome and the membrane, leading to a ligand-free region
on the liposome. The PEG polymer aggregation and ligand-free region on the liposome
surface block the further membrane wrapping and result in the ‘bouncing back’ of the liposome to a less wrapped state. By systematically varying the molar ratio of PEGylation
and membrane tension, we find that the PEGylated liposomes are overall more difficult
to be fully wrapped than PEGylated rigid NPs. To understand the physical mechanisms
behind this difference, we analyzed the free energy changes of a PEGylated liposome during
its membrane wrapping process, including the bending energy change of the liposome, the
elastic energy change of the membrane, the ligand-receptor binding energy change, and the
free energy change of the PEG polymers, and compare them with those of the PEGylated
rigid NP. We find that the free energy penalty induced by aggregation of PEG polymers is
about ∼ 800 kB T for the PEGylated liposome, which is twice that of a PEGylated rigid NP.
We therefore conclude that the large free energy penalty induced by PEG aggregation, and
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the ligand-free region on liposome surface are the main reasons that PEGylated liposomes
cannot be efficiently taken up by tumor cells. In addition, we suggest that by increasing
the repulsive interactions between grafted PEG polymers or targeting moieties might help
to limit their aggregation, and in turn, facilitate the internalization of the PEGylated liposome. The current study provides fundamental insights into the endocytosis of PEGylated
liposomes, which could help to design of PEGylated liposomes with high efficacy for drug
delivery.

4.5

Model and Methods

All coarse-grained molecular simulations performed in this work are based on the dissipative
particle dynamics (DPD) method 194,195 . The basic interacting sites in DPD simulations are
represented by soft beads. Between each pair of DPD beads, effective two-body interactions
consist of three major forces 194,195 : a conservative force FC , a random force FR and a
dissipative force FD . Specifically, the conservative force between beads i and j is FC
ij =
aij ω(rij )eij , where rij denotes the distance between the two beads i and j, and eij is the
unit vector pointing from i to j; aij represents the maximum repulsion force. The weighting
factor ω(rij ) is a normalized distribution function as ω(rij ) = 1 − rij /r0 for rij ≤ r0 ,
while ω(rij ) = 0 for rij > r0 . Here r0 is the cutoff distance for pairwise interactions.
p
The random forces are specified by FR
2βij kB T /∆t ω(rij )αeij , where α represents a
ij =
normal distributed Gaussian random number with zero mean and unit variance, ∆t = 0.01τ
p
(τ = mr02 /kB T ), denotes the integration time step, βij is a bead friction coefficient. The
2
dissipative force is given by FD
ij = −βij ω (rij )(eij · vij )eij , where vij is the relative velocity

vector between beads i and j. All pair-wise interactions aij between different types of beads
are listed in the supplementary materials Table.A.1.
All the lipid molecules in our simulations share the same model, in which two lipid
tails (with four tail beads each) are connected with two head beads respectively. The
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head group contains three head beads. Adjacent beads making the lipid molecules are
connected by a harmonic spring potential Us1 = Ks1 (rij − rs1 )2 , with spring coefficient
Ks1 = 64 kB T /r02 , and equilibrium distance rs1 = 0.5r0 . The stiffness of the lipid tails
is guaranteed by an angular potential Uθ1 = Kθ1 (1 − cos θ) with Kθ1 = 15 kB T . Under
control of these potentials, the tension of a planar bilayer is linearly related to the lipid
molecular area 196,197 . The stretch modulus of the membrane can be obtained by the related
slope (supplementary materialsFig.A.17) as KA = 17.42 kB T /r02 . The bending rigidity of
the membrane is given by 97,198 κ = KA d2hh /48 with κ ≈ 6 kB T . The physical length
corresponding to our simulation units are obtained by comparing the membrane thickness
in simulations dHH = 4 r0 to the thickness of a real membrane, dHH ≈ 3.53 nm 91 , indicating
r0 = 0.9 nm. The experimental lipid lateral diffusion coefficient of DMPC 92 is D ' 5 µm2 /s.
In our simulations, the lipid lateral diffusion coefficient Dlipid ' 7.3×10−2 r02 /τ , is calculated
by averaging the values under different membrane tensions (cf.Fig.A.18 in supplementary
materials). Then, we obtain the physical time scale τ = 11.8 ns. Note that these spatial
and temporal mappings are only used to approximate the length and time scales of all DPD
simulations, which are different from the real length and time scales in all-atom molecular
dynamics simulations.
A hydrophilic PEG polymer in our DPD simulations is modeled by a linear chain consisting of coarse-grained monomers. The monomers of PEG polymers are sequentially
connected by a harmonic bond potential: Us2 = Ks2 (rij − rs2 )2 , with spring stiffness
Ks2 = 2111.3 kB T /r02 and equilibrium distance rs2 = 0.4125 r0 . The known flexibility of the
PEG polymer is taken into account by an angular potential between each three consecutive
monomers, defined by Uθ2 = Kθ2 (cos θ −cos θ0 )2 , with bending stiffness Kθ2 = 16.4946 kB T ,
and equilibrium angle θ0 = 130 °. Such a DPD PEG model could correctly reproduce the
conformation of a PEG polymer in water, including the radius of gyration and end-to-end
distance, as shown in our previous studies 72,123 . To describe the PEGylated lipid, one end
of the PEG polymer is bonded to the lipid head bead through a harmonic bond potential.
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In addition, the monomers at the free end of PEG polymers are defined to act as targeting
moieties (ligands) (cf. Fig. 4.1). The polymerization degree of PEG polymers in our simulation is set as N = 30 (representing a molecular weight around 1000 Da), falling within
the typical range of 500-5000 Da in experiments 50,164,199 .
To mimic the ligand-receptor interaction during endocytosis, we assume that 50% of lipid
molecules in the planar bilayer act as receptors. In this way, the receptor diffusion will not
be a factor that limits the efficiency during the membrane wrapping in our simulation 31,73 .
Receptors in the planar membrane follow the same configuration as a lipid, with the head
bead acting as an active site to interact with the ligand. The ligand-receptor interaction
follows a modified Lennard-Jones potential 72,123 as Uij = 4ligand [(σb /rij )12 − (σb /rij )6 ] −
Ucut , when rij ≤ rcut and Uij = 0 otherwise. Here, rcut = r0 for a short-range attractive
interaction and Ucut = 4ligand [(σb /r0 )12 − (σb /r0 )6 ]. The equilibrium distance is fixed by
σ = 0.624r0 . Additionally, the repulsive force is limited to 25 kB T /r0 . We use ligand = 12
kB T . The single ligand-receptor binding energy is then around 6.8 kB T 72 .
Due to the elasticity of the lipid membrane, the tension of membranes in cells can be
adjusted, changing from 0.01 to 10 mN/m 178 . The N -varied DPD method is applied during
the endocytosis process to ensure a constant tension of the planar membrane 70,72,123,171,172 .
In practice, the boundaries of the lipid bilayer are treated as a lipid reservoir for addition
and removal of lipids. If the lipid number per unit area is larger (or smaller) than the target
density ρ1 (or ρ2 ), lipid molecules will be deleted (or inserted) into this boundary region
to maintain a constant lipid number density. Meanwhile, a corresponding number of water
molecules will be inserted (or deleted) randomly in the simulation box to ensure a constant
bead density of 3.0/r03 in the simulation box. By using the N -varied DPD protocol, the lipid
density in the membrane can easily be controlled to maintain the membrane’s lateral tension
during the endocytosis process. More details are given in the supplementary materials for
Chapter 4.
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Chapter 5

Interplay between Ligand Mobility
and Nanoparticle Geometry during
Cellular Uptake of PEGylated
Liposome and Bicelle
5.1

Abstract

We explore the cellular uptake process of PEGylated liposome and bicelle by investigating
their membrane wrapping process using large-scale molecular dynamics simulations. We
find that due to the mobility of ligands on the liposome/bicelle, the membrane wrapping
process of a PEGylated liposome/bicelle can be divided into two stages, whose transition
is determined by a critical wrapping fraction fc ; it is reached when all the ligands are exhausted and bounded to receptors within the cell membrane. Before this critical scenario is
approached, the grafted polyethylene glycol (PEG) polymers aggregate together within the
membrane–wrapped region of the liposome/bicelle, driven by ligand-receptor binding. For
wrapping fractions f > fc , membrane wrapping cannot proceed unless a compressive membrane tension is provided. By systematically varying the membrane tension and PEG molar
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ratio, we establish phase diagrams about wrapping states for both PEGylated liposome and
bicelle. According to these diagrams, we find that the absolute value of the compressive
membrane tension required by a fully wrapped PEGylated bicelle is smaller than that of
the PEGylated liposome, indicating that the PEGylated bicelle is easier to be internalized
by cells. Further theoretical analysis reveals that compared to a liposome, the flatter surface at top of a bicelle makes it energetically more favored beyond the critical wrapping
fraction fc . Our simulations confirm that the interplay between ligand mobility and NP
geometry can significantly change the understanding about the influence of NP geometry
on the membrane wrapping process. It can help us to better understand the cellular uptake
process of PEGylated liposome/bicelle and to improve the design of lipid-like NPs for drug
delivery.

5.2

Introduction

Nanoparticle (NP) based cancer nanomedicine aims to improve the diagnosis and treatment
of diseases by engineering NPs to specifically identify or deliver drugs to tumor sites. 200–202
After being injected into human body, NPs need to circulate in blood flow, 203 penetrate
leaky vessel wall under the enhanced permeability and retention (EPR) effect, 204 diffuse
through extracellular matrix of tumor stroma, 205,206 and finally enter into tumor cells.
During this process, there are many biological barriers confronted by NPs. For instance,
serum proteins in the blood flow can detect and absorb NPs on their surfaces, thus act as
an indicator for macrophage cells to clear these NPs. 50 The cell membrane is an additional
physical barrier to inhibit the NPs from entering the cytoplasm of tumor cells. 60 Therefore,
compositions and surface modifications of NPs are of great importance to NP delivery
efficiency. 23,24,58,65,207
Lipid-like NPs stand themselves out among various NP candidates. 23,110,208,209 For instance, a liposome that consists of a fluid or gel state lipid bilayer shell and aqueous core is
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one of the first studied NPs as a drug carrier. 210–212 The phospholipids surface of a liposome
makes it biologically inert, weakly immunogenic, and low intrinsic toxic. 49,110 Specifically,
Doxil (PEGylated liposome-encapsulated doxorubicin) is the first US Food and Drug Administration approved NP-based delivery formulation for clinical application. 110 By grafting
polyethylene glycol (PEG) polymers on their surface, liposomes demonstrate a prolonged
blood circulation time, which significantly improves the drug accumulation within tumor
sites through the EPR effect. 213 By loading doxorubicin into the PEGylated liposomes,
Doxil demonstrates a higher efficacy for cancer therapy than freely administrated doxorubicin molecules. 110 Nevertheless, liposomes still have some limitations, such as morphology
instability, 210,214 low delivery efficiency 215 and difficulty in size control. 210,216
A bicelle that is composed of a single disc-like lipid bilayer has attracted a lot of attention due to its unique properties and its biocompatibility which it shares with the liposome. 217–219 For instance, bicelles are found to be able to penetrate through the narrow
intercellular spaces of the stratum corneum and show a promising platform for dermal applications. 217 Furthermore, compared with liposomes, bicelles are found to have a better
chance to be internalized by tumor cells. For example, Wang et al. 220 compared the cellular
uptake of bicelles and liposomes with the modification of octa-arginine (R8) sequence in four
different cell lines, including MM-231, human breast cancer cell MCF-7, human umbilical
vein endothelial cell HUVEC and murine macrophage cell RAW264.7. They found that bicelles are more efficiently internalized by all these cells. Particularly, the number of bicelles
internalized by MCF-7 cells is 2.5 times larger than that of liposomes. Additionally, Aresh
et al. 221,222 also found that the cellular uptake efficiency of bicelles is significantly higher
compared with liposomes, based on three different human cancer cell lines of CCRF-CEM,
KB and OVCAR-8.
Despite these important and promising applications in nanomedicine, knowledge about
the interactions between cells and a liposome/bicelle is still quite limited. One of the
key reasons is the possible interplay between NP elasticity, NP geometry, and the ligand
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mobility during the cellular uptake process. First, a fluid or gel state liposome/bicelle is
soft and has the ability to deform itself. 74,105,223?

,224

Second, a liposome is spherical, while

a bicelle is disc-like. These two shapes have dramatically different curvature distributions
on their surfaces, leading to different internalization kinetics. 123 Third, ligands tethered
on PEGylated lipids can freely diffuse on the liposome/bicelle surface. 144,225 Each of these
factors can influence the cellular uptake process of a PEGylated liposome/bicelle. For
instance, due to the deformation of elastic NPs, a soft NP is less energetically favorably
wrapped by the membrane than its rigid counterpart. 45,136 Compared with a spherical NP,
a disc-like NP is more difficult to be fully wrapped by the cell membrane due to its highly
curved surface edge. 78,117? Moreover, the mobility of ligands would induce the aggregation
of PEG polymers and ligands, which suppresses the membrane wrapping. 144,225 However,
it is still not clear how the NP elasticity, geometry and ligand mobility can play together
to influence the whole membrane wrapping process. Particularly, the question on why a
bicelle is more efficiently internalized by cancer cells remains to be answered.
To fill the knowledge gap between experimental results and our current understanding,
we explore the cellular uptake of a PEGylated liposome and bicelle through large-scale
molecular dynamics simulations. In our simulations, the cellular uptake process is mimicked by a membrane wrapping process initiated by ligands on grafted PEG terminals and
receptors in the cell membrane (cf. Fig. 5.1). To get a full picture for the membrane wrapping process of the PEGylated liposome/bicelle, the membrane tension and PEG molar
ratio are systematically varied. In this work, we define the wrapping fraction f as the
ratio between the membrane’s wrapped surface area and the total surface area of the liposome/bicelle. As the ligands are mobile on the surface, the ligand-receptor binding fraction
is defined separately. We find that due to the mobility of ligands on the liposome/bicelle,
the membrane wrapping process can be divided into two stages, separated by a critical
wrapping fraction fc . This fc is defined as the wrapping fraction f when all the ligands are
exhausted and bounded to receptors. As long as f < fc PEG polymers aggregate within
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the membrane–wrapped region of the liposome/bicelle, driven by ligand-receptor binding,
while for f > fc the membrane wrapping cannot proceed unless a compressive membrane
tension is provided. From the phase diagrams about different wrapping states, we find that
the absolute value of compressive membrane tension boundary for the PEGylated bicelle
is smaller than that of the PEGylated liposome, indicating that the PEGylated bicelle is
easier to be internalized. We further proceed to analyze the free energy changes due to
PEG polymers, NP elastic deformations, and membrane bending. The free energy analysis
reveals that the energy barrier induced by PEG polymers is much larger than that of the
NP elastic deformation. These energy barriers can be overcome by ligand-receptor binding
when f < fc . Otherwise, the membrane wrapping is driven by a compressive membrane
tension. Our theory confirms that due to its flatter surface at the top, a bicelle is easier
wrapped than a liposome when f > fc . Our simulations reveal the interplay between the
mobility of PEG polymers and NP geometry and demonstrate that under certain situations
a disc-like NP is energetic more favored than a spherical NP. These findings help us better
understand the cellular uptake process of PEGylated liposome/bicelle, and can thus become
useful in the design of lipid-like NPs for drug delivery.

5.3

Computational Model and Methods

All coarse-grained molecular simulations performed in this work are based on the dissipative
particle dynamics (DPD) method. 194,195 The basic interacting sites in DPD simulations are
represented by soft beads. Between each pair of DPD beads, effective two-body interactions
consist of three major forces: 194,195 a conservative force FC , a random force FR and a
dissipative force FD . Specifically, the conservative force between beads i and j is FC
ij =
aij ω(rij )eij , where rij denotes the spatial distance between the two beads i and j, and eij
is the unit vector pointing from i to j; aij represents the maximum repulsion force strength.
The weighting factor ω(rij ) is a normalized distribution function as ω(rij ) = 1 − rij /r0 for
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Figure 5.1: Molecular structures of computational models: (A) PEGylated bicelle, (B) PEGylated
liposome, and (C) lipid and PEG polymer models for both PEGylated bicelle and liposome. Lipid
heads and tails in a liposome/bicelle are colored in light blue and ice blue, respectively. The PEG
polymers are colored in blue. The ligands (targeting moieties) conjugated on the distal ends of PEG
polymers are represented by red beads. (D) Lipid membrane with over-expressed receptors. Lipid
heads and tails in the membrane are colored in green and gray, respectively. The molecular structure
of receptors is the same as that of lipids in simulations. The bead colored in tan on the receptor
head is the active site to specifically bind to a ligand. As highlighted in (A) and (B), the maximum
radii of liposome and bicelle are the same, sharing a value of 11 r0 .

rij ≤ r0 , while ω(rij ) = 0 for rij > r0 . Here r0 is the cutoff distance for pairwise interactions.
p
The random forces are specified by FR
2βij kB T /∆t ω(rij )αeij , where α represents a
ij =
normal distributed Gaussian random number with zero mean and unit variance, ∆t = 0.01τ
p
(τ = mr02 /kB T ), denotes the integration time step, βij is a bead friction coefficient. The
2
dissipative force is given by FD
ij = −βij ω (rij )(eij · vij )eij , where vij is the relative velocity

vector between beads i and j. All pair-wise interactions aij between different types of beads
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are listed in Table.A.2 of the supplementary materials .
Two different lipid models are adopted in our simulations to represent the lipid molecules
in a liposome/bicelle and the membrane, respectively. A DPD lipid model that mimics the
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) is utilized to assemble the liposome
and bicelle. In this model, the head group of each lipid molecule is represented by three
linearly connected hydrophilic beads, while each of the two tails is represented by 5 hydrophobic beads, 72,226 cf. Fig. 5.1(C). Adjacent two beads are connected by a harmonic
spring potential Us1 = Ks1 (rij −rs1 )2 . The stiffness of the head and tail groups is controlled
by a harmonic bending potential applied on the adjacent three beads Uθ1 = Kθ1 (ϑ − ϑ01 )2 ,
where ϑ denotes a bending angle. Due to the flexible head group in this DPPC lipid model,
the energy penalty to form the bilayer edge in the bicelle is relatively small, facilitating the
formation of a larger sized bicelle. The line tension of the edge in this model is around
λ = 1.4 kB T /r0 . Because of the favorable energy state, a bicelle will transform into liposome only above a critical size. It is impossible in the simulation to create a liposome and
bicelle with identical lipid number. Following the idea in experiments, 220,222 the liposome
and bicelle are assumed to have the same size, around R = 11 r0 (as denoted in Fig. 5.1),
in our simulations. Our liposome and bicelle have 800 and 392 lipid molecules, respectively.
A DPD lipid model that mimics the 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)
is utilized to form the planar membrane. In this lipid model, two lipid tails (carrying four
tail beads each) are connected with two head beads respectively, cf. Fig. 5.1(D). The head
group contains three head beads. Adjacent beads in each lipid molecule are connected by a
harmonic spring potential Us2 = Ks2 (rij −rs2 )2 . The stiffness of the lipid tails is guaranteed
by the bending potential Uϑ2 = Kϑ2 (1 − cos ϑ). Using this DMPC lipid model, the tension
of a planar bilayer is linearly related to the lipid molecular area. 196,197 The stretch modulus
of the membrane can be obtained from the related slope (cf. Fig.A.23 of supplementary
materials) as KA = 17.42 kB T /r02 . The bending rigidity of the membrane is given by 97,198
κm = KA d2hh /48 with κm ≈ 6 kB T , which is within the range of 5-50 kB T obtained in the
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experiments. 99,227 The size of planar membrane bilayer used to investigate the membrane
wrapping is (70×70)r02 . Please refer to the supplementary materials of Chapter 5 for details
about the interaction potential parameters and the calibration of mechanical properties.
A hydrophilic PEG polymer in our DPD simulations is modeled by a linear chain consisting of coarse-grained monomers. The PEG monomers are linearly connected by the
harmonic bond potential Us3 = Ks3 (rij − rs3 )2 , with spring stiffness Ks3 = 2111.3 kB T /r02
and equilibrium distance rs3 = 0.4125 r0 . The semi-flexibility of the PEG polymer is taken
into account by adding the bending potential Uϑ3 = Kϑ3 (cos ϑ − cos ϑ03 )2 , with bending
stiffness Kθ3 = 16.4946 kB T , and equilibrium bending angle θ03 = 130 ° between each three
consecutive monomers. Such a DPD PEG model could correctly reproduce the conformation of a PEG polymer in water, including the radius of gyration and end-to-end distance,
as shown in our previous studies. 72,123 To describe the PEGylated lipid, one end of the PEG
polymer is bonded to the lipid head bead through a harmonic bond potential. In addition,
the monomers at the free end of PEG polymers are defined to act as targeting moieties
(ligands) (Fig. 5.1). The polymerization degree of PEG polymers in our simulation is set as
N = 20 (representing a molecular weight around 660 Da), falling within the typical range
of 500-3000 Da in experiments. 50,164,199 Four different sets of PEG polymer molar ratios of
40, 50, 60, and 70 mol% will be investigated. The corresponding numbers of PEG polymers
nc on liposome are 320, 400, 480 and 560, respectively. Those nc on bicelle are 156, 196,
235 and 274, respectively.
To mimic the ligand-receptor interaction, we assume that 50% of lipid molecules in the
planar bilayer act as receptors. In this way, the receptor diffusion will not be a factor that
limits the efficiency of membrane wrapping in our simulations. 31,73 Receptors in the planar
membrane follow the same configuration as a lipid, cf. Fig. 5.1(D), with the head bead
acting as an active site to interact with the ligand. The ligand-receptor interaction follows
a modified Lennard-Jones potential 72,123 as Uij = 4ligand [(σb /rij )12 − (σb /rij )6 ] − Ucut ,
when rij ≤ rcut and Uij = 0 otherwise. Here, rcut = r0 for a short-range attractive
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interaction and Ucut = 4ligand [(σb /r0 )12 − (σb /r0 )6 ]. Due to the difference between this
ligand-receptor cutoff distance and bilayer thickness, ligands on the NPs can only interact
with the receptors on the outer leaflet. The equilibrium distance is fixed by using σb =
0.624r0 . Additionally, the repulsive force is limited to 25 kB T /r0 . We use ligand = 12
kB T . The single ligand-receptor binding energy is then around 6.8 kB T . 72 This pair-wise
interaction setting between ligands and receptors is a commonly used strategy in simulations
to speed up the membrane wrapping process. 74,105,207,224 Different from the valence-limited
interactions, 228 the pair-wise potential can lead to multivalent ligand-receptor interactions.
The maximum bounded receptors for a ligand is 6 in our simulations. Such a multivalent
interaction is also experimentally possible by engineering antibodies. 229
Due to the elasticity of the lipid membrane, the tension of membranes in cells can
be adjusted, changing from 0.01 to 10 mN/m. 178 The N -varied DPD method is applied
during the membrane wrapping process to ensure a constant tension of the planar membrane. 70,72,123,171,172 In practice, boundaries of the lipid bilayer are treated as a lipid reservoir for addition and removal of lipids. If the lipid number per unit area is larger (or smaller)
than a target density ρ, lipid molecules will be deleted (or inserted) into this boundary region to maintain a constant lipid number density. Meanwhile, a corresponding number
of water molecules will be randomly inserted into (or deleted from) the simulation box to
ensure a constant bead density of 3.0/r03 in the simulation box. The target density ρ is
taken based on the relation between membrane tension and lipid area given in Fig.A.23 of
supplementary materials. By using the N -varied DPD protocol, the lipid density in the
membrane can easily be controlled to maintain the membrane’s lateral tension during the
membrane wrapping process.
The physical length corresponding to our simulation unit is obtained by comparing
the membrane thickness in simulations dHH = 4 r0 to the thickness of a real membrane,
dHH ≈ 3.53 nm, 91 indicating r0 = 0.9 nm. The experimental lipid lateral diffusion coefficient
of DMPC is D ' 5 µm2 /s. 92 In our simulations, the lipid lateral diffusion coefficient Dlipid '
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7.3 ×10−2 r02 /τ , is calculated by averaging the values under different membrane tensions.
Herefrom, we deduce the physical time scale τ = 11.8 ns. Note that these spatial and
temporal mappings are only used to approximate the length and time scales of all DPD
simulations, which are different from the real length and time scales in all-atom molecular
dynamics simulations.

5.4

Results and Discussion
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Figure 5.2: Membrane wrapping process of PEGylated liposome and bicelle. (A) The snapshots in
the upper panel represent the membrane wrapping process of PEGylated liposome. The snapshots
in the lower panel show the corresponding morphology change of liposome. (B) The snapshots in
the upper panel represent the membrane wrapping process of PEGylated bicelle. The snapshots in
the lower panel show the corresponding morphology change of bicelle. Water beads are not shown
for clarity. The membrane tension is maintained at −0.74 kB T /r02 . The PEG molar ratio of both
PEGylated liposome and bicelle is 60%. (The scale bar indicates 20 nm)

5.4.1

Membrane wrapping of PEGylated liposome and bicelle

PEG polymers aggregate during membrane wrapping process.
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Figure 5.3: Detail information about membrane wrapping process of PEGylated liposome and
bicelle. (A-B) The comparison between ligand-receptor binding ratio and membrane wrapping fraction for liposome and bicelle, respectively. (C) The evolution of asphericity for both liposome and
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moments of the gyration tensor (rgx ≤ rgy ≤ rgz ) for a NP. (D) The evolution of average end-to-end
distance for PEG polymers in both PEGylated liposome and bicelle.

We firstly investigate the membrane wrapping process of the PEGylated liposome and
bicelle under a membrane tension of −0.74 kB T /r02 , where 1 kB T /r02 corresponds to 5 mN/m.
The PEG polymer molar ratio in both liposome and bicelle is 60% mol. As given in Fig. 5.2,
the PEGylated liposome and bicelle are initially placed above the membrane at a distance of
5 r0 . The PEG polymers are almost evenly distributed on the liposome and bicelle surfaces
at t = 0. Due to the attraction between ligand and receptor, the PEGylated liposome
quickly adheres on the membrane. At the same time, the membrane starts to bend and
partially wrap the liposome. Furthermore, the PEG polymers aggregate within the wrapped
region of the liposome because of their mobility. 144 The aggregation is more pronounced at
t = 118 µs in Fig. 5.2(A), which results in a PEG/ligand free region at the top of the yet
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unwrapped part of liposome. As investigated in our previous work, 144 the ligand depletion
on top of a NP will suppress the membrane wrapping on PEGylated liposome compared to
a rigid NP. At t = 472 µs, the membrane begins to protrude and spread over the top part
of the liposome. At t = 944 µs the liposome is fully wrapped (f = 1). Associated with
this full wrapping, the PEG polymers rearrange and redistribute over the entire liposome
surface. As shown in the lower panel of Fig. 5.2(A), the liposome adjusts itself to deform
along with the evolution of the wrapped state.
The wrapping process of the PEGylated bicelle shows a similar configurational pathway
in terms of the PEG polymers’ aggregation and rearrangement in Fig. 5.2(B). Half of the
bicelle is quickly wrapped by the membrane at t = 59 µs. PEG polymers start to aggregate
within the wrapped region. At t = 118 µs, with more PEG polymers aggregated, the
bicelle elongates into a strip-like shape. Compared to a disc-like geometry, this strip-like
shape has a longer edge, in which it produces a large curvature. This large curvature at
the edge can release the increased interactive energy between aggregated PEG polymers. 230
At t = 236 µs, the bicelle slightly rotates to release the membrane energy. At the same
time, lipids in the membrane start to protrude. Following the membrane protruding and
PEG polymer rearrangement, the bicelle recovers its initially disc-like shape when fully
wrapped at t = 336 µs. It is also interesting to note that during the wrapping processes for
both liposome and bicelle, the ligands arrange in a ordered strip-like pattern. This specific
arrangement of ligands should be caused by the competition between the PEG free energy
and ligand-receptor binding energy.
To explore more details behind the membrane wrapping process, we proceed to calculate both the ligand-receptor binding fraction and wrapping fraction f . The binding
fraction is defined as the ratio of bonded ligand number over total ligand number in the
liposome/bicelle. As given in Fig. 5.3(A) and Fig. 5.3(B), due to the mobility of ligands
on PEG polymers, the increment of binding fraction is much faster than that of f in both
the PEGylated liposome and the bicelle. As highlighted by the dashed lines, it is worth
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noticing that all the ligands in the liposome and bicelle are bound to receptors in the membrane and exhausted at the critical wrapping ratio fc ≈ 0.7. It means that no driving
force can be provided by ligands at the later wrapping state (f > fc ). To fully wrap the
liposome/bicelle, the key question is what will drive the membrane wrapping after ligands
have been exhausted.
40 % mol

50 % mol

60 % mol

70 % mol

(B) 40 % mol

50 % mol

60 % mol

70 % mol

PEGylated bicelle

PEGylated liposome

(A)

Figure 5.4: Membrane wrapping states of PEGylated (A) liposome and (B) bicelle with different
PEG molar ratios under membrane tension of 0.09 kB T /r02 . All the simulations are run long enough
without further wrapping state changes.

We further calculate the asphericity of liposome/bicelle, and the end-to-end distance of
2 − 0.5(r 2 + r 2 ),
grafted PEG polymers. The asphericity of liposome/bicelle, defined by rgz
gx
gy
2 , r 2 and r 2 are the ordered principal mois plotted against f in Fig. 5.3(C). Here, rgx
gy
gz
2 ≤ r 2 ≤ r 2 ). A large asphericity value indicates a
ments of the NP gyration tensor (rgx
gy
gz

pronounced anisotropic shape. 142 As we can see in Fig. 5.3(C), the variation of asphericity
is more pronounced for the bicelle. Especially, near the wrapping fraction of f ≈ 0.75,
the asphericity of the bicelle has increased by a factor 2 compared with its initial value.
This large variation corresponds to the strip-like shape of the bicelle at t = 118 µs, cf.
Fig. 5.2(B), when all the PEG polymers are aggregated within the wrapped region. The
2 i1/2 as given in Fig. 5.3(D), is another indicator of
average end-to-end distance Ree = hRee

PEG polymers configurations. The Ree for both liposome and bicelle increase with increasing wrapping fraction below f ≈ 0.7, since PEG polymers still tend to aggregate within
the wrapping region. Afterwards, their Ree values change slightly with the redistribution
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of PEG polymers.
PEGylated liposome and bicelle cannot be fully wrapped under positive
membrane tension
To explore possible different states for both the PEGylated liposome and bicelle during
the membrane wrapping process, we next investigate the situation with a slightly positive
membrane tension 0.09 kB T /r02 . Additionally, a series of different PEG molar ratios, ranging
from 40% mol to 70% mol, are considered. As we can see in Fig. 5.4, under the positive
membrane tension, all of the PEGylated NPs cannot be fully wrapped by the membrane, and
remain in a partial wrapped state. Furthermore, due to their mobility, all PEG polymers are
aggregated within the wrapped region of the liposome/bicelle, leaving a ligand-free region
at the top. Specifically, the morphology of the liposome at the trapped state is highly
dependent on the PEG molar ratio as shown in Fig. 5.4(A). At 40% mol and 50% mol, the
liposomes deform into ellipsoidal shapes. The membrane wrapping process of 50% mol is
given in Fig.?? of supplementary materials. At 60% mol, it is interesting to find that lipids
at one side of the liposome’s contact edge form a tubular shape. This tubular shape should
be caused by the continuously aggregating PEG polymers, which results in highly packed
PEG polymers (and linked lipids) states in the contact edge (cf. Fig.A.25 of supplementary
materials). The formation of the tubular shape is favorable as it releases the increased steric
interaction for both PEG polymers and lipids. More importantly, the liposome with 70%
mol PEG polymers ruptures during the wrapping process and deforms into a strip-like shape
at the end of simulation. The rupture of the liposome should be induced by a decrease of the
water storage space. Details about the rupture process of the PEGylated liposome during
the membrane wrapping process are available in the supplementary materials of Chapter 5.
Concerning the PEGylated bicelle, its configuration within the trapped state is also
dependent on the PEG molar ratio. At 40 % mol and 50 % mol, the trapped bicelle
maintains its disc-like shape, while it finally deforms into the above–mentioned strip-like
shape at 60 % mol and 70 % mol. The membrane wrapping processes for bicelles with 50%
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Comparison between PEGylated bicelle and liposome

mol and 70% mol PEG polymers are given in Fig.A.26 of supplementary materials.
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Figure 5.5: Phase diagrams for membrane wrapping of PEGylated (A) liposome and (B) bicelle
under the influence of the membrane lateral tension and PEG molar ratio. The red circles represent
the cases of being fully membrane wrapped. The green triangles represent the rupture of PEGylated
liposomes. The blue squares are the cases of being partially membrane wrapped. The half open blue
squares in PEGylated liposome represent the cases that the liposome is protruded into a tubular
shape. The open squares in PEGylated bicelle are the cases that the bicelle is elongated to strip-like
shape.

Phase diagrams reveal a compressive (negative) membrane tension boundary

In view of the different wrapping states of the PEGylated liposome/bicelle, to come
up with a complete picture, we proceed to investigate the influence of both membrane
tension and PEG molar ratio. The membrane tension is varied from negative tension
of −0.74kB T /r02 to positive tension of 1.0kB T /r02 , beyond which the membrane has large
chances to ripple or rupture in the simulation. A phase diagram is obtained for both the
PEGylated liposome and bicelle as shown in Fig. 5.5. For the PEGylated liposome, according to Fig. 5.5(A), there are three main regions in the phase diagram: (1) When the PEG
molar ratio is high, the liposome ruptures. This upper boundary about PEG molar ratio
limits the maximum number of decorated ligands. (2) If the PEG molar ratio is not large
enough or the membrane tension positive, the liposome is only partially wrapped by, and
trapped inside the membrane. (3) A fully wrapped state for the PEGylated liposome exists
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only for the situation with high PEG molar ratio and compressive (negative) membrane
tension. For the phase diagram of PEGylated bicelles shown in Fig. 5.5(B), there are two
main regions: (1) When the membrane tension is positive and the PEG molar ratio is small,
the PEGylated bicelle is partially wrapped by, and trapped inside the membrane. (2) If
the membrane tension is sufficiently small and the PEG molar ratio high, the PEGylated
bicelle is fully wrapped by the membrane. Additionally, both the PEGylated liposome and
bicelle have extra minor regions about tubular and strip-like shapes, respectively.
Comparing these two phase diagrams, we find that the PEGylated bicelle has a larger
chance to be fully wrapped. First, the possibility for the PEGylated liposome to rupture
sets an upper limit boundary to the PEG polymer molar ratio, which does not exist for the
PEGylated bicelle. Additionally, the minimum required PEG molar ratio for the PEGylated liposome is larger than that of PEGylated bicelle. More importantly, it is interesting
to find that the full wrapping (f = 1) of the PEGylated liposome and bicelle can only
happen when the effective membrane tension is compressive. Due to the mobility of PEG
polymers, the ligands on the liposome/bicelle are exhausted before its fully wrapped state
is reached. It is the compressive tension that makes it energetically favorable and drives
the membrane wrapping after ligands exhausted. Furthermore, the PEGylated bicelle has
a larger membrane tension boundary compared to that of the PEGylated liposome , i.e.,
the absolute value of the compressive membrane tension boundary for the PEGylated bicelle is smaller than that of the PEGylated liposome. This suggests that a PEGylated
bicelle is easier to be fully wrapped by the membrane than its liposomic counterpart. The
key question about the membrane tension boundary is why the PEGylated bicelle is more
favorable. In living cells, the required compressive membrane tension can be produced
through active mechanisms. 231 For instance, the contraction of actomyosin can produce
a compressive stress on the cytoskeletal network, resulting in a locally compressive membrane tension. 232,233 It might also suggests that for the cellular uptake of the PEGylated
liposome/bicelle, other biological mechanisms should be involved apart from the receptor115
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Figure 5.6: Critical wrapping fraction against PEG molar ratio for PEGylated liposome and bicelle.
The critical wrapping fraction is defined by the wrapping fraction for ligand-receptor binding fraction
approaching 1.0. The membrane tension for the cases listed in the figure is −0.744 kB T /r02 .

Considering the importance of ligand exhausting, we calculate and compare the critical
wrapping fraction fc for a PEGylated liposome and bicelle. When f > fc , any further
membrane wrapping is driven by the compressive membrane tension alone. As shown in
Fig. 5.6, the fc is increasing with the increment of PEG molar ratio. At the same PEG
molar ratio, PEGylated liposome and bicelle share a similar fc value. Moreover, within the
studied range of PEG molar ratio, all the fc values are larger than 0.68.

5.4.2

Free energy analysis on membrane wrapping process

To provide deep insights into why a PEGylated bicelle is easier to be wrapped than a PEGylated liposome under otherwise similar condition, we perform a free energy analysis for the
membrane wrapping process. During this process, free energy changes are composed of four
major parts: (1) The ligand-receptor binding energy ∆FLR that provides the driving force
for membrane wrapping. (2) The energy change caused by PEG polymers aggregation and
configurational changes, ∆FPEG . (3) The energy change induced by the deformation of soft
liposome or bicelle, ∆FNP . (4) The energy change associated with the membrane bending,
∆Fm . In our simulations, the individual binding strength between the ligand and receptor
is about 6.8 kB T . Therefore, ∆FLR has a linear relationship with the ligand-receptor bind116

ing fraction. In the following parts, we will analyze these free energy changes. Note that
the possible free energy changes induced by the membrane fluctuation and translational
entropy loss of receptors (and solvent molecules) are small compared with above free energy
changes. 106,107 We ignore their contributions to simplify the free energy analysis.
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Figure 5.7: (A-B) Cross-sectional views of PEG polymer volume fraction distribution during the
membrane wrapping process: (A) PEGylated liposome and (B) PEGylated bicelle.

Aggregation of PEG polymers leads to a large energy barrier
We firstly investigate the free energy change of PEG polymers. Along with the aggregation and rearrangement of PEG polymers, their free energy change consists of three
parts: 72,123,168 (1) Elastic energy change ∆Fel , associated with the stretching or compressing
of polymer chains, in analogy to elastic springs. (2) Interaction free energy change ∆Fint ,
caused by the change of interaction strength between PEG polymers. (3) Translational free
energy change ∆Ftrans , reflecting the translational entropy loss of polymers. Therefore, the
total free energy change of PEG polymers can be expressed as

∆FPEG = ∆Fel + ∆Fint + ∆Ftrans .

(5.1)

Following the approaches in our previous works, 72,123,144,153,179 each part of ∆FPEG can be
estimated by feeding self-consistent mean field (SCF) theory with the information about
PEG polymer configurations and local volume fractions from DPD simulations. Based on
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the SCF theory, the mean elastic energy Fel per chain is linearly proportional to the mean
2 i, F /n k T = 3hR2 i/2R2 , where R represents the equisquared end-to-end distance hRee
c B
0
el
ee
0

librium span of an unconstrained PEG polymer with polymerization degree N , and nc de2 i using the available N –dependent
notes the number of PEG chains. We employ R02 ∝ hRee
w
2 i values for a single PEG chain in water. 72 The mean interaction free energy of each
hRee
w

chain Fint is quantified through the spatially inhomogeneous volume fraction φ(r) of PEG
R
monomers. Fint /kB T = fmix (φ)d3 r, where fmix (φ) = (φ2 + φ3 )/v is a mixing free energy
density, and v = 0.0633 nm2 is the excluded volume for a PEG monomer. The integral
extends over the whole PEG–populated volume. The translational free energy ∆Ftrans is
directly related to the variable distribution of mobile PEG tethering points on the NP surR
face. It is estimated by the volume fraction profile as Ftrans /nc kB T = φ ln(φ)d3 r/N v. Note
that the intrinsic relaxation time of a PEG polymer with polymerization degree N = 20 is
smaller than 100 ps. 186 While a time step ∆t in our DPD simulations corresponds to 118
ps. It indicates that PEG polymers are able to relax themselves on a time scale that is short
compared with the total simulation time, the equilibrium SCF approach can be considered
applicable, and we can extract ∆FPEG in the course of simulation time.
Taking the membrane wrapping processes in Fig. 5.2 for example, the local volume fraction distributions φ(r) of PEG polymers change dramatically during their aggregation and
redistribution, as quantified in Fig. 5.7. Under the conditions of 60% mol PEG polymers
and −0.744kB T /r02 membrane tension, the evolution of φ(r) can be divided into two different stages. Before the exhausting of ligands (t = 472 µs and t = 118 µs for PEGylated
liposome and bicelle, respectively), the PEG volume fraction in the wrapped part of the
liposome/bicelle significantly increases due to the aggregation of PEG polymers and to the
expense of a dramatically reduced φ(r), associated with the depletion of PEG polymers, in
the unwrapped part. This highly inhomogeneous PEG volume distribution manifests itself
in coexisting highly compacted and reduced occupied regions for PEG polymers, disfavored
by Fmix . Along with the spreading of membrane over the top part of the liposome/bicelle,
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the PEG volume fraction starts to recover its initial homogeneous distributed state. Note
that if the liposome/bicelle remains at the trapped state as for the positive membrane tension cases, the PEG volume fraction distribution is maintained at the highly inhomogeneous
state as shown in Fig.A.27 of supplementary materials.
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Figure 5.8: Free energy changes of PEG polymers during membrane wrapping process for PEGylated (A) liposome and (B) bicelle, respectively.

Combining the above PEG volume fraction distribution and end-to-end distance of PEG
polymers in Fig. 5.3, we can estimate the free energy change of each of the three contributions to ∆FPEG as shown in Fig. 5.8. The dashed lines denote the location of the fc
values. For the PEGylated liposome, ∆FPEG dramatically increases along with the ligandreceptor binding and PEG aggregation as long as f < fc . The maximum value of ∆FPEG
is around 1000 kB T for the liposome. The changes of elastic energy ∆Fel and interaction
energy ∆Fint are seen to dominate the PEG energy increment. Compared with ∆Fel and
∆Fint , the translational entropy change of PEG polymers ∆Ftrans is near zero and can be
neglected. With the recovering to a homogeneous PEG distribution, the ∆FPEG decreases.
The PEG free energy changes of the PEGylated bicelle follow a similar trend, while they
are overall smaller due to the smaller number of PEG polymers in our bicelle; the maximum
energy barrier is at ∆FPEG ≈ 600 kB T for the bicelle. Note that for the trapped state of
the liposome/bicelle, the ∆FPEG will maintain at its maximum value due to the end-to-end
distance increment and highly inhomogeneous PEG volume fraction distribution as given in
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Fig.A.27 of supplementary materials. In short, the PEG polymers produce a large energy
barrier during the membrane wrapping process for both PEGylated liposome and bicelle.
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Figure 5.9: Free energy changes from elastic deformations of liposome and bicelle versus wrapping
fraction f .

Nanoparticles’ elastic deformation energy is small
We proceed to analyze the energy change ∆FNP accompanying the deformations of
liposome and bicelle. We consider the membrane wrapping processes in Fig. 5.2 as representative examples to estimate the energy penalty due to NP deformation. For the deformed
liposome as given in Fig. 5.2(A), its surface area is usually assumed to be time-independent.
Additionally, the energy change caused by an osmotic pressure variation is negligible because of the relaxed initial state of the liposome. 45 Therefore, the major contribution to
∆FNP for liposome should be the bending energy associated with curvature variation. This
bending energy can be estimated by fitting the shape of the liposome by an ellipsoid as we
proposed in our previous work. 144 Based on this fitted shape, the bending energy of the
R
liposome can be obtained by following Helfrich’s expression, Elip = 12 κlip s (c1lip + c2lip )2 dS,
where κlip is the assumed spatially homogeneous bending rigidity of the liposome, and c1lip
and c2lip are the principal curvatures of the fitted ellipsoidal surface. For a bicelle, its total
deformation energy consists of bending energy and edge energy. 234,235 The bending energy
change of the bicelle is negligible, due to the small variation of curvature during the entire
membrane wrapping process, c.f. Fig.A.28 in supplementary materials. To estimate the en-
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ergy change from edge length variation, we fit the bicelle by an ellipse. The energy change
of the bicelle can then be obtained as Ebic = Lλ, where L is the perimeter of the fitted
ellipse, and λ the line tension of the bicelle. The estimated free energy changes ∆FNP for
both liposome and bicelle are given as function of f in Fig. 5.9. The energy variation of
the liposome is smaller than 25kB T during the whole wrapping process, consistent with the
observed small asphericity (Fig. 5.3). For the bicelle, its energy increases more significantly
with its elongation. Its maximum value is around 70kB T . However, comparing with the
energy change ∆FPEG due to PEG polymers, FNP is much smaller for both liposome and
bicelle.
(A)

Liposome
(B)

Bicelle

Deformed bicelle

(C)

Figure 5.10: Membrane energy change. (A) Illustration of the membrane wrapping for NPs with
different geometries at f = 0.85. The red part of NPs denotes the wrapped region. The unwrapped
part of NPs is colored by blue. (B) Membrane bending energy versus f . The inserted figure is
the derivative of membrane bending energy versus f . (C) Critical tension versus f for different NP
geometries. The inserted figure is the amplified plot for the regime 0.7 < f < 1.0. The critical
tension σcritical is defined by the minimum required membrane tension that can drive the membrane
wrapping, when the wrapping is only driven by compressive tension.
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Critical membrane tension is crucial for full wrapping
As we mentioned, the PEG polymers produce a large free energy barrier during the
membrane wrapping process. This barrier can be overcome below the fc by consuming
the ligand-receptor binding. However, beyond the fc , ligands on the liposome/bicelle are
exhausted. The membrane wrapping cannot proceed unless any other driving force is provided. As revealed by the phase diagrams, a compressive membrane tension is required
for a successful wrapping. Therefore, the membrane energy change plays a crucial role for
f > fc . Here, we provide a theoretical analysis about membrane energy change to reveal
and compare the required compressive membrane tensions for liposome and bicelle.
The membrane energy Em consists of two parts: (1) membrane bending energy Embend
and (2) membrane tension energy Emtens ,

Em = Embend + Emtens .

(5.2)

To estimate Em , we assume that an uncorrugated membrane wraps around a solid NP.
The geometry of the solid NP is taken based on the shape of the liposome and bicelle in
Fig. 5.2. As illustrated in Fig. 5.10(A), three different shapes are considered. The first one
is a spherical NP to represent the liposome. The radius of the spherical NP is taken as
14.5 r0 , based on the radius of the liposome 11 r0 and the thickness 3.5 r0 of PEG polymer
shell. The second one is an oblate NP to mimic the undeformed bicelle. Its principle radii
are R1 = R2 = 14.5 r0 and R3 = 6 r0 , obtained from the principle radius of the bicelle and
thickness of the PEG polymer shell. The third one is a biaxial ellipsoidal shape to represent
the elongated bicelle, with the principle radii R1 = 19 r0 , R2 = 10 r0 and R3 = 4 r0 . These
values are taken from the fitted ellipsoidal shapes of the entire PEGylated bicelle during the
wrapping process (cf. Fig.A.29 in supplementary materials). To simplify the analysis, we
only consider the wrapped (red) part of NPs, which can effectively catch the main membrane
energy penalty during the wrapping process. 224,236,237 With these parameters at hand, the
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contributions to the membrane energy (Eq. 5.2) at a certain wrapping fraction f can be
expressed as

Embend (f ) =

κm
2

Z

(c1m + c2m )2 dS,

Emtens (f ) = σ∆S

(5.3)
(5.4)

where κm is the bending rigidity of the membrane; c1m and c2m are its spatially dependent
principal curvatures. The integration is taken over the wrapped region of the NP; σ is
the membrane tension and ∆S is the excess membrane area caused by membrane bending.
The details about the expressions of curvatures and excess membrane area are given in the
supplementary materials for Chapter 5. We firstly calculate the membrane bending energy
Embend for these three NPs. As given in Fig. 5.10(B), the Embend is always positive and
monotonically increasing with increasing f due to the large curvature of NPs. Additionally,
near the critical wrapping fraction (f ≈ 0.7), the Embend of the bicelle is larger than that
of the liposome, consistent with our previous observations. 123 However, the derivative of
Embend with respect to f is smaller for the bicelle than for the liposome. Note that, according to our previous discussions, the membrane wrapping is driven by the compressive
membrane tension for f > fc . To gain an energetically favorable state by membrane wrapping, the derivative of the membrane energy with respect to f should be smaller than zero,
dEm (f )/df ≤ 0. Based on the derivative of the membrane energy, we can thus conclude
that σ(f ) ≤ σcritical must hold, where the critical membrane tension is given by

σcritical = −

κm
2



d
df

Z

 

d∆S
(c1m + c2m )2 dS /
.
df

(5.5)

The corresponding numerically evaluated σcritical for all three shapes is given in Fig. 5.10(B).
Comparing the critical membrane tension for liposome and bicelle, it is interesting to find
that there are two regions. For wrapping fractions f < 0.7, the σcritical for the bicelle is
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smaller than that of the liposome because of its highly curved edges. However, for f > 0.7,
the σcritical for the bicelle is larger than that of the liposome, which indicates it is easier
to wrap the bicelle after f = 0.7. After f = 0.7, the σcritical for liposome/bicelle are both
around σcritical = −0.1 kB T /r02 . Interestingly, this value is consistent with the membrane
tension boundary we found in the phase diagrams (Fig. 5.5). Moreover, the transition
wrapping fraction of f = 0.7 is in good agreement with the critical wrapping fraction fc in
Fig. 5.6. These agreements further prove that our membrane energy analysis can estimate
the key energy barrier for the bilayer wrapping on a NP. In short, our theoretical analysis
explains why bicelle is energetically more favorable than the liposome after the exhausting
of ligands.
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Figure 5.11: (A) Comparison between critical membrane tensions of spherical and oblate NPs.
The surface area of these NPs is assumed to be identical. The radius of the spherical NP is taken
as R = 14.5 r0 . The shape of the oblate ellipsoidal NP is specified by R1 = R2 > R3 , where R1 , R2
and R3 are its principle radii. The curve with aspect ratio R1 /R3 = 1 represents the spherical NPs.
The membrane bending rigidity is taken as 6 kB T . (B) Cross wrapping fraction against aspect ratio
R1 /R3 . The cross wrapping fraction is defined as the wrapping fraction where the oblate starts to
have a larger critical membrane tension.

The free energy analysis above reveals that the membrane tension required by the disclike bicelle is larger than that of the liposome. It suggests that under the driving of compressive membrane tension beyond the fc , the disc-like bicelle is energetically more favorable
than the spherical liposome. Our result is different from the previous conclusion that driven
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by the ligand-receptor binding, a disc-like NP is energetically difficult to be fully wrapped
compared to a spherical NP. 78,117,118 Our results indicate that the interplay between ligand/PEG mobility and NP geometry can significantly change the existing picture about
the influence of NP geometry on the membrane wrapping process. To confirm the interplay
between ligand/PEG mobility and NP geometry, we further analyze the critical membrane
tension for spherical and oblate NPs with different aspect ratios at f > 0.5. The surface
areas of spherical and oblate NPs are considered identical. As given in Fig.5.11, all the
oblate NPs with aspect ratio > 1 require larger membrane tensions than spherical NPs.
Furthermore, the wrapping fraction, beyond which an oblate NP is energetically favorable,
is decreasing with increasing aspect ratio. This fact indicates that driven by the compressive
membrane tension, an oblate NP with larger aspect ratio is easier to be fully wrapped in
the later membrane wrapping stage (at f > fc ) due to its flat surface on top.

5.5

Conclusions

In this work, we performed large scale DPD simulations to understand the membrane wrapping processes of PEGylated liposome and bicelle. We find that during the wrapping process, characterized by the wrapping fraction f , PEG polymers on liposome and bicelle
aggregate within their wrapped region due to the mobility of polymers and ligands-receptor
binding. This aggregation promotes the ligand-receptor binding in the early membrane
wrapping state. But the quick ligand and receptor binding results in a critical wrapping
fraction fc , after which the ligands are exhausted. According to the fc , the entire membrane
wrapping process for PEGylated liposome/bicelle can be divided into two different stages:
(1) As long as f < fc , the membrane wrapping is driven by ligand-receptor binding. (2)
For f > fc , no driving force can be provided by ligand-receptor binding. Membrane wrapping cannot proceed unless a compressive membrane tension is provided. Furthermore, by
systematically varying the molar ratio of PEG polymers and membrane tension, we find
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that the PEGylated liposome is overall more difficult to be fully wrapped than PEGylated
bicelle because of two major reasons: (1) the possibility of rupture of the liposome at high
PEG molar ratio sets the upper limit of ligand number. Such rupture did not occur for the
bicelle under all PEG molar ratios studied in our simulations. (2) The absolute value of the
compressive membrane tension boundary of the PEGylated bicelle is smaller than that of
the PEGylated liposome, which indicates the the bicelle is the one that is easier to be fully
wrapped.
Our free energy analysis revealed that PEG polymer aggregation leads to a large free
energy barrier, while the energy barrier caused by NP deformation is relatively small and
negligible. By analyzing the membrane energy, we find that the absolute value of the
compressive membrane tension required by a disc-like bicelle is smaller than that of a
spherical liposome, which suggests that the disc-like bicelle is energetically more favorable
than the spherical liposome at f > fc , where a compressive membrane tension is required to
provide the driving force. The compressive membrane tension in living cells can be produced
through active mechanisms. 232,233,238 Our results confirm that the interplay between ligand
mobility and NP geometry can significantly change our understanding about the influence
of NP geometry on the membrane wrapping process. This work can also help understand
the cellular uptake process of PEGylated liposome and bicelle, which might improve the
design of new lipid-like drug delivery platforms.
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Chapter 6

Self-Assembly of Core-Polyethylene
Glycol-Lipid Shell (CPLS)
Nanoparticles and the Potential as
Drug Delivery Vehicles
6.1

Abstract

Herein a new multifunctional formulation, referred to as a core-polyethylene glycol-lipid shell
(CPLS) nanoparticle has been proposed and studied in silico via large scale coarse-grained
molecular dynamics simulations. A PEGylated core with surface tethered polyethylene glycol (PEG) chains is used as the starting configuration, where free ends of the PEG chains
are covalently bonded with lipid molecules (lipid heads). A complete lipid bilayer is formed
at the surface of the PEGylated particle core upon addition of free lipids, driven by the hydrophobic properties of the lipid tails, leading to the formation of a CPLS nanoparticle. The
self-assembly process is found to be sensitive to the grafting density and molecular weight
of the tethered PEG chains, as well as the amount of free lipids added. At low grafting
densities the assembly of CPLS nanoparticles cannot be accomplished. As demonstrated
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by simulations, a lipid bud/vesicle can be formed on the surface when excessive amount of
free lipids are added at high grafting density. Therefore, the CPLS nanoparticles can only
be formed under the proper conditions of both PEG and free lipid. The CPLS nanoparticle
is recognized to be able to store a large quantity of water molecules, particularly with high
molecular weight of PEG chains, signaling its capacity for carrying hydrophilic molecules
such as therapeutic biomolecules or imaging agents. Under identical size and surface chemistry conditions of a liposome, it has been observed that the CPLS particle can be more
efficiently wrapped by the lipid membrane, indicating its potential for greater efficiency in
delivering its hydrophilic cargo. As a proof-of-concept, the experimental realization of CPLS
nanoparticles is explicitly demonstrated in this study. To test the CPLS’s capacity to store
small molecule cargo a hydrophilic dye was successfully encapsulated in the particles’ water
soluble layer. The results of this study show the power and potential of simulation-driven
approaches for guiding the design of more efficient nanomaterial delivery platforms.

6.2

Introduction

The development of nanoparticles (NPs) as drug delivery carriers has been driven by the
need for biocompatible targeted delivery of small molecules. For instance, the freely administered drug agents for cancer treatments can be quickly filtered after blood circulation
post injection. 204 By loading drug molecules into the NP-based drug carriers, the blood circulation time can be significantly improved. 110 It has been shown that tumor accumulation
of small drug molecules can be increased due to the enhanced permeability and retention
(EPR) effect, 204 induced by the leakage of the vascular walls at or near the tumor site.
To design drug carriers with greater potential to deliver drug cargoes that are compatible
with the complex biological environment of human and animal bodies, the following barriers
should be considered: 1) the reticuloendothlia system (RES) organs that can sequestrate
NPs within the liver or spleen; 2) the high pressure at the tumor site and tightly packed
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extracellular matrix (ECM) around the tumor that could prevent the NPs from reaching
the tumor cells by diffusion; 3) the lipid membrane of tumor cells that may prohibit the
internalization of NPs. 23 On the other hand, these suggested features could be used for targeting tumors. For example, the vascular wall leakage induced EPR effect has been widely
used for designing NPs which passively target tumors. 239–241
Recognizing the above biological features, the size, shape, stiffness and surface functionalities presented by NPs are tunable features which can be designed to specifically
overcome these barriers and to enhance the carrier’s overall efficacy. 23,24,58,65,242–246 It has
been reported that the probability that NPs will be sequestrated by RES organs increases
as the size of a liposome increases. 211 The EPR effect has been shown to prefer spherical
NPs with diameters less than 100 nm to extravasate the porous blood capillaries near the
tumor. 110 Moreover, the ligand-receptor mediated endocytosis of NPs is governed by the
diffusion of free receptors residing on cell membranes along with the bending energy of
the membrane. 60 Thus, there exists an optimal size of NPs to be delivered into tumors. 23
In addition, NPs developed without surface functionalization can be quickly detected by
serum proteins, and subsequently removed by the mononuclear phagocyte system (MPS).
To combat this, surface grafting of hydrophilic polyethylene glycol (PEG) is typically used
to prevent the absorption of serum proteins, and increase blood circulation times. 72,247,248
PEGylated NPs can therefore be more efficiently delivered into the tumor site due to the
EPR effect. 55
In light of these findings, various NP types have been proposed and investigated, including liposomes, dendrimers, micelles and gold NPs, among many others. Despite these
developments, the in vivo and clinical testing results are not very encouraging. 249,250 To
date, only a few of these NPs have been approved by the U.S. Food and Drug Administration (FDA) to be commercially available on the market. 208 Among them, Doxil was the first
approved by the FDA for cancer treatment. 110 By loading anticancer drug molecules such
as doxorubicin, into liposomes, the accumulation of these drug molecules was significantly
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enhanced with the help of the EPR effect compared to that of the free drug molecules
on their own. The success of Doxil relies on three major principles 110 : 1) PEGylation of
nano-liposomes serves to increase the blood circulation time and to avoid the RES organ
sequestration; 2) a transmembrane ammonium sulfate gradient which allows high and stable
remote loading of doxorubicin and drug release at the tumor site; 3) the lipid molecules
within liposomes are in a ‘liquid ordered’ phase. However, the efficiency of Doxil is still
limited by several factors, both from a synthetic and delivery point of view. As synthesized
liposomes do not have uniformity in size and require extrusion prior to administration. 216
In addition, they have limited stability during the early phases of drug delivery (crossing of
the cell’s lipid bilayer) and can leak their contents before arrival at their intracellular target
due to pore formation and degradation of the liposome. 251 Lastly, as aforementioned, the
size of NPs should fall in a narrow range to overcome biological barriers and utilize the
EPR effect for passive targeting.
With these limitations in mind, we present here a rationally designed NP formulation
that mimics a liposomes outer bilayer but that can achieve uniform size through a bottom
up synthetic approach afforded by an inorganic NP scaffold at its core. The proposed NP
was found through both simulation and experiments to have a more uniform size and as
demonstrated through simulation, exhibits an enhanced stability compared with a traditional liposome. We hypothesize that this NP formulation can be used as drug carrier with
high efficacy. In this design, PEG polymers synthesized with one end of the PEG chain covalently linked to a lipid molecule (attached at the lipid head group) is covalently bound to
the surface of an inorganic NP core, as shown in Fig. 6.1. The inorganic core could be made
of gold, silica, superparamagnetic iron oxide and many other nanomaterials. The particle
can equally be considered as a PEGylated NP with all its terminal PEG chains bonded
with lipid molecules (lipid heads). These lipid molecules are denoted as ‘anchored lipids’.
In water, the PEGylated particles display the charged head groups of the anchored lipids
to enhance their solubility. The addition of free lipids to the PEGylated particles induces
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the automatic absorption and formation of a lipid bilayer, due to the hydrophobic nature
of the lipid tails, as long as a sufficient amount of free lipid molecules are added (cf. Fig.
6.1). This way, a core-shell structure is built out from the inorganic NP core, where PEG
polymer is sandwiched between the core and lipid bilayer shell. Within this core-PEG-lipid
shell (CPLS) NP, the grafted PEG polymers support the bilayer. The proposed CPLS NP
is thus potentially more stable than a traditional liposomes. The distance between the core
and shell is constrained by the brush height of the tethered PEG polymers, giving rise to a
more uniform size of the self-assembled CPLS NPs. Compared with liposomes, we hypothesize that the CPLS NP would have the following advantages: 1) size uniformity due to
the constraints applied through the grafting density and molecular weight of tethered PEG
chain polymers; 2) enhanced stability due to the solid inorganic NP core and the covalent
linking with PEG chains; 3) multifunctional properties, such as ‘theranostics’ (hybrid of
therapy and diagnosis), 252 with the lipid vesicle accounting for drug carriers and inorganic
NP core useful for diagnostic imaging and photothermal therapy; 4) efficient cellular uptake
due to the integrity of the core-shell structure.
Herein, we will demonstrate that the CPLS NPs can be formed by the proposed selfassembly process through large scale molecular simulations and supported by experiments.
The influence of the grafting density and molecular weight of tethered PEG polymers is
elucidated through molecular simulations. The paper is organized as follows. Section 2
presents details regarding the computational model and the relevant method for studying
the self-assembly process of CPLS NPs. The experimental materials are also provided in
this section. Section 3 demonstrates the self-assembly process of CPLS NPs, discusses the
influences of grafting density and molecular weight of the PEG polymers on their formation,
and provides various properties of the self-assembled NPs. In addition, a free energy analysis
has been carried out to interpret the physical mechanisms underlying the self-assembly
process. And finally, the membrane wrapping process of the liposomes and CPLS NPs are
further explored through computation. As a proof-of-concept, the experimental realization
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Figure 6.1: Schematic of the self-assembly process for a CPLS NP. A spherical core is surface
functionalized by PEG chains displaying lipid moieties. Upon addition of free lipid molecules, it will
form a complete lipid bilayer shell at the core’s surface, driven by the hydrophobic nature of lipid
tails. The NP core is colored in silver, which could represent gold, silica, superparamagnetic iron
oxide or other materials. The PEG polymer is colored in yellow. The lipid head and tails are colored
in blue and cyan, respectively. Note that the free ends of the PEG polymer are covalently bonded
to the heads of anchored lipids. The upper panel shows the PEGylated core with polymerization
degree of PEG N = 10 and grafting density σp = 0.64 chains/r02 . The lower panel is for N = 40 and
σp = 0.64 chains/r02 . The diameter of the core is about 10 r0 , where r0 ≈ 1.14 nm is a characteristic
length set by the lipid.

of CPLS nanoparticles is also explicitly demonstrated. Concluding remarks are provided in
Section 4.
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6.3
6.3.1

Computational Method and Experimental Materials
Computational Model and Method

Dissipative Particle Dynamics (DPD) Method
The DPD method, by grouping a cluster of atoms into a single bead, is a coarse-grained
molecular simulation method, which can correctly and accurately capture hydrodynamic
behavior. 195 The method has been widely used and successfully applied for studying problems related to cell membranes and drug delivery processes. 61,72,123,253 For instance, DPD
models had been used to shed light on the self-assembly process of lipid bilayers and vesicles, 254 the fusion between lipid vesicle and bilayer, 197 and interactions between NPs and
lipid bilayers. 255,256 The basic interacting sites in DPD simulations are soft beads. These
beads represent a group of atoms or molecules. Their motion is governed by specific molecular interactions. Between each pair of DPD beads, effective two-body interactions consist
of three major forces: a conservative force FC , a random force FR and a dissipative force
FD . Specifically, the conservative force between beads i and j is FC
ij = aij ω(rij )eij , where
rij denotes the distance between beads i and j, and eij the unit vector pointing from bead
i to bead j; aij represents the maximum repulsive force acting between beads i and j.
The weighting factor ω(rij ) is a normalized distribution function as ω(rij ) = 1 − rij /r0 for
rij ≤ r0 , while ω(rij ) = 0 for rij > r0 . Here r0 is the cutoff distance for pairwise interactions.
p
The random force FR = 2γkB T /∆t ω(rij )αeij , where α represents a normal distributed
Gaussian random number with zero mean and unit variance. ∆t is the time step used in the
molecular simulations, kB and T denote the Boltzmann constant and temperature, respec2
tively, and γ a bead friction coefficient. The dissipative force is FD
ij = −γω (rij )(eij vij )eij ,

where vij represents the relative velocity vector between beads i and j. The conservative
force is a purely repulsive interaction, while the random and dissipative forces acting along
the centers of the soft beads will conserve the linear and angular momentum. Periodic
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boundary conditions are applied along all directions. The number density of beads in the
simulation box is fixed at 3/r03 . 195

Lipid Molecule Model
In the DPD simulation, the lipid molecule has been coarse-grained by simplifying lipid heads
and tails into hydrophilic and hydrophobic beads, respectively. There are different ways of
coarse-graining in the existing literature, including the double tail model and linear chain
model. 100,257,258 Most of these DPD models can capture the self-assembly process of the lipid
bilayer during the simulations, without interdigitating within the middle plane, where the
thickness of lipid bilayer is near twice the lipid length. 100 Moreover, the bending stiffness and
viscosity of the lipid bilayer are found to be close to the experimental values. 226 Thus, these
models can be used to describe the amphiphilic properties of lipid molecules. In this work,
for simplicity and reducing the computational cost, we adopt the linear chain model, as each
lipid molecule is represented by one hydrophilic head bead and three hydrophobic tail heads
denoted as HT3 . Such a model has been used to correctly predict the bilayer properties and
domain behaviors in vesicles. 100,258 The amphiphilic properties of the lipids are ensured by
a large repulsion between the lipid tail and water molecule, using atw = 100kB T /r0 . The
subscripts ‘t’ and ‘w’ denote the lipid tail and water bead, respectively. The lipid heads
are hydrophilic and thus, ahw = 25kB T /r0 , where the subscript ‘h’ represents the lipid head
beads. The remaining pairwise interaction parameters between the same types of beads
are aww = ahh = att = 25kB T /r0 . Apart from the pairwise interactions, bond and angle
potentials are applied on the lipid molecules to correctly reproduce their conformations.
The neighboring beads in a lipid molecule are connected by a harmonic spring potential:
Us = Ks (rij − rs )2 , where Ks and rs are the spring coefficient and equilibrium bond length,
respectively. Here Ks = 50kB T /r02 and rs = 0.7r0 . A bond angle potential is applied on
the lipid tail to ensure its rigidity and to prevent the incorrect interaction in the middle
plane of the self-assembled bilayer. The form of the bond angle potential is given by Uθ =
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Kb (θ − θ0 )2 , where Kb and θ0 are the bending stiffness and equilibrium angle, respectively.
Here Kb = 3.0kB T and θ0 = 180◦ . Under these interactions, the random lipid molecules are
able to self-assemble into a vesicle or a planar membrane under suitable concentrations.

PEGylated NP Model
NPs for small molecule drug delivery studies in DPD simulations are usually treated as
tightly packed beads with specific shapes, such as spheres, rods etc. 60,259 In the present
study, the beads representing a rigid NP core are arranged on a FCC lattice with lattice
parameter 0.8r0 , covered by a layer of spherical shell beads. There are 1575 beads in total
for the core of a NP with a radius of 5r0 . Such a packing will prevent the penetration of
other beads, such as water or lipids, during the simulations. On the surface of the core,
the hydrophilic PEG polymers were covalently grafted through a harmonic bond potential.
The monomers of PEG polymers are connected by the same harmonic bond potential as
Us = Ks (rij − rs )2 , with spring stiffness Ks = 2111.3kB T /r02 and equilibrium distance
rs = 0.4125r0 . The stiffness of the PEG polymer is further ensured by an angular potential
between three consecutive monomers, defined by Uθ = Kb (cos θ − cos θ0 ), with bending
stiffness Kb = 16.4946kB T , and equilibrium angle θ0 = 130◦ . Such a model can be used to
correctly reproduce the conformation of a PEG polymer in water, including the radius of
gyration and end-to-end distance, as shown in previous studies. 72,123 Note that the coarsegrained models for lipids and PEG chains do not have torsional stiffness.
In the experiments shown here, the typical grafting density of PEG polymers on the
core is about 0 − 2.0 chains/nm2 , with PEG molecular weights ranging from 500 to 5000
Da. 50,164,199 Accordingly, we set the grafting density σp of the PEG polymer in our DPD
simulations as 0.128, 0.256, 0.384, 0.512, 0.640, and 0.768 chains/r02 . The corresponding
number of PEG chains are M = 40, 80, 121, 161, 201, and 241, respectively. Considering
the computational cost, the polymerization degree of the tethered PEG polymer is taken
to be 10 and 40, representing molecular weights of 450 and 1800 Da, respectively. All
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the free ends of grafted PEG polymers are bonded with lipid (head) molecules through a
harmonic potential. For simplicity, we assume that this harmonic potential Us is as the
same as the one for PEG polymers. In this way, one end of the PEG polymer is tethered
on the core surface, while the other end is covalently connected to a lipid molecule. All the
repulsive interaction parameters aij for different types of beads are given in the TableA.3
of supplementary materials

N-varied DPD Method for Endocytosis
During endocytosis the internalization of NPs should not affect the surface tension of the cell
membrane in view of the length scale difference between the NP (< 100 nm) and cell (∼ 10
µm). To mimic this condition and to reproduce the constant membrane surface tension
in our DPD simulations, we adopted the N-varied DPD method. Instead of controlling
the lateral pressure/force of the membrane, this method takes an alternative approach to
ensure a constant membrane tension, by controlling the number of lipids per unit area. It
has been widely used to study the endocytosis of NPs in DPD simulations. 70,72,123,171,172
In this method, the boundaries of the lipid bilayer are treated as a lipid reservoir for the
addition and removal of lipids. If the lipid number per unit area is larger (or smaller)
than the target density ρ1 (or ρ2 ), lipid molecules will be deleted (or inserted) into this
boundary region to maintain a constant lipid number density. Meanwhile, a corresponding
number of water molecules will be inserted (or deleted) randomly in the simulation box to
ensure a constant water bead density of 3.0/r03 in the DPD simulations. Here, the densities
ρ1 and ρ2 are chosen as 1.345/r02 and 1.455/r02 respectively. With this choice the lipid
bilayer has a slightly negative tension. Such a feature facilitates the rapid endocytosis of
NPs. 70 The density of lipids in the boundary region was verified every 1000 time steps. By
using the N-varied DPD protocol, the lipid density in the membrane is easily controlled
to maintain the membrane’s lateral tension during the endocytosis process. To mimic the
ligand-receptor mediated drug delivery process, we assumed that 50% of the lipid molecules
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act as receptors, which has been proven to be an effective way to simulate the endocytosis
of NPs. 73,255,260 The lipid heads (receptors) of these molecules are assigned to have less
repulsion with the ligands on NPs, defined by a smaller repulsive interaction parameter
aRh Lh = 4.0kB T /r0 . All the lipid heads located on the surface of a liposome or a CPLS
NP are considered to behave like ligands. The reduced repulsion between the ligand and
receptor beads provides an attractive force and captures an important empirical feature of
the ligand-receptor interaction. 105
Within our DPD model the different types of beads have identical masses and identical
cutoff distances for their pairwise interactions. For the sake of transferability of our results,
the mass, length and time scales are all normalized and denoted as the reduced LJ units.
The unit length is taken to be the cutoff distance r0 . The unit mass is m for all the beads and
set to be 1 in our DPD simulations. In addition, the unit energy is defined by the thermal
energy kB T . Thus, all other dimensional quantities can uniquely be made dimensionless in
terms of these basic units (and vice versa). In terms of reduced units, we use the classical
value γ = 4.5 for the bead friction coefficient. The time step in our simulations is ∆t = 0.01τ
p
with τ = mr02 /kB T . The velocity-Verlet integration algorithm is adopted for the time
integration. The reduced units can be mapped to SI units according to the bilayer thickness
and the diffusion coefficient of the lipids in the bilayer. For example, the thickness of the
lipid bilayer is around 3.5r0 , by using the linear lipid (HT3 ) molecules. Compared with the
typical bilayer thickness of 4 nm measured in the experiments for 1-palmitoy1-2-oleoyl-sngycero-3-phosphocholine(POPC) bilayer, 90 the basic unit length in our DPD simulation is
about r0 ' 1.14 nm. Mapping the diffusion coefficient around 5 µm2 s−1 of POPC bilayer,
the time unit in DPD simulation is about τ = 14.2 ns.

6.3.2

Experimental Methods and Materials

Amine-terminated silica/FITC coated silver NPs (Si@AgNP) were purchased from NanoComposix. 5K 1,2-distearyl-3-glycero-sn-ethanolamine-PEG-N-hydroxysuccinimide (DSPE-PEG137

NHS) was purchased from Nanocs. 1,2-dioleyl-sn-glycero-phosphoethanolamine (DOPE)
was purchased from Avanti Lipids. All reagents were used as received without further
purification.
Synthesis of CPLS NPs. 40 µL of 0.25 mg/mL Si@AgNP were diluted to 0.02 mg/mL
in absolute ethanol. 35 µL of DIPEA were added to the NPs and the solution was allowed
to equilibrate at 37°C, while shaking at 800 rpm, for approximately 20 min. 10 mg of 5K
DSPE-PEG-NHS were added as a powder to a clean 1.5 mL tube and the NP solution
was decanted using a Pasteur pipette on to the 5K DSPE-PEG-NHS powder. This tube
was wrapped in foil and set to shake at 800 rpm at 37°C for 5 hours. 800 µL of hexanes
were added to precipitate now PEGylated particles, which were then washed twice with
1:4 acetone to hexanes mixture and then three times with ethyl ether. After rinsing, the
intermediate particle were dried using a heat gun to remove trace organic solvent. The
particles were reconstituted in water and characterized by a combination of dynamic light
scattering(DLS) and zeta potential measurements to access their average size and surface
charge. The particles were then lyophilized and reconstituted in 40 µL of chloroform. To
this a 44 µL solution of DOPE was added and the mixture was dried under nitrogen to
remove any residual solvent. The mixture was allowed to equilibrate and dry completely for
another 30 min. The particles and DOPE were reconstituted in water in 5 µL increments,
sonicating for 1 min in between each addition until 20 µL was reached. The particles were
then diluted to 40 µL, sonicated for 2 min, and diluted to 100 µL in water and finally
sonicated for an additional 2 min. Alternating between using a cold bath of ethanol and
dry ice, and a thermomixer at 37°C, 10 repetitions of freezing and thawing separated by
3 min sonicating cycles was performed to equilibrate the DOPE at the particle’s surface.
The synthesized CPLS NPs were ultimately characterized by a combination of DLS, zeta
potential, transmission electron microscopy (TEM), and fluorescence spectrophotometry.
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6.4
6.4.1

Results and Discussion
Self-assembly Process of CPLS NP

t=0

t=1.5

t=

t=2

t=3

t= 5

Figure 6.2: Self-assembly process of a CPLS NP upon adding 2500 free lipids at t = 0. The
snapshots represent (from left to right) the self-assembly process at times t = 0, 1.5 × 103 τ , 104 τ,,
2 × 104 τ , 3 × 104 τ , and 5 × 104 τ . The upper and lower panels shows the whole and cross-sectional
views, respectively. The color scheme is the same as Fig. 6.1. The water beads are not shown
for clarity. The NP is coated at grafting density σp = 0.64 chains/r02 by PEG polymers with
polymerization degree N = 10.

Due to the amphiphilic nature of lipid molecules, they can self-assemble into micelles,
vesicles or bilayers. Taking advantage of this property, we hypothesize that the CPLS NP
can be formed by the self-assembly of anchored lipids on the PEGylated NP with nearby
free lipid molecules, as schematically depicted in Fig. 6.1. Note that there are two different
types of lipid molecules in our simulations. One is the free lipid. The other is the anchored
lipid, constrained by the tethered PEG polymers. These anchored lipids may behave as
active sites for attracting nearby free lipids. With each additional increase in the amount of
absorbed free lipids at the PEGylated NP’s surface, the lipids become closer to eventually
forming a self-assembled lipid bilayer that constitutes the fully formed CPLS NP.
To test and support this speculation, we performed large scale DPD simulations where
we studied the self-assembly process of the PEGylated NPs in the presence of free lipids,
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where the free terminal ends of the tethered PEG polymers are bonded to the head groups
of the anchored lipids. The (bead) polymerization degree of PEG is taken to be N = 10
with grafting density σp = 0.64 chains/r02 (corresponding to M = 201 chains). To create
a starting configuration, the PEGylated NPs are firstly equilibrated in the simulation box
(50 × 50 × 50r03 ) with water molecules for a duration of at least 2 × 104 time steps, until
the mean end-to-end distance of the PEG polymers reached a constant value. Due to the
hydrophobic properties of the lipid tails, the tethered PEG polymers tend to be collapsed
on the surface of the NP core to minimize the lipid tail interactions with surrounding water
molecules, as visible in Figs. 6.1 and 6.2. These aggregated lipids form the ‘island’ structure
on the core surface, acting as the attracting sites for nucleating free lipid molecules. After
the PEGylated NP has been fully equilibrated, an additional 2500 free lipid molecules are
randomly added into the simulation box. In the course of time sampled these free lipids
become absorbed on the ‘island’ structures, driven by their hydrophobic nature, and was
demonstrated in Fig. 6.2. During this process, the free lipid molecules can self-assemble
into regular vesicles (cf. Fig. 6.2c). Simultaneously, these vesicles can be absorbed on
the surface of the PEGylated core. This way, the anchored lipids behave as active sites
characterized by their ability to trigger the self-assembly process of CPLS NPs.
At time t = 1.5 × 103 τ , the free lipids captured by their anchored counterparts could
form a vesicle, micelle or curved sheet by their fusion on the core surface. Due to the
constraints applied through the tethered PEG chains, these free lipids tend to stay with
the PEGylated core after absorption. With the growing amount of captured free lipids, the
size of absorbed lipid vesicles increases with time. However, unlike vesicle growth in water,
the specific locations of anchored lipids and the constraints applied through PEG polymers
cause the growth of the absorbed lipids to proceed in a unique and specific fashion. At
time t = 104 τ , the absorbed lipid vesicles have been fully eliminated from the surface of
the PEGylated core. Only lipid micelles and sheets are left. The disappearance of lipid
vesicles is seen to be induced by their fusion with nearby lipids. These lipid sheets could
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continue growing while capturing additional free lipid molecules, as given at t = 2 × 104 τ .
More interestingly, at time t = 3 × 104 τ , two large lipid sheets are formed on the surface, by
covering opposing poles of the core. The formed lipid sheets however are not large enough
to fully cover the surface of the PEGylated core. With increasing simulation time, more
and more free lipids get absorbed onto the edges of these sheets and a complete CPLS NP
has been formed at t = 5 × 105 τ . The self-assembly process could be potentially influenced
by the lipid tail length. The driving force for self-assembly of CPLS NPs is provided by
the hydrophobic nature of lipid tails. Therefore, the longer lipid tails, exhibiting stronger
hydrophobic property, the more they can contribute a stronger driving force for the selfassembly.

6.4.2

Effect of Grafted PEG Length

t=0

t=2

t=5

t= 1.295

t=1.7

Figure 6.3: Self-assembly process of a CPLS NP upon adding 6500 free lipids at t = 0. The
snapshots represent (from left to right) the self-assembly process at times t = 0, 104 τ , 2 × 104 τ ,
5 × 104 τ , 1.295 × 105 τ , and 1.7 × 105 τ . The upper and lower panels show the whole and crosssectional views, respectively. The color scheme is the same as Fig. 6.1. The water beads are not
shown for clarity. The NP is coated at grafting density σp = 0.64 chains/r02 by PEG polymers with
polymerization degree N = 40.

As shown by the above simulation results, the CPLS NP can be formed by the selfassembly of the PEGylated core with free lipids. However, the tethered PEG chain is very
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short (molecular weight around 450 Da), which is far away from the experimental situation.
Moreover, the molecular weight of PEG polymers can be an important design parameter for
CPLS NPs. Thus, we chose to further explore the self-assembly process of the CPLS NPs
with larger more experimentally relevant molecular weight, that of 1800 Da, corresponding
to a polymerization degree N = 40 of PEG. The grafting density is kept at 0.64 chains/r02
with an additional 6500 free lipids added. Similar to the previous case, the PEGylated core
was firstly equilibrated without adding free lipid molecules. The simulation box volume is
≈ 70 × 70 × 70r03 . Instead of using the temperature T = 1.0, we increased the simulation
temperature to T = 2.0, in order to accelerate the self-assembly process. As shown in Fig.
6.3, the self-assembly process of N = 40 is actually very similar to that of N = 10. At
time t = 104 τ , the absorbed lipids form micelles, a vesicle and small sheets on the surface
of the PEGylated core. These absorbed vesicles form large sheets by fusing with additional
lipids, as shown at t = 2 × 104 τ . The micelle on the top of the NP has grown to a small
vesicle at t = 5 × 104 τ . In addition, the two lipid sheets on its bottom have fused together.
Until t = 1.295 × 105 τ , the vesicle and sheet are kept intact. Compared with the case
of N = 10, the life time of the lipid vesicle is much longer, which could be attributed to
the large molecular weight of the tethered PEG polymers. Finally, when additional lipids
have absorbed on the edges of the sheet, fusion between the vesicle and sheet occurs and a
complete CPLS NP formed, shown in Fig. 6.3.
Here we should emphasize that the above self-assembly process has been accomplished
at a relatively high temperature T = 2.0. At the normal temperature T = 1.0, a large vesicle
can be formed at the surface of the core. Such a large vesicle prohibits the formation of
lipid sheets on the core surface within the time approachable by our simulations. Thus, the
trapped state will not be favorable for self-assembly of CPLS NPs. We have increased the
simulation temperature to overcome this energy barrier, utilizing the thermal fluctuation
effect. After the CPLS NPs have been formed under this high temperature, they are further
annealed to the normal temperature T = 1.0, at which temperature a spherical CPLS NP
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can be obtained.
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Figure 6.4: Phase diagrams for the self-assembly of CPLS NPs:(A) polymerization degree of PEG
N = 10 and (B) N = 40. The phase diagram is constructed as a function of PEG grafting density
and total number of free lipid molecules. According to the final configurations, the results can be
classified into three states: (1) over-encapsulated region; (2) perfect encapsulated region; and (3)
partially encapsulated region.

Based on the above findings which serve to characterize the self-assembly process of
CPLS NPs, the molecular weight of the tethered PEG polymer appears to play an important
role. In addition to its molecular weight, the grafting density of the PEG polymers emerged
as another important parameter, as the free ends of the anchored lipids act as attractive sites
for free lipids to ultimately form a lipid bilayer. Thus, we consider that both the molecular
weight (polymerization degree N ) and grafting density (σp ) of grafted PEG polymer are two
essential design parameters for CPLS NPs. To further understand their influence on the selfassembly process, we have systematically varied σp at fixed polymerization degree N = 10
or N = 40. In addition, we varied the number of free lipids added into the simulation box,
again systematically. When the number of free lipids remains below a certain threshold,
the self-assembled bilayer could not fully cover the surface of the PEGylated core. Under
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such conditions a partially encapsulated state is formed. On the contrary, if too many free
lipids are added, the excessive lipids tend to form a bud-like structure on the surface of the
PEGylated core. This latter case is denoted as the over-encapsulated state. Between the
two extremes a perfect encapsulated state exits for CPLS NPs, balanced by the grafting
density σp , polymerization degree N of PEG polymers and number of free lipids.
Phase diagrams representing the status of self-assembled CPLS NPs as a function of the
grafting density σp and the number of free lipids were calculated from a series of independent
simulation runs (cf. Fig. 6.4) . These results confirm that the final states of the selfassembled NPs are highly dependent on tethering density σp and number of free lipids, as
well as the PEG polymerization degree N . When σp is very low, there are too few active
sites on the surface of the PEGylated core. Thus, the NP cannot attract enough free lipids
to form a complete bilayer on its surface, regardless of the number of free lipids. Such a
partially encapsulated state should be avoided in applications. The formation of a CPLS NP
is more easily achieved upon increasing the grafting density σp . However, when the number
of free lipids falls beyond a threshold LU , an over-encapsulated state will be reached, as
the excessive lipids can form bud-like structures on the surface. When the number of free
lipids remains below another threshold LL , the attracted free lipids cannot form a bilayer
to fully cover the NPs surface, corresponding to the partially encapsulated state. Only for
a number of free lipids between LL and LU (LU > LL ), can a perfect encapsulated state be
achieved for CPLS NPs. The corresponding σp and N of PEG, and number of free lipids
can be used as experimental conditions to synthesize the CPLS NPs.
Equally interestingly, two different partially encapsulated states are observed during
these simulations, highlighted in Fig. 6.4. For the one at low grafting density 0.128 chains/r02
with N = 10, the partially encapsulated state is formed due to the large absorbed lipid
vesicle that does not fuse with other absorbed lipids exhibiting less active sites. Such a
long-lived vesicle prevents the formation of a lipid sheet on the core surface. For the one at
high grafting density, such as 0.64 chains/r02 for N = 10, the surface of the core cannot be
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fully covered by absorbed lipid sheets, as long as there is an insufficient amount of free lipids.
Partially encapsulated states thus occur at low grafting density and/or at low amounts of
free lipids. The same scenario we observe for the case with N = 40.
Comparing the phase diagrams between N = 10 and 40, the critical values of grafting
density and number of free lipids are dramatically affected by N . When N = 10, at the low
grafting density σp = 0.256 chains/r02 , a complete CPLS NP can be formed in the presence
of a sufficient amount of free lipids. However, for the high molecular weight (N = 40)
system, the same grafting density σp = 0.256 chains/r02 does not allow for the formation
of a complete CPLS NPs, regardless of the number of free lipids. As it has been revealed
in our previous study, 72 the brush height of the tethered PEG polymer is determined by
its grafting density σp and polymerization degree N . At a given σp , the brush height of
tethered PEG significantly increases with the polymerization degree N . Thus, at N = 40,
the effective size of the PEGylated core (size of the core plus the brush height of PEG) is
much larger. The NP will require more active sites on the core surface to attract free lipids
for complete self-assembly. As the number of active sites is linearly proportional to the
grafting density at a given core radius, the threshold of the PEG grafting density has been
enlarged from 0.256 to 0.512 chains/r02 with polymerization degree N increasing from 10
to 40. The necessary grafting density is of great importance for the self-assembly of CPLS
NPs, which is affected by the polymerization degree of the PEG polymer and the radius of
the inorganic core. However, the self-assembly is a dynamic process, affected by the fusion
of anchored lipids with free lipids, movement of tethered PEG polymers, and many others.
Thus, the relationship between this critical grafting density and polymerization degree N is
very complicated, which cannot be easily approximated in this work.
The last interesting observation is that the range of free lipids (LU − LL ) for perfect
encapsulation became much broader upon increasing the polymerization degree N . For
example, when N = 10 and σp = 0.64 chains/r02 , LL = 2250 and LU = 3600. While at
the same grafting density, LL = 5500 and LU = 8200 for N = 40. As aforementioned,
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the anchored lipids are constrained by the tethered PEG polymers. Therefore, the number
of free lipids required to fully cover the core surface depends on the effective size of the
PEGylated core. When N is small, the tethered PEG chains appear less flexible. Thus, the
number of required free lipids for perfect encapsulation is rather fixed. However, when N
gets enlarged, the flexibility of PEG chains has been improved as well. Hence, the effective
size of the PEGylated core can vary over a large range. This way, the range (LU − LL ) of
free lipids for the complete self-assembly of CPLS NPs is effectively broadened.

Structural Analysis on CPLS NPs
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Figure 6.5: Number density distribution of different molecular species, including PEG monomer,
anchored lipid and water, (A) before the self-assembly and (B) after the self-assembly. The polymerization degree N = 40 and grafting density σp = 0.64 chains/r02 . The radius of the core is 5 r0 .
6500 free lipids are added during the self-assembly process.

As mentioned in the introduction, the CPLS NPs can potentially be used as drug carriers. It is important to characterize their structural properties, as these properties are
highly related to the capacity of these NPs for hosting small molecules such as drugs. The
number densities of the different molecular species before and also after completion of the
self-assembly process, including PEG monomer, anchored lipid and water, are given in Fig.
6.5 as the function of their radial distance to the core’s center. Here, the grafting density of
PEG with N = 40 repeat units is σp = 0.64 chains/nm2 . The number of free lipids added
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is 6500 (as demonstrated in Section 3.2).
Before initiation of the self-assembly process, anchored lipids are mainly distributed
within a radial distance 8–12r0 from the core center. After the CPLS NP has been formed,
the same anchored lipids are predominantly localized within radial distance 12–15.5r0 , as a
lipid bilayer has been formed in this distant region. The distribution of PEG monomer has
thus been significantly changed, indicating a free energy change of the tethered chains. 72,123
The amount of water molecules present has also been modified during the self-assembly
process. For the PEGylated core, the number density of water has been gradually increasing
with increasing radial distance within the region (5–12r0 ) occupied by grafted PEG chains.
Beyond this region, the number density of water reaches a constant value, 3.0/r03 , as specified
by our DPD simulations. In contrast, water molecules are separated into two parts by the
lipid bilayer in the CPLS NP (after self-assembly). One part is enveloped by the lipid
shell, the other is surrounding the shell. For the first part, the density distribution of water
molecules follows a parabolic profile, as they are confined by both the core and lipid bilayer
shell. For the other part, the number density quickly increases with radial distance and
approaches its plateau value 3.0/r03 . All these changes are related to the formation of the
lipid bilayer shell on the surface of the NP. The encapsulated water molecules within the
shell region are of great interest, as they are correlated with the free space within the CPLS
NPs for storing drug molecules or other therapeutic agents.
The number of water beads within the CPLS NPs after self-assembly as a function of
PEG grafting density is plotted in Fig. 6.6. Note that these water molecules are confined
by the lipid bilayer shell and core, indicating the loading capacity of the CPLS NPs for
small drug molecules or imagining agents. When the polymerization degree of PEG is
N = 10, the number of water beads encapsulated within the CPLS NPs is not significantly
affected by the grafting density. On average, there are about 1500 water beads stored
within the CPLS NPs. In a typical DPD simulation, each water bead represents three
water molecules. 226 As each water molecule has a van der Waals volume of about 30 Å3 ,
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Figure 6.6: Number of stored water beads within the CPLS NPs after self-assembly and subsequent
equilibration: (A) PEG polymerization degree N = 10 and (B) N = 40. This number indicates the
storage capacity of CPLS NPs for small therapeutic molecules or imagining agents.

the total volume of these stored water beads is about 135 nm3 . With increasing molecular
weight of the PEG polymer, the storage capacity of the CPLS NPs is greatly enlarged. The
average number of water beads within the CPLS NPs is about 16000 for N = 40, ten times
larger than that obtained for N = 10. Thus, the corresponding volume is about 1440 nm3 .
As the typical solvent accessible volume of a doxorubicin molecule (FDA approved drug
molecule for cancer chemotherapy) is about 1426 Å3 , the space within CPLS NPs can store
up to 95 and 1010 doxorubicin molecules for PEG polymerization degree N = 10 and 40,
respectively, assuming all the space occupied by the water beads is taken by doxorubicin.
As the molecular weight of PEG can be as large as 5000 Da, corresponding to N = 121,
the space within self-assembled CPLS NPs can be dramatically enlarged to store many
doxorubicin molecules, even therapeutic oligonucleotide such as siRNA.

6.4.5

Free Energy Change of PEG Chains

During the self-assembly process of CPLS NPs, the hydrophobic property of lipid tails
provides the driving force for free lipids to be absorbed on the surface of the PEGylated
core and to form a complete lipid bilayer shell with anchored lipids. Over the course of
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Figure 6.7: Free energy analysis on conformational entropy change of PEG chains during selfassembly. (A) and (B) show the change of elastic free energy ∆Fel and interaction free energy ∆Fint
per chain. (C) The total free energy change ∆Fpolymer of CPLS NPs during the assembly process is
obtained by multiplying ∆Fel + ∆Fint by the number of PEG chains.

this process, the translational entropy of different molecular species, including PEG chains,
anchored lipids, free lipids and water beads, will be changed. The redistribution of the
water beads can introduce an osmotic pressure nearby the PEGylated core region. 59 More
importantly, the conformational entropy of tethered PEG chains will be dramatically altered
during this process, as indicated by the end-to-end distance change of PEG in Tables A.4 and
A.5 of the supplementary materials. Before the self-assembly, the anchored lipids aggregate
together to form ‘island’ structures on the surface of the PEGylated core. The tethered
PEG chains also collapse on the surface to minimize the interaction between anchored lipids
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and water molecules. When the free lipids are added, these anchored lipids are pulled out
to interact with free lipids and to form the lipid vesicle, sheet and bilayer. Thus, their
connected PEG chains are stretched out to allow for the self-assembly of the lipid shell,
evidenced by the observed increment of the end-to-end distance, reported in Tables A.4 and
A.5 of the supplementary materials. The conformational entropy change of PEG polymers
could thus serve as the major energy barrier during the self-assembly process. Further
studies to probe this hypothesis will explored in further detail.
Self-consistent field (SCF) theory is applied here to study the conformational free energy change of the PEG polymer during the assembly process. A similar approach has
been followed in our previous studies to evaluate the free energy change of PEG chains
on PEGylated NPs during endocytosis. 72,123 According to SCF theory, the configurational
free energy of PEG polymers Fpolymer consists of an elastic free energy Fel and an interaction free energy contribution Fint reflecting the excluded volume and the effective, eventually
solvent-mediated interaction between different monomers. 72,123 The conformational free energy change of a single PEG polymer is given by
2 i
Fpolymer
3 hree
=
+
kB T
2 R02
Fel
kB T

=

2 i
3 hree
2 R02

Z

fm (φ)d3 r

(6.1)

2 i of PEG chains,
is linearly proportional to the squared end-to-end distance hree

assuming that PEG chains behave like elastic springs. R0 represents the equilibrium size
R
of a PEG polymer. kFBintT = fm (φ)d3 r can be directly quantified through the spatially
inhomogeneous volume fraction φ of PEG monomers. fm = (φ2 + φ3 )/v, where v = 0.0633
nm2 denotes the excluded volume of PEG monomer, is integrated over the volume of a
single chain. 72 Note that φ is linearly proportional to the bead density distribution of PEG,
as shown in Fig. 6.5. More details about the SCF theory are given in the supplementary
materials for Chapter 4. When the polymerization degree of tethered PEG is N = 10, the
change in end-to-end distance, ∆Ree , is rather small and close to zero, regardless of the
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grafting density σp , as presented TablesA.4 and A.5 of the supplementary materials. The
corresponding change of the elastic energy ∆Fel is rather small as well, and about 0.5kB T
per chain (cf. Fig. 6.7A). Yet, for N = 40, ∆Ree has been significantly enlarged. Thus, the
elastic energy change ∆Fel has been increased to 2.5 − 3kB T per chain, as shown in Fig.
6.7A.
The distribution of PEG monomers has been altered after the self-assembly (cf. Fig.
6.5), signaling the change of Fint , as given in Fig. 6.7B. For N = 10, the change of interaction
energy ∆Fint is about 0–0.2kB T and unaffected by the grafting density σp , similar to that of
∆Fel . Interestingly, for N = 40, ∆Fint is about −0.6kB T (negative) and slightly influenced
by σp . As discussed before, the collapsed PEG chains are stretched out from the core surface
during the self-assembly. The distance between different chains has been increased. Therefore, the interaction energy Fint between different chains are reduced during this pulling out
process. After the values of ∆Fel and ∆Fint per chain are obtained, the conformational entropy change of PEG chains can be easily calculated by multiplying the number of tethered
chains on the core surface with their summation, as presented in Fig. 6.7C. Regardless of
the polymerization degree N , the conformational entropy change ∆Fpolymer monotonically
increases with increasing grafting density σp . For N = 10, ∆Fpolymer has been enlarged
from 10 to 140 kB T while σp increased from 0.256 to 0.64 chains/r02 . When the molecular
weight of tethered PEG chains was enlarged, their conformational entropy change also significantly increased to 375–550 kB T . The dramatic conformational entropy change of PEG
chains might explain that when the polymerization degree N has been enlarged, and that’s
why it will be more difficult for CPLS NPs to be self-assembled. Thus, the CPLS NPs can be
more easily formed when N = 10 at normal temperature T = 1.0. When N = 40, elevated
temperature T = 2.0 needs to be used to overcome this high energy barrier to complete the
self-assembly process. As aforementioned, the short PEG polymers will be favorable to the
self-assembly, while the CPLS NPs with long PEG polymers have a large capacity to store
drug molecules. Considering these competing factors that are equally important details to
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the overall design of an optimized drug delivery platform, an optimal PEG molecular weight
should be further explored through computational study and self-consistent field analysis.

6.4.6

Membrane wrapping of CPLS NPs
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Figure 6.8: Lipid membrane wrapping processes. (A) Liposome and (B) CPLS NP at times
t = 0, 2000τ , 5000τ , 6000τ , 8000τ from left to right. The liposome in (A) is formed by 6500 lipid
molecules. The CPLS NP in (B) self-assembled from the PEGylated core with PEG polymerization
degree N = 40, grafting density σp = 0.64 chains/r02 and 6500 free lipids. The color scheme is
the same as in Fig. 6.1. The lipid tails in the bilayer are colored in gray; the lipids coated with
receptors in the bilayer are colored in tan, while the regular lipid heads are colored in purple. The
drug molecules encapsulated within liposome and CPLS NPs are colored in red. Water is not shown
for clarity.

To further evaluate the potential of CPLS NPs as drug carriers, the internalization
of CPLS NPs and liposomes (lipid vesicles) have been studied through DPD simulations.
Specifically, we focused on the rearrangement of the lipid bilayer around these NPs, as it is
the most important step to be considered in light of the NPs route of entry via endocytosis
by diseased cells. 123 To eliminate the NP size effect, the liposome is prepared with the
same number of lipids in the shell of CPLS NPs. The liposome is self-assembled and further
equilibrated at a relatively high temperature T = 2.0 for 1 million time steps. Subsequently,
it is gradually annealed to normal temperature T = 1.0 during another half million time
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steps and further equilibrated for about 1 million time steps at this temperature. During
this process, the interfacial pressure of the liposome can be fully relaxed. The obtained
liposome has the identical surface chemistry as CPLS NPs, and the same size. Thus, the
NP size and surface effects have been eliminated. Yet, the CPLS NPs could be more rigid
than liposomes, as the PEGylated core within CPLS NPs behaves as a scaffold to support
the lipid bilayer shell.
To simulate this membrane wrapping process, the CPLS NPs and liposomes were loaded
with roughtly 50% drug molecules to mimic potential hydrophilic drug molecules. For simplicity, these drug beads interact with other molecular species as water beads. Initially, the
liposomes or CPLS NPs are placed above the lipid bilayer at a distance 3r0 . The membrane
wrapping processes of a liposome and a CPLS NP are compared in Fig. 6.8. At the beginning (t = 0), both the liposome and CPLS NPs are located above the lipid membrane.
With the help of thermal fluctuations, the ligands on the NP surface can find and interact with receptors over-expressed on the lipid membrane. The effective attraction between
the ligands and receptors will then lead to the adhesion of NPs at the lipid membrane.
At t = 1000τ , both the liposome and CPLS NPs have approached the bilayer. The lipid
membrane is bent and wrapped around these NPs. Moreover, their shape has been changed
from sphere to ellipse for maximizing their adhesion energy to the membrane. As time proceeds, at t = 5000τ , the majority of the surfaces of liposome and CPLS NPs are covered by
the lipid membrane, accompanied by a protrusion of the upper-leaf of the lipid membrane.
Such a protruding phenomenon has also been observed during the endocytosis of PEGylated NPs, 72,123 liposomes 70 and other NPs. 61,172 More interestingly, at time t = 6000τ , the
liposome has been ruptured during this membrane protrusion process. The leakage of encapsulated drug molecules occurs due to the rupture of liposome. This rupture phenomenon
has also been observed in a previous study, 70 and usually occurred near the contact region
between the liposome and bilayer membrane, where the liposome has a higher curvature
compared to other regions. Thus, the interfacial tension in this region might cause rupture.
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In comparison, the CPLS NP can still maintain its spherical shape, as the integrity of the
lipid shell has been enhanced through the presence of the tethered PEG chains. In this
way, none of the drug molecules loaded within the CPLS NPs escapes. At the end of the
simulation (t = 8000τ ), the liposome could still be wrapped by the lipid membrane, while
leaving more than 67% payload outside. Yet, the CPLS NP is fully wrapped with all the
loaded drug molecules. When the size of the liposome and CPLS NPs has been reduced,
both of them can be fully wrapped by the lipid membrane without rupture, as shown in
Fig.A.3 of the supplementary materials. The CPLS NP can be wrapped slightly faster than
the liposome.
The above observations could be related to the stiffness of these NPs. Compared with the
liposome, the CPLS NPs are more rigid due to the constraints applied through tethered PEG
polymers. During the membrane wrapping process, the liposome could be deformed more
than CPLS NPs, creating an additional energy barrier, which is consistent with previous
theoretical and computational studies. 45,67,70 Therefore, there is reason to believe the CPLS
NPs could effectively be used as a drug carrier that exhibits prolonged retention of its cargo
when directly compared with that of a traditional liposome.

6.4.7

Experimental Synthesis and characterization of CPLS NPs

From above computational studies, it has been proven that CPLS NPs could be selfassembled using the PEGylated core as a starting point where all PEGylated chains are
terminated with a covalently attached lipid. In order to physically generate the PEGylated NP core, an amine terminated silica/silver (Si@Ag) coreshell NP terminated with
amines (aminated silica) was utilized, as given in Fig. 6.9A. In order to covalently attach
a PEG-lipid molecule to the surface of these NPs, an NHS-terminated PEG molecule that
was modified with a lipid tail was reacted with the surface of the aminated Si@Ag NPs.
Once conjugated to the surface through the formation of an amide bone, the outermost
layer of the particle will present a hydrophobic lipid monolayer. This reaction has been
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Figure 6.9: (A) Synthesis of CPLS NPs. A PEGylated lipid is first covalently crosslinked to the
surface of an inorganic NP. The NP used in the synthesis is a silver core with a silica shell. The
silica shell is embedded with FITC dye for easier analysis and tracking. To this lipid functionalized
inorganic NP a second lipid, DOPE, is added in excess, which self assembles at the lipidated inorganic
NP’s surface due to hydrophobic driving forces. (B-D) TEM micrographs of NPs at each stage of
assembly of the CPLS construct when stained with an aqueous solution of uranyl acetate. (B)
Staining of the amine-terminated polymer at the surface is evident as the stain associates with the
charged surface of the NP evident as a dark higher contrast line. (C) after addition of the lipidated
PEG molecule at the CPLS NP’s surface, limited staining is evident. All scale bars indicate 100 nm.
(D) after self assembly of the lipid bilayer, a darker stained ring is again evident as the second lipid
of the bilayer is assembled, displaying a polar head group at the outer most layer of the particle’s
surface. Excess lipids are seen forming separate micelles in background. (E) and (F) Representative
Dynamic light scattering (DLS) of particles shown in (C) and (D) respectively. A shift in the overall
size of the particles is evident. The average size shifts from 202 ± 28 nm with a PDI of 0.185 to
399 ± 49 nm with a PDI of 0.3. (G) Representative solutions of the CPLS NPs in water after various
forms of purification, viewed using either 473 or 635 nm laser excitation. Tube 1 is water as a control,
while Tubes 2-4 are the same solution, containing the fully functionalized CPLS NP, presented with
different wavelength fluorescence. Tube 2 displays 473 nm excitation of the FITC dye embedded in
the silica shell, while Tube 3 displays the 635 excitation of the encapsulated CF 633 dye. Tube 4
is the representation of both Tube 2 and 3 overlaid and shows that the particle has the potential
for to contain a significant amount of dye. See supplementary materials for Chapter 6 for further
experimental details.

conducted in chloroform to facilitate the solubility of both the ligands and the final particle
construct. Interestingly, post assembly, the addition of the second monolayer (unsaturated
lipid 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine (DOPE)) is driven by hydrophobic
association in water. By being in water, these molecules prefer to either form their own
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micelle or, according to the simulation, form the upper bilayer around the lipidated Si@Ag
NP surface.
The CPLS NPs were fully characterized using a combination of transmission electron
microscopy (cf. Figs. 6.9B-D), and dynamic light scattering (cf. Figs. 6.9E-F) paired
with zeta potential measurements (cf. Fig. A.31 of supplementary materials) to ensure the
increase in size and any changes in surface charge that would be attributed to the PEGylated
lipid layer attachment followed by formation of the final lipid bilayer at the CPLS NPs
surface (stepwise synthesis and self assembly process shown in Fig. 6.9A). The CPLS NPs
were found to be fully stable in water as synthesized and remained intact in the aqueous
solution for several days without degradation as observed by dynamic light scattering. In
order to further investigate the capacity of the CPLS NPs to carry a hydrophilic cargo
within the PEGylated layer, we synthesized a second version of the particle in which a
small hydrophilic dye was added prior to the final lipid encapsulation step by DOPE. CF
633 was chosen for this purpose as it is water soluble and emits at a longer wavelength than
the FITC dye (abs. 492 nm) embedded in the silica layer of the inorganic NP scaffold. Using
these two wavelengths we were able to track the presence of the loaded dye independent
of the CPLS NP using laser excitation on a laser gel scanner system (cf. Fig. 6.9G). As
can be seen in Fig. 6.9G, post size exclusion and purification of the particles from starting
materials (excess lipids, free dye) the particles maintained a significant amount of dye.
These studies were performed on a relatively large sized inorganic core with a long PEG
chain layer. Future experiments are underway to synthesize the CPLS NPs with a range of
NP core sizes and PEG linker lengths in order to determine the maximal loading capacity
as predicted by simulations. For the particle size investigated here, the capacity to both
load and visualize a small molecule payload is successfully shown.
The proposed CPLS NPs consist of lipids, PEG polymers and an inorganic core. The
inorganic core could be made of gold, silica, superparamagnetic iron oxide and many other
materials, which have been extensively studied before as nanomaterials for biomedical appli156

cations. Moreover, the lipids and PEG polymers have been FDA-approved as biocompatible
and nontoxic. The CPLS NPs in this study can be thought of as analogous to a liposome,
a long utilized nanomaterial used for drug delivery. The CPLS NP’s surface chemistry is
mostly identical to that of a liposome. The main difference is the lipidated inorganic NP
core. Therefore, although these components are known to be individually nontoxic, follow
up studies to test the cytotoxicity of these constructs will be carried out in several different
cell lines to understand their broader applicability. Our goal in the experimental portion
of this study was to determine the possibility of encapsulating a hydrophilic cargo (small
molecule dye) and to determine the stability of the overall construct over the course of
several days, both of which were demonstrated successfully. Further biological response of
the CPLS NPs will be thoroughly explored through follow up in-vitro cell studies.

6.5

Concluding Remarks

Nanomaterials have revolutionized the delivery of therapeutics into cells. Therapeutic payloads ranging from small molecule drugs to antisense DNA and RNA cargoes have been
effectively delivered into cells using a variety of nanoscale materials. We have hypothetically
designed a new multifunctional nanomaterial, so-called CPLS NPs in this study, through
large scale DPD simulations. The CPLS NPs can be self-assembled at a PEGylated NP
core with additional free lipid molecules. As the free ends of PEG chains are bonded with
anchored lipids, a lipid bilayer shell forms and fully covers the surface of the NP core, driven
by the hydrophobic nature of lipid tails. Since the lipid bilayer shell is connected with the
core through PEG polymer chains, its stability has been further enhanced, compared with
traditional liposomes. To further strength our hypothesis we synthesized a representative
nanoparticle in which the approach outlined by the simulations and shown to be most effective was implemented. The results of these experiments provided visual evidence for the
effect of the need to control the specific ratio of excess lipid when forming the CPLS NPs
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and provides a basis for synthetic considerations that will be important when implementing
the results found using this new approach to designing nanomaterials through simulation.
Taken together, the proposed CPLS NPs have significant potential to be used as drug carriers with high efficacy and nontoxicity, as their surface chemistry is identical to liposome
yet their stability is superior as indicated by the simulation explained in this study. Further
research efforts will be focused on the experimental characterization of proposed CPLS NPs
and the investigation of their cellular uptake mechanisms and toxicity in light of computer
simulations put forth in this work.
In a recent study by Hu et al. 261 , NPs enveloped by polymer-tethered lipid membrane
have been pre-assembled in computer simulations, by using solvent-free lipid models. 76 The
extension of the tethered polymer chains and their forces are found to play predominate
roles in the stability of pre-assembled structures. The present study however focuses on the
self-assembly process of CPLS NPs in the presence of explicit aqueous solvent, under the
influences of varying grafting density and molecular weight of grafted PEG polymers, along
with the number of free lipids in a given solution. Therefore, it provides unique insights into
the formation of CPLS NPs, compared with the investigation of a pre-assembled structure,
which can be useful and serve as a guide to the experimental synthesis of CPLS NPs.
Moreover, the storage capacity of payload for CPLS NPs has also been revealed through
this study, signaling its potential for drug delivery with high efficacy.
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Chapter 7

Self-Assembled Core-Polyethylene
Glycol-Lipid Shell Nanoparticles
Yield High Stability in Shear Flow
7.1

Abstract

A core-polyethylene glycol-lipid shell (CPLS) nanoparticle consists of an inorganic core
coated with polyethylene glycol (PEG) polymers, surrounded by a lipid bilayer shell. It can
be self-assembled from a PEGylated core with surface-tethered PEG chains, where all the
distal ends are covalently bonded with lipid molecules. Upon adding free lipids, a complete
lipid bilayer shell can be formed on the surface driven by the hydrophobic nature of lipid
tails, leading to the formation of a CPLS nanoparticle. The stability of CPLS nanoparticles
in shear flow has been systematically studied through large scale dissipative particle dynamics simulations. CPLS nanoparticles demonstrate higher stability and less deformation
in shear flow, compared with lipid vesicles. Burst leakage of drug molecules inside lipid
vesicles and CPLS NPs can be induced by the large pore at their tips. This pore is initiated
by the maximum stress at the waist region. It further grows along with the tank-treading
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motion of vesicles or CPLS NPs in shear flow. However, due to the constraints applied
from PEG polymers, CPLS NPs are less deformed than vesicles with comparable size under
the same flow conditions. Thus, the less deformed CPLS NPs express a smaller maximum
stress at waists, demonstrating higher stability. Pore formation at waists, evolving into
large pores on vesicles, leads to the burst leakage of drug molecules and complete rupture of
vesicles. In contrast, although similar drug leakage in CPLS nanoparticles can occur under
high shear rates, pores initiated under moderate shear rates tend to be short-lived and close
due to the constraints mediated by PEG polymers. This kind of ‘self-healing’ capability
can be observed under a wide range of shear rates for CPLS nanoparticles. Our results suggest self-assembled CPLS nanoparticles to exhibit high stability during blood circulation
without rapid drug leakage. These features render CPLS nanoparticles as candidates for a
promising drug delivery platform.

7.2

Introduction

Freely administrated drug molecules cannot be efficiently delivered into diseased cells. By
loading these molecules into nanoparticle (NP)-based drug carriers, they can be more easily
accumulated within tumors. 262,263 For instance, by encapsulating drug molecules into liposomes, the peak drug accumulation can be increased by one to two orders of magnitude, 264
compared with their freely administrated counterparts. The development of a NP-based
drug delivery platform has therefore been extremely attractive in recent years. 16,24,34,265,266
To deliver loaded drug molecules into tumors, intravenous injected NPs need to circulate
along with the blood flow through the vascular network and passively accumulate in the
tumor site by extravasating through the leaky vessel wall (a process known as enhanced
permeation and retention or EPR effect). 241
To design NP-based carriers with high efficacy, unfavorable physiological barriers should
be considered during the blood circulation, or near the tumor sites. 49,158,267 For example,
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NPs circulating in blood flow might be subject to a shear rate up to 10000 s−1 , 268 which
requires the high stability of NPs under shear flow. Furthermore, serum proteins in the
blood flow might interact and be absorbed on NP surfaces. These protein coated NPs
could be detected and subsequently removed by the mononuclear phagocyte system (MPS)
before reaching tumor site. In addition, the tumor stroma mainly composed of collagen
and fibroblasts is a performance-disturbing barrier for extravasated NPs to reach tumor
cells. 205 Due to these kinds of complex biological environments, although different types of
NPs have been proposed and investigated, at present, only a few NP formulations have been
clinically approved. 16 Among them, liposome is one of the most favorable drug carriers due
to its biocompatibility and biodegradablility. 161,269,270 Specifically, liposomes composed of
natural phospholipids are biologically inert and weakly immunogenic, showing low intrinsic
toxicity. For instance, Doxil (PEGylated liposome-encapsulated doxorubicin) is the first
US Food and Drug Administration approved NP-based delivery formulation for clinical
application. 110 . By grafting polyethylene glycol (PEG) polymers on its surface, a liposome
demonstrates a prolonged blood circulation time 49,161,213 , which significantly improves the
drug accumulation within tumor sites through the EPR effect. By loading doxorubicin into
the PEGylated liposomes, Doxils demonstrate a higher efficacy for cancer therapy than free
doxorubicin molecules.
Although the liposome-based drug carriers have been widely adopted, further improvements are limited by the challenges in the instability of liposome in plasma 110,210 and
nonuniform size distribution. 216 For example, a nonuniform size distribution prevents the
large size liposomes from taking advantage of the EPR effect to extravasate into the tumor
site. 271 Considering the instability of liposomes, for instance, the encapsulated doxorubicin
in a liposome might experience a burst leakage during blood circulation and the escaped
doxorubicin molecules could cause undesirable side effects, such as cardiac toxicity. 110 The
final leakage could be induced by different mechanisms: 1) interactions between protein and
liposome surface might affect the drug membrane/medium partition coefficient, resulting
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in the rapid release of the encapsulated drugs; 49,110 2) pore formation in liposomes could
be another reason for the burst leakage, 251 especially for the liposome in its fluid state.
The stability of liposomes in blood flow could be affected by factors such as the packing
of lipid bilayers, fluidity, and size. 49 Although many works have been done to explore the
deformation of lipid vesicles under shear flow, 272–274 to the best of our knowledge, only few
of them clarify the stability of vesicles, such as the pore formation and evolution of vesicles
under shear flow. 214
Anchored lipid

PEG

NP core

PEGylated core
Lipid shell

Core-PEG-lipid shell

Figure 7.1: Schematic of a core-polyethylene glycol-lipid shell (CPLS) NP. A spherical core is
surface decorated by PEG chains, with all their free ends bonded by lipid moieties. Upon addition
of free lipids or a pre-assembled lipid bilayer shell, the PEGylated NP core will be covered by a
spherical lipid shell, due to the hydrophobic nature of the lipid tails. The NP core is colored in
silver to represent gold, silver, superparamagnetic iron oxide or other inorganic materials. The
PEG polymer is colored in yellow. The anchored lipid heads and tails are colored in tan and gray,
respectively. Lipid heads and tails in the shell are colored in blue and cyan respectively. Encapsulated
water molecules are not shown for clarity.

To overcome the mentioned limitations of liposomes, we have recently proposed a new
formulation, named core-polyethylene glycol-lipid shell (CPLS) NPs. 153 As deciphered in
Fig. 7.1, a CPLS NP consists of an inorganic core coated with polyethylene glycol (PEG)
polymers, surrounded by a lipid bilayer shell. It can be self-assembled from a PEGylated
core whose distal polymer ends are covalently bonded with lipid molecules. Upon adding free
lipids, a complete lipid bilayer shell can be formed on the surface driven by the hydrophobic
nature of lipid tails, leading to the formation of a CPLS NP. Such self-assembled CPLS
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NPs have been realized experimentally, and studied in detail through large scale dissipative
particle dynamics (DPD) simulations. 153 By mimicking the similar surface chemistry of
liposomes, the CPLS NPs should inherit the advantages of liposome in biocompatibility.
In addition, the inorganic core can be made of gold or superparamagnetic iron oxide, to
be visible via magnetic resonance imaging or computer tomography for diagnosis purposes,
rendering CPLS NPs as a multi-functional drug delivery platform. Moreover, due to the
constraints acting between the core and lipid shell through the grafted PEG polymers, selfassembled CPLS NPs have a fairly uniform size compared with liposomes, as revealed by our
experiments and simulations. 153 These CPLS NPs are also found to be highly stable in water
and to be able to remain intact for several days without degradation. Self-assembled CPLS
NPs could thus serve as drug carriers with high efficacy, while overcoming the limitations
of liposomes. In short, comparing with liposomes, we hypothesize that the CPLS NPs
would have the following advantages: (1) size uniformity due to the constraints applied
through the grafting density and molecular weight of tethered PEG chain polymers; (2)
enhanced stability due to the solid inorganic NP core and the covalent linking with PEG
chains; (3) the potential for multifunctional properties and development as a ‘theranostic’
material, 275,276 where the lipid vesicle can account for drug carrier capabilities and the
inorganic NP core can be useful as a diagnostic imaging agent 275,277 either as an optical
tag or core for photothermal therapy. 278,279
To understand the instability of liposomes and explore the stability of CPLS NPs during blood circulation, we are going to present and analyze results from large scale DPD
simulations. Vesicles under shear flow are found to release encapsulated drug molecules
rapidly through opened pores near their tips. These opened pores are initiated at the waist
of vesicles induced by the maximum tension. CPLS NPs are found to demonstrate the
same pore opening mechanism and drug leakage phenomenon. However, CPLS NPs with
the same size as vesicles are less deformed under the same shear rates, which in turn leads
to the smaller tension at their waist region. In accord with the constraints applied through
163

PEG polymers, the CPLS NPs are found to exhibit improved shape resistance and higher
stability in shear flow, when compared with lipid vesicles. Upon increasing the shear rate,
vesicles can get completely destroyed, while pores are formed on the surfaces of CPLS NPs.
These pores are transient structures and disappear not only after succession of flow but
already during flow due to the PEG polymer linking between the core and lipid shell, indicating a ‘self-healing’ capability of CPLS NPs. Moreover, the critical shear rate, defined
as the shear rate required to destroy the NPs, is found to be significantly higher for CPLS
NPs. All these features indicate that CPLS NPs can be used as a promising drug delivery
platform.

7.3
7.3.1

Model and Methodology
DPD Method

All simulations performed in the course of this study are based on the DPD method, a
coarse-grained molecular dynamics simulation technique. DPD simulations can correctly
and accurately capture hydrodynamics of complex fluids, while retaining essential information about the structural properties of the system components. 194,195 The DPD method had
been widely used and successfully applied for studying problems related to behaviors of lipid
vesicles or polymers and their interactions with lipid bilayers. 58,59,61,72,244,245,280–283 The basic interacting sites in DPD simulations are represented by soft beads. Between each pair of
DPD beads, effective two-body interactions consist of three major forces 194,195 : a conservative force FC , a random force FR and a dissipative force FD . Specifically, the conservative
force between beads i and j is FC
ij = aij ω(rij )eij , where rij denotes the distance between
the two beads i and j, and eij is the unit vector pointing from i to j; aij represents the
maximum repulsion force. The weighting factor ω(rij ) is a normalized distribution function
as ω(rij ) = 1−rij /r0 for rij ≤ r0 , while ω(rij ) = 0 for rij > r0 . Here r0 is the cutoff distance
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for pairwise interactions. The random forces are specified by FR
ij =

p
2βkB T /∆t ω(rij )αeij ,

where α represents a normal distributed Gaussian random number with zero mean and
unit variance, ∆t denotes the integration time step, β is a bead friction coefficient, and kB
and T stand for Boltzmann’s constant and temperature, respectively. The dissipative force
2
is given by FD
ij = −βω (rij )(eij · vij )eij , where vij is the relative velocity vector between

beads i and j. The conservative force is a purely repulsive interaction, while the random
and dissipative forces acting along the centers of the soft beads conserve linear and angular
momentum, respectively.

7.3.2

Vesicle and CPLS NP Models

For CPLS NPs, the inorganic core is composed of 1575 beads with a radius 5r0 ( number
density ρ = 3/r03 ). These beads are arranged on a FCC lattice with lattice parameter
0.8r0 . To get a smooth spherical surface, the core is thus essentially covered by a layer
of spherical shell beads. The tight packing of the core and its large repulsion with other
beads (aij = 100 kB T /r0 ) prevent the penetrations of water, polymer and lipid beads. The
whole NP core moves like a rigid body during the simulation 255 . This kind of spherical NPs
structure has been successfully applied in simulations to explore interaction between NP
and membrane. 172,284,285 Hydrophilic, linear PEG chains are covalently grafted by one of its
terminals through a harmonic bond potential onto the surface of the core. The monomers
of PEG polymers are sequentially connected by the same harmonic bond potential: Us1 =
Ks1 (rij − rs )2 , with spring stiffness Ks1 = 2111.3kB T /r02 and equilibrium distance rs =
0.4125r0 . The known semiflexibility of the PEG polymer is taken into account by an angular
potential between each three consecutive monomers, defined by Uθ1 = Kθ1 (cos θ − cos θ0 )2 ,
with bending stiffness Kθ1 = 16.4946kB T , and equilibrium angle θ0 = 130°. Such a DPD
model could correctly reproduce the conformation of a PEG polymer in water, including
the radius of gyration and end-to-end distance, as shown in our previous studies. 72,123 The
polymerization degree N of the tethered, monodisperse PEG polymers is varied between 10
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and 60, representing a molecular weight ranging between 450 Da and 2700 Da. The grafting
density of the PEG polymer is fixed at 1.0 chains/r02 , and there are 201 chains in total.
These values represent typical experimental conditions. A typical grafting density is 0.5-2.0
chain/nm2 and the molecular weight ranges from 500-5000 Da. 50,164,199 One lipid molecule
(anchored lipid) is bonded to the distal group of each PEG polymer by connecting the free
end of the PEG polymer with the lipid head through a harmonic bond potential. A lipid
bilayer shell, consisting of free lipids and anchored lipids, covers the tethered PEGylated core
and forms the CPLS NP. All the lipid molecules in the DPD simulations are adopted from
the same model, in which two lipid tails (with four tail beads each) are connected with two
head beads, while the head group contains three head beads (cf. Fig. 7.1). Adjacent beads
making the lipid molecules are connected by the harmonic spring potential Us2 = Ks2 (rij −
rs )2 , with spring coefficient Ks2 = 64kB T /r02 , and equilibrium distance rs = 0.5r0 . The
stiffness of the lipid tails is further guaranteed by an angular potential Uθ2 = Kθ2 (1 − cos θ)
with Kθ2 = 15kB T . This kind of lipid model is adopted from existing studies, 196,197 that
were able to accurately and successfully capture the characteristics of fluid-state bilayer
such as bending rigidity and stretch modulus. The interaction parameters aij of PEG
polymers and lipids are taken from our previous studies 72,123 and Lipowsky’s works 196,197 ,
respectively. Details are given in the TableA.7 of supplementary materials. Note that the
aij between PEG polymer beads and lipid beads are taken to reflect the hydrophilic of PEG
polymers.

7.3.3

Simulation Protocol

Within our DPD model, different types of beads have identical masses and cutoff distances
for pairwise interactions. For the sake of transferability, the mass, length and time scales
are all normalized. The unit length is taken to be the cutoff distance r0 . The unit mass is m
for all the beads and is set to unity. In addition, the unit energy is defined by the thermal
energy kB T . All other dimensional quantities can thus uniquely be made dimensionless in
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terms of these basic units (and vice versa). Here we use the classical value β = 4.5 for the
bead friction coefficient. The time step in our DPD simulations is chosen as ∆t = 0.01τ ,
p
with τ =
mr02 /kB T . The number density of beads in the simulation box is fixed at
3/r03 . 195 The velocity-Verlet integration algorithm is adopted for the time integration. The
reduced units can be mapped to SI units using a real bilayer thickness and a measured
value for the diffusion coefficient, as shown in previous studies. 196,197 Periodic boundary
conditions are applied along all directions of the simulation box, unless otherwise noted.
All the simulations are performed by using the Large-scale Atomic/Molecular Massively
Parallel Simulator (LAMMPS), distributed by Sandia National Laboratories. 89
NP-based drug carriers need to circulate within blood flow after being injected. Blood
flow is usually considered as shear flow in simulations. 24,286,287 And blood in a large vessel
with a characteristic diameter larger than 1 mm is typically modeled as a Newtonian fluid
with constant shear viscosity due to its high shear rate (or Weissenberg number). 288 To
investigate the behaviors of NPs within blood flow, a simple shear flow is applied in our
simulations. Specifically, the system containing NPs and water is confined between two rigid
and flat substrates. The substrates, with thickness of 5r0 , are made of frozen beads arranged
in a FCC lattice structure with lattice parameter 1.10064 r0 , reaching a number density
around 3/r03 . These two substrates are both placed within the x-y plane and thus normal
to the z direction, at gap size l0 . A relatively large pairwise interaction (aij = 100kB T /r0 )
between the substrates and other types of beads is set to prevent the penetration, as given
in the TableA.7 of supplementary materials. Shear flow is activated by pulling the upper
substrate (z = l0 ) with a constant velocity vx along the x-direction, while the lower substrate
(z = 0) is kept frozen. The corresponding shear rate is γ̇ = vx /l0 . The simulation box size
is given by (84.75 × 50.63 × 70.00) r03 for CPLS NPs and vesicles with radius R below 14r0 .
For NPs exceeding this radius, the simulation box size is enlarged to (90.25 × 70.44 × 80.00)
r03 . Simulations with larger box sizes for each CPLS NP are performed to confirm that the
box size does not affect the results. The dimensions of the simulation box along x and y
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directions are chosen to match the lattice constant of the substrate. With this kind of model,
the no-slip boundary conditions could be achieved in our simulations. 289,290 Viscosities of
water beads inside and outside the vesicles or CPLS NPs are the same for the unchanged
β values. Such a condition has been widely applied to investigate the behaviors of vesicles
under shear flow. 280,283

7.3.4

Self-Consistent Field Theory

To explore the role of PEG polymers in CPLS NPs more precisely, we employ an independent
self-consistent field (SCF) theoretical approach 291,292 to estimate the free energy changes of
PEG polymers inside CPLS NPs between steady state under shear flow and initial relaxed
state. Within the SCF theory, the single chain free energy is composed of elastic and
interaction parts,
2 i
Fp
3 hree
=
+
kB T
2 R02

Z

fm (φ)d3 r

(7.1)

R
2 i = V −1 (r − d/2)2 φd3 r is the mean squared extension of a polymer that is
where hree
tethered on a sphere of diameter d = 10r0 whose center defines the origin of the coordinate
system in which the radial distance r is measured, properly normalized by the occupied
R
chain volume V = φd3 r = N ν, and R0 = R0 (N ) represents the equilibrium size of a
2 /ei, using the available R2 (N ) values for a single
PEG polymer. Here we take R02 = hRee
ee

PEG chain. The above free energy is minimized with respect to the volume fraction profile,
subject to the constraint of conserved V and the tethering condition, φ(r < d/2) = 0. More
details are given in our previous works 72,123 for the SCF theory and free energy calculation.

7.3.5

Potential of Mean Force Calculation

In addition to SCF theory, the free energy change during pulling a single PEG polymer
with anchored lipid inserted into a planar bilayer is evaluated to investigate the constraint
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from the PEG polymer. The reaction coordinate is chosen as the projection of the PEG
polymer’s end-to-end vector on the direction normal to the bilayer plane, denoted as ξ.
The potential of mean force (PMF) along this reaction pathway is calculated through the
umbrella sampling method. 293 . A harmonic potential U = 12 k(ξ − ξ0 )2 is applied on the free
end of the PEG polymer; ξ0 is the equilibrium distance in each window, with a force constant
k = 500kB T /r0 . Series of windows are performed at different values of ξ0 at a resolution of
0.1r0 . Each simulation window runs 4000τ to achieve equilibration and sufficient statistics.
The weighted histogram analysis method (WHAM) is adopted to sample the PMF profile
during the pulling process. 294 Simulations with longer equilibration times in each window
are also performed to ensure the accuracy of the presented PMF profiles.

7.4
7.4.1

Results and Discussion
Properties of Relaxed CPLS NPs and Vesicles

Table 7.1: Properties of pre-assembled CPLS NPs and their corresponding lipid vesicles. The first
column specifies the total number of lipids L within CPLS NPs or vesicles. The radius of a CPLS
NP or vesicle, R, is calculated as the mean distance between its center and the lipid shell. The shell
area per lipid A is calculated via A = 8πR2 /L, with R and L denoting radius and total number of
lipids, respectively. The drug number ND indicates the number of water molecules inside the CPLS
NPs or vesicles after fully equilibration. N represents the polymerization degree of PEG polymers
in CPLS NPs. Ree denotes the end-to-end distance of PEG polymer.

L

1701
2201
2701
3201
4201

CPLS NPs
(r02 )

R (r0 )

A

10.28
11.43
12.51
13.44
15.03

1.56
1.49
1.46
1.42
1.35

Vesicles

ND

N

Ree (r0 )

R (r0 )

A (r02 )

ND

2748
4016
6288
8589
13334

10
20
30
40
60

2.77
4.42
5.66
6.67
8.45

9.81
11.06
12.17
13.17
15.01

1.42
1.40
1.38
1.36
1.35

4954
7840
11509
15662
25372

To systematically explore the stabilities of CPLS NPs and vesicles under shear flow
and to allow for a comparison, CPLS NPs and vesicles consisting of the same number of
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lipids are built and fully relaxed. CPLS NPs with PEG polymerization degree ranging from
N = 10 to 60 have been pre-assembled for simplicity. A spherical lipid bilayer shell formed
by a proper number of lipids is placed around the surface of the PEGylated core. A large
number of water beads are added between the lipid shell and NP core simultaneously. Due
to the osmotic pressure induced by water molecules, a pre-assembled lipid shell can rupture,
resulting in a pore on its surface. The pre-assembled CPLS NPs have been equilibrated at
a relatively high temperature T = 2.0 for 106 time steps, then annealed back to normal
temperature T = 1.0 during a period of 106 time steps, and further equilibrated for another
106 time steps at temperature T = 1.0. During this process, the opened pore closes by fusion
of neighboring lipids on the surface, releasing extra water molecules from the interior of the
CPLS NPs. The above process allows us to capture the similar characteristics during the
self-assembly of CPLS NPs. 153 Following the described protocol, an almost perfect spherical
lipid bilayer shell is formed on the surface, and subsequently fused with the anchored lipids
that are bonded to the distal groups of the PEG polymers. On the other hand, vesicles
with an identical number of lipid molecules are built by following a very similar protocol.
Thus, both CPLS NPs and vesicles are ensured to be fully relaxed with similar size, which
can be used for further shear tests.
As listed in Tab. 7.1, the sizes of CPLS NPs and vesicles monotonically increase with the
number of lipids. More importantly, both the CPLS NPs and vesicles exhibit a comparable
size (difference is smaller than 3%) when they contain the same number of lipids. From
the outside, the CPLS NPs cannot be distinguished from the lipid vesicles, signaling their
identical surface chemistry. While, under the same lipid bilayer surface, PEG polymers
support the lipid shell inside CPLS NPs as a scaffold. End-to-end distance Ree of PEG
polymers within CPLS NPs linearly increases along with the polymerization degree N .
Their values are slightly larger than that of free PEG polymers in water 72 , indicating that
PEG polymers inside the CPLS NPs are being stretched. In the following parts, stabilities
of CPLS NPs and lipid vesicles under shear flow will be discussed in detail. To evaluate their
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drug delivery capability, the encapsulated water molecules are considered to be hydrophilic
drug molecules.

7.4.2

Stability of Vesicles in Shear Flow

A

t=0

t=6220

t= 6360

t=7920

t=7840

B
t=0

t=6220

t= 6360

t=7840

Figure 7.2: Behaviors of a vesicle with radius R = 11.06r0 under shear flow rate of γ̇ = 0.5τ −1 .
(A) Snapshots of deformation and pore evolution process after the activation shear flow at different
times (t = 0, 6220, 6360, 7840, 7920 τ ). The lipid colored black in these figures is the same lipid
molecule, and used as a marker to track the tank-treading motion of the vesicle. The white line on
snapshot (t = 7840τ ) represents the direction of 45◦ along the x-axis. The encapsulated drug beads
are colored in red. The water beads outside the vesicle are not shown for clarity. (B) Local lipid
area distribution on vesicle surfaces at corresponding times of t = 0, 6220, 6360, 7840 τ .

Tank-treading, pore opening and rupture process of a vesicle in shear flow are observed in
our simulations. Responses of a vesicle with radius R = 11.06r0 upon the activation of shear
flow (γ̇ = 0.5τ −1 ) are given in Fig. 7.2A. The black lipid acts as a marker for the motion of
the vesicle. The tank-treading of the vesicle can be clearly identified from different positions
of the marked lipid in these snapshots. Similar tank-treading motion of vesicles has also
been observed in experiments. 273 At t = 6220τ , the initial spherical vesicle has already been
deformed into an ellipsoidal shape. In addition, a small pore opens near the tip region at
this time, as shown in the insets of Fig. 7.2A. Interestingly, the opened pore is closed and
no existing pores can be observed on the surface of the vesicle at time t = 6360τ , while the
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vesicle is still under shear. Experiments also confirm the similar ‘self-healing’ behavior of
vesicles under shear stress. 214 However, a small pore opens again at time t = 7840τ between
the waist and tip regions of the vesicle. Note that this opened pore quickly grows with the
tank-treading motion and further evolves into a large pore near the tip of the vesicle at time
t = 7920τ , leading to a burst leakage of encapsulated drug molecules. The evolution from
the initiation and enlargement of a pore on the surface of the vesicle should be highly related
to the tank-treading behavior. Nevertheless, the tank-treading alone might not be enough
to explain the pore open-close-reopen phenomenon. The nonuniform stress distribution on
the surface of the vesicle should be another important factor. 214,272
To explore the stress distribution of the vesicle under shear, we try to get the local
tension of bilayer in vesicles. But it is the diffuculty to explicity measure the tension of
vesicle 90 . Instead, lipid area distribution is used. The lipid area has a linear relationship
with the bilayer tension for planar bilayer(cf. A.36 of supplementary materials). In this
process, the surface of the vesicle is fitted to an ellipsoid shape. Then, the surface of the
ellipsoid is discretized into small triangles. Lipids located within a triangle are counted to
calculate the lipid area on that spot. Note that the vesicle curvature is expected to riase the
tension of bilayer. However, it does not qualitively alter the relationship between lipid area
and tension as shown in Ref 90 . Particularly, we expect that the curvature induced tension
will not affect our exploration of nonuniform stress distribution of vesicle under shear stress.
As presented in Fig. 7.2B, the lipid area distribution of the fully relaxed state (t = 0) is
significantly different from that of the deformed state. At the relaxed state (t = 0), the
lipid area distributes evenly on the surface of the vesicle with values about 1.30 to 1.40 r02 ,
which indicates the uniform and close-to-zero tension of the vesicle.
In comparison, for the deformed vesicle at time t = 6220τ , the waist region has a much
higher lipid area value of 1.66 r02 , indicating a high tension. While, the lipids near the tip
region experience compression with a lower lipid area of 1.18 r02 . The lipid area difference
between the waist and tip regions is more pronounced at time t =6360 and 7840 τ . This
172

kind of lipid area difference is in good agreement with theoretical predictions that vesicles
subjected to simple shear flow experience tension at the waist while compression near the
tip. 214 It is also confirmed that the local lipid area distribution could qualitatively capture
the nonuniform stress distribution in vesicle.
From the above picture, the pore open-close-reopen on the surface of the vesicle can
be understood in following way. Under the influence of the tank-treading motion and
compression near the tip region, the opened pore can be closed before it grows dramatically.
However, if the initiated pore happens to be large enough, it might not have enough time
to close along with the tank-treading motion. Therefore, the difference between velocities
at the edges of the pore can result in the further growth of the pore and final rupture of the
vesicle, as shown in Fig. 7.2A. Future studies are needed to understand this phenomena in
detail.
A

B

t=10509

t=10511

t=10515

C

t=7640

t=7771

t=7775

Figure 7.3: Pore opening process for vesicles with different sizes. (A) Sketch of maximum and
minimum stresses on a vesicle under shear flow. The largest elongation rate eigenvector is oriented
along e1 , which makes an angle of π/4 with x direction. While e2 is the eigenvector normal to
e1 within the same plane of shear flow. (B) Pore opening process of a small vesicle with radius
R = 9.81r0 under shear rate of γ̇ = 0.55τ −1 . (C) Pore opening process of a large vesicle with radius
R = 15.01r0 under shear rates of γ̇ = 0.325τ −1 .

After inspecting the local lipid number (or stress) distribution on the surface of the
vesicle, a question needed to be further answered is how the pore can be initiated under
shear flow. For a vesicle in simple shear flow with vx = γ̇z, the positive elongation rate
eigenvector e1 makes an angle of π/4 along the x axis, as given in Fig. 7.3A. The maximum
173

stress σ max is located at waist of the vesicle, while the minimal stress σ min is located
at the perpendicular direction that makes angle with e1 . 214 In the previous theoretical
study, 214 Marmottant et al. predicted that vesicles under shear flow could rupture by
two different mechanisms: 1) the high tension at waists could exceed the critical tension
of the bilayer; 2) the compression at tips could lead to buckling, which further results in
the rupture of vesicles. The buckling-driven rupture was stated to be confirmed by the
phenomenon of tip streaming in vesicles through experiments. 214 Here we try to clarify
these two mechanisms through DPD simulations. The pore initiation and evolution of
vesicles with different sizes in shear flow are systematically studied. Although the vesicles
rupture under different shear rates, pores always initiate at waists of vesicles, as shown
in Fig. 7.3 and Fig.A.37 in supplementary materials. Nevertheless, these pores are too
small to be observed through experiments. These opened pores can grow with the tanktreading motion of vesicles, leading to a burst leakage of encapsulated drug molecules near
the tips. In comparison, the buckling-driven rupture mechanisms cannot be confirmed by
our simulations. It could be induced by the fact that the initial deflation of vesicles is rather
small, which cannot contribute to the large deformation as argued in the Ref. 214 Besides,
the simulation results suggest that the observed breakup at the tips of vesicles cannot be
used as a necessary evidence for the buckling-driven rupture mechanism. In short, our DPD
simulations confirm that vesicles in shear flow can rupture due to the high tension at their
waists.

7.4.3

Stability of CPLS NPs in Shear Flow

For CPLS NPs with radius R = 11.43r0 , i.e., of size comparable with the vesicles shown in
Fig. 7.2, the burst leakage of encapsulated drug molecules cannot occur until the shear rate
reaches γ̇ = 0.625τ −1 . Such a shear rate is higher than that of the corresponding vesicles
(γ̇ = 0.5τ −1 ). As deciphered in Fig. 7.4A, the pore initiation and growth process of CPLS
NPs in shear flow is very similar to the vesicles (cf. Fig. 7.2). At time t = 5190τ , the
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Figure 7.4: Behaviors of a CPLS NP (R = 11.43r0 ) with comparable size of a vesicle (R = 11.06r0 )
under different shear rates. (A)(Top) Snapshots of deformation and pore opening process of a CPLS
NP (R = 11.43r0 ) under high shear rate of γ̇ = 0.625τ −1 at different time steps (t = 0, 5190,
5200, 5230, 5280 τ ). (A)(Bottom) Local lipid area distribution on the shell of a CPLS NP at the
corresponding times t = 0, 5190, 5200, 5230 τ . (B) Snapshots indicate ‘self-healing’ process of a
CPLS NP (R = 11.43r0 ) under moderate shear rate of γ̇ = 0.55τ −1 at different times (t = 0, 3500,
4000, 4500, 10000 τ ). (C) Snapshots of a CPLS NP (R = 11.43r0 ) under low shear rate of γ̇ = 0.5τ −1
at different times (t = 0, 4500, 5050, 5100, 10000 τ ).
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lipid shell in CPLS NPs gets deformed without pores. However, a pore opens at the waist
of the CPLS NP at time t = 5200τ , as given in the partial enlarged panels in Fig. 7.4A.
This pore grows quickly and results in the burst leakage of drug molecules near the tip of
the CPLS NP at time t = 5280τ . Besides, the lipid shell also experiences a tank-treading
motion as indicated by the marked lipid. In addition, the PEGylated core also moves with
the motion of lipid shell (cf. Fig.A.38 of supplementary materials). It is noteworthy that
although the shear rate here (γ̇ = 0.625τ −1 ) is larger than the one in Fig. 7.2 (γ̇ = 0.5τ −1 ),
the CPLS NP is still less deformed than the corresponding vesicle. For the similarity in
mechanical properties stretch between PEG polymer tethered planar bilayer and planar
bilayer (cf. Fig.A.36 in supplementary materials), the local lipid area distribution of the
CPLS NP is further investigated as given in Fig. 7.4A. At the beginning (t = 0), the lipid
area distribution is quite uniform and its mean value is slightly larger than that of the
vesicle, due to its larger size. After being deformed, the lipid shell also demonstrates higher
local lipid area (about 1.66r02 ) at waists and lower values at tips (about 1.18r02 ). It is also
interesting to see that the pore opens at sites with a local lipid area value around 1.66r02 ,
which is basically the same as that of the corresponding vesicle. This is also confirmed by the
similar lipid area – bilayer tension relationships as presented in Fig.A.36 of supplementary
materials. The stabilities of CPLS NPs with other sizes are also investigated. We find that
all the pores leading to the burst leakage of drug molecules initiate at the waists of CPLS
NPs, as presented in Fig.A.39 of supplementary materials. Therefore, we can conclude that
the high tension at the waists of CPLS NPs is the major driving force for their pore-opening
instability.
An interesting ‘self-healing’ behavior is also identified for CPLS NPs, when the shear rate
is reduced below the critical shear rate for their rupture. As demonstrated in Fig. 7.4B, the
pore open-close phenomenon repeats in the lipid shell of CPLS NPs with radius R = 11.43r0
under shear flow of γ̇ = 0.625τ −1 . During this process, a small pore opens on the surface of
the lipid shell at time t = 3500τ . Subsequently, the PEG polymers fill in the opened pore
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with their bonded lipid molecules inserting at pore edges. In contrast to the pore opening
under high shear rate, this pore does not continuously grow and is quickly healed due to
the fusion of neighboring lipids at time t = 4000τ . A new pore opens again at the same
location at time 4500τ . This newly opened pore closes again in the present of shear flow
during our simulations. More importantly, the CPLS NPs keep intact without degradation
till the end of the simulation (t = 20000τ ). Such a ‘self-healing’ behavior looks similar as
the one observed for vesicle (cf. Fig. 7.2). However, unlike the temporal pore open-close
behavior in vesicles, the ‘self-healing’ capability of CPLS NPs can be observed in a wide
range of shear rates. For example, the self-healing behavior happens between shear rates of
γ̇ = 0.625τ −1 and γ̇ = 0.55τ −1 for CPLS NPs with radius R = 11.43r0 . Moreover, it can
be observed for all the CPLS NPs with different sizes. The existence of PEG polymers and
anchored lipids seems to facilitate the closure of an opened pore. And two major favorable
conditions in PEG polymers and anchored lipids could be involved: 1) anchored lipids at the
pore edge behave like the nucleating sites to attract other lipids, leading to the fusion of an
opened pore; 2) the distal groups of grafted PEG polymers are covalently bonded with the
anchored lipid molecules (lipid heads), providing constraints to the anchored lipids. During
the self-healing process, the encapsulated drug molecules can escape from the interior of
CPLS NPs through short-lived pores, as demonstrated in Fig. 7.4B.
When the shear rate is further reduced to γ̇ = 0.55τ −1 , which is the critical shear rate
for the rupture of vesicle with radius R = 11.06r0 , the CPLS NP keeps intact without any
pore opening during the course of simulation (t = 20000τ ), as given in Fig. 7.4C. From
visual inspection, the deformation of CPLS NP is much less than the corresponding vesicle
(cf. Fig. 7.2). The PEG polymers inside CPLS NPs act as a scaffold to support the lipid
shell and resist the deformation. In this case, the lipids bonded to the distal ends of PEG
polymers provide anchoring sites for PEG polymers linking the lipid shell to the core and
they further counterbalance the shear stress within the lipid shell. The local lipid area distribution of CPLS NPs also indicates that the waist parts are subjected to a lower tension
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compared with the corresponding vesicles under the same shear rate. Therefore, the CPLS
NPs are more stable than vesicles with comparable size in the same shear flow.
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Figure 7.5: Comparison of deformations between vesicles and CPLS NPs. (A) Size changes of
a CPLS NP (R = 15.03r0 ) and a comparable vesicle (R = 15.01r0 ) under shear rate of γ̇ =
0.025τ −1 . R1 and R2 represent dimensions along the major and minor axes of the CPLS NP
or vesicle, respectively, illustrated in the insert figure. (B) Taylor parameters of vesicles and CPLS
NPs of various size under the same shear rate of γ̇ = 0.025τ −1 .

According to the theoretical study, 214 the maximum stress at waists is closely related
to the deformation of vesicles, i.e. a more pronounced deformation signals larger maximum
stress at waists. Therefore, the deformation of CPLS NPs and vesicles are further investigated in detail to understand their difference in shear flow. The shear rate is fixed at
γ̇ = 0.025τ −1 , under which both of vesicles and CPLS NPs with different sizes can keep
intact without pores. Since the shape of these NPs has been changed from spherical to
ellipsoidal or rodlike under shear flow, the radial dimensions along its major and minor
axes, denoted by R1 and R2 respectively (cf. insert of Fig. 7.5A), are used to characterize
the deformation of these drug carriers, and their already mentioned axis ratio R1 /R2 . As
shown in Fig. 7.5A, the vesicle with radius R = 15.01r0 has been dramatically elongated
upon activation of shear flow, accompanied by an increase of R1 . It rather quickly reaches
plateau values R1 and R2 at around t = 4000τ . During this process, the R1 of the vesicle
has been enlarged by 33%, compared with its undeformed state. In accord with volume con-
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servation of the vesicle, its R2 value has been dramatically reduced, displayed in Fig. 7.5A,
since R1 R22 is constant within errors in the course of time (as long as the vesicle does not
break). In remarkable contrast, the deformation of the CPLS NP is relative small at the
same shear rate and the variation of both R1 and R2 is less than 18%. Such a characteristic
difference in deformation behavior exists for CPLS NPs and vesicles independent of their
size. To confirm this, we also calculate the Taylor parameter, which is defined as the ratio
of (R1 − R2 )/(R1 + R2 ). As given in Fig. 7.5B, although the Taylor parameter increases
with the increasing size of vesicles or CPLS NPs, the value of CPLS NPs is always significantly smaller than that of vesicles with comparable size. All of these results confirm
that CPLS NPs are significantly stiffer and stabler than vesicles of identical equilibrium size.
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Figure 7.6: Critical shear rates versus radius of CPLS NPs or vesicles. The critical shear rate
for vesicles is defined as the shear rate to destroy vesicles, denoted by ‘rupture’ in the subscript.
Considering the self-healing capability of CPLS NPs, two critical shear rates are defined. One is the
critical shear rate to open a pore on the surface of CPLS NPs, denoted by ‘pore’ in the subscript.
The other one is defined as the shear rate to completely break the CPLS NPs, denoted by ‘rupture’
in the subscript.

To systematically compare the different responses of CPLS NPs and vesicles in shear
flow, we investigate these NPs with different sizes under a series of shear rates. A critical
shear rate is defined for vesicles, beyond which the vesicles get destroyed within simulation
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time, while permanently exposed to shear flow. For CPLS NPs, two critical shear rates
need to be defined, due to the self-healing behavior. One is the critical shear rate to
temporarily open a pore on the surface of CPLS NPs. The other one is defined as the
shear rate to completely break the CPLS NPs. For larger rates the opened pore does not
heal anymore. Between these two shear rates, the self-healing behavior of CPLS NPs can
happen, indicated by the shadow area in Fig. 7.6. The simulations have been run up to
2 × 106 time steps (t = 20000τ ) to ensure the accuracy of these critical shear rates. The
critical shear rate monotonically decreases with the increasing size (radius) of the vesicles
(Fig. 7.6), indicating that the larger vesicles are less stable at identical flow conditions.
Concerning the CPLS NPs, the critical shear rate for pore opening also monotonically
decreases with their increasing size. It is always higher than the critical shear rate of the
vesicles, consistent with our previous observations. More importantly, the critical shear rate
required to rupture a CPLS NP is significantly higher than the critical shear rate for the
corresponding vesicle, especially for the large particles with radius R = 15.05r0 , signaling
the high stability of CPLS NPs within shear flow.

7.4.4

Free Energy Analysis

Self-Consistent Field (SCF) Analysis
The observed differences between CPLS NPs and vesicles in shear flow should be attributed
to the existence of the PEGylated core inside the CPLS NPs. The lipid bilayer shell of the
CPLS NPs is supported by the PEGylated core through tethered PEG polymers. Upon
activation of shear flow, the deformation of lipid shell has been constrained by the PEG
polymers within CPLS NPs. Thus, the PEGylated core acts like a scaffold to support
the lipid shell. And the CPLS NPs demonstrate less deformation and higher resistance to
rupture, in comparison with their corresponding vesicles. These behaviors are evidently
related to the properties of the tethered PEG polymers, including their polymerization

180

N=20

Before
After

0.060

B

Before

After

D

Before

After

Probability

0.045

0.030

0.015

A

0.000

2

3

4

5

6

7

PEG end-to-end distance [r0]

0.08

N=60

Before
After

Probability

0.06

0.04

0.02

0.00

C
4

6

8

10

12

PEG end-to-end distance [r0]

14

Figure 7.7: (A) and (C) End-to-end distance Ree distribution of PEG polymers and (B) and (D)
cross sectional views of PEG monomer volume fraction distribution. ‘Before’ represents the initial
relaxed state. ‘After’ represents the steady state under shear flow rate γ̇ = 0.025τ −1 . (A-B) CPLS
NP with radius R = 11.43r0 and PEG polymerization degree N = 20. (C-D) CPLS NP with radius
R = 15.03r0 and PEG polymerization degree N = 60.

degree (molecular weight) and grafting density. To further understand the important role
played by PEG polymers, we adopt the SCF theory 72,123 to analyze the free energy change
of PEG polymers within CPLS NPs between initial relaxed state and deformed steady-state
in shear flow. The shear rate is fixed to be γ̇ = 0.025τ −1 , under which all of the CPLS NPs
keep intact as aforementioned. According to SCF theory 72,123 , the free energy change of
PEG polymers ∆Fpoly can be decomposed into two parts: elastic energy change ∆Fel and
interactive energy change ∆Fint . ∆Fel can be well approximated by the mean squared endto-end distance of PEG polymers, assuming they behave like entropic elastic springs. The
estimation of ∆Fint requires the volume fraction field of PEG monomers 72,123 , characterizing
the distribution and interaction between different chains. As shown in Fig. 7.7, the end-toend distance Ree of PEG polymers follows the Gaussian distribution in the relaxed state.
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Under the steady-state shear flow, CPLS NPs deform to counterbalance the shear stress,
resulting in elongation at its major axis and compression at minor axis. Following the
deformation of lipid shells, the PEG polymers inside CPLS NPs are stretched along their
major axes and compressed along their minor axes (cf. Figs. 7.7 A and C). Similarly, the
volume fraction distribution of PEG monomers demonstrates large values near the core
surface at relaxed state. While, under the shear flow, the PEG polymers rearrange their
configurations to demonstrate high concentrations of PEG monomers both at major and
minor axises, as presented in Figs. 7.7 B and D.
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Figure 7.8: Free energy change of PEG polymers within CPLS NPs under shear flow. (A) Free
energy change per chain of elastic ∆Fel and interactive ∆Fint parts, and their summation ∆Fpoly ;
(B) Total free energy change of PEG polymers, in comparison with the bending and stretching
energy change of lipid shells of vesicles or CPLS NPs. The shear rate is fixed at γ̇ = 0.025τ −1

Fig. 7.8A shows the free energy change of PEG polymers, obtained from the SCF analysis. Both ∆Fel and ∆Fint monotonically increase with the PEG polymerization degree N
(or radius of the CPLS NP). More importantly, the free energy change of PEG polymers is
mainly contributed by ∆Fint , induced by the redistribution of PEG polymers within CPLS
NPs. The elastic energy change ∆Fel is relative small, since the PEG polymers are stretched
and compressed along the major and minor axises, respectively. Therefore, the stretching
and compression of PEG polymers can cancel out the change of ∆Fel . The maximum free
energy change per chain for PEG polymers is about 1.75kB T , when the polymerization
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degree is N = 60. Thus, the total free energy change of PEG polymers is about 350kB T
for N = 60. Such a large free energy of PEG polymers inside CPLS NPs could explain the
high resistance of CPLS NPs under shear flow, since the shear stress experienced by the
lipid shell is transferred into the PEG polymers.
We further calculate the elastic energy change of the lipid bilayer shells of CPLS NPs
and vesicles, and compare it with the free energy change Fpoly of PEG polymers. According
to the Helfrich theory 95,295 , the free energy of a vesicle under shear flow consists of two
parts: one is the bending energy of the lipid shell Fbend and the other is the stretching
R
energy Fstretch . Fbend can be calculated as Fbend = 2κ(H − c0 )dA, where κ, H and c0 are
the bending rigidity, mean curvature and spontaneous curvature of the vesicles, respectively.
Here the spontaneous curvature is ignored as c0 = 0, since the lipid bilayer is symmetric.
The stretching energy is Fstretch = KA (A − Aopt )2 /(2Aopt ), where KA and Aopt are the area
compressibility modulus and initial area of the vesicle, respectively, while A stands for the
current area of a vesicle in the presence of shear flow. According to previous studies 196,197 ,
the bending rigidity κ = 9.5kB T and area compressibility modulus KA = 18.2kB T /r02 for our
model vesicles. Both Fbend and Fstretch for vesicles and CPLS NPs are given in Fig. 7.8B.
For vesicles under shear flow, Fbend and Fstretch monotonically increase with the size of
vesicles, while Fstretch increases much faster. Thus, the deformation and rupture of vesicles
are mainly induced by the stretching of lipid bilayers, as observed in Fig. 7.2. In contrast,
the changes of Fbend and Fstretch for CPLS NPs are relative small and negligible, since the
majority of deformation and shear stress have been transferred into linked PEG polymers.
Therefore, the CPLS NPs demonstrate high stability in shear flows, compared with their
vesicle counterparts.

Potential of Mean Force Analysis
To further understand the role of PEG polymers within CPLS NPs, we explore the potential
of mean force (PMF) change by pulling a single PEG polymer with bonded lipid inserted
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Figure 7.9: Potential of mean force (PMF) analysis for pulling a PEG polymer with anchored lipid
from a planar lipid bilayer. (A) Snapshots of pulling the end bead of PEG polymer (N = 20) with
anchored lipid inserted in a planar bilayer. (B) Change of PMF along with the reaction coordination
ξ, which is defined as the end-to-end distance of PEG polymer projected along the direction normal
to the planar membrane. ‘N = 10, 20, 30, 40, 60’ represent different PEG polymerization degrees.
‘Lipid’ denotes the one without PEG polymer.

in a planar lipid bilayer, as shown in Fig. 7.9A. The PEG polymer has been fully relaxed
before the pulling. The reaction coordinate is defined along the z direction, which is normal
to the planar bilayer, and the distance in Fig. 7.9B is defined as the projection of the PEG
polymer’s end-to-end distance onto the positive z direction. The process of pulling the PEG
polymer with polymerization degree N = 20 is shown in Fig. 7.9A. As shown in Fig. 7.9B,
the PMF change by pulling a single lipid molecule from a lipid bilayer is about 45kB T .
By linking the lipid molecule with PEG polymers, the PMF change has been significantly
enlarged up to 75kB T , which further confirms the important role played by PEG polymers.
They tend to constrain the deformation and rupture of their lipid bilayer shell. Especially,
CPLS NPs demonstrate a unique ‘self-healing’ capability within a range of shear rates (cf.
Fig. 7.6), which cannot be observed for vesicles.
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7.5

Conclusions

In summary, we have systematically investigated the stability of vesicles and CPLS NPs
exposed to shear flow of varying strength through large scale DPD simulations. It has
been demonstrated that with the support from a PEGylated core, CPLS NPs are more
stable and stiffer than vesicles in the presence of shear flow. Burst leakage of encapsulated
drug molecules can be induced by the large pores on tips of vesicles under shear. And
these pores initiate at waists of vesicles due to the maximum stress. However, due to the
constraints mediated by tethered PEG polymers, CPLS NPs are less deformed than vesicles
with comparable sizes under identical flow conditions. Therefore, the less deformed CPLS
NPs express smaller maximum stress at waists. The pore initiation at waists of CPLS
NPs requires higher shear rates. In addition, due to the constraints applied through PEG
polymers between lipid shell and core, a self-healing phenomenon has been observed for
CPLS NPs within a range of moderate to small shear rates. Furthermore, through a free
energy analysis, the dramatic free energy change of PEG polymers within CPLS NPs can be
the main reason for their high stability. We expect the qualitative trend to be unchanged in
mixed flows, and pure elongational flows, as only the deformation component of the shear
flow is responsible for the elongation of these particles. And particles do not tumble due
to the tank-treading motion and the rotational part of the shear flow is therefore of minor
relevance for the process investigated here. All these observations suggest that CPLS NPs
are superior to vesicles during blood circulation, due to their high stability and resistance
to rupture. These unique properties of CPLS NPs make them potentially useful as a multifunctional drug delivery platform.

185

Chapter 8

Polymer Stiffness Governs
Template Mediated Self-Assembly
of Liposome-Like Nanoparticles:
Simulation, Theory and
Experiment
8.1

Abstract

This study suggests that the self-assembly of a template-mediated liposome (TML) can be
utilized as a general method to produce liposomes with controlled sizes. A polymer tethered
core is used here as a starting configuration of a TML. Lipids anchored to the free ends of
the tethered polymers direct the self-assembly of surrounding free lipid molecules to form
liposome-like nanoparticles. Characterizing the flexibility of polymers by their persistence
lengths, we performed large scale molecular simulations to investigate the self-assembly
process of TMLs with tethered polymers of different stiffness values. The stiffness of tethered
polymer is found to play a crucial role in the self-assembly process of TMLs. The flexible
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and rigid-like polymers can accelerate and delay the self-assembly of TMLs, respectively.
In addition, the critical grafting of tethered polymers and required lipid concentrations to
from perfectly encapsulated TMLs are found to increase with the flexibility of tethered
polymers. To scrutinize these simulation-based findings, we synthesized DNA-polyethylene
glycol (PEG) TMLs and performed corresponding experiments. To this end we incorporate
increasing concentrations of DNA as a proxy for increasing the rigidity of the tethered
polymers. We find that the resulting structures are indeed consistent with the simulated
ones. Finally, a theory is developed that allows one to estimate the required free lipid
number (or lipid concentration) and grafting density analytically for polymers of a given
persistence length. Through these combined computational, experimental, and theoretical
studies, we present a predictive model for determining the effect of polymer stiffness on the
self-assembly of TMLs, which can be used as a general approach for obtaining perfectly
encapsulated TMLs as potential drug delivery vehicles.

8.2

Introduction

Nanoparticle (NP) mediated drug delivery has attracted great attention due to its promising
capability to protect loaded drug molecules and deliver them to diseased cells 158,200–202,296 .
During the delivery process, NPs need to traverse cellular compartments that present physical barriers to successful drug delivery. For example, proteins in the blood quickly adsorb
onto NP surfaces forming often unwanted protein corona effects 50 . These adsorbed proteins can trigger macrophage cells to clear the NPs before they can reach their intended
target 65,297 . Therefore, it is crucial that the properties of NPs, such as size, shape, stiffness and surface functionalization, are carefully designed in a predictable manner so that
the trajectories of NPs can be better controlled during the cellular delivery and uptake
process. 23,24,58 Although hundreds of different NP formulations have been proposed and
synthesized in laboratories, few of them have been transferred successfully to clinical trials
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due to difficulties in administration that result in a lack of targeted delivery or toxicity in
vivo 16,109 . Among the various NP candidates designed, liposomes and liposome-like NPs
stand out due to their phospholipid composition which can favorably integrate with existing cellular lipid bilayers 210,211,298 . The phospholipid surface of a liposome resembles the
lipid membrane of the cell, often using a lipid composition that contains the same phospholipids that the cell produces, reducing toxicity and immunogenicity as compared to other
nanoparticle formulations. 161,269,270 For instance, by loading doxorubicin into a polyethylene glycol protected liposome, Doxil became the first U.S. Food and Drug Administration
(FDA) approved drug delivery platform. 110
Despite the promising applications of liposomes in drug delivery, it is still challenging
to synthesize liposomes with controlled size, geometry and surface chemistry. For instance,
to produce liposomes with uniform size distribution, external forces such as sonication and
extrusion are necessary for obtaining monodisperse liposomes. 216,299,300 However, limitations in experimental set-up, including the duration of the treatment and the position of
the ultrasound source and power input, can lead to difficulty in size control during sonication. 300 In addition, liposomes modified through extrusion are limited to the order of
several hundred nanometers and to certain lipid compositions 301–303 . Moreover, different lipid compositions can significantly affect the size of a self-assembled liposome. Even
when the expected size contribution of a particular lipid used for synthesizing a liposome
is known, experimental conditions for synthesizing a specific liposome size and shape remain to be empirically determined 304,305 . This current challenge for experimentalists, to
control the liposome size distribution with nanometer precision, is a highly desirable aspect
that can contribute greatly to successful drug delivery. It has been shown that the size
of various nanomaterials can influence important delivery features such as NP penetration
in the extracellular collagen matrix 205,206 and the extent of cellular uptake of NPs during
the endocytosis process 31,36,306 . Therefore, predictable size and reproducible synthesis of
liposomes would aid tremendously in the broader application of liposomes for drug delivery
188

and accelerate their clinical applications.
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Figure 8.1: Schematic of the self-assembly of a TML. The spherical inorganic core is surface
functionalized by polymer chains displaying anchored lipids at terminals. Upon addition of free
lipid molecules around the polymer tethered core, a complete lipid bilayer shell forms at the surface,
driven by the hydrophobic nature of lipid tails. The inorganic core is colored in silver, which could
represent gold, superparamagnetic iron oxide or other materials. The polymer is colored yellow. The
lipid heads and tails are colored in blue and cyan, respectively. Note that the free ends of the polymer
are covalently bonded to the heads of anchored lipids. The lower panel shows the configurations of
the polymer tethered cores at a series of different polymer persistence lengths.

To address these challenges, researchers have begun to explore template-mediated selfassembly of liposomes. For instance, Yang and co-workers utilized a DNA ring as a template
for synthesizing highly monodispersed sub-100 nm liposomes with different lipid compositions 307 . The liposome self-assembly process was nucleated and confined inside these rigid
DNA nanotemplates with pre-defined sizes. In our recent work, we proposed to use a
polymer-tethered inorganic core as a template to guide the self-assembly of liposome-like
NPs by taking advantage of highly monodispersed inorganic NPs 153 . As shown in Fig. 8.1,
our system consists of polymers tethered to an inorganic NP core. These polymers were
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functionalized with a phospholipid moiety, anchoring individual lipids to the NP core. These
anchored lipids act as an initiator, seeding the assembly of free lipids and forming a lipid
bilayer at the surface. We refer to these templated NPs as Core-Polyethylene Glycol-LipidShell Nanoparticles (CPLS NPs), as we use hydrophilic and biocompatible polyethylene
glycol (PEG) as the tethered polymer for displaying anchored lipids on the NP surface.
Using this new construct, we successfully encapsulated a hydrophilic dye within the PEG
layer that is present in the immobilized layer of the CPLS bilayer as a way to indirectly
show the presence of a successfully formed lipid bilayer at the nanoparticle’s surface. We
have predicted that this template-mediated, self-assembled liposome would have inherent
advantages over a traditional liposome 153,179,212 . Specifically, we have shown that we could
tune the PEG polymerization degree and core size of the CPLS NP to control its size with
high accuracy. We have also demonstrated that our CPLS NPs would have a higher overall
stability than a standard liposome when subjected to shear flow 179 . Additionally, the inorganic core can be made of gold, or superparamagnetic iron oxide, to be visible via magnetic
resonance imaging for computer tomography for diagnosis purposes, making CPLS NPs a
promising multi-functional drug delivery platform.
Using our newly developed CPLS NP system, we have set out to investigate the effects
of incorporating different tethered polymers on the template mediated liposome (TML)
process inherent to the CPLS NP design. In particular, we have chosen to incorporate
tethered DNA molecules, inspired by the spherical nucleic acid (SNA) design 308–310 . SNAs
have achieved great success in applications such as gene regulation due to their unique
surface properties, including limited toxicity 311 high binding efficiency, enhanced nuclease
resistance 312 , and minimal immune response 313 . However, further development of SNAs is
needed to improve their blood circulation time and bypass their degradation in late endosomes 314–316 . Encapsulating an SNA in a lipid bilayer may reduce the protein adsorption
and increase its blood circulation time. Additionally, the lipid membrane surface may enable fusion between NPs and cell membranes allowing direct delivery of oligonucleotides
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into the cytosol.48 Compared with the flexible nature of PEG polymers, DNA ligands are
quite rigid. In simulations they are treated as a rigid rods at the SNA surface 317,318 , due to
their large persistence length of about 40 nm 319 . Therefore, to understand how the DNA
might behave when used as an anchoring unit in the CPLS NP, we chose to investigate
what effect adding increasing concentrations of DNA to the current CPLS NP platform
would have on the self-assembly process. In this way, we could study the influence of tethered polymer semiflexibility on self-assembly of TMLs, while also providing a strategy for
incorporating biodegradable tethers that can dually serve as therapeutic agents within the
CPLS NP platform such as antisense oligonucleotides (ASOs) 296 .
To test whether the self-assembly of TMLs can serve as a general method to produce
liposome-like NPs with different tethered polymers of well controlled size, we systematically
investigated the role that polymer stiffness plays in the self-assembly of a TML. A general
set of design principles for generating “perfect” TMLs both in respect to polymer stiffness
and grafting density are provided through large scale molecular simulations. Furthermore,
the incorporation of DNA molecules as a tethered polymer for our new liposome design
is explored to help us understand the self-assembly process and the role of the anchoring
polymers stiffness as it is related to the extent of liposome bilayer formation. For this purpose, we have experimentally synthesized CPLS NPs consisting of PEG polymers mixed
with varying ratios of poly thymidine (polyT) DNA:PEG to mimic the conditions of different persistence lengths within the tethered polymer layer of CPLS NPs. These particles
were dually studied via electron microscopy and dynamic light scattering in parallel with
dissipative particle dynamic simulations.
The structure of this paper is summarized as follows: First, by investigating the selfassembly process of TMLs through our simulation studies, we found that the stiffness of
the tethered polymer greatly influences the self-assembly kinetics of the outer lipid layer
(section 8.3.1). Next, we systematically investigated the effect of free lipid number and
grafting density on the self-assembly process of TMLs constructed with tethered polymers
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of four different persistent lengths, and a phase diagram was obtained for each case (section
8.3.2). To verify the relevance of these predictions, we synthesized DNA-PEG CPLS NPs
in which we incorporated increasing concentrations of DNA as a proxy for increasing the
rigidity of the tethered polymer layer of the CPLS NPs. Using dynamic light scattering
(DLS) and transmission electron microscopy (TEM) we analyzed the self-assembly process
of free lipids on DNA-PEG CPLS NPs upon varying DNA to PEG ratios. We show that
the resulting structures present degrees of encapsulation by free lipids that are consistent
with the simulated studies, particularly the phase diagrams. Additional details on physical
properties available from simulation, such as size and density distributions are examined in
section 8.3.3. Subsequently, a theory is provided for predicting the size of the TMLs and
corresponding optimal conditions for synthesis, indicating ideal grafting densities for the
tethered polymer layer and optimal free lipid numbers (section 8.3.4). Conclusions are provided in section 8.4, followed by details on computational (section 8.5.1) and experimental
(section8.5.2) methods.

8.3
8.3.1

Results and discussion
Dynamic process for self-assembly of TMLs

We start our work by investigating the influence of polymer stiffness on the self-assembly
process of TMLs in simulations. As given in Fig. 8.1, four different polymers with normalized persistence lengths, lp = 0.17, 0.21, 1.21, and 2.21, were assessed, where lp = lp /L0
is defined as the ratio between the persistence length lp and polymer contour length L0 .
When lp = 0.17, the polymer lp is only 17 percent of its contour length L0 , which indicates
a flexible polymer. While for lp = 2.21, the polymer lp is more than twice of its contour
length L0 , suggesting an almost rigid rod-like polymer. The radius of the inorganic core
in all simulations is fixed as 5 nm. All polymer chains tethered on the inorganic core have
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the same polymerization degree of N = 30. To accelerate the self-assembly process, the
simulation temperature is controlled at T = 2.0 (reduced LJ unit). At the beginning of the
self-assembly process, the fully relaxed polymer tethered cores are placed in the center of
simulation box of 606060 nm3 , with randomly distributed free lipids. For implementation
details see section
refch8:sec4.1.
Polymer stiffness determines the self-assembly process of TMLs The snapshots
in Fig. 8.2(A) and (B) show the evolution of configurations during the self-assembly process
of TMLs with polymer grafting density σg = 0.35 nm−2 . Their normalized polymer persistence lengths are lp = 0.17 (flexible polymer) and lp = 2.21 (rigid rod-like polymer). The
free lipid numbers (Nf ) for these two cases are kept the same with Nf = 3500. As given in
Fig. 8.2(A) for lp = 0.17, at the beginning of simulation (time t = 0), the anchored lipids
on terminals of tethered polymers aggregate into several small micelles on the surface of
inorganic core. These small micelles act as active sites to recruit the surrounding free lipids
due to the strong hydrophobicity of lipid tails in aqueous solution. At t = 6µs, a portion of
free lipids are absorbed onto the polymer tethered core due to the anchored lipids. Another
portion of free lipids quickly assemble into small micelles due to their amphiphilic nature.
Those free micelles continue to fuse with each other, forming free vesicles evolving into a
bilayer structure at t = 224µs. More importantly, a portion of free micelles can fuse with
the anchored lipid micelles, resulting in vesicles anchored to the inorganic core, which are
relatively isolated. The simulation shows that under thermal fluctuations, the free vesicles
perform random walks and adsorb by the polymer-tethered core once they fuse with the
anchored vesicles. These localized events increase the surface area of the anchored vesicles
until they are no longer isolated and are able to make contact and fuse with each other
to form a curved bilayer patch that partially covers the core surface (t = 280µs). With
the continued adsorption of free vesicles and lipids, the anchored vesicles and bilayer patch
increase their overall size and finally fuse with each other to form a perfect bilayer shell
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that covers the entire polymer tethered core (t = 672µs). At the end of the simulation,
with the direction of anchored lipids, the self-assembly of free lipids results in a perfectly
encapsulated TML.
Compared with the flexible tethered polymers (lp = 0.17), the self-assembled process of
TML with rigid rod-like polymers (lp = 2.21 ) exhibits completely different behaviors, as
given in Fig. 8.2(B). At t = 0, the lipids displayed at the terminals of tethered polymers
also aggregate into separate anchored micelles. At the same time, the polymers form several
distinct bundles. Compared to the flexible case in Fig. 8.2(A), the tethered polymers
become straight due to their enhanced stiffness. These rigid polymer bundles also result in
a increased distance between the anchored micelles and the inorganic core surface. Over the
course of the simulation, the free lipids in the simulation box get absorbed onto the anchored
micelles, resulting in the formation of anchored bilayer patch or vesicle (t = 112, 280 µs).
However, different from those formed from lp = 0.17, these anchored lipid structures are far
away from each other due to the reduced polymer flexibility. Therefore, they never have the
chance to contact and fuse together. Instead, these anchored vesicles and bilayer patches
remain isolated, which eventually results in a partially encapsulated TML (t = 260 µs).
It is important to note that increasing the free lipid number does not qualitatively change
the outcome (see Fig. A.40 for the case with Nf = 8500 in supplementary materials).
From these results, we can conclude that the stiffness of tethered polymers influences the
self-assembly process and state of TMLs.
High grafting density benefits perfectly encapsulated TMLs The aforementioned two cases demonstrate that it is more difficult to form a perfectly encapsulated
TMLs from tethered polymers with higher stiffness. With this in mind, the next question
we sought to answer is how to make a perfectly encapsulated lipid bilayer around an inorganic core when the stiffness of tethered polymers is high. To answer this question, we first
investigated the self-assembly process of rigid rod-like polymers tethered on NPs with high
grafting density through simulations, followed by a series of complementary experiments.
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As shown in Fig. 8.2(C), while the normalized persistence length of tethered polymers is
still lp = 2.21. We increased the grafting density to σg = 0.8 nm−2 . The free lipid number in
the simulation box is Nf = 8500. As we can see in Fig. 8.2(C), at t = 0, the anchored lipids
also aggregate to form separated micelles at the terminals of tethered polymers. Compared
with the low grafting density scenario in Fig. 8.2(B), the number of anchored micelles has
increased. At t = 23 µs, the anchored micelles transform into small bilayer patches as the
adsorption of surrounding free lipids occurs. These anchored bilayer patches are able to fuse
with each other as they are relatively close to each other, resulting in several curved bilayer
patches on the terminals of tethered polymers (t = 56 µs). With the further adsorption of
free lipids, these curved bilayer patches connect with each other through fusion, forming two
large curved patches (t = 112 µs). At the end of the simulation, all free lipids are adsorbed
onto the surface of the polymer tethered core, resulting in a perfectly encapsulated TML at
t = 764 µs. Therefore, it can be concluded that increasing the grafting density of tethered
polymers benefits the formation of perfectly encapsulated TMLs.

8.3.2

Phase diagram for self-assembly of TMLs

Both the polymer stiffness and grafting density can greatly affect the self-assembly of
TMLs. To quantitatively capture the effects of these parameters, we systematically investigated the self-assembly process of TMLs with four normalized persistence lengths of
lp = 0.17, 0.21, 1.21, 2.21 characterizing the tethered polymers. Additionally, different grafting densities, ranging from σg = 0.05 nm−2 to σg = 0.8 nm−2 , were investigated for all four
persistence lengths. This resulted in a phase diagram describing the self-assembly states
of TMLs as a function of grafting density σg and free lipid number Nf at each persistence
length. For each point in the phase diagram, two different processes are studied: (1) a polymer tethered core experiencing a self-assembly process at a specific free lipid number at the
temperature of T = 2.0; (2) to obtain the self-assembled state at standard temperature (i.e.
room temperature), the entire system is annealed to the temperature of T = 1.0 within a
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period of 112 µs after all the free lipids are absorbed on the surface of the polymer tethered
inorganic core.
Three different states are discovered for self-assembly of TMLs As given in
Fig. 8.3, three qualitatively different self-assembled states can be found in each phase
diagram. (1) When the grafting density is below a critical value or the free lipid number is
smaller than a critical value, a partially encapsulated state is assembled at the end of the
self-assembly process. The partially encapsulated state is mainly due to two reasons: (I)
if the grafting density is insufficiently large, anchored vesicles on the terminals of tethered
polymers are unable to fuse with each other, resulting in isolated anchored vesicles; (II) if
the grafting density is suitable, but the free lipid number still too small, the fused bilayer
patches are not large enough to cover the entire surface of the inorganic core. (2) When the
grafting density is suitable, but the free lipid number is too large, the anchored lipids form
a spherical bilayer with a bud connecting on the surface. This leads to an over-encapsulated
state. (3) A perfectly encapsulated state is obtained when both the grafting density and
free lipid number fall into a suitable region. By comparing these four phase diagrams, it
becomes clear that when synthesizing a perfectly encapsulated TML, the critical grafting
density and upper and lower boundaries of free lipid numbers are determined by the degree
of polymer semiflexibility.
Critical grafting density of tethered polymers It is shown in Fig. 8.3 that the
critical grafting density σcrit increases with increasing polymer stiffness. As given in Fig.
8.3(A), at a persistence length of lp = 0.17, the σcrit is located within (0.05 − 0.2) nm−2 . As
the persistence length increases to lp = 0.21, its σcrit also grows to the range of (0.2 − 0.35)
nm−2 . For larger persistence lengths of lp = 1.21 and lp = 2.21, the σcrit is within (0.35−0.5)
nm−2 . As aforementioned, during the self-assembly process of TMLs, the grafting density
is directly proportional to the number of anchored lipids, which form the anchored micelles
and direct the whole self-assembly process. This indicates that the grafting density directly
determines the probability that the anchored vesicles will fuse with each other and form
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the anchored curved bilayer patch. Detailed analysis about the relationship between the
critical grafting density and polymer stiffness will be discussed in the following section.
Free lipid number boundary When the grafting density of tethered polymers is
larger than the critical grafting density σcrit , the perfectly encapsulated TMLs can only be
formed in a limited range of free lipid numbers, defined by the upper and lower free lipid
number boundaries. For the normalized persistence lengths of lp = 0.17 and 0.21, similar
free lipid number boundaries are observed due to their similar persistence lengths. The lower
free lipid boundary for different grafting densities falls within 3000–4500. The upper free
lipid boundary is located within 4500–6500. Compared to the boundaries of high flexibility
polymers, both the lower and upper free lipid boundaries for a persistence length of lp = 1.21
increase dramatically. At lp = 1.21, the lower boundary is around 5500–7000. Additionally,
its upper free lipid boundary is located within 8500–9500. When the persistence length of
tethered polymer is further increased to lp = 2.21, their free lipid number boundaries shift
to larger values again. More importantly, compared to the flexible polymers of lp = 0.17
and lp = 0.21, the free lipid number boundaries for perfectly encapsulated TMLs become
wider for lp = 1.21 and lp = 2.21.
Experimental validation In order to see how effectively our simulations reflect the
solution-based self-assembly of a TML with a variable grafting density and persistence
length, we synthesized four CPLS NPs consisting of two different polymer components,
cf. Methods section 8.5.2. The first polymer is a thiolated heterobifunctional PEG functionalized with a phospholipid, 1,2-distearyl-sn-glycero-3-phosphoethanolamine, (SH-PEGDSPE) and the second is a short DNA oligomer, poly thymidine (polyT) used as a backfill.
These polymers were mixed in solution prior to adsorption onto the inorganic nanoparticle surface, in this case a 30 nm gold nanoparticle (Au NP), to achieve polymer tethered
cores which presented 100%, 75%, 50%, and 0% PEG as seen in Fig. 8.4. This method is
a slightly modified approach to the synthesis of CPLS NPs that we previously developed
(Fig. A.41 in supplementary materials) 307 . PolyT is a rigid molecule approximately 7 nm
197

in length. We chose a thymidine homo polymer of DNA as it is least likely to have hydrogen bonding with itself and is known to pack well on Au NP surfaces 320 . Through the
incorporation of the rigid thiolated polyT DNA at the surface of the CPLS NP in increasing concentrations relative to the SH-PEG-DSPE, we sought to limit the conformational
flexibility and the grafting density of the tethered PEG-DSPE to determine the effects this
rigid backfill would have on the extent of templated encapsulation possible on the polymer
tethered core. As can be seen in Fig. 8.4, with increasing amounts of polyT incorporated at
the NP core’s surface, the ability of the free lipid to fully encapsulate the core is diminished.
The distribution of various states of lipid encapsulation, defined as perfectly encapsulated,
budding (over encapsulation), anchored vesicles, and no encapsulation was observed and
tallied as a function of total number of particles analyzed (200 CPLS particles per sample)
to determine relative encapsulation distributions of each state (see supplementary materials for counting protocol). Additional TEM micrographs used for statistical analysis of the
various encapsulation states can be found in Fig. A.42–A.42 in supplementary materials.
The overall size of each particle containing increasing concentrations of PEG tether were
analyzed using dynamic light scattering (Fig. A.46 and A.47 in supplementary materials),
indicating similarly sized particles with a large size distribution, likely due to the remaining
flexibility of the PEG tether despite increased concentration of DNA ligand as a backfill.
The trends shown in Fig. 8.4A–D reflect that the relative distribution of encapsulation
states that are predicted by the phase diagrams (Fig. 8.3) and is consistent with the grafting
densities of PEG tethered on the NP surfaces and the amount of free lipid added to the
system. These results show the predictive power of the simulation and provide a guide for
how to obtain specific states of encapsulation when the stiffness of the underlying anchored
polymer-lipid can be controlled.
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8.3.3

Physical properties of TMLs

As discussed above, at all four different polymer persistence lengths, a perfectly encapsulated TML can always be made through self-assembly when situated in a suitable region
as outlined within the phase diagrams (Fig. 8.3). Herein, we will calibrate the physical
properties of perfect encapsulated TMLs by calculating their radius, density distribution
and the amount of stored water embedded within the templated lipid bilayer.
Size distribution As given in Fig. 8.5(A), the radii of perfectly encapsulated TMLs
under different persistence lengths is shown as a function of the polymer grafting density.
The radius is obtained by averaging the radii of perfectly encapsulated TMLs at a particular
grafting density. There are two important things we can learn from Fig. 8.5(A). First, with
the same polymer persistence length, the radius of perfectly encapsulated TMLs slightly
increases as the grafting density increases. For instance, at lp = 0.17, the radius of TMLs
increases from R = 9 nm at σg = 0.2 nm−2 to R = 11 nm at σg = 0.8 nm−2 . Similarly, at
lp = 1.21, the radius of TMLs increases from R = 13.5 nm at σg = 0.5 nm−2 to R = 15 nm
at σg = 0.8 nm−2 . However, this variation in size at each persistence length is no larger than
23%, which indicates that the size of perfectly encapsulated TMLs can be well controlled
by the nature of the tethered polymers. Second, the size of a perfectly encapsulated TML
increases as the persistence length of tethered polymers increases. The averaged radii of
the perfectly encapsulated TMLs are R ' 10, 11, 14, 16 nm, respectively for persistence
lengths of lp = 0.17, 0.21, 1.21, 2.21.
Density distributions After inspecting their size, we further investigated the structure
of perfectly encapsulated TMLs by calculating the radial density distribution of each component. In addition to the inorganic core, there are three different components within TMLs,
including the tethered polymers, lipids and encapsulated water molecules. The density distribution in Fig. 8.5(B) is obtained from the perfectly encapsulated TML with a persistence
length of lp = 0.21. The corresponding grafting density and free lipid number is σg = 0.8
nm−2 and Nf = 5500. The density distribution for the other perfectly encapsulated TMLs
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is very similar. As we can see from Fig. 8.5(B), the density of tethered polymers decreases
dramatically from the surface of the inorganic core from a distance of D = 5 nm to the
radius of the entire TML at around 12 nm. At D = 12 nm, a lipid density peak appears,
due to the lipid coverage on the surface. Since water is repelled from the lipid-containing
region, its density can be divided into two separate regions. When D > 12 nm, the water
density increases quickly from 0 to 3 nm−2 . This population of water molecules outside the
TML is due to the hydrophobicity of the lipid bilayer core. When D < 12 nm, the water
density starts increasing from D = 5 nm at the core surface and then drops quickly near
the lipid bilayer shell. This portion of water molecules is encapsulated by the lipid bilayer
and stored within the TMLs.
Stored water The portion of stored water molecules inside TMLs represents the free
space of the NP that can be used to load other hydrophilic molecules, including small
drug molecules. To further explore the TMLs capacity for storing water, we calculated the
amount of stored water for each polymer persistence length as a function of the grafting
density. As given in Fig. 8.5(C), for all the perfectly encapsulated TMLs, the number of
stored water beads is on the order of 104 . More importantly, consistent with the increment
of the TML radius, the stored number of water molecules increases dramatically from 1×104
at lp = 0.17 to 3.4 × 104 at lp = 2.11. A water bead in the DPD simulation is generally used
to represent three water molecules 226 . Taking the volume of a water molecule as 310−2 nm3 ,
we can estimate that the free space of the TMLs ranges from 300 to 3000 nm3 , depending
on the flexibility of tethered polymers.

8.3.4

Theoretical estimations on free lipid number and critical grafting
density for perfectly encapsulated TMLs

As noted, a perfectly encapsulated TML can only form when a suitable amount of free
lipids is present, and when the grafting density is optimal. In quantitative terms, the
corresponding numbers are given by the free lipid number boundary and critical grafting
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density. In this part, we will explore the physical mechanism that determines the suitable
range of these parameters within the phase diagrams of Fig. 8.3.
Estimation of free lipid number. To estimate the suitable free lipid number, we
will explore the parameters that determine the radius of a perfectly encapsulated TML.
The free lipid number needed by a perfectly encapsulated TML should be determined by
its radius R, whose relationship should be given as:

Nfneed ≈ 2

4πR2
ap

(8.1)

where ap is the area per lipid molecule. The next task is to determine the radius R of a
perfectly encapsulated TML before the self-assembly process. At the perfectly encapsulated
state, all the anchored lipids are inserted into the lipid bilayer shell. Therefore, the tethered
polymers are confined within a region formed by the inorganic core and the lipid bilayer
shell. If the radius of the lipid bilayer shell is too small, the tethered polymers will produce
a large osmotic pressure that might cause the rupture of the lipid bilayer shell. On the
other hand, if the radius of the lipid bilayer shell is too large, the tethered polymers will
experience an extensive force. This would result in the anchored lipid being pulled out of
the lipid bilayer. From this perspective, the radius of the lipid bilayer shell should be in
a suitable region to prevent the large osmotic pressure and extensive force from tethered
polymers.
To confirm our analysis and determine the relationship between the encapsulated TML
radius and free energy state of the tethered polymers, we performed a test for tethered
polymers as given in Fig. 8.6(A) and (B). The free ends of the tethered polymers are
confined within a spherical indenter surface. The terminal of each polymer can freely
translate on the indenter surface. The indenter surface produces a repulsive force acting
on the monomers if these individual monomers reside outside the indenter surface. On the
other hand, if the terminal monomer of a polymer chain is located inside of the indenter
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surface, the indent will produce an outward repulsive force. This way, the indenter surface
can mimic the lipid bilayer shell and is able to measure both the osmotic pressure and
extensive force. During this process, we systematically changed the radius of the indenter
to investigate the variation of the tethered polymer energy against the possible radius of a
perfectly encapsulated TML.
As given in Fig. 8.6(C) at the persistence length of lp = 0.17 the free energy of the
tethered polymers is large for both the small and large indenter radii. At the smaller radius,
the tethered polymers produce a large osmotic pressure. At the larger radius, the large free
energy is caused by extension of tethered polymers. A low energy state appears in the radius
range from 10 to 13 nm. This low energy region correlates extremely well with the perfectly
encapsulated TML radii (9–11 nm) we obtained through self-assembly simulations. Similar
low energy ranges are found for the tethered polymers with other persistence lengths. More
importantly, if we take the optimal indenter radius as the region that is no larger than 5
kB T of its minimum value (marked by light shaded regions), the optimal radii are 10–13 nm,
11–13 nm, 14–16 nm and 15–16.4 nm, respectively for the normalized persistence lengths
lp = 0.17, 0.21, 1.21, and 2.2. This low energy state range at each persistence length is
consistent with the radius of perfectly encapsulated TMLs. Therefore, we can conclude
that the radii of perfectly encapsulated TMLs are mainly determined by the free energy of
the tethered polymers. The self-assembly process finally results in a perfectly encapsulated
TML at the most favorable energy state for the tethered polymers.
More importantly, if we take the area per lipid ap as 0.7 nm2 as given in the Fig. A.48
of the supplementary materials, the suitable free lipid number for each persistence length
is around (3.6–6.1) × 103 , (4.3–6.1) × 103 , (7.0–9.2) × 103 and (8.1–9.7) × 103 , based on the
relationship in Eq.8.1. All of these estimated values are located within the perfectly encapsulated region as given in the phase diagram (Fig. 8.3). Therefore, as long as the persistence
length of tethered polymers is given, we are able to estimate its perfectly encapsulated size
in simulation and evaluate the required number of free lipids using Eq.8.1.
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Estimation of critical grafting density. The next question is how to determine the
critical grafting density for a perfectly encapsulated TML. Based on the phase diagrams
in Fig. 8.3, the critical grafting density increases as the tethered polymers become stiffer.
As we discussed above, the key driving force during the self-assembly process is that the
anchored lipids attract surrounding free lipids, which contributes to the fusion between
anchored vesicles/bilayer patches. Based on what we have learned from the planar tethered
lipid bilayer membrane, we know that the density of anchored lipids should be larger than
a critical value, σpc 321,322 . For our TMLs, the radius of the polymer tethered core increases
with increasing polymer stiffness. This increment of size reduces the effective density of
anchored lipids. Taking the spherical geometry into account, the critical grafting density
σcrit of the perfectly encapsulated TMLs should obey the following relationship as 261 :

σcrit ≈ σpc (

RNP 2
)
RCore

(8.2)

where RNP and RCore are the radii of a perfectly encapsulated TML and the inorganic
core, respectively. To confirm our analysis, we further investigated the self-assembly process of a planar substrate with tethered polymers of different stiffness. To form a perfect
planar tethered bilayer on the terminals of tethered polymers, the free lipid number can be
estimated through the lipid area and the size of substrate as given in Fig. 8.6(D). Here, the
substrate size is (50 × 50) nm2 . The free lipid number is 7000. As shown in Fig. 8.6(D), the
self-assembly process of the planar substrate is quite similar to that of the aforementioned
TMLs. The formation of the planar tethered lipid bilayer is mainly determined by fusion
between anchored vesicles and bilayer patches. By systematically changing the grafting
density of tethered polymers, we find that the critical grafting density of polymers with
persistence lengths of lp = 0.21, 1.21, 2.21 is insensitive to stiffness, with a value about
σpc = 0.06 nm−2 . The σpc for lp = 0.17 is slightly smaller with a value around 0.04 nm−2
(refer to the supplementary materials for more details, Fig. A.50-A.53). If one takes the
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σpc of planar tethered lipid bilayer as 0.06 nm−2 and inserts it into Eq 8.2, one obtains the
relationship between the critical grafting density σcrit of a perfectly encapsulated TML and
the ratio RNP /RCore , as given in Fig. 8.6(E). Interestingly, we find that the data points
obtained from the phase diagram and the TML radii are consistent with the curve resulting
from Eq 8.2. The critical grafting density σcrit of tethered polymers can therefore be directly
estimated by Eq 8.2.
Table 8.1: Comparison of boundary values for perfectly encapsulated TMLs between simulation
and theory.

lp = 0.17

lp = 0.21

lp = 1.21

lp = 2.21

Lower free lipid number (×103 )

3.0 − 4.5

3.0 − 4.5

5.5 − 7.0

6.5 − 7.5

(×103 )

4.5 − 6.5

5.0 − 7.0

8.5 − 9.5

9.5 − 10.5

0.05 − 0.20

0.20 − 0.35

0.35 − 0.50

0.35 − 0.50

Lower free lipid number (×103 )

3.6

4.3

7.0

8.1

Upper free lipid number (×103 )

6.1

6.1

9.2

9.7

Grafting density (1nm−2 )

0.20

0.24

0.43

0.58

Simulation results

Upper free lipid number
Grafting density

(1nm−2 )

Theoretical predictions

To summarize this analysis as it relates to the free energy state of tethered polymers,
the radius of the perfectly encapsulated TMLs increases as the polymer stiffness increases.
The radius of the perfectly encapsulated TML at a given polymer persistence length can
be evaluated through an indenter test in simulations, which is a time-saving alternative to
the self-assembly simulations. As soon as the radius of a perfectly encapsulated TML is
determined, its optimal free lipid number and critical grafting density can both be estimated
from Eq 8.1 and 8.2. Based on Eq8.2, it is also interesting to note that the increment of
the inorganic core radius will reduce the critical grafting density, as observed in the selfassembly of TML (with R = 5 nm) and planar tethered bilayer (with R = ∞). Here, we
also need to mention that the direct relation between the polymer stiffness and brush height
of the tethered polymer at most favorable energy state requires additional systematically
204

works, which will be explored in our further study. As listed in Table 8.1, the theoretical
predictions agree well with the simulation results regarding the lower and upper free lipid
boundaries and grafting density boundary. In summary, we here provided and tested an
efficient way to predict the free lipid number and critical grafting density for synthesizing
TMLs using tethered polymers with variable degree of semiflexibility.

8.4

Conclusions

In this work, we proposed that the self-assembly of TMLs can be utilized as a general
approach to produce liposomes with controlled sizes using tethered polymers of varying
stiffness. To confirm this, large scale molecular simulations were performed and used to
investigate the self-assembly process of TMLs in the presence of four types of tethered
polymers that differ in their persistence lengths. For each type, a phase diagram was established that describes the self-assembled structures as a function of free lipid number and
polymer grafting density. Three different states, including partially encapsulated, perfectly
encapsulated, and over encapsulated TMLs are featured in each of the phase diagrams. It
is found that the perfectly encapsulated TMLs can only be created under conditions of
optimal polymer grafting density and suitable free lipid number, which in turn depend on
the degree of semiflexibility. To support our simulation findings, experimental validations
were undertaken. In these experiments, we synthesized DNA-PEG CPLS NPs upon incorporating increasing concentrations of DNA as a proxy for increasing the rigidity of the
tethered polymer layer. Using transmission electron microscopy analysis we confirmed that
the resulting structures exhibit degrees of encapsulation by free lipids that are consistent
with the corresponding simulations. Further analysis of the properties of the perfectly encapsulated TML case showed that the radius of a TML is well controlled by the flexibility
of tethered polymers. To provide a better understanding and a general guidance for synthesizing a perfectly encapsulated TML, a numerical indenter test was proposed that allows
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to estimate the radius of a TML. We found that the radius of a perfectly encapsulated
TML is determined by the lowest free energy state of the tethered polymers. More importantly, analytical expressions are provided to directly estimate the required free lipid number
and critical grafting density for given persistence length and polymerization degree of the
tethered polymer. Through these combined computational, experimental and theoretical
studies, we ended up with a seemingly powerful predictive model for determining the effect
of polymer stiffness on the self-assembly of TMLs. In addition, the polymerization degree of
tethered polymers can be further tuned to control the sizes and loading capacities of these
TMLs. It may potentially be used as a general approach to obtain perfectly encapsulated
TMLs as potential drug delivery vehicles.

8.5
8.5.1

Methods
Computational model and method

Dissipative particle dynamics (DPD) method. The DPD method is a coarse-grained
molecular simulation method which can correctly and accurately capture hydrodynamic behavior 194,195 . The basic interacting sites in DPD simulations are soft beads. Between each
pair of DPD beads, effective two-body interactions consist of three major forces: a conservative force FC , a random force FR , and a dissipative force FD . Specifically, the conservative
force between beads i and j is FC
ij = aij ω(rij )eij , where rij denotes the spatial distance
between beads i and j, and eij the unit vector pointing from bead i to bead j; aij represents the maximum repulsive force strength acting between beads i and j. The weighting
factor ω(rij ) is a normalized distribution function as ω(rij ) = 1 − rij /r0 for rij ≤ r0 , while
ω(rij ) = 0 for rij > r0 . Here r0 is the cutoff distance for pairwise interactions. The random
p
(2γkB T /∆t)ω(rij )αeij , where α represents a normal distributed Gaussian
force FR
ij =
random number with zero mean and unit variance. ∆t is the time step used in the molec-

206

ular simulations, kB and T denote the Boltzmann constant and temperature, respectively,
2
and γ is a bead friction coefficient. The dissipative force is FD
ij = −γω (rij )(eij v̇ij )eij ,

where vij represents the relative velocity vector between beads i and j.
Lipid molecule model. A linear chain model is taken for each lipid molecule for
simplicity and its efficiency. A lipid molecule in our simulation contains one hydrophilic
head (H) bead and three hydrophobic tail (T ) heads denoted as HT3 . The amphiphilic
properties of the lipids are ensured by a large repulsion between the lipid tail and water
molecule, using atw = 100 kB T /r0 . The subscript letters ‘t’ and ‘w’ denote the lipid tail
and water bead, respectively. The lipid heads are hydrophilic and thus ahw = 25 kB T /r0 ,
where the subscript ‘h’ represents the lipid head beads. The remaining pairwise interaction
parameters between the same types of beads are aww = ahh = att = 25 kB T /r0 . Apart
from the pairwise interactions, bond and angle potentials are applied to the lipid molecules
to correctly reproduce their conformations. The neighboring beads in a lipid molecule are
connected by a harmonic spring potential: Us1 = Ks1 (rij − rs1 )2 , where Ks1 and rs1 are the
spring coefficient and equilibrium bond length, respectively. Here Ks1 = 50 kB T /r02 and
rs1 = 0.7 r0 . A bond angle potential is applied to the lipid tail to ensure its rigidity and
to prevent the incorrect interaction in the middle plane of the self-assembled bilayer. The
form of the bond angle potential is given by Uθ1 = Kθ1 (θ − θ01 )2 , where Kθ1 and θ01 are the
bending stiffness and equilibrium angle, respectively. Here Kθ1 = 3.0 kB T and θ01 = 180◦ .
Under these interactions, the random lipid molecules are able to self-assemble into a vesicle
or a planar membrane under suitable concentrations 100,258 .
Polymer and nanoparticle model. All polymer chains tethered on the inorganic
core have the same polymerization degree of N = 30. The monomers within a polymer
are connected by a harmonic bond potential: Us2 = Ks2 (rij − rs2 )2 , with spring stiffness
Ks2 = 2111.3 kB T /r02 and equilibrium distance rs2 = 0.4125 r0 . Additionally, an angular
potential, defined as Uθ2 = Kθ2 (cos θ − cos θ02 )2 , is applied between three consecutive
monomers to tune the stiffness of polymer. To be specific, when Kθ2 = 16.4946 kB T and
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equilibrium angle θ02 = 130◦ the polymer can correctly reproduce the conformation of
a PEG polymer in water 72,123 . Three additional angular constants, Kθ2 = 0, 100, 500
kB T are used to model polymers with different stiffness. The equilibrium angles in these
three cases are taken as θ02 = 180◦ . To calibrate the polymer stiffness, we calculate the
polymer persistence length under these parameters. Four different persistence lengths of
lp = 0.17, 0.21, 1.21, 2.21 are obtained for the angular constants of Kθ2 = 0, 16.4946, 100,
and 500 kB T , respectively. Please refer to the supplementary materials for details about the
estimation of polymer persistence length. In order to take the flexible linker between the
inorganic core and tethered polymer, the angular constant for the angle potential relating
the bead on inorganic core and the first two beads in each polymers is taken as zero.
The inorganic core is represented by a rigid NP and corresponding beads are arranged
on a FCC lattice with a lattice parameter 0.8 r0 , covered by a layer of spherical shell beads.
There are 1575 beads in total for the core with a radius of 5 r0 . A polymer is grafted on
the surface of the rigid core through a harmonic potential. The grafting density σg of the
tethered polymer in our DPD simulations is 0.05, 0.2, 0.35, 0.5, 0.65, and 0.8 chains per
r02 . The corresponding numbers of polymer chains is M = 15, 63, 110, 157, 204 and 251,
respectively. All free ends of the grafted polymers are bonded with lipid (head) molecules
through a harmonic potential. For simplicity, we assume that this harmonic potential is
the same as that for polymers. In this way, one end of the polymer is tethered on the core
surface, while the other end is covalently connected to a lipid molecule.
Simulation protocol. All the repulsive interaction parameters aij for different types
of beads are the same as the those for Chapter 6. Periodic boundary conditions are applied
along all directions. The number density of beads in the simulation box is fixed at 3/r03 195 .
The physical length corresponding to our simulation units are obtained by comparing the
membrane thickness in simulations dHH = 3.4 r0 to the thickness of a DMPC membrane,
dHH ≈ 3.53 nm 91 , indicating r0 ≈ 1 nm. The experimental lipid lateral diffusion coefficient
of DMPC is D ≈ 5 µm2 s−1 92 . The lipid lateral diffusion coefficient in simulation is,
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Dlipid ≈ 5.59 × 10−2 r02 /τ . Therefore, we estimate the physical time scale τ = 11.2 ns.

8.5.2

Synthesis and Characterization of CPLS-PEG-DNA NPs

Synthesis of CPLS NPs with DNA backfill.
Materials. DNA oligomer was synthesized in house using reagents purchased from Glen Research. Gold(III) chloride trihydrate, sodium citrate tribasic dihydrate, dithiothreitol, 30%
ammonium hydroxide and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were purchased from Millipore-Sigma. 5000 molecular weight 1,2-distearyl-sn-glycero-3-phosphoethanolaminepolyethylene glycol-thiol (DSPE-PEG-SH) was purchased from NanoCS. NAP-5 Sephadex
columns were purchased from GE Healthcare.
Synthesis of Au NPs. 30 nm Au NPs were synthesized through citrate reduction.
13.8 mg of gold(III) chloride trihydrate were diluted to 49 mL in water. 43.8 mg of sodium
citrate tribasic dihydrate were diluted to 1 mL in water. The gold solution was heated until
refluxing with constant stirring. The citrate solution was added via syringe to the gold
solution. The mixture was incubated while refluxing for 30 minutes. The resulting citrate
capped Au NP solution was filtered through a 0.22 µm PTFE filter.
Synthesis of DNA oligomer. DNA was synthesized through standard phosphoramidite coupling chemistry using an automated DNA synthesizer. A polyT 20 DNA sequence was synthesized on a 3’-thiol-modifier-6 S-S CPG. The DNA was cleaved at room
temperature using 30% ammonium hydroxide and the resulting solution was deprotected at
55 ◦ C for 18 hours. The ammonium hydroxide was removed under vacuum and redissolved
in water. The resulting solution was then purified through a NAP-5 Sephadex column.
Synthesis of polymer tethered core NPs. Ligands were added to the citrate capped
Au NPs in a 10000 : 1 molar ratio. The DNA was treated with dithiothreitol for 30 minutes
and purified using a NAP-5 Sephadex column. DSPE-PEG-SH was weighed out under an
inert atmosphere in a glovebox and diluted to 500 µl with ethanol. The DNA and DSPE-
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PEG-SH were combined together prior to adding to the Au NPs. The resulting solutions
were added to the Au NPs and diluted to 300 µl with water. These were sonicated for 1
hour. After sonication, samples were diluted to 746 µl with water. These were incubated
on a rotisserie for 1 hour at room temperature. 1.25 µl of 2 mM sodium chloride solution
was then added to each sample and were allowed to mix on the rotisserie overnight at room
temperature. 1.25 µl of 2 mM sodium chloride was then added and allowed to incubate
for an hour. The samples were then washed by pelleting on a centrifuge at 9400 g for 30
minutes one time. Resulting samples were immediately encapsulated with free lipid.
Free lipid encapsulation. Using a gas tight syringe, 15 µl of 130 µM DOPE was
added to a 1.5 mL microcentrifuge tube for each sample. Chloroform solvent was allowed to
evaporate, forming a thin film. The functionalized Au NPs were pelleted using a centrifuge
at 9400 g for 30 minutes, the supernatant was removed until a 30 µl volume remained. The
Au NPs were briefly sonicated to mix, and added to the DOPE thin film. The solution was
then sonicated for 1 hour. Nanoparticle characterization. Samples were dropcast on a 400
mesh Cu grid with carbon formvar coating (Electron Microscopy Sciences). All samples
were stained with 0.5% uranyl acetate prior to imaging. Transmission Electron Microscopy
(TEM) images were taken on a ThermoFisher Tecnai 12 G2 Spirit BioTWIN TEM with
an accelerating voltage of 120 keV . Dynamic light scattering measurements observed on a
Malvern Zetasizer ZS90.
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Figure 8.2: Self-assembly of TMLs at different stiffness of the tethered polymers. (A and B) Selfassembly process of TMLs with different normalized persistence lengths of lp = 0.17 and lp = 2.21.
The grafting density and free lipid number are the same for both cases with values of σg = 0.35
nm−2 and Nf = 3500. (C) Self-assembly process of TML with lp = 2.21, σg = 0.8 nm−2 and
Nf = 8500. The upper and lower panels in each figure show the whole and cross-sectional views
respectively. Water beads are not shown for clarity
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Figure 8.3: Phase diagrams of TMLs with tethered polymers of different stiffness. (A–D) Phase
diagrams for TMLs with tethered polymers of normalized persistence lengths lp = 0.17, 0.21, 1.21,
and 2.21, respectively. Each phase diagram is constructed as a function of free lipid number and
grafting density. The results in each diagram can be classified into three different phases exhibiting
(1) perfectly encapsulated states, (2) over encapsulated states, and (3) partially encapsulated states.
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Figure 8.4: Computed images of the major morphology categories observed through in silico
experiments. (B–E) TEM and statistical characterization of 100%, 75%, 50%, 0% PEG-DSPE CPLS
NPs. Scale bars are 50 nm for higher magnification, 100 nm for lower magnification. Samples are
stained with 0.5% uranyl acetate. Statistical parameters are discussed in supplementary materials
for Chapter 8.
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Figure 8.5: Properties of the perfectly encapsulated TMLs. (A) Radius of a perfectly encapsulated
TML as a function of tethered polymer grafting density at different persistence lengths. (B) Radial
bead number density of a perfectly encapsulated TML with lp = 0.21, σg = 0.8 nm−2 , Nf = 5500.
(C) Number of stored water beads within the encapsulating lipid bilayer
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Figure 8.6: Estimation of required free lipid number and tethered polymer grafting density for
perfectly encapsulated TMLs. (A and B) Schematic of indenter test for polymer tethered cores at
the normalized persistence lengths of (A) lp = 0.17 and (B) lp = 2.21. The red beads are those
polymer terminals that can freely translate on the indenter wall. The indenter wall will produce an
outward repulsive force for the terminal beads, if their positions are inside the indenter wall. On the
other hand, the indenter wall will produce an inward force for other polymer beads, if their positions
are outside the indenter wall. (C) Tethered polymer free energy as a function of the indenter size
at different tethered polymer persistence lengths. The optimal indenter size is marked in light red.
(D) Self-assembly process of planar tethered lipid bilayers at different polymer persistence lengths.
An intact membrane is formed at the grafting density of σpc = 0.06nm−2 2 for each case. (E)
Comparison of the estimated critical grafting density obtained with eqn (2) (solid line) and those
values in the phase diagram (scattered points).
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Chapter 9

pH-Dependent Aggregation and
pH-Independent Cell Membrane
Adhesion of Monolayer-Protected
Mixed Charged Gold Nanoparticles
9.1

Abstract

Design of pH-responsive monolayer-protected gold nanoparticles (AuNPs) that are mixed
charged with the ability to switch its net surface charge based on the stimuli of environmental pH is a promising technique in nanomedicine. However, understandings of the
pH-responsive mixed charged AuNPs behaviors in terms of their stability and cellular interaction are still limited. In this work, we study the aggregation of pH-responsive AuNPs
and their interaction with model lipid bilayers by adopting the Martini coarse-grained (CG)
molecular dynamics simulations. The surface of these AuNPs is decorated by the both positively and negatively charged ligands. The AuNP is positively charged at low pH values
due to protonation of negatively charged ligands. Its net charge is lowered at higher pH by
increasing the ratio of deprotonated negative charge ligands. We find that the AuNPs are
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severe aggregated at moderate pH value, where each AuNP has overall neutral charge, and
they are stable and dispersed at both low and high pH values. Further free energy analysis
reveals that the energy barrier before the location of hydrophobic driving force potential
well plays the key role that determines the stability of monolayer-protected AuNPs at different pH values. This energy barrier is dramatically decreased at moderate pH value, leading
to the severe aggregation of AuNPs. By investigating the interaction between AuNPs and
model lipid bilayers, we find that all the AuNPs adhere onto the lipid bilayer, independent
of the pH value. Moreover, the lipids originally in the bilayer are extracted by these AuNPs
through a process of protrusion and upward climbing. The extraction of lipids can cause
dehydration and disruption of bilayers, when multiple AuNPs adhered. Free energy analysis
reveals that the penetration of AuNPs will induce dramatic free energy increment because
of deformation of ligands with hydrophilic functional end groups. We have systematically
studied the stability of pH-responsive AuNPs and their interactions with lipid bilayers in
simulation, which might pave the way for the design of pH-responsive monolayer protected
AuNPs for biomedical applications.

9.2

Introduction

Monolayer-protected gold nanoparticles (AuNPs) have wide applications in nanomedicine
as drug delivery vehicles 323,324 and nanothermal 325–327 and diagnostic 328,329 agents. Particularly, AuNPs featured with the unique electronic, optical and biocompatible properties stand themselves out among various NP candidates 330,331 . Furthermore, the gold NP
surface can be easily passivated by Au-S covalent bonds that facilitate the decoration of
sulfur-containing organic molecules on AuNPs core to form the monolayer-protected surface
with tunable hydrophobicity and electronic charge 332 . In the setting of nanomedicine, it
is desirable for the NPs to circulate along with the blood flow through the vascular network, passively accumulate in tumor sites through the enhanced permeation and retention
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Figure 9.1: Computational model. (A) Components of the monolayer protected AuNPs. The
yellow beads represent the Au core. The tan beads represent the sulfur atoms that cover
the Au core. Two different ligands are tethered on Au surfaces; the N,N,N-trimethyl(11mercaptoundecyl)ammonium ion (TMA) is composed of an alkane chain (colored in white) and
a terminal functionalized with a positive, protonated amino group (-NH+
3 ) (colored in red). The
other is the 11-mercaptoundecanoic acid (MUA) ligand, which consists of an alkane chain and its
neutral carboxyl terminal (-COOH). (B) The carboxyl group in MUA can be deprotonated at high
pH and becomes negative (colored in blue). (C) The curves of deprotonated ratio of MUA and the
AuNP’s net charge against the pH value. The dash line in the figure denotes the location of pKa
value of MUA. (D) Relaxed configuration of AuNPs at a series of different pH values.

(EPR) effect, and adhere onto or uptaken by tumor cells 241 . One of the key challenges in
nanomedicine is the low delivery efficiency of NPs to solid tumors 333 . For instance, only
0.7% of injected NPs on average are successfully delivered to tumor sites in mouse models 16 .
Therefore, the design of NP surface properties, which determine NPs’ interactions with biological environments, is crucial to improve the efficacy of nanomedicine 23,58,206,253,334 .
Design of NPs that are responsive to the pH of the local biological environment in
the human body is a promising strategy to enhance NP delivery efficiency 23,335–337 . The
human body shows quite a range of pH values in the micro-environment at the tissue level.
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For instance, the pH of normal healthy tissue is pH ≈ 7.4 338 . The micro-environment
around a tumor, however, has a much lower pH, around 6.5 339 . A pH-responsive NP
could smartly respond to the proton concentration at different pH values so that it can
achieve an extension of circulation time and enhanced internalization by tumor cells 336 . In
the designs of pH-responsive NPs, utilizing the mixed charged monolayer-protected AuNP
to switch its net surface charge based on the stimuli of environmental pH is one of those
promising techniques 23,336,340 . For instance, Pillai et.al 341 designed a AuNP tethered with
two different ligands: N,N,N-trimethyl (11-mercaptoundecyl) ammonium ion (TMA) and
11-mercaptoundecanoic acid (MUA). The TMA is always positively charged, while the pKa
of MUA is 5.08. Therefore, the MUA can be neutral or negatively charged depending on its
protonation or deprotonation at low or high pH values. The monolayer-protected AuNPs in
their experiments are negatively charged at high pH value and positively charged at low pH,
which facilitate their stability and promote cellular uptake efficiency. Although the strategy
of engineering pH-respoinsive monolayer protected AuNPs is promising, understandings of
the behaviors of pH-responsive mixed charged AuNPs in terms of their stability and cellular
interaction are still limited. 341–344
Good stability or dispersity of NPs in a biological environment is one of the primary
properties of NPs for extended blood circulation 345,346 . Moreover, the aggregation of NPs
may induce toxicity and reduce the NP delivery efficiency 347 . In experiments, Grzybowski
et.al 348,349 found that oppositely charged monolayer protected AuNPs with different sizes
and charge ratios express ‘ionic-like’ stability: these opposite charge AuNPs are stable in
solution and precipitate only at a threshold point that is determined by the condition of
electroneutrality. On the other hand, it is found that the same signed-charge AuNPs might
aggregate and precipitate in solution despite their electrostatic repulsion 350,351 . In theory,
as pointed in Ref 352 , the Derjaguin-Landau-Verwey-Overbeek (DLVO) theory, which is used
to predict the aggregation behavior of charged colloidal particles 353,354 , might not be useful,
due to the contradiction between its continuum assumption and the small size of AuNPs
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(< 10 nm). Therefore, computational simulations are applied to explore the molecular
details and the physical mechanism for aggregation. For instance, Lin et.al 355 found that
the aggregated cluster morphology of monolyer-protected AuNPs is largely determined by
the tethered hydrophobic ligand length by using the Martini coarse-grained (CG) model.
Lehn et.al 352 adopted an implicit solvent model to study the free energy change of two
identical anionic monolayer protected AuNPs. They found that the aggregation of these
AuNPs is driven by the short-range hydrophobic attraction. However, the effect of charged
groups on aggregation behaviors of AuNPs is not clear. Furthermore, to the best of our
knowledge, no simulation has been done to make a one-to-one comparison between the
aggregation behavior of AuNPs and the corresponding free energy change between two
AuNPs. Therefore, it is difficult to correlate the phenomena in cluster formation of AuNPs
to the physical mechanisms about energy barrier and driving force.
Cellular uptake efficiency of AuNPs is another aspect to determine the overall efficacy of
NPs. Due to the fact that tumor cell membranes are negatively charged, some experimental
evidence shows that cationic NPs are more efficient to be uptaken compared to their anionic counterparts 341,356–358 . However, it has also been proven in experiments that cationic
AuNPs might be cytotoxic and disruptive by inducing hole formations in membranes and
membrane thinning 359–361 . In simulation, Lehn et.al 362,363 found that free energy change
for AuNP penetration into bilayer is a result of competition between the hydrophobic driving force provided by the favorable interaction between alkane chain and lipid tail and the
energy penalty induced by the end functional group snorkeling. They also proposed that
the kinetic pathway of AuNPs insertion is initiated by the protrusion of lipids, which form
the first contact between the alkane chain and lipid tails that facilitates the insertion of
AuNPs 364 . Lin et.al 365 also investigated the interaction between lipid bilayers and AuNPs
with different signs and densities of surface charge. They found that the AuNPs show either
repulsive, adhesive, or penetrating behavior toward the lipid bilayers, when their surface
changed from negatively to positively charged. Especially, a defective area was founded in
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bilayer when the AuNP was highly positive. Though numerous simulation works have been
done, the molecular details of the interaction between monolayer protected AuNPs and lipid
bilayers is not fully understood. For instance, it is still unclear how non-inserted AuNPs
can cause the dehydration of lipid bilayer, which is associated with the decreasing of the
area per lipid and the bilayer thickness 360 . Furthermore, few works have been published to
clarify the interaction between lipid bilayers and pH-responsive mixed charged AuNPs.
In views of the importance of pH-responsive monolayer protected AuNPs in drug delivery, we utilize the Martini CG model to understand their stability in solution and interaction
with tumor cells. Particularly, the monolayer protected AuNP contains two different ligands (cf.Fig.9.1.A). The first is positively charged TMA, and the other is MUA with pKa
= 5.08. Therefore, in a low pH environment, the MUA is neutral. While, at a high pH,
its carboxyl end group is deprotonated, resulting in a negatively charged MUA. With a
ratio of TMA:MUA=1:1.6, the AuNPs are positively charged at low pH and negatively
charged at high pH. We firstly investigate the aggregation behavior of AuNPs at different
pH values. Then, a series of one-to-one comparisons about free energy analysis associated
with the aggregation at different pH are performed. It is interesting to find that the AuNPs
show server aggregated state at moderate pH near the pKa value of MUA and are dispersed
at low or high pH. Furthermore, two different correlated states between AuNPs are found
within the aggregated cluster. These two different states are caused by two different minimum values existing in the potential of mean force (PMF) between AuNPs. Interestingly,
instead of the global minimum caused by the hydrophobic attraction between ligands, the
energy barrier before it determines the aggregation of AuNPs. Additionally, we further
explore the interaction between AuNPs and the negatively charged model lipid bilayers at
different pH values. Both unbiased and free energy analysis simulation are performed. With
all the terminals are functionalized, we find that no AuNP can penetrate into the bilayer,
which will cause a dramatic free energy increment due to the hydrophilic ends. Instead
of penetrating, all of the AuNPs adhere on the lipid bilayer. Moreover, the AuNPs can
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extract up to 10 lipids from the lipid bilayer. This extraction of lipids follows a protrusion
and climbing up process, which might be able to explain the lipid bilayer dehydration if
multiple AuNPs exist. Our simulations systematically study the stability of pH-responsive
AuNPs and their interaction with model lipid bilayers, which might pave the way for the
design of pH-responsive monolayer protected AuNPs for biomedical applications.

9.3

Computational Model and Methods

The Martini CG force field 366,367 is adopted in our work to investigate the aggregation and
bilayer interaction process of pH-responsive monolayer-protected AuNPs. In the Martini
force field, 3 or 4 heavy atoms are treated as one CG interactive bead. The Martini force
field is particularly suitable for studying the biomolecular systems, which has been parameterized in a systematic way, combining top-down and bottom-up strategies. The non-bonded
interactions are derived from the top-down approach by reproducing the experimental partition free energies between polar and apolar phases of a large number of chemical species;
while all the bonded interactions are obtained by the bottom-up approach, derived from reference all-atom molecular simulations. Therefore, the conformation, dynamics, mechanical
properties and free energy profile of different lipids and molecular species can be correctly
reproduced by the Martini force field in the CG molecular dynamics simulations 366,367 . The
Martini force field has been extensively used to study biomolecules such as lipids 368 , proteins 369 , and polymers 370 . It has recently been widely applied for investigating problems
related to NP-NP 355,371 and NP-membrane 365,372 interactions.
The model of AuNP used in our simulations is adopted from Ref 365 , which could reproduce the structure and dynamic properties of Au core in experiment. The Au core of the
NP is cut out of a bulk FCC lattice with a constant of 0.408 nm 372 . The gold core is a
truncated-octahedron with a diameter around 2.2 nm. Two different ligands are tethered on
each NP by binding with the sulfur beads on the surface of Au core. One is the TMA that
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is composed of an alkane chain with its positive protonated amino terminal group (-NH+
3 ).
The other ligand is MUA consisting of an alkane chain and a terminal carboxyl group (COOH) (cf. Fig.9.1.A). There are 104 ligands in total on the AuNP surface, with the ratio
of TMA:MUA= 1 : 1.6. The TMA ligand is always positive in all simulation cases, while
MUA can be neutral or negatively charged, due to its pKa= 5.08 341 . Correspondingly, the
deprotonated ratio of MUA can be calculated as 373 :

x=1−

10pKa−pH
1 + 10pKa−pH

(9.1)

where x is the deprotonated ratio, which corresponds to the number of deprotonated MUA
ligands on the AuNPs surface in simulation. Under these parameters, the deprotonated
ratio and the net charge of AuNPs are presented in Fig.9.1.C. At the low pH, no MUA
is deprotonated and the AuNPs surface is positively charged.

With the increment of

pH value, the number of deprotonated negatively charged MUA increases. The AuNPs
surface at high pH is mixed with positive and negative functional groups and possesses
overall negative charge after the pH= 5.3. To systematically explore the effect of pHresponsive ligands on the monolayer protected AuNP, 9 different pH values are investigated: pH = 2.0, 3.0, 4.0, 4.5, 5.0, 5.3, 6.0, 7.0, 8.0. As we can see in Fig.9.1.D, at pH= 2.0,
the AuNP has a highly positive charge of +40. At pH=5.3, 62% of MUA ligands are deprotonated and the AuNP has overall zero net charge. At the high pH of 8.0, all of the MUA
ligands are deprotonated and the AuNP has a negative charge of -24. The diameter of the
monolayer-protected AuNPs is around 5.5 nm at the relaxed state. The interactive parameters under the framework of Martini force-field for the monolayer-protected AuNPs are
given in Table A.8 of the supplementary materials. Particularly, the hydrophobic Au core
beads are represented by C5 type bead. The sulfur beads are neutral and represented by N0
type. The alkane chain of MUA/TMA ligands is represented by three C1 type beads. The
functional group of MUA/TMA is Qda type for their hydrophilic properties 374 . Moreover,
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the functional group on TMA possesses +1 charge. The functional group on MUA has −1
charge when deprotonated and no charge when protonated. The interactive beads within
each ligand are connected using the bond potential, and the Au core with sulfur surface
is treated as a rigid body in the simulations. All of these parameters are taken from the
previous study 365 . To mimic the negatively charged tumor membrane, the lipid bilayer used
in our simulations consists of negatively charged 1,2-dipalmitoyl-sn-glycero-3-phospho-(1’rac-glycerol) (DPPG) and neutral 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine (DPPC)
phospholipids. The lipid bilayer in our simulations has total lipid count of 800, with the
ratio of DPPG:DPPC = 5 : 1. Please refer to reference 367 for the details of the interactive
parameters of lipid and water bead.
To construct the free energy profiles that determine the aggregation and penetration
of AuNPs, the umbrella sampling method is used 293 . Specifically, when calculating the
free energy change between two AuNPs, a harmonic potential U = 12 k(ζ − ζ0 )2 is applied
on the center-of-mass (COM) of two AuNPs to push them towards each other. The force
constant is k = 5 kcal/mol. ζ denotes the distance between COMs of these two NPs. A
series of windows were performed at different values of ζ0 . The width of each window is
taken as 0.1 nm to ensure the overlap of NPs positions at two constitutive windows 365 . The
weighted histogram analysis method (WHAM) is adopted to calculate the corresponding
free energy change 294 . A similar procedure is utilized to estimated the free energy change
during penetration of AuNPs through lipid membrane. During the penetration, ζ represents the distance between the COM distances of NP and the lipid bilayer in the direction
perpendicular to the bilayer plane. In both cases, each window lasts for 30 ns in order to
allow relaxation and acquire enough configurations. As we can see in Fig.A.55 in supplementary materials, the potential of mean force (PMF) is already converged at 24 ns . The
temperature in all of the simulations is controlled at 310 K. The pressure of the systems
during aggregation is maintained at 1 bar in all directions; During the interaction between
AuNP and lipid bilayer, the pressure within the plane of the bilayer is coupled controlled at
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1 bar. The pressure along the out-of-plane direction is independently controlled at 1 bar.
In such a way, the membrane tension in the simulation is guaranteed to be zero. Periodic
boundary conditions are used in all of our simulations. The time step of all simulations is set
as 30 fs. All simulations are performed using the Large-scale Atomic/Molecular Massively
Parallel Simulator (LAMMPS) software 89 . The snapshots during the simulation process
are rendered by the Visual Molecular Dynamics (VMD) software 375 .

9.4
9.4.1

Results and Discussion
pH-dependent stability of AuNPs

AuNPs show severe aggregation at moderate pH. The stability of the pH-responsive
AuNPs is firstly investigated in our simulation. To study the aggregative or dispersed
state of AuNPs in different pH environments, 27 AuNPs are initially evenly distributed in
a simulation box of (30 × 30 × 30) nm3 at each pH value. Positively charged sodium or
negatively charged chloride beads are added in each case to neutralize the simulation system.
Each of the 27 AuNPs has been relaxed in a smaller simulation box of (10 × 10 × 10) nm3
for 100 ns before the aggregation simulation. Snapshots demonstrating the progression of
AuNP state at pH values of pH = 2.0, 5.3, 8.0 are given in Fig A.54 of the supplementary
materials. Under the thermal fluctuation, each AuNP performs a random walk and has the
chance to encounter and contact with each other. During this process, the AuNPs might
be attractive or repulsive to each other, depending on their surface charge at different pH
environments. The simulation of 27 AuNPs at each pH value lasts for 400 ns, beyond which
the aggregative or dispersed state of NPs does not change. The relaxed structures of AuNPs
are given in Fig.9.2 at each pH value. As we can see from the figure, the equilibrated state
of the 27 AuNPs is critically affected by the pH value of environment. At pH= 2.0, due to
the highly positive charged AuNP surfaces, these AuNPs are barely observed to contact or
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Figure 9.2: Equilibrated state of 27 AuNPs at different pH environments. The water and ionic
beads are not shown for clarity.

correlated with each other. Most of them are well dispersed in the simulation box. Similar
well-dispersed states are observed at pH= 3.0, 4.0. All of these indicate that the AuNPs
have good stability at low pH, despite the hydrophobic alkane chain. At the pH value of
4.5, around 20 percent of MUA ligands are deprotonated, which is associated a dramatic
decrease of positive net charge compared to pH= 2.0 (cf.Fig.9.1.C). Several AuNPs are
observed connecting with each other to form a cluster at the state of equilibrium. This
phenomenon is more pronounced at pH= 5.0, where most of the AuNPs are correlated
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within their own clusters. These clusters do not increase their sizes with the simulation
time, being dispersed in the simulation box instead of the individual AuNP. Furthermore,
almost all of the AuNPs are correlated within one large cluster at the pH= 5.3. This large
cluster suggests severe aggregation of AuNPs at pH= 5.3. It is also interesting to note that
each AuNP has zero net charge at pH= 5.3. As the increment of pH value, more MUA
groups on the AuNPs are deprotonated, and each AuNP expresses overall negative charge
in the system. At the pH values of 7.0 and 8.0, a similar state to the one at pH=5.0 is
observed: the small AuNPs clusters are dispersed in the simulation box. Note that these
well dispersed small clusters are different from the large cluster at pH= 5.3. These small
clusters are stable in the simulation box and will not increase their size (cf. Fig.A.56 in
supplementary materials), which indicates that these AuNPs at high pH values can maintain
their stability in solution. All of these simulation results indicate that the stability of AuNPs
has the trend to recover with the increase of pH value.
To quantitatively characterize the aggregation behaviors of AuNPs, we calculate the
radial distribution function (RDF) of the AuNPs and the corresponding second virial coefficient B2 at different pH values. When calculating the RDF, only the COM of each
AuNPs is considered to avoid the unreasonable peak caused by the FCC arrangement of
Au beads. The RDF curve of each system is calculated by averaging 20 samples at their
equilibrated states. As given in Fig.9.3, corresponding to the equilibrated state of AuNPs
as shown in Fig.9.2, the RDF value of AuNPs is critically dependent on the pH environment. When pH <= 4.0, these is no evident peak value in the RDF curves, which reflects
the well-dispersed state of AuNPs. However, for the AuNPs at pH >= 4.5, there are two
pronounced peak values in RDF curves. The first peak appears at a distance around 3 nm,
and the second peak is located at a distance around 5 nm. These two peak positions should
be related to attractive interactions between ligands, which will be discussed in the free
energy analysis. Furthermore, the value of the first peak is much larger than the second
peak value. These two peak values in the RDF curves suggest that in the AuNP clusters
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Figure 9.3: Aggregation information about AuNPs at different pH values. (A) Radial distribution
function (RDF) of AuNPs at different pH values. (B) The functions of the first and second peak
values in RDF against the pH value. The first peak value for each pH value is the local maximum in
the RDF curve at the distance around 3 nm. The second peak value for each pH value is the local
maximum in the RDF curve at the distance around 5 nm. (C) The function of the B2 value of the
AuNPs against pH value. (D) The function of maximum cluster size against the pH value.

observed in Fig.9.2, there are two different states corresponding to the COM distances of
3 nm and 5 nm. As we mentioned above, the diameter of the Au core is around 2.2 nm,
and the diameter of a monolayer protected AuNP is around 5.5 nm. This indicates that at
the location of the first peak value, the AuNPs need to deform their ligands to interact and
contact with each other.
To systematically compare the first and second peak values, we plot them against the
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Figure 9.4: Free energy analysis on aggregation of AuNPs. (A) The profile of potential of mean
force (PMF) between two AuNPs against center-of-mass (COM) distance. (B) The change of energy
barrier value to aggregate against pH values. (C) The change of energy barrier value to dissociate
against pH values. (D) Configuration of AuNPs at different COM distances.

pH values as shown in Fig.9.3.B. The first peak dramatically increases after pH=4.0 and
reaches its maximum value at pH=6.0. After pH=6.0, it starts to decrease. A similar
trend is observed for the second peak; while its maximum value occurs at pH=5.3. To more
precisely quantify the AuNPs aggregated state, we calculate the B2 based on the RDF curves
R
according to the definition as B2 = −0.5 (g(r)−1)4πr2 dr, where g(r) is the RDF of AuNPs.
The B2 value is a good indicator of the aggregation behavior of proteins and NPs 376–378 . A
positive B2 value indicates good dispersion of AuNPs, while a negative B2 value suggests
phase separation of AuNPs. As shown in Fig.9.3.C, the B2 value of AuNPs dramatically
decreases to negative values after pH = 4.5. However, it increases after pH = 6.0 with
increment of pH value. To calibrate the cluster size in Fig.9.2, we further calculate the
maximum cluster size in each system. AuNPs are considered to belong to a cluster if the
COM distance between the AuNPs and any one within the cluster is smaller than 5.5 nm.
As given in Fig.9.3.D, at the pH value of 5.3 and 6.0, maximum cluster size is significantly
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larger than the other pH. The cutoff distance will not affect the trend in these curves when
counting the cluster size. As we can see, B2 and maximum cluster size are consistent with
each other. All of these indicate that around pH= 5.3, the AuNPs are severely aggregated.
The AuNPs show well dispersed state at low pH and moderate dispersed at high pH. Our
simulation results are consistent with those in experiments showing that the pH-responsive
AuNPs are stable at both low and high pH 341 . This typical characteristic of pH-responsive
AuNPs can be utilized when designing smart NPs by choosing a suitable pKa value of
functional groups according to the local pH environments in the blood flow and the tumor
sites.
pH=2.0

pH=3.0

pH=4.0

pH=4.5

pH=5.0

pH=5.3

pH=6.0

pH=7.0

pH=8.0

Figure 9.5: Equilibrated snapshots of AuNPs adhering to lipid bilayers at different pH values.
The head groups of DPPG are colored in pink, and the head groups of DPPC are colored in purple.
The tails of lipids are colored in gray. The lipids extracted by the AuNPs are highlighted in green.
The color scheme of the monolayer protected AuNP is the same as the one in Fig.9.1. All of the
snapshots are obtained after a simulation time of 10 µs.

Free energy analysis reveals energy barrier before hydrophobic attraction.
To reveal the physical mechanisms that determine the stability of AuNPs at different pH
environments, we proceed to analyze the free energy change of two AuNPs approaching
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towards each other using the umbrella sampling method. This free energy change between
the two AuNPs can reflect the interactive potential between them that determines the
aggregation or dispersion of AuNPs in solution, as mentioned above. During the analysis
process, the two AuNPs are freely rotated to adjust their orientations. The potential of
mean force (PMF) between two AuNPs are calculated against their COM distance. The
PMF profile of AuNPs at the pH of 2.0, 5.3, and 8.0, and the corresponding configurations
of AuNPs at different COM distances are given in Fig.9.4. PMF profiles for AuNPs at other
pH values show similar trends. As we can tell from Fig.9.4.A, there are four typical regions
found in the PMF profiles. At the initial COM distance around 7 nm, the AuNPs do not feel
each other (cf.Fig.9.4.D). When they are approaching each other, there is a local minimum
value in the PMF curve at a distance around 5.5 nm, which suggests the existence of an
attractive force between AuNPs at this point. This attractive force should be associated
with the second peak value in the RDF curves. Similar attraction is observed between
two cationic NPs 379,380 ; this attraction is considered to be induced by an electrostatic
bridging and a depletion-like force. For the mixed charged AuNPs, this attraction should
also be caused by the electronic attraction between the functional groups. As shown in
the configurations of AuNPs in Fig.9.4.D, at the distance of D = 5.5 nm for pH = 5.3
and pH = 8.0, the end groups in deprotonated negative MUA are attracted to the positive
TMA end groups, which is reflected by the stretched ligand chain. When the two AuNPs are
getting close to each other, there is a local maximum value around the distance of D = 4.5
nm. At this distance, the functional groups on the AuNPs begin to overlap with each other, a
situation which might result in a large repulsive steric and electrostatic force. After D = 4.5
nm, the PMF between AuNPs dramatically decreases and reaches a global minimum at the
distance of D = 3.0 nm. This global minimum is shown by the first peak position in the
RDF curves and should be brought by the interaction between the hydrophobic chain as
shown in the configurations in Fig.9.4.D. When the distance further decreases, the PMF
instantly increases to a large positive value. Correspondingly, the ligands on AuNPs are
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highly overlapped.
The short ranged hydrophobic interaction is considered as a driving force for the aggregation of monolayer protected AuNPs 352 . This hydrophobic driving force is also consistent
with the global minimum in the PMF profile in our simulation. However, as we can see in
the PMF profile, before the global minimum free energy state caused by the hydrophobic
alkane chain, the AuNPs need to overcome an energy barrier between the local minimum at
D = 5.5 nm and D = 4.5 nm. We mark this energy barrier as ∆E1 . In addition, we mark
the energy barrier between the local maximum at D = 4.5 nm and the global minimum at
D = 3.0 nm as ∆E2 . This energy difference height of ∆E2 should be related to the dissociation ratio of AuNPs after they fall into the potential well at D = 3.0 nm. The variations
of ∆E1 and ∆E2 against pH are plotted in Fig.9.4.B and Fig.9.4.C. As we can see in the
figure, the energy barrier ∆E1 decreases from the value of 6.5kcal/mol at pH = 2.0 to the
value around 4.5 kcal/mol at pH = 5.3. After pH = 5.3, the ∆E1 slightly increases. On
the other hand, the dissociation energy barrier ∆E2 increases from the value of 42kcal/mol
at pH = 2.0 to the value around 60 kcal/mol at pH = 5.3. Then it slightly changes against
the pH value. It is interesting to note that all of the dissociation barriers ∆E2 are larger
than 40 kcal/mol, which is much larger than the thermal fluctuation. This indicates that
for AuNPs at all pH values, they can hardly dissociate at the distance D = 3.0 nm, where
the hydrophobic interaction plays the role. Therefore, a dispersed or aggregated state of
AuNPs is determined by the value of energy barrier ∆E1 . If ∆E1 is larger than the energy
obtained from thermal fluctuation, the AuNPs will be well dispersed. Otherwise, the AuNPs
will aggregate together. To further confirm this hypothesis, we calculate the transnational
kinetic energy distribution of a single AuNPs at T=310 K. As given in Fig.A.58 in supplementary materials, the mean transnational kinetic energy of an AuNPs is round 0.93
kcal/mol. And the largest transnational kinetic energy during the testing time (300 ns)
is 3.67 kcal/mol with a probability of 2 × 10−4 . Comparing the values of transnational
kinetic energy and energy barrier ∆E1 , we can get that ∆E1 =6.5 kcal/mol at pH= 2.0 is
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large enough to prevent the AuNPs aggregate together. On other other hand, the value of
∆E1 =4.5 kcal/mol is comparable to the largest transnational kinetic energy, resulting the
aggregation of AuNPs at pH= 5.3. To the best of our knowledge, this is the first time, it has
been clarified using simulation that the energy barrier before the hydrophobic attraction is
crucial to the stability of monolayer protected AuNPs in solution.
As indicated by the B2 and maximum cluster size, the stability of AuNPs starts to
recover at pH= 7.0 and pH= 8.0. In comparison, their ∆E1 and ∆E2 are similar to the ones
at pH= 5.3 and pH= 6.0. We hypothesize that this is caused by the angular dependence
of the PMF profiles due to the random distribution of ligands on AuNP surface. Note
that during the umbrella sampling process, the AuNPs are free to rotate to search the
minimal energy at each COM position. The similarity in ∆E1 and ∆E2 suggests that the
AuNPs at pH= 7.0 and pH= 8.0 are able to associated with each other at certain relative
angular position. But at other certain relative angular positions, the ∆E1 and ∆E2 might
be different. To confirm this, we perform the umbrella sampling process of two AuNPs
at pH= 7.0 and pH= 8.0 with a fixed relative orientation. As given in Fig.A.57 of the
supplementary materials, with the fixed relative orientation, the ∆E1 values at pH= 7.0
and pH= 8.0 increase to 5.7 kcal/mol and 5.8 kcal/mol, respectively, which are comparable
to the one (6.0 kcal/mol) at pH= 3.0. The combination of PMF profiles with free rotation
and fixed rotation should be able to explain the phenomena that at high pH values, the
AuNPs form small clusters. But these small clusters are stable and will not increase their
size.

9.4.2

pH-independent adhesion of AuNPs on lipid bilayer

AuNPs adhere on lipid bilayer at all pH values. After clarifying the aggregation
behavior of AuNPs at different pH environments, we proceed to study the interaction between AuNPs and lipid bilayers. In this part, the AuNPs at different pH values are initially
placed above the lipid bilayers with a distance of 7 nm. The lipid bilayers in all of these
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Figure 9.6: (A) Adhesion process of AuNPs at pH = 2.0 and pH = 8.0 onto the lipid bilayer. The
lipids marked in green are those extracted by the AuNPs. (B) Number of AuNP-extracted lipids
over simulation time at pH = 2.0 and pH = 8.0. (C) The number of AuNP-extracted lipids at
different pH values.

cases have the same composition of DPPG:DPPC = 5 : 1. Sodium beads are added in each
case to neutralize the simulation system. We run these simulations for more than 10 µs. It
is interesting to find that none of the AuNPs can insert into the bilayers at all pH values,
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as shown in the equilibrated state of each system in Fig.9.5. Instead, all of the AuNPs
show preference to adhere onto the bilayer surface, due to the attraction between the positive charged TMA ends and the negative charged lipid bilayers. Furthermore, as marked
in Fig.9.5, the lipids in the bilayer are observed to be extracted by the adhering AuNPs.
These extracted lipids climb up onto the AuNPs surface. It is also noteworthy that even
at the high pH values (pH = 7.0, 8.0) where the AuNPs have net negative charge, they still
show adhesion on the lipid bilayer and extraction of lipid molecules after adhering. Our results seem to conflict with those done by Lin et.al 365 showing that the monolayer-protected
AuNPs have the chance to penetrate into the lipid bilayer, which is highly dependent on
the surface charge of AuNPs. However, different from the AuNPs studied by Lin et.al, all
the hydrophobic alkane chains here, are modified with hydrophilic functional groups on the
pH-responsive AuNPs. The penetration process of monolayer protected AuNPs is reported
to be a balance between the hydrophobic driving force and the energy cost to snorkeling
the functional end groups 362,381 . With the hydrophilic ends, snorkeling of the end groups
might require a large energy penalty. To further confirm this, we investigate all-TMA and
no-MUA AuNPs interacting with lipid bilayer. The surface of all-TMA AuNP is only decorated with TMA ligands. Comparing with the pH-responsive AuNPs, the MUA ligands
are replaced by the pure hydrohpobic alkane chains on the no-MUA AuNP. The setting of
no-MUA AuNP is similar to the one in Ref. 363 . As we can in Fig.A.59 of supplementary
materials, though the all-TMA AuNP has a larger surface charge, it adheres on the lipid
bilayer over the entire simulation time. However, the no-MUA AuNP quickly penetrates
into the lipid bilayer. Further free energy analysis for penetration will be revealed in the
following section. On the other hand, the extraction of lipids has interesting implications.
It has been shown that the extraction of lipids by nanomaterials such as graphene 382 might
be destructive to the cell membrane. This information might indicate another destructive
mechanism for the charged AuNPs other than the direct pore opening on the cell membrane 365 . In addition, the lipid extraction might be able to explain the dehydration of lipid
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bilayers 360 even when the AuNPs are not inserted into the bilayer. We will discuss the
membrane destruction and dehydration in the following part. We should also emphasize
that the mixed-charged AuNPs in previous experimental studies 341 are much larger than
the ones considered in present simulations. In addition, serum proteins exist during the
cellular uptake process. These serum proteins decorated large size AuNPs (> 5 nm) might
be internalized by the endocytosis pathways 23 . While the small size proteins free AuNPs
(< 5 nm) could penetrate into lipid bilayer under certain conditions 365 .
Extraction of lipids show a protrusion and climbing up process.

To reveal

the details about this adhesion and lipid extraction process, we show the snapshots of this
interactive process with highly positive and negative charge AuNPs at the pH values of
2.0 and 8.0, respectively. As given in Fig.9.5.A for pH = 2.0, the AuNP is initially placed
above the lipid bilayer at a distance of D ≈ 7 nm. Because of the attraction between the
positively charged TMA on AuNP and the negatively charged DPPG head group, the AuNP
quickly adheres onto the lipid bilayer. Furthermore, driven by the hydrophobic attraction
between the alkane chain in the TMA/MUA ligands and the lipid tails, the ligands on the
AuNP surface deform and the lipids in the bilayer rearrange themselves, which result in a
hydrophobic contact area between the AuNP and the lipid bilayer (t = 0.15 µs in Fig.9.5.A
for pH = 2.0). As we can tell in the snapshot, the lipids near the contact region are highly
disordered. These disordered lipid molecules are supposed to promote the lipid protrusion
that helps the insertion of AuNP into the lipid bilayer 364 . Interestingly, as highlighted at
t = 0.16 µs, one lipid protrudes with a tail group that remains interacting with the lipids in
the bilayer. While, the other tail group starts to insert into the hydrophobic part of ligands
on the AuNP. The lipid molecule protrudes and splays between the AuNPs and lipid bilayer.
Afterwards, rather than help the insertion of AuNPs as reported in Ref 364 , the protruded
lipid molecule quickly climbs up on to the AuNPs surface, with its two tail groups splay and
are embedded in the hydrophobic part of the ligand, and its head group points towards the
outside of AuNP surface. After a long period of 10 µs, there are almost 10 lipid molecules
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extracted by the adhering AuNPs following the same protruding and climbing up process.
Moreover, though the AuNP at high pH value of 8.0 possesses highly negatively charge, a
similar process is observed. This might suggest that the local charge distribution of the
monolayer-protected AuNPs, rather than the net charge, is more important to the adhesion
of AuNPs on cell membranes. We further monitor the evolution of extracted lipid number
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on AuNPs of pH = 2.0 and pH = 8.0 as shown in Fig.9.6.B. It is interesting to note that in
both cases, the number of extracted lipids increases dramatically at the early state (t < 2
µs) and then saturates at the later state. It is also noteworthy that the extracted lipids still
have the chance to return back to the lipid bilayer, as we can tell from the fluctuation of the
extracted lipid number. We also calculate the extracted lipid numbers of AuNPs at different
pH values as given in Fig.9.6.C. The extracted lipid number of other cases is around 10.
This saturated lipid number might be affected by the AuNPs size and the length of ligands,
which can be manipulated when designing the surface functionalization of AuNP. Note that
the extraction of lipids has also been observed by Van Lehn and Alexander-Katz 383 after the
insertion of AuNPs into bilayers, which indicates that lipid extraction might be a common
behavior of charged monolayer protected AuNPs interacting with cell membrane.
Free energy analysis reveals large energy barriers associated with AuNP
penetration. To understand why the pH-responsive AuNPs are adhering onto rather than
penetrating into the bilayer, we perform a series of simulations to analyze the free energy
change when inserting the AuNP into the bilayer. This penetration process is directed by
a spring potential as mentioned in the corresponding section of the description of methods.
As shown in Fig.9.7.A of the PMF profile, this penetration process can be divided into two
regions. Before the COM distance of D = 4.0 nm, due to the attraction between positive
charge TMA and negative DPPG head group as we can see in Fig.9.7.C at D = 4.0 nm, the
free energy decreases a small amount to a global minimum value. When the AuNPs and
lipid bilayer further approach each other, the PMF values dramatically increase. Within
this COM distance region, though the hydrophobic interaction between the alkane chain
and lipid tail is preferred, due to the energy barrier induced by the hydrophilic functional
group, the ligand on the AuNPs surfaces can hardly translocate through the hydrophobic
part of lipid bilayer and reach the other side of the bilayer. Instead, the ligands on the
AuNPs largely deform to squeeze each other, which is combined with the highly curved
lipid bilayers as shown in Fig.9.7.C at D = 2.0 nm. The PMF value further increases,
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Figure 9.8: Interaction between multiple AuNPs and model lipid bilayer. (A) Snapshots of interaction process between multiple AuNPs and lipid bilayer. The lipids extracted by AuNPs are
highlighted in green. A pore opened in lipid bilayer is highlighted by circles. (B) Number of extracted lipids over simulation time. (C) Evolution of the lipid bilayer area. The pH value in the
system is 2.0.

even if the ligands on AuNPs snorkels and the AuNP is translocated through the lipid
bilayer. As we can tell in Fig.9.7.C at D = 0.0 nm, the snorkeling of ligands causes great
stretching of the ligand chains, which indicates that the large steric interaction might lead
to this high energy state when the AuNPs are inserted into the lipid bilayer. A similar
PMF profile is observed by Chen et.al 384 , when most of the ligand is functionalized with
anonic groups. The PMF profiles of AuNPs at different pH values are similar. Only a
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slight shift in the PMF value is observed, due to the existence of negatively charged (or
deprotonated) MUA. To evaluate the energy cost of inserting the AuNPs into the bilayer,
we calculate the free energy difference between the global minimum and maximum in the
PMF profile and name it as ∆E. As we can see in Fig.9.7.B, due to the increased deprotonated MUA at higher pH value, the ∆E increases with the pH value. However, it is
more important to note that the energy cost of ∆E in all cases is larger than 150 kcal/mol,
which is much larger than the thermal fluctuation. This energy cost ∆E for AuNPs with all
alkane chains functionalized with hydrophilic end groups is totally different from the ones
with negative and hydrophobic ligands in Ref 362,363 . When a part of the ligand is an alkane
chain without a functional group, the free energy decreases around 100 kcal/mol for the
favorable hydrophobic interaction 362,363 . This indicates that it is thermodynamically unfavorable to insert the pH-responsive AuNPs into the lipid bilayer when all the alkane chains
are functionalized. This is further confirmed by the comparison of PMF profiles between
different AuNPs at pH= 2.0: mixed charged AuNPs, all-TMA AuNP and no-MUA AuNPs
as given in Fig.A.60 of supplementary materials. Disordered lipid membrane region and
longer alkane chain length might be desirable, if the penetration of pH-responsive AuNPs
is preferred 362,384 .
Interaction between multiple AuNPs and model lipid bilayer. To test our hypothesis about the relation between lipid extraction and membrane disruption/dehydration,
we proceed to investigate the interaction between multiple AuNPs and model lipid bilayer.
The pH value of system here is pH= 2.0. As given in Fig.9.8.A, 9 monolayer-protected
AuNPs are placed above the lipid bilayer at t = 0. Similar to the adhesion process of single
AuNP, all the AuNPs are adhered on the lipid bilayer at t = 0.3 µs. At the same time,
many lipids are extracted by these AuNPs, which causes the wrinkle of bilayer. At t = 1.5
µs, the AuNPs adjust their position on the bilayer. With more lipids extracted, a small pore
opens in the bilayer. This pore dose not expand much at t = 2.1 µs and t = 3.9 µs, when
the AuNPs are almost covered by the extracted lipids. We further calculate the number
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of extracted lipids and the area of lipid bilayer in Fig.9.8.B, and Fig.9.8.C respectively. As
we can tell, the extracted lipid number increases up to 140. With the extraction of lipids
in bilayer, the bilayer area significantly decreases from 260 nm2 to 170 nm2 . To avoid
the potential influence of small membrane size on the lipid extraction and dehydration, we
further perform simulations of a larger membrane with initial area of 1225 nm2 . As given
in Fig.A.61 and Fig.ch9:Fig.S9 of supplementary materials, two different AuNP numbers,
36 and 25, are studied, similar lipid extraction and bilayer dehydration are observed. Our
results confirm that the adhesion of multiple AuNPs can significantly increase the extracted
lipid number and lead to the dehydration of lipid bilayer. Furthermore, the pore induced
by extracted lipids provides another possible mechanism about cell membrane disruption,
apart from the penetration induced pore opening 365 . Note that the similar phenomena have
been observed at other pH values in our simulations (results not shown here).

9.5

Conclusions

In this work, we have systematically investigated the stability and cellular interaction of
pH-responsive monolayer protected AuNPs through CG molecular dynamics simulations.
The AuNPs in our simulations are decorated with positively charged TMA ligands and
MUA ligands with pKa= 5.08. Therefore, MUA ligands are protonated and neutral at
low pH (< 5.3) and deprotonated and negatively charged at high pH (> 5.3). All of
these factors combined together make the AuNPs pH-responsive. The monolayer protected
AuNPs are positively charged at low pH and posses negative overall charge at high pH.
Our simulation results suggest that the pH-responsive AuNPs are severely aggregated at
a moderate pH value around 5.3, and they are stable and dispersed at both low and high
pH. The RDF of AuNPs indicates that there are two peak values at the RDF curves, which
correspond to COM distances around 5.5 nm and 3.0 nm, respectively. These two peak
values suggest two different correlated states within the aggregated cluster. Furthermore, we
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perform the free energy analysis of two AuNPs to understand free energy barriers associated
with AuNPs aggregation. We found that the first peak at D = 3.0 nm is induced by
the hydrophobic driving force between alkane chain of ligands, while the second peak at
D = 5.5 nm is caused by the electrostatic bridging between two mixed charged AuNPs.
More importantly, it is found that the energy barrier between D = 5.5 nm and D = 3.0
nm is the key that determines the stability of monolayer-protected AuNPs at different
pH values. This energy barrier is dramatically decreased at moderate pH values, which
contributes to the severe aggregation of AuNPs. We further investigate the interaction
between AuNPs and lipid bilayers; it is interesting to find that all AuNPs adhere onto the
lipid bilayer, independent of their surface charges. Moreover, the lipids originally in the
bilayer are extracted by the AuNPs through a protrusion process. This extraction of lipids
will result in dehydration and disruption of bilayers, if multiple AuNPs exist. Further free
energy analysis reveals that the penetration of AuNPs will lead to dramatic free energy
increase because of deformation of ligands and hydrophilic functional end groups. Our
simulations for the first time systematically study the stability of pH-responsive AuNPs
and their interaction with lipid bilayers in simulation, which might help the design of pHresponsive monolayer protected AuNPs.
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Chapter 10

Summary and Perspectives
10.1

Summary

Utilizing the muti-scale molecular dynamics simulation, we have systematically investigated
the influence of NP properties during the drug delivery process. Particularly, our simulations
provided a detailed mechanistic understanding for the membrane wrapping processes of
elastic NPs, PEGylated liposomes and PEGylated bicelles. Furthermore, we provided a
design strategy for new liposome-like NPs and a guideline for pH-responsive smart NPs.
Chapter 2 and Chapter 3 focus on the elastic NPs. In Chapter 2, we have developed an
elastic NP model with well-controlled mechanical properties. In simulations, the mechanical
properties of elastic NPs can be precisely controlled by the in-plane, area, volume and
bending potentials. Nano-indentation tests further confirm that the stiffness of elastic NPs
is determined by their size and bending rigidity. The stiffness of elastic NPs monotonically
increases with bending rigidity kb under given size. For large bending rigidity (kb = 100),
the stiffness of elastic NPs can be dramatically reduced by the increment of NP radius from
10σ to 25σ. Utilizing the elastic NP model in Chapter 3, we have systematically investigated
the receptor-mediated membrane wrapping process of elastic NPs with different sizes and
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shapes using CGMD simulations. The membrane wrapping efficiency of elastic NPs is
found to be governed by the receptor recruitment speed and free energy barriers. The
receptor recruitment speed is determined by the receptor diffusion flux and contact edge
length between the NP and membrane. The free energy barriers are mainly determined by
the free energy changes of NPs and membrane. For spherical NPs, under the control of
volume constraint, the contact edge lengths of soft and rigid NPs are found to be similar.
Comparatively, soft spherical NPs have significantly higher energy barriers due to their
ability to deform. Due to the increased energy barriers, soft spherical NPs need to recruit
more receptors to provide the driving force for the membrane wrapping. Therefore, they
are less efficiently fully wrapped than rigid ones. Furthermore, the free energy barrier
for membrane wrapping of soft spherical NPs is increasing with their size under the same
bending constant. As a result, the difference in the wrapping efficiency between soft and
rigid spherical NPs increases with their size.
For non-spherical oblate and prolate NPs, the rigid oblate NP needs to overcome a larger
energy barrier compared to the rigid prolate NP. However, the oblate NP has a significantly
large contact edge length which enables it to be fully wrapped faster than the prolate NP.
More importantly, due to the prominent large contact edge length, the wrapping efficiency
of the soft oblate NP is the least sensitive to the bending constant variation among the
geometries of spherical, prolate and oblate shapes. Under the same bending constant, the
wrapping efficiency is ranked as oblate NP > spherical NP > prolate NP for the tip-first
entry mode. However, this ranking sequence is totally reversed when the entry angle of
oblate and prolate NPs is changed to the side-first entry mode. It is worthy to note that
according to our simulations, both the soft spherical and non-spherical NPs remain at a
high energy state when fully wrapped and cannot return to their initial stress-free state.
These simulations provide a way to understand the conflicting experimental results in terms
of the influence of NP geometry and elasticity on their endocytosis efficiency.
Chapter 4 and Chapter 5 focus on the cellular uptake process of PEGylated liposomes
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and PEGylated bicelles. In Chapter 4, we performed large scale DPD simulations to understand the influence of PEG polymer mobility during the endocytosis of PEGylated liposomes. Comparing between the membrane wrapping processes of a PEGylated rigid NP and
a liposome under identical conditions, we find that the PEGylated liposome gets only partially wrapped, while the PEGylated rigid NP can be fully wrapped by cell membrane. During the membrane wrapping process, the mobility of PEG polymers enables them to diffuse
on the liposome surface and to rearrange themselves to promote the ligand-receptor binding
and adhesion of the PEGylated liposome. However, the aggregation of PEG polymers also
occurs within the contact region between the liposome and the membrane, leading to a
ligand-free region on the liposome. The PEG polymer aggregation and ligand-free region
on the liposome surface block the further membrane wrapping and result in the ‘bouncing
back’ of the liposome to a less wrapped state. By systematically varying the molar ratio
of PEGylation and membrane tension, we find that the PEGylated liposomes are overall
more difficult to be fully wrapped than PEGylated rigid NPs. To understand the physical
mechanisms behind this difference, we analyzed the free energy changes of a PEGylated
liposome during its membrane wrapping process, including the bending energy change of
the liposome, the elastic energy change of the membrane, the ligand-receptor binding energy
change, and the free energy change of the PEG polymers, and compare them with those of
the PEGylated rigid NP. We find that the free energy penalty induced by aggregation of
PEG polymers is about ∼ 800 kB T for the PEGylated liposome, which is twice that of a
PEGylated rigid NP. We therefore conclude that the large free energy penalty induced by
PEG aggregation, and the ligand-free region on liposome surface are the main reasons that
PEGylated liposomes cannot be efficiently taken up by tumor cells. In addition, we suggest
that by increasing the repulsive interactions between grafted PEG polymers or targeting
moieties might help to limit their aggregation, and in turn, facilitate the internalization of
the PEGylated liposome.
In Chapter 5, we have compared the membrane wrapping processes of PEGylated li244

posomes and bicelles. We find that during the wrapping process, the aggregation of PEG
polymers on liposomes and bicelles results in a critical wrapping fraction fc , after which
the ligands are exhausted. According to the fc , the entire membrane wrapping process
for PEGylated liposome/bicelle can be divided into two different stages: (1) As long as
f < fc , the membrane wrapping is driven by ligand-receptor binding. (2) For f > fc ,
no driving force can be provided by ligand-receptor binding. Membrane wrapping cannot
proceed unless a compressive membrane tension is provided. Furthermore, by systematically varying the molar ratio of PEG polymers and membrane tension, we find that the
PEGylated liposome is overall more difficult to be fully wrapped than PEGylated bicelle
because of two major reasons: (1) the possibility of rupture of the liposome at high PEG
molar ratio sets the upper limit of ligand number. Such rupture did not occur for the bicelle under all PEG molar ratios studied in our simulations. (2) The absolute value of the
compressive membrane tension boundary of the PEGylated bicelle is smaller than that of
the PEGylated liposome, which indicates the the bicelle is the one that is easier to be fully
wrapped. By analyzing the membrane energy, we find that the absolute value of the compressive membrane tension required by a disc-like bicelle is smaller than that of a spherical
liposome, which suggests that the disc-like bicelle is energetically more favorable than the
spherical liposome at f > fc , where a compressive membrane tension is required to provide
the driving force. Our results confirm that the interplay between ligand mobility and NP
geometry can significantly change our understanding about the influence of NP geometry
on the membrane wrapping process.
In Chapter 6, Chapter 7 and Chapter 8, we utilize the advantage of MD simulation to
help design new liposome-like NPs. In Chapter 6, we have hypothetically designed a new
multifunctional nanomaterial, so-called CPLS NPs through large scale DPD simulations.
The CPLS NPs can be self-assembled at a PEGylated NP core with additional free lipid
molecules. As the free ends of PEG chains are bonded with anchored lipids, a lipid bilayer
shell forms and fully covers the surface of the NP core, driven by the hydrophobic nature
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of lipid tails. Since the lipid bilayer shell is connected with the core through PEG polymer
chains, its stability has been further enhanced, compared with traditional liposomes. To
further strength our hypothesis we synthesized a representative nanoparticle in which the
approach outlined by the simulations and shown to be most effective was implemented. The
results of these experiments provided visual evidence for the effect of the need to control the
specific ratio of excess lipid when forming the CPLS NPs and provides a basis for synthetic
considerations that will be important when implementing the results found using this new
approach to designing nanomaterials through simulation. Taken together, the proposed
CPLS NPs have significant potential to be used as drug carriers with high efficacy and
nontoxicity, as their surface chemistry is identical to liposome.
In Chapter 7, we have systematically investigated the stability of vesicles and CPLS
NPs exposed to shear flow of varying strength through large scale DPD simulations. It
has been demonstrated that with the support from a PEGylated core, CPLS NPs are more
stable and stiffer than vesicles in the presence of shear flow. Burst leakage of encapsulated
drug molecules can be induced by the large pores on tips of vesicles under shear. And
these pores initiate at waists of vesicles due to the maximum stress. However, due to the
constraints mediated by tethered PEG polymers, CPLS NPs are less deformed than vesicles
with comparable sizes under identical flow conditions. Therefore, the less deformed CPLS
NPs express smaller maximum stress at waists. The pore initiation at waists of CPLS
NPs requires higher shear rates. In addition, due to the constraints applied through PEG
polymers between lipid shell and core, a self-healing phenomenon has been observed for
CPLS NPs within a range of moderate to small shear rates. Furthermore, through a free
energy analysis, the dramatic free energy change of PEG polymers within CPLS NPs can be
the main reason for their high stability. We expect the qualitative trend to be unchanged in
mixed flows, and pure elongational flows, as only the deformation component of the shear
flow is responsible for the elongation of these particles. And particles do not tumble due
to the tank-treading motion and the rotational part of the shear flow is therefore of minor
246

relevance for the process investigated here. All these observations suggest that CPLS NPs
are superior to vesicles during blood circulation, due to their high stability and resistance
to rupture.
In Chapter 8, we proposed that the self-assembly of TMLs can be utilized as a general
approach to produce liposomes with controlled sizes using tethered polymers of varying
stiffness. To confirm this, large scale molecular simulations were performed and used to
investigate the self-assembly process of TMLs in the presence of four types of tethered
polymers that differ in their persistence lengths. For each type, a phase diagram was established that describes the self-assembled structures as a function of free lipid number and
polymer grafting density. Three different states, including partially encapsulated, perfectly
encapsulated, and over encapsulated TMLs are featured in each of the phase diagrams. It
is found that the perfectly encapsulated TMLs can only be created under conditions of
optimal polymer grafting density and suitable free lipid number, which in turn depend on
the degree of semiflexibility. To support our simulation findings, experimental validations
were undertaken. In these experiments, we synthesized DNA-PEG CPLS NPs upon incorporating increasing concentrations of DNA as a proxy for increasing the rigidity of the
tethered polymer layer. Using transmission electron microscopy analysis we confirmed that
the resulting structures exhibit degrees of encapsulation by free lipids that are consistent
with the corresponding simulations. Further analysis of the properties of the perfectly encapsulated TML case showed that the radius of a TML is well controlled by the flexibility
of tethered polymers. To provide a better understanding and a general guidance for synthesizing a perfectly encapsulated TML, a numerical indenter test was proposed that allows
to estimate the radius of a TML. We found that the radius of a perfectly encapsulated
TML is determined by the lowest free energy state of the tethered polymers. More importantly, analytical expressions are provided to directly estimate the required free lipid number
and critical grafting density for given persistence length and polymerization degree of the
tethered polymer. Through these combined computational, experimental and theoretical
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studies, we ended up with a seemingly powerful predictive model for determining the effect
of polymer stiffness on the self-assembly of TMLs. In addition, the polymerization degree of
tethered polymers can be further tuned to control the sizes and loading capacities of these
TMLs. It may potentially be used as a general approach to obtain perfectly encapsulated
TMLs as potential drug delivery vehicles.
In Chapter 9, we have systematically investigated the stability and cellular interaction of
pH-responsive monolayer protected AuNPs through CG molecular dynamics simulations.
The AuNPs in our simulations are decorated with positively charged TMA ligands and
MUA ligands with pKa= 5.08. Therefore, MUA ligands are protonated and neutral at
low pH (< 5.3) and deprotonated and negatively charged at high pH (> 5.3). All of
these factors combined together make the AuNPs pH-responsive. The monolayer protected
AuNPs are positively charged at low pH and posses negative overall charge at high pH.
Our simulation results suggest that the pH-responsive AuNPs are severely aggregated at
a moderate pH value around 5.3, and they are stable and dispersed at both low and high
pH. The RDF of AuNPs indicates that there are two peak values at the RDF curves, which
correspond to COM distances around 5.5 nm and 3.0 nm, respectively. These two peak
values suggest two different correlated states within the aggregated cluster. Furthermore, we
perform the free energy analysis of two AuNPs to understand free energy barriers associated
with AuNPs aggregation. We found that the first peak at D = 3.0 nm is induced by
the hydrophobic driving force between alkane chain of ligands, while the second peak at
D = 5.5 nm is caused by the electrostatic bridging between two mixed charged AuNPs.
More importantly, it is found that the energy barrier between D = 5.5 nm and D = 3.0
nm is the key that determines the stability of monolayer-protected AuNPs at different
pH values. This energy barrier is dramatically decreased at moderate pH values, which
contributes to the severe aggregation of AuNPs. We further investigate the interaction
between AuNPs and lipid bilayers; it is interesting to find that all AuNPs adhere onto the
lipid bilayer, independent of their surface charges. Moreover, the lipids originally in the
248

bilayer are extracted by the AuNPs through a protrusion process. This extraction of lipids
will result in dehydration and disruption of bilayers, if multiple AuNPs exist. Further free
energy analysis reveals that the penetration of AuNPs will lead to dramatic free energy
increase because of deformation of ligands and hydrophilic functional end groups. Our
simulations for the first time systematically study the stability of pH-responsive AuNPs
and their interaction with lipid bilayers in simulation, which might help the design of pHresponsive monolayer protected AuNPs.

10.2

Perspectives

Nanoparticle-mediated drug delivery process has been researched for decades. However, due
to the overwhelming complexity of the biological environments, there still many challenges
remained during the progress to make effective drug delivery platforms. For instance, only
0.7% of the administrated NPs reported to reach tumor sites 16,385 . A low drug delivery
efficiency is still one of the major challenge for nanoparticle-mediated drug delivery. From
a computational perspective, a more complex simulation system might be needed to reflect
the diversity of biological environment. We will discuss how the MD simulations can combine
with other techniques (such as machine learning) and continue to serve as a useful tool for
the problems as follows:

Design decorated ligands on nanoparticles for specific cellular response
Rational design decorated ligands on NPs for specific bioactivities is highly desirable in
nanomaterial research 386 . However, the search of such a ligand molecule on experiments
heavily depends on traditional “trail and error” protocols. Furthermore, due to poor characterization and different operations in experiments, results for the same material may be
different in different laboratories 387 . Therefore, establishing a relationship between NPs
with decorated ligands and biological performance in simulations for experimental research
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is highly encouraged 388 . In order to build the relation between ligands decorated NPs and
the cell membrane response, there might be two key limitations in simulations: (1) The cell
membranes in simulations are usually composed of a few types of lipid without considering
the diversity of lipid molecules 389 . However, such a diversity of lipid membrane might be
important to search the chemical space of a decorated ligand. For instance, AuNPs decorated with hydrophobic ligands prefer to penetrate into the lipid membrane within the
liquid disorder region 384 . In addition, the phase-separation in lipid membrane can largely
affect the interactive mechanism between NPs and membranes 390 ; (2) Although traditional
quantitative structure-activity relationship (QSAR) modeling methods has been applied to
predict the behaviors of the small molecules like ligands 391 , the factors such as NP size,
NP shape and ligand grafting density for ligand decorated NPs might make it difficult to
obtain a suitable chemical descriptors 392,393 . To overcome these limitations in simulations,
it might be necessary to build a cell membrane with all representative lipids by following
the protocol of Martini force-field 394–396 . Taking the advantage of MD simulations, a large
database for describing the interactions between different ligands decorated NPs and the
cell membrane might need to be established, which can be later used to build the relation
through machine learning technique 397 .

Interaction between nanoparticles and protein corona
Controlling the NP properties is still difficult to achieve in vivo. Following intravenous
administration, a myriad of proteins in the blood are adsorbed on the NPs surface, forming
a protein corona. Such a protein corona dramatically changes the physical and chemical
properties imparted to the NPs 297,398,399 . The protein corona on the NPs can affect the
NP behavior in diverse ways. For example, the proteins can directly shield the ligandreceptor interactions during the cellular uptake process 400–402 . In addition, proteins on
surface can increase the NP size and induce agglomeration, resulting in faster elimination
of NPs 403 . Therefore, low-fouling materials, such as PEG polymers, has been extensively
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investigated to prevent the NP surfaces from proteins adsorption. However, a small amount
of absorbed proteins are inevitable, which still can significantly change the behaviors of
NPs 400,401,404 . On the other hand, certain types of proteins might be helpful during the
drug delivery process. For instance, the absorbed dysopsonins (like albumin and clusterins)
on NPs can prolong their circulation time and reduce the nonspecific cellular uptake 26,405 .
Therefore, design the NPs surface with specific decorated polymers, such as copolymers,
to recruit specific proteins is a more promising strategy 297,405 . From a MD simulation
perspective, a suitable coarse-grained method to model the proteins should be developed
to investigate the adsorption of proteins and help design copolymers. It has been already
proved that the coarse-grained method can be successfully applied to study the interactions
between proteins and copolymers 406,407 . Similar strategy in MD simulations can be applied
explore to the interactions between a copolymers decorated NP and proteins. The machinelearning strategy might be helpful to build a relation between properties of proteins and
their interactions with NPs.
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Supplementary materials for Chapter 2
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Figure A.1: Configurations for the deformation of elastic NPs with different bending rigidities.
(A) Comparisons of membrane and NP (R = 15σ) with bending rigidities kb = 0.1, 1.0, 10, 100
under wrapping ratios of f = 0.4, 0.7 and 0.9. (B) Comparisons of membrane and NP (R = 20σ)
253wrapping ratios of f = 0.4, 0.7 and 0.9. The NP
with bending rigidities kb = 0.1, 1.0, 10, 100 under
is colored in yellow. The membrane is colored with semi-transparent blue. The ligand is not shown
on NP surface for clarity.
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Figure A.2: Comparison of wrapping ratio for elastic NPs with different bending rigidities. (A)
Evolution of wrapping ratio for NP with radius R = 15σ. (B) Evolution of wrapping ratio for NP
with radius R = 20σ. The insets are the wrapping ratio near the end of membrane wrapping process.
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Figure A.3: Ligand-receptor binding ratio and elastic energy change of NP with radius R = 25σ.
(A) The relation between ligand-receptor binding ratio and membrane wrapping ratio. (B) The
relation between elastic energy change of NPs and membrane wrapping ratio.
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A.2

Supplementary materials for Chapter 3

Lipid membrane
One-bead solvent-free lipid model is adopted in our simulations. This highly coarse-grained
lipid model can correctly reproduce the dynamic and mechanical properties of lipid membrane 132,151 . In this one-bead lipid model, each lipid molecule is represented by a single
spherical bead which contains both the translational and rotational degrees of freedom.
Consequently, the interactive force between lipid beads depends on both their relative distance r and orientation. The potential function between two beads are given as 132,151

U (rij , ni , nj ) =




UR (r) + [1 − φ(r̂ij , ni , nj )],

r < rmin ,



UA (r)φ(r̂ij , ni , nj ),

rmin < r < rc ,

(A.1)

where UR (r) and UA (r) are the distance dependent repulsive and attractive potentials,
respectively, rmin is the repulsive force range, and rc is the cutoff distance of the pair-wise
interaction. φ(r̂ij , ni , nj ) is a weight function to tune the lipid interaction force, where
r̂ij = rij /r is the vector direction of the relative distance vector rij between two beads, and
ni and nj represent the axes of symmetry of beads i and j, respectively. Specifically, the
distance dependent functions are taken as 132,151 :
UR (r) = [(rmin /r)4 − 2(rmin /r)2 ],


π(r − rmin )
UA (r) = − cos2ζ
,
2(rc − rmin )

r < rmin ,
(A.2)
rmin < r < rc ,

where  and σ are the energy and length units, respectively, taken as unity in the simulations.
Moreover, rmin = 21/6 σ and rc = 2.6σ. The repulsive part is the Lennard-Jones (LJ)-42
potential. The attractive part is a cosine function which smoothly connects the repulsive
part at r = rmin and decays to zero at the cutoff distance r = rc . ζ is taken as 4 here. The
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orientation-dependent function is given as 132,151
φ = 1 + µ[a(r̂ij , ni , nj ) − 1]

with
(A.3)

a = (ni × r̂ij ) · (nj × r̂ij ) + sin θ0 (nj − ni ) · r̂ij − sin2 θ0 ,
where φ reaches its maximum of 1 as the angle between two lipid molecules is θ0 . Otherwise,
φ is less than 1. Here θ0 is the most energetically favorable angle between two lipids, which
is taken as 0 in our simulations. The parameter µ is correlated to the membrane bending
rigidity and taken as 3. The temperature of the membrane is controlled at T = 0.18/kB ,
under which the membrane maintains a fluid state. The membrane tension is maintained
at zero by controlling the xy in-plane pressure through a modified Berendsen method 39,88 .
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Figure A.4: (A) The function of mean squared displacement (MSD) of lipid molecules against
time. The lipid diffusion constant D is determined as D = 0.2σ 2 /τ . (B) Out-of-plane fluctuation
spectrum of a planar membrane as a function of the wave number q. The membrane bending rigidity
as κ = 24 kB T which falls within the experimental range (10 kB T –50 kB T ) 98,99
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Figure A.5: (A) Snapshots of the membrane wrapping of a rigid spherical NP of radius R = 25 nm
(A) and 30 nm (B). Due to the limited ligand number, the NP of R = 25 nm in the case A is trapped
during the membrane wrapping process. In contrast, the NP in B can be quickly fully wrapped.
(C) Snapshots of the membrane wrapping of a soft spherical NP (R = 30 nm) with the bending
constant kbend = 0.1. Compared to the rigid NP of R = 30 nm, the soft NP is trapped owing to
the increment of energy barrier.
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Computation of membrane bending energy
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Figure A.6: (A) Surface patches of a triangulated NP around vertex i. (B) Evolution of the
wrapped part of NPs. The wrapped region of the NP is colored in blue. (C) The comparison
between theory and simulation for the membrane bending energy change ∆EMem as a function of
the wrapping ratio f .

In the wrapped part, the membrane is firmly attached onto the NP surface as shown in
Fig.3.2 in the Chapter 3. Therefore, the membrane bending energy in the wrapped part can
be calculated according to the NP curvature as marked in Fig. A.6B. For the triangulated
NP surface, the mean curvature H at the node i can be calculated as 408,409

H=

σij
1
ni · Σj(i)
(xi − xj ),
σi
lij

(A.4)

where ni is the surface normal at node i, lij is the distance between the nodes i and j, and
σi = Σj(i) σij lij /4 with σij = lij [cot(θ1 ) + cot(θ2 )]/2. The angles θ1 and θ2 are marked in
Fig. A.6. The summation is conducted over the neighbors of site i.
Then the membrane bending energy can be calculated as 409

2
σij
κ 1
Σj(i)
(xi − xj ) .
E = Σi
2 σi
lij

(A.5)

As shown in Fig. A.6C, our results are in good agreement with the theoretical value 8πκf 141 ,
where f is the wrapping ratio.
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Deformation of spherical nanoparticles
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Figure A.7: Local curvature field of a soft spherical NP of kbend = 0.1 and radius R = 75 nm.
Corresponding snapshots of the membrane wrapping are given in Fig.3.3 in the Chapter 3. The
color map represents the mean curvature with a unit of nm−1 .
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Figure A.8: (A-B) The total area and volume variations of the soft spherical NP (R = 75 nm,
kbend = 0.1) as a function of wrapping ratio.

Nonspherical nanoparticles
To analyze the driving force of rotation for both oblate and prolate NPs in simulations,
we further compute the membrane energy change of oblate and prolate NPs with the fixed
entry angle theoretically. We assume zero membrane tension. For an ellipsoidal NP with a
shape function of (x2 + y 2 )/a2 + z 2 /b2 = 1 (a and b are the lengths of half major and minor
axes, respectively), the bending energy of the wrapping part can be determined as
Z
EBwrap = 2κ
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M 2 (θ)dS,

(A.6)
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Figure A.9: Driving force analysis of NP rotation. (A) Illustration of an ellipsoidal NP. a and b are
the lengths of half major and minor axes, respectively. (B) Comparison of the membrane bending
energy change for rigid oblate NP in simulation with free rotation and theory with fixed angle. (C)
Comparison of the membrane bending energy change for the rigid prolate NP in simulations with
free rotation and theory with fixed angle. Corresponding membrane wrapping processes for oblate
and prolate NPs are given in Fig.3.5 in the Chapter 3.

where the mean curvature M (θ) at the point P = (a sin θ, −b cos θ) is given by

M (θ) =

λ 1 + cos2 θ + λ2 sin2 θ
2a (cos2 θ + λ2 sin2 θ)3/2

(A.7)

with λ = b/a. Here the oblate and prolate NPs in theory have the same λ and initial entry
Rθ
angle. The surface area of the wrapped part is S(θ) = 2πa2 0 sin θ0 (cos2 θ0 +λ2 sin2 θ0 )1/2 dθ0 .
As shown in Fig. A.9, due to the rotation of oblate NP, the associated membrane energy
barrier in simulations is smaller than that in theory at a fixed entry angle. It indicates that
the membrane bending energy provides the driving force for the oblate NP to rotate. On
the other hand, the prolate NP in simulations barely change its orientation. The membrane
energy changes in simulations and theory are almost the same.
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Figure A.10: (A-B) Local curvature fields of the soft oblate and prolate NPs with bending constant
kbend = 3. Corresponding snapshots of the membrane configurations are given in Fig.3.7 in the
Chapter 3. The color map represents the mean curvature with a unit of nm−1 . (C-D) Comparisons
of membrane energy change and NP energy changes during the membrane wrapping of oblate NPs
with kbend = ∞ and kbend = 3. (E-F) Comparisons of the membrane energy change and NP energy
change during the membrane wrapping of prolate NPs with kbend = ∞ and kbend = 3.
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Figure A.11: The orientation angle comparison between rigid and soft oblate (A) and prolate (B)
NPs with the same entry angle. It is indicated that decreasing the bending constant can promote
the NP rotation during the membrane wrapping process. Corresponding snapshots of the membrane
configurations are given in Fig.3.7 in the Chapter 3.
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Figure A.12: (A-C) Analysis of the contact edge length for oblate, prolate and spherical NPs of
different bending constants kbend . (D-F) Analysis of energy barrier for oblate, prolate and spherical
NPs of different kbend .
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Entry angle influences internalization of nonspherical NPs
As we described above, the membrane wrapping efficiency is determined by the competition
between the free energy barrier and contact edge length (or the speed of receptor recruiting).
For nonspherical NPs, due to their anisotropic properties, the initial entry angle of both
oblate and prolate NPs will affect their contact edge length and energy barrier evolution
pathway 87,118,121,123 . To explore the effect of entry angle, we further study the membrane
wrapping process of oblate and prolate NPs (kbend = 10) with their minor and major
axes parallel to the membrane plane, respectively. We call this wrapping scenario as the
side-first entry mode. As shown in Fig. A.13, the membrane wrapping pathway is totally
different from the tip-first mode for both oblate and prolate NPs with the same bending
constant. With the initial small contact area, the oblate NP prefers to lay down first
(1250 µs < t < 3750 µs). It is noteworthy that the oblate NP with the side-first entry mode
is less efficient to be wrapped during the entire process than the tip-first entry mode as
well as the spherical NP with the same bending constant. In comparison, with the initial
large contact area, the prolate NP barely undergoes orientational change during the whole
wrapping process. Furthermore, the prolate with the side-first entry mode is much more
efficient to be fully wrapped than the tip-first entry mode and the corresponding spherical
NP. Intriguingly, with the side-first entry mode, the wrapping efficiency of NPs with the
same bending constant is ranked as prolate > spherical > oblate. This ranking sequence
is totally reversed for the nonspherical NPs with the tip-first entry mode. These results
suggest that the entry angle might be an important factor that contributes to the conflicting
experimental results 114–116 .

Cellular uptake of other nonspherical elastic NPs
In experiments, other nonspherical, such as disc, rod-like and cubic NPs are also widely
used 146–148 . To systematically understand the membrane wrapping behaviors of these non-
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Figure A.13: Effects of the entry angle on the wrapping of prolate and oblate NPs. (A-B) The
membrane wrapping of soft oblate NPs (kbend = 10) with the initially side-first entry mode and tipfirst entry mode, respectively. (C-D) The membrane wrapping process of soft prolate NPs (kbend =
10) with the initially side-first entry mode and tip-first entry mode, respectively. The wrapping
ratios for soft oblate (E) and prolate (F) NPs with tip-first and side-first entry modes.
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Figure A.14: (A-C) Snapshots of the membrane wrapping of soft disc-like, rod-like, and cubic NPs
with the bending constant kbend = 10. Wrapping ratio comparison between disc-like, oblate and
spherical NPs (D), between rod-like, prolate and spherical NPs (E), between cubic and spherical
NPs (F).

spherical NPs, we further investigate the membrane wrapping process of soft disc-like,
rod-like and cubic NPs at kbend = 10. The surface areas of all these NPs are set the same
as the spherical NP of radius R = 75 nm. The aspect ratio of disc-like and rod-like NPs
are controlled as the same as the oblate and prolate NPs, respectively. Tip-first entry mode
is adopted for disc-like and rod-like NPs. Particularity, we want to explore whether NPs
of the same geometric category (one-dimensional shape: rod-like and prolate NPs; twodimensional shape: disc-like and oblate NPs; three-dimensional shape: cubic and spherical
NPs) share the same membrane wrapping pathway and wrapping efficiency. As given in
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Figure A.15: Wrapping time as a function of the bending constant for spherical and cubic NPs.

Fig. A.14A, the disc-like NP is fully wrapped at t = 6875 µs and shares the similar threestages membrane wrapping pathway as its oblate counterpart in Fig. A.13B. Importantly,
the wrapping ratio evolutions of disc-like and oblate NPs are similar, and both of them are
more efficient to be wrapped than the spherical NP (kbend = 10) as shown in Fig. A.14D.
The rod-like NP lays down gradually as its prolate counterpart does in Fig. A.13D, and
they share similar wrapping efficiency. Moreover, both of the rod-like and prolate NP are
less efficient to be fully wrapped in comparison with the spherical NP (see Fig. A.14E). The
cubic and spherical NPs share the similar wrapping efficiency (cf. Fig. A.14F). Furthermore, the bending rigidity dependent wrapping efficiency of cubic NPs is similar to that of
spherical NPs as indicated in Fig. A.15. In short, with the tip-first entry mode, the NPs of
similar geometry exhibit the similar membrane wrapping pathway and wrapping efficiency.
Note that the disc and rod-like NPs might buckle at kbend < 10. Please refer to the method
part in the Chapter 3 for the details about models of disc, rod-like and cubic NPs.

Influence of receptor diffusion flux

266

(B)
50

6.08x10-4/nm2

12.16x10-4/nm2

24.32x10-4/nm2

36.48x10-4/nm2

1.0

0.8

40

Wrapping ratio

Free receptor density (x10-4/nm2)

(A)

30

20

0.6

6.08x10-4/nm2

0.4

12.16x10-4/nm2
24.32x10-4/nm2

0.2

10

0

36.48x10-4/nm2

0.0
0

100

200

300

400

0

1

2

(C)

(D)

400

4

5

6

7

8

8
7

Wrapping time (x103 s)

350

Receptor flux (nm-1s-1)

3

Time (x103 s)

Distance to NP center (nm)

300
250
200
150
100

6
5
4
3
2
1

50

0

0

-1
0

10

20

30

40

50

60

Receptor density (x10-4/nm2)

0

10

20

30

40

50

60

Receptor density (x10-4/nm2)

Figure A.16: Effects of the receptor diffusion flux on the membrane wrapping of a rigid spherical
NP of radius R = 75 nm. (A) Densities of the unbounded receptors in the membrane at the
wrapping ratio f = 0.5. The x-axis represents the distance away from the center of mass of the
NP. (B) Corresponding wrapping ratio evolutions at different receptor densities. (C) The relation
between receptor diffusion flux and receptor density. The receptor diffusive flux is calculated based
on the Fick’s first law J = −D dφ
dx , where J is the diffusive flux, φ is the receptor density and D is
the diffusion coefficient, taken as D = 5µm2 /s. The slope of dφ
dx is obtained by fitting the receptor
density in the range of 100-200 nm with a linear function. (D) The wrapping time versus the receptor
density. The solid line is obtained by fitting the simulation results with an exponential function.
The saturation of wrapping time at large receptor densities indicates the elimination of receptor
diffusion effect.
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A.3

Supplementary materials for Chapter 4

Computational Model and Methodology
DPD Method
All simulations performed in the course of this study are based on the DPD method, a
coarse-grained molecular dynamics simulation technique. DPD simulations can correctly
and accurately capture hydrodynamics of complex fluids, while retaining essential information about the structural properties of the system components 194,195 . The DPD method
has been widely used and successfully applied for studying problems related to behaviors
of lipid vesicles or polymers and their interactions with lipid bilayers. 58,59,61,72,244,245,280–283
The basic interacting sites in DPD simulations are represented by soft beads. Between
each pair of DPD beads, effective two-body interactions consist of three major forces 194,195 :
a conservative force FC , a random force FR and a dissipative force FD . Specifically, the
conservative force between beads i and j is FC
ij = aij ω(rij )eij , where rij denotes the distance between the two beads i and j, and eij is the unit vector pointing from i to j;
aij represents the maximum repulsion force. The weighting factor ω(rij ) is a normalized
distribution function as ω(rij ) = 1 − rij /r0 for rij ≤ r0 , while ω(rij ) = 0 for rij > r0 .
Here r0 is the cutoff distance for pairwise interactions. The random forces are specified by
p
FR
2βij kB T /∆t ω(rij )αeij , where α represents a normal distributed Gaussian random
ij =
number with zero mean and unit variance, ∆t denotes the integration time step, βij is a
bead friction coefficient taken as below 197 :




4.5




βij = 9.0






20.0

aij < 35
35 ≤ aij < 75
aij ≥ 75
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(A.8)

kB and T stand for Boltzmann’s constant and temperature, respectively. The dissipative
2
force is given by FD
ij = −βij ω (rij )(eij · vij )eij , where vij is the relative velocity vector

between beads i and j. The conservative force is a purely repulsive interaction, while the
random and dissipative forces acting along the centers of the soft beads conserve linear and
angular momentum, respectively.

Lipid and PEG Models
All the lipid molecules in our simulations share the same model, in which two lipid tails
(with four tail beads each) are connected with two head beads respectively. And the head
group contains three head beads. Adjacent beads making the lipid molecules are connected
by the harmonic spring potential Us1 = Ks1 (rij − rs1 )2 , with spring coefficient Ks1 = 64
kB T /r02 , and equilibrium distance rs1 = 0.5r0 . The stiffness of the lipid tails is guaranteed
by an angular potential Uθ1 = Kθ1 (1 − cos θ) with Kθ1 = 15kB T . Pair-wise interactions
aij between lipid beads are listed in Table A.1. Under control of these parameters, the
tension of planar bilayer follows a linear relation with the lipid molecular area 196,197 . The
surface tension of bilayer is defined as the integral of difference between normal and lateral
component of the pressure tensor: 226,257 .
Z
Σ=

dz[pzz (z) − 1/2(pxx (z) + pyy (z))]

= A−1

X
(Fij,z zij − 1/2(Fij,y yij + Fij,x xij ))

(A.9)

i<j

where z-axis is the normal direction of the bilayer interface. pzz , pyy or pxx is the pressure. A
is the area of the xy-plane. Fij is the total conservative force between particles i and j. The
stretch modulus of membrane can be obtained by the slope in Fig. A.17, KA = 17.42kB T /r02 .
And the bending rigidity of membrane obtained from κ = KA d2HH /48 97,198 is round κ ≈ 6
kB T .
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Figure A.17: Relation between membrane tension and lipid area.

A hydrophilic PEG polymer in DPD simulations is modeled by a linear chain consisting of coarse-grained monomers. The monomers of PEG polymers are sequentially
connected by a harmonic bond potential: Us2 = Ks2 (rij − rs2 )2 , with spring stiffness
Ks2 = 2111.3kB T /r02 and equilibrium distance rs2 = 0.4125r0 . The flexibility of the PEG
polymer is tuned by an angular potential between each three consecutive monomers, defined
by Uθ2 = Kθ2 (cos θ − cos θ0 )2 , with bending stiffness Kθ2 = 16.4946kB T , and equilibrium
angle θ0 = 130°. Such a DPD PEG model could correctly reproduce the conformation of a
PEG polymer in water, including the radius of gyration and end-to-end distance, as shown
in our previous studies 72,123 . To describe the PEGylated lipid, one end of the PEG polymer
is bonded to the lipid head through a harmonic bond potential. And the monomer on the
free end of a PEG polymer is considered as targeting moiety. The molecular weight of a
PEG polymer in experiments ranges from 500-5000 Da 50,164,199 . Note that tethered PEG
polymers with large molecular weight on surface leads to a pronounce growth in NP size,
which requires tremendous computational cost to finish the membrane wrapping process.
The polymerization degree N of PEG polymers in our simulation is set as N = 30 (representing a molecular weight around 1000 Da), to reach a balance between computational
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efficiency and generality.
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Figure A.18: Diffusion coefficient of lipid in planar membrane and PEG polymer on liposome
surface. (A) Diffusion coefficients of lipid in membranes under different membrane tensions. (B)
Diffusion coefficients of PEG polymers on liposome with different PEG molar ratios. The radius of
liposome is R = 7r0

To explore influence of membrane tension on the diffusion of lipid molecules, we calculate
the lipid diffusion coefficients under different membrane tensions. The diffusion coefficient
of lipid in the planar membrane is obtained from measuring mean squared displacement,
Dlipid =< (∆x)2 + (∆y)2 > /4t, where ∆x and ∆y are the displacements of lipids in planar
directions. t is the time difference over which diffusion is tested. As shown in Fig.A.18.A,
the lipid diffusion coefficients only slightly change with membrane tensions. The deviation of
diffusion coefficients is less than 9%, which indicates that the diffusion of lipid in membrane
is irrelevant to the membrane tension. This kind of relation is in consistent with the results
in experiment 410 . Finally, we get the lipid diffusion coefficient Dlipid ' 7.3 × 10−2 r02 /τ by
averaging the values under different tensions.
The diffusion of ligand on the free end of PEG polymers might be affected by the variation of PEG polymer molar ratio on the liposome surface. We then further tested the ligand
diffusion coefficients. The ligands on PEG polymers are directly connected with the PEGylated lipids in liposome. Here, we measured the diffusion coefficients of PEGylated lipids
to reflect the diffusion behaviors of ligands. The lateral diffusion coefficient of PEGylated
lipid is calculated from its mean squared displacement on the spherical liposome surface.
271

Therefore, the diffusion coefficient of ligand is given by 411 Dligand =< 4R2 ϕ2 > /t, where
R is the radius of liposome. ϕ is the angle between the membrane normal vector at t = 0
and t = t. The normal vector is defined as the connecting vector between center-of-mass
(COM) of liposome and COM of the PEGylated lipid. Here, the diffusion coefficient is
obtained by fitting the mean squared displacement in the first 106 time steps. As given in
Fig.A.18.B, due to the more tightly packing between PEG polymers under higher moral
ratio, the diffusion coefficient of ligand Dligand decreases with the increasing of PEG molar ratio. Additionally, the diffusion coefficients of ligand Dligand is smaller than that of
lipid/receptor.
Within our DPD model, different types of beads have identical masses and cutoff distances for pairwise interactions. For the sake of transferability, the mass, length and time
scales are all normalized. The unit length is taken to be the cutoff distance r0 . The unit
mass is m for all the beads and is set to unity. In addition, the unit energy is defined
by the thermal energy kB T . All other dimensional quantities can thus be uniquely made
dimensionless in terms of these basic units (and vice versa).
The time step in our DPD simulations is chosen as ∆t = 0.01τ , with τ =

p
mr02 /kB T .

The number density of beads in the simulation box is fixed at 3/r03 195 . The velocityVerlet integration algorithm is adopted for the time integration. The reduced units can
be mapped to SI units using a real bilayer thickness and a measured value for the in-plane
diffusion coefficient of lipids, as shown in previous studies 196,197 . From the experiments, the
thickness of membrane is dHH ≈ 3.53 nm 91 and thickness in our simulation is dHH ≈ 4 r0 .
The physical length scale could then obtained by the relation of r0 ' 0.9 nm. Comparing
the experimental lipid lateral diffusion coefficient D ' 5 µm2 /s of DMPC 92 and one in our
simulation Dlipid ' 7.3 × 10−2 r02 /τ , we can obtain the physical time scale τ = 11.8 ns.
Periodic boundary conditions are applied along all directions of the simulation box. All the
simulations are performed by using the Large-scale Atomic/Molecular Massively Parallel
Simulator (LAMMPS), distributed by Sandia National Laboratories 89 .
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Table A.1: Interaction parameters, aij , between beads i and j, in the DPD simulation. S, H, T,
and E represent solvent (water), lipid head, lipid tail, and PEG beads, respectively.

aij [kB T /r0 ]
S
H
T
E

S
25.0
30.0
75.0
26.3

H
30.0
30.0
35.0
26.3

T
75.0
35.0
10.0
33.7

E
26.3
26.3
33.7
25.0

Simulation Protocol
To prepare the PEGylated NPs, lipid molecules is firstly randomly distributed into a simulation box to form a liposome through self-assembly process at temperature T = 1.0. Then
certain number of lipids in the outer layer is randomly chosen to graft with PEG chains on
the lipid head beads according to the targeted PEGylated lipid molar ratio. The PEGylated
liposomes then further relax for 1 × 106 τ under temperature of T = 1.0. Two kinds of
liposomes with 800 and 1701 lipids are prepared. Their radius sizes are around 7 r0 and 15
r0 , respectively. Planar membrane bilayer is relaxed in the box size of (70 × 70 × 100) r03 ,
which is large enough to avoid the influence of simulation box size on endocytosis. Finally,
the fully relaxed PEGylated liposomes are placed above the planar bilayer to investigate the
membrane wrapping process. During this process, to explore the effect of PEG mobility,
bilayer in liposome and the included water beads are treated with three different ways: (1)
No additional restriction is applied on the liposome, such that the liposome itself is able
to deform under stress and the PEGylated lipid could freely diffuse on the surface because
of the fluid state of the bilayer; (2) All of the lipid molecules and the water beads inside
together are considered as a single rigid body, which means that the liposome could not
deform (like a solid NPs) and the tethered points of PEG polymers are fixed on the surface;
(3) All the water beads inside liposome are treated as a single rigid body, in which situation the liposome can hardly deform under stress because of the rigid water core, while the
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PEG polymer can still move on the liposome surface. Following these procedures, we can
ensure that the chemical properties of all the PEGylated NPs are the same. By comparing
the differences during endocytosis of these three kinds of NPs, we can clearly reveal the
influence of PEG mobility on endocytosis.
During endocytosis, in view of the length scale difference between the NP (< 100 nm)
and cell (∼ 10 µm), the internalization of NPs should not affect the surface tension of
the cell membrane. To mimic this condition and reproduce the constant membrane surface
tension in our DPD simulations, we adopt the N -varied DPD method. Instead of controlling
the lateral pressure/force of the membrane, this method takes an alternative approach to
ensure a constant membrane tension, by controlling the number of lipids per unit area. It
has been widely used to study the endocytosis of NPs in DPD simulations 70,72,123,171,172 . In
practice, the boundaries of the lipid bilayer are treated as a lipid reservoir for the addition
and removal of lipids. If the lipid number per unit area is larger (or smaller) than the target
density ρ1 (or ρ2 ), lipid molecules will be deleted (or inserted) into this boundary region
to maintain a constant lipid number density. Meanwhile, a corresponding number of water
molecules will be inserted (or deleted) randomly in the simulation box to ensure a constant
water bead density of 3.0/r03 in the DPD simulations. By using the N -varied DPD protocol,
the lipid density in the membrane is easily controlled to maintain the membrane’s lateral
tension during the endocytosis process.
To mimic the ligand-receptor interaction, we assume that 50% of the lipid molecules
in the planar bilayer act as receptors, which means that the number of receptors is large
enough compared to the number of ligands on the NPs surface. Then, the receptor diffusion
induced limited efficiency 31 in the endocytosis could be excluded in our simulations. The
targeting moieties (ligands) conjugated to the free ends of PEG polymers interact with
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receptors as following:

Uij =




4

ligand [(σb /rij )

12

− (σb /rij )6 ] − Ucut ,



0,

rij <= rcut

(A.10)

rij > rcut

Here, rcut = r0 for a short-range attractive interaction. Ucut = 4ligand [(σb /r0 )12 − (σb /r0 )6 ].
The equilibrium distance is fixed to be σ = 0.624r0 . Additionally, the repulsive force is set
to be 25 kB T /r0 , if it is larger than 25 kB T /r0 . Then the ligand-receptor binding strength
could be computed as:
Z

∞

dr[exp(−Uij ) − 1]}

b = ln{1 +

(A.11)

0

Here we set ligand = 12kB T , corresponding to the binding strength around 6.8kB T .

Self-consistent mean field theory
To interpret the DPD simulation results and reveal the underlying physical mechanism, we
employ an independent self-consistent field (SCF) theoretical approach to estimate the free
energy of PEG polymers with fixed tethered point. The SCF result allows us to calculate
the radial volume fraction profile φ(r) of the spherical brush, the volume fraction profile of
the terminal monomers, φ(r) and the corresponding free energy, Fpolymer . The measured
PEG profiles could be recovered using a simplest classical model of a polymer under good
solvent conditions 72,123 , which is characterized by a dimensionless mixing free energy density
νfm (φ) = τ φ2 + ωφ3 with τ = ω = 1, where ν = 0.0633 nm3 denotes the excluded volume
of a PEG monomer. Within the SCF we basically aim at minimizing a single chain free
energy function that is composed of elastic and interaction parts,
2 i
Fp
3 hree
=
+
kB T
2 R02

Z

fm (φ)d3 r

(A.12)

R
2 i = V −1 (r − d/2)2 φd3 r is the mean squared extension of a polymer that
where hree
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is tethered on a sphere of diameter d, properly normalized by the occupied chain volume
R
V = φd3 r = N ν, and R0 = R0 (N ) represents the equilibrium size of a PEG polymer. Here
2 i/e, using the available R2 (N ) values for a single PEG chain. The above
we take R02 = hRee
ee

free energy is minimized with respect to the volume fraction profile, subject to the constraint
of conserved V and the tethering condition, φ(r < d/2) = 0. A most common numerical
implementation of the related optimization problem on a geometry-adapted grid have been
introduced by Scheutens and Fleer 412 . We follow the implementation described in detail by
Wijmans and Zhulina 292 . To this end, a single flexible polymer is grown sequentially, using
a constant bond length a = 0.33 r0 (for PEG), starting from a spherical surface of diameter
d. During random growth within the space surrounding the NP, the representative chain
creates its own radial volume fraction profile to which it reacts, as the volume fraction enter
the probability to choose from all possible directions, at each step of growth procedure.
To be precise, it reacts by its current radial coordination r to the dimensionless exchange
0 (φ) = 2φ + 3φ2 contained in a segment weighting
chemical potential U (φ)/kB T = νfm

factor G1 (r) = exp(−U (r)/kB T ), where we recall that φ = φ(r). The problem is thus
closely related to a diffusion process in the presence of a potential and boundary, and can
in principle also be formally treated using Green’s functions. Accordingly, one introduces
Gn (r), the average statistical weight of an n-mer of which the last segment is located in
layer r. Gn (r) = Gn−1 (r)G1 (r) for n = 2, . . . , N , where the spatial average is taken over a
sphere of radius a. We are left with a closed set of coupled equations, where the average play
the role of the coefficients of a linear system of equations that can be solved in an iterative
fashion using simple matrix inversions. Due to head-tail symmetry of the polymer chains,
the volume fraction profile of an n-mer is subsequently obtained from the solution Gn (r)
via φ(r) = Cn Gn (r)GN −n+1 (r)/G1 (r), where the Cn ’s are normalization factors that follow
R
from ν = φ(r)d3 r and finally φ(r) = ΣN
n=1 φ(r) as well as φN (r) are obtained. Because
the volume fraction profiles φ of the unwrapped PEGylated NP are all well recorded, we
can estimate the free energy difference ∆Fpolymer = ∆Fp between wrapped and unwrapped
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PEGylated NP upon inserting the two measured φ(r)’s separately in to Eq.A.12

Computation of membrane energy
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Figure A.19: (A) Illustration of membrane wrapping geometry and parameters. θ is the wrapping
angle. S is the arc length. φ is the angle tangent to the membrane profile. The wrapping region
of membrane is represented by red line. The free part of membrane is represented by the blue line.
(B) Illustration of an ellipsoidal nanoparticle. a and b are the lengths of half major and minor axes,
respectively.

To estimate the membrane elastic energy in our simulations, a theoretical model is developed. In the theory, we assume that a planar membrane wraps around a solid NP (cf.
Fig. A.19.A), which has rotational symmetry with the axis z. Based on the Canhamhelfrich’s framework 95 , the total elastic energy of membrane under certain wrapping angle
could be described as

EMEM = EMBend + EMTen

(A.13)

where EMBend is the membrane bending energy. EMTen represents the membrane tension
energy. In our model, we consider a symmetric membrane and assume no topological change
during the whole wrapping process. Then the bending energy for the membrane could be
expressed as:
Z
EMBend =

κ(c1 + c2 )2 ds

S
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(A.14)

where, κ is the membrane bending rigidity. c1 and c2 are the principle curvatures on the
membrane surface, respectively. The tension energy could be calculated by

EMTen = σ∆S

(A.15)

where σ is the membrane tension and ∆S is the excess area caused by the bending of
membrane.

Spherical nanoparticle
As illustrated in Fig. A.19, the elastic energy of membrane could be divided into two
parts:(1) the wrapping part and (2) the free part. The geometry of the wrapping part is
determined by the shape of NP. For a spherical NP, the bending energy in the wrapping part
is EBwrap = 4πκ(1 − cos θ). And the corresponding tension energy is ETwrap = πr2 σ(1 −
cos θ)2 , where r is the radius of spherical NPs. To calculate the membrane geometry of the
free part, we assume tangent angle φ(s2 ) has a Fourier series from with respect to the free
part of arch length s2 181,182 .
n

π 
X
φ1 − φ0
s2 +
ai sin
is2
φ(s2 ) = φ0 +
L
L

(A.16)

i=1

where ai is Fourier amplitude and L is the total arch length of free part membrane. φ0
is the tangent angle of membrane in the contact region between wrapping and free parts.
φ1 is the tangent angle of membrane far away from NPs. This kind of method has been
successfully applied to explore the profile of vesicle induced by the interactive NPs in the
works of Gozdz et al. 182 and Wang et al. 181 . To satisfy the boundary condition, in the
connecting region, both φ0 = θ and z(0) = r − cos(θ)r should be satisfied to ensure the
smooth connection between wrapping and free parts of membrane. In the region far wary
from NPs, φ1 = 0 and

dφ
ds2

= 0, which can ensure the bending and tension energies vanish
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for the membrane far wary from NPs 141 . More terms in Fourier series are better, for the
free part of membrane here, we find that n = 20 could already well describe the profile of
deformed membrane. After characterization, the membrane bending and tension energies
of free part could be obtained by
Z
EBfree = πκ

L

rs (s2 )[

Z

0
L

dφ
sin φ 2
+
] ds2 ,
ds2 rs (s2 )

πrs (s2 )ds

ETfree = σ

(A.17)
(A.18)

0

where rs (s2 ) =

R s2
0

cos φds0 + sin(θ)r. Then the total elastic energy of free part becomes

a function of ai and L. By performing the energy minimization, we could get the profile
of membrane and the energy of EBfree + ETfree . We use the particle swarm optimization
(PSO) algorithm to do the numerical optimization 413 .

Ellipsoidal nanoparticle
For an ellipsoidal NP with shape function of (x2 + y 2 )/a2 + z 2 /b2 = 1 (a and b are the
lengths of half major and minor axes, respectively), the bending energy of the wrapping
Rθ
λ 1+cos2 θ+λ2 sin2 θ
part could be obtained by EBwrap = 2a2 πκ 0 M (θ0 )dθ0 , where M (θ) = 2a
(cos2 θ+λ2 sin2 θ)3/2
is the mean curvature at the point P = (a sin θ, −b cos θ) on the ellipsoid, λ = b/a. The
tension energy of wrapped part could then be calculated by ETwrap = σ(S(θ) − πrs2 (θ)),
Rθ
where S(θ) = 2a2 π 0 sin θ(cos2 θ + λ2 sin2 θ)dθ is the surface are of the wrapped part. And
rs (θ) = a sin θ is the distance from the point P to the axis of rotation. In addition, the
boundary conditions at the connection between wrapping and free parts tan(φ0 ) = b/a tan θ
and z(0) = b − b cos θ are satisfied. Also, rs (s2 ) in the Eq. A.18 follows the relation as
Rs
rs (s2 ) = 0 2 cos φ ds0 + a sin θ. All other procedures are the same as spherical NP.
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Figure A.20: Representative snapshots for membrane wrapping processes of (A) PEGylated rigid
NP and (B) PEGylated liposome with size of r = 15 r0 . The membrane tension in both cases is
controlled at 0.08 kB T /r02 . Water beads are not shown for clarity.

Endocytosis of large PEGylated rigid nanoparticle
Endocytosis of PEGylated nanoparticle with rigid water core
To further exclude the influence from liposome deformation, we try to explore the membrane
wrapping of PEGylated nanoparticle with rigid water core. Here, the water beads inside
the liposome in the Chapter 4 of Fig.4.2.B are treated as a single rigid body. Thus, the
PEG polymers in PEGylated nanoparticle with rigid water core could freely diffuse on the
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Figure A.21: Comparison of (A) wrapping ratio, (B) ligand-receptor binding ratio and (C) asphericity between PEGylated rigid NP and liposome during the membrane wrapping process in
Fig.A.20.

surface. However, because of the rigid water core, the lipid bilayer on the surface could
barely deform. All other conditions are the same as the ones in Fig.4.2 of Chapter 4. As
given in Fig. A.22, the whole membrane wrapping process is similar as the one of PEGylated
liposome. The PEG polymers aggregate in the contact region due their mobility. The halfwrapped PEGylated nanoparticle with rigid water core bounces back to the less wrapped
state afterwards. Both the detailed information about wrapping ratio and ligand-receptor
binding ratio are identical as that of PEGylated liposome (Fig. A.22.B and C). However, the
asphericity value of rigid NP is kept constant. Thus we could confirm that the PEG mobility
is the main reason for the PEG polymers aggregation and ‘bouncing back’ of PEGylated
liposome.

A.4

Supplementary materials for Chapter 5

Computational Model and Methodology
Lipid Model
The lipid models for liposome/bicelle and planar membrane are given in Fig. S1(A). In the
liposome/bicelle model, the head group of lipid molecule is represented by three linearly
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Figure A.22: Endocytosis of 20 mol% PEGylated nanoparticle with rigid water core under membrane tension of −0.038kB T /r02 . (A) Snapshots of PEGylated nanoparticle with rigid water core
during endocytosis. (B-C) Comparison of wrapping ratio, ligand-receptor binding ratio and asphericity between PEGylated rigid water NP here and the PEGylated liposome in Fig.4.2 of the
Chapter 4.

connected hydrophilic beads, while each of the two tails is represented by 5 hydrophobic
beads. Neighboring beads i and j are connected by harmonic spring potentials,

Us1 = Ks1 (rij − rs1 )2 ,

(A.19)

where the spring constant Ks1 = 50 kB T /r02 and the equilibrium bond length rs1 = 0.7
r0 226 . The stiffness of head and tail groups is controlled by an bending potential applied
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Figure A.23: (A) Lipid models for liposome/bicelle (beads 1–13) and planar membrane (beads
1–11). (B) Relation between membrane tension and lipid area for the (blue) lipids model of the
liposome/bicelle and (green) lipid model of the planar membrane.

on the adjacent three beads,
Uϑ1 = Kϑ1 (ϑ − ϑ0 )2 ,

(A.20)

where Kϑ1 , ϑ and ϑ0 are the bending constant, the inclination angle and the equilibrium
angle, respectively. Different Kϑ1 and ϑ0 values are used to reflect the flexibility in different
locations of each lipid molecule 226 . For three consecutive lipid head/tail beads in the lipid,
Kϑ1 = 3.0 kB T and ϑ0 = 180◦ . For beads 3, 4, and 9, Kϑ1 = 1.5 kB T and ϑ0 = 120◦ .
For the two consecutive head beads connected to the first bead in the tail (beads 2, 3, 4
and beads 2, 3, 9), Kϑ1 = 2.25 kB T and ϑ0 = 120◦ . Due to the flexible head group in this
DPPC lipid model, the energy penalty to form the bilayer edge in the bicelle is relatively
small, facilitating the formation of a larger sized bicelle.
In the model for the planar membrane, adjacent beads making the lipid molecules are
connected by harmonic springs,

Us2 = Ks2 (rij − rs2 )2 ,
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(A.21)

with spring coefficient Ks2 = 64 kB T /r02 and equilibrium distance rs2 = 0.5r0 196,197 . The
stiffness of the lipid tails is guaranteed by a bending potential

Uϑ2 = Kϑ2 (1 − cos ϑ),

(A.22)

where Kϑ2 = 15kB T 196,197 .
All pair-wise interactions parameters aij between lipid beads are listed in Table A.2.
Note that a larger repulsion between lipids in the liposome/bicelle and membrane is used
to avoid their possible fusion. Under control of these parameters, the bilayer thickness in
the liposome/bicelle is around dHH1 = 5r0 . The bilayer thickness in the planar membrane
is around dHH2 = 4r0 . The mechanical properties of these two lipid models are calibrated
through stretching a patch of a planar bilayer in the simulation box of size (50 × 50 × 50)
r03 . The relations between the tension of the planar bilayer and the lipid molecular area
for these two lipid models are given in Fig. S1(B). The stretch modulus can be extracted
from the slope of these curves. For the lipid bilayer in the liposome/bicelle, its stretch
modulus is KA1 = 13.30 kB T /r02 , while the one for the planar membrane is KA2 = 17.42
kB T /r02 . The corresponding bending rigidity can be obtained from κ = KA d2HH /48 97,198 .
The bending rigidity of the liposome/bicelle is therefore κlip ≈ 7kB T ; the bending rigidity
of membrane is κm ≈ 6kB T . Additionally, to estimate the line tension of the bilayer for
liposome/bicelle, we systematically change the size of the bicelle to find the transition size
from bicelle to liposome Rtrans ≈ 10r0 . The line tension of the bicelle can be estimated
via λ = 2κlip /Rtrans 235 , resulting in λ ≈ 1.4kB T /r0 . Note that the transition size increases
when the lipid heads get decorated with PEG polymers.
Within our DPD model, different types of beads have identical masses and cutoff distances for pairwise interactions. For the sake of transferability, the mass, length and time
scales are all normalized. The unit length is taken to be the cutoff distance r0 . The
unit mass is m for all the beads and is set to unity. In addition, the unit energy is de-
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Table A.2: Interaction parameters, aij in units of kB T , between lipid bead types i and j, in
the DPD simulation. S and E represent solvent (water) and PEG beads, respectively. H1 and T1
represent the lipid head and tail beads for liposome/bicelle. H2 and T2 represent the lipid head and
tail beads for the planar membrane.

S
H2
T2
H1
T1
E

S
25.0
30.0
75.0
25.0
100.0
26.3

H2
30.0
30.0
35.0
100.0
100.0
26.3

T2
75.0
35.0
10.0
100.0
100.0
33.7

H1
25.0
100.0
100.0
25.0
100.0
26.3

T1
100.0
100.0
100.0
100.0
25.0
33.7

E
26.3
26.3
33.7
26.3
33.7
25.0

fined by the thermal energy kB T . All other dimensional quantities can thus be uniquely
made dimensionless in terms of these basic units (and vice versa). The time step in our
p
DPD simulations is chosen as ∆t = 0.01τ , with τ = mr02 /kB T . The number density of
beads in the simulation box is fixed at 3/r03 195 . The velocity-Verlet integration algorithm
is adopted for the time integration. The reduced units can be mapped to SI units using a
real bilayer thickness and a measured value for the in-plane diffusion coefficient of lipids, as
shown in previous studies 196,197 . From the experiments, the thickness of the membrane is
dHH ≈ 3.53 nm 91 and the thickness of the planar membrane in our simulation is dHH ≈ 4
r0 . The physical length scale could then be obtained as r0 ' 0.9 nm. Comparing the
experimental lipid lateral diffusion coefficient D ' 5 µm2 /s of the DMPC 92 with the one
from our simulation D ' 7.3 × 10−2 r02 /τ , we obtain the physical time scale τ = 11.8 ns.
Periodic boundary conditions are applied along all directions of the simulation box. All the
simulations are performed by using the Large-scale Atomic/Molecular Massively Parallel
Simulator (LAMMPS), distributed by Sandia National Laboratories 89 .

285

Simulation Protocol
To prepare a PEGylated liposome, lipid molecules are firstly randomly placed into a simulation box to form a liposome through a self-assembly process at temperature T = 1.0.
Subsequently, a certain number of lipids in the outer layer is randomly chosen to be grafted
with PEG chains on the lipid head beads, in accord with the molar ratio of the targeted
PEGylated lipid. A PEGylated liposome then further relaxes for a duration of 106 τ at
T = 1.0. To prepare a PEGylated bicelle, a small patch of a planar bilayer is first relaxed
in a simulation box. Afterwards, as certain number of lipids in the upper and lower leaflet
are randomly chosen to graft with PEG chains on the lipid head beads. Afterwards, we
enlarge the simulation box in the lateral direction while keeping the size of the PEGylated
bilayer. The space in the edge of simulation box is filled with water to the keep the density
of the system unaltered. A PEGylated bicelle is obtained by relaxing the system for 106 τ
at T = 1.0. The planar membrane bilayer is relaxed in the box of size (70 × 70 × 100) r03 ,
which is large enough to avoid an influence of simulation box size on endocytosis. Finally,
the fully relaxed PEGylated liposomes are placed above the planar bilayer to investigate
the membrane wrapping process.

Computation of membrane energy

(A)

(B)
𝑹3

𝑹3
𝑹1

𝜃

𝑹2

𝑹2

Figure A.24: (A) Illustration of membrane wrapping for an ellipsoidal NPs. The three principle
radii of the ellipsoid are R1 , R2 and R3 . The red part in the NP denotes the region that wrapped
by membrane. While the blue part of the NP represents the unwrapped part of NP. (B) Illustration
of cross cutting of the ellipsoidal NP.
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To estimate the membrane elastic energy, we assume that a planar membrane wraps
around a ellipsoidal NPs as given in Fig. A.24(A). The three principle radii of the ellipsoid
we denote by R1 , R2 and R3 . The ellipsoidal surface can be parameterized as

x = R1 cos φ sin θ,

y = R2 sin φ sin θ,

z = R3 cos θ,

(A.23)

where 0 ≤ θ < π and 0 ≤ φ < 2π. When R1 = R2 = R3 , the ellipsoid returns to a
spherical shape. If R1 = R2 , the ellipsoid is symmetric in the plane of the membrane. An
area element dS and the mean curvature H on any point of the ellipsoidal surface can be
expressed as the function of θ and φ as follows 414

dS(θ,φ)=sin(θ)

H(θ,φ)=

√

Rc2 sin2 θ(R12 sin2 φ+R22 cos2 φ)+R12 R22 cos2 θ dφdθ

2+R2 )+2R2+(R2+R2−2R2 ) cos(2θ)−2(R2−R2 ) cos(2φ) sin2 θ]
R1 R2 R3 [3(R1
2
3
1
2
3
1
2
2 R2 cos2 θ+R2 [R2 cos2 φ+R2 sin2 φ] sin2 θ}3/2
8{R1
1
3 2
2

(A.24)

(A.25)

For simplicity, we consider a membrane patch that wraps around the NPs. Additionally,
we assume that the membrane wrapping follows the evolution of θ as given in Fig. A.24(B).
Therefore, the wrapping fraction f of the ellipsoidal NPs is a function of parameter θ only,
and defined by
R θ R 2π
f (θ) = R 0π R02π
0

0

dS(θ0 , φ)
dS(θ0 , φ)

,

(A.26)

with dS(θ0 , φ) from Eq. A.24. According to Helfrich’s theory 95,180 , the membrane elastic
energy can be expressed as:
Z
Em = Embend + Emtens = 2κm

H 2 dS + σ∆S,

(A.27)

where κm is the bending rigidity of the membrane, σ is the membrane tension, and ∆S is
the excess area induced by membrane bending. Specifically, with the area element dS and
mean curvature H at hand, the membrane bending energy at a certain wrapping fraction
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f can be written as:
Z θZ

2π

Embend (θ) = 2κm
0

H 2 (θ0 , φ)dS(θ0 , φ).

(A.28)

0

Additionally, the membrane stretching energy can be obtained as:
Z θ Z
Emtens (θ) = σ
0

2π


dS(θ , φ) − πR1 sin(θ)R2 sin(θ) .
0

(A.29)

0

As we can see for the expressions above, the membrane elastic energy is a function of θ.
The integrals cannot be performed analytically; the integral over φ alone can be expressed
in terms of an elliptic integral. Given the expressions of Eqs. A.26, A.28 and A.29, the
critical membrane tension can be directly obtained by following the Eq.5.4 in the Chapter
5.

Membrane wrapping process for PEGylated liposome under the membrane tension of 0.09kB T /r02
The membrane wrapping processes for PEGylated liposomes with PEG molar ratios of 50%
mol, 60% mol and 70% mol are given in Fig. A.25. The membrane tension of these three
cases is maintained at 0.09kB T /r02 . As we can see from Fig. A.25(A) at 50% mol, the
PEGylated liposome quickly adheres on the membrane due to the ligand-receptor binding
(at t = 59 µs). Additionally, the membrane starts to bend and wrap around the liposome.
During this process, the PEG polymers keep aggregating within the wrapped region of the
liposome. Finally, the liposome is partially wrapped and trapped on the membrane. The
membrane wrapping process of 40% mol PEGylated liposome is similar to the one of the
50% mol PEGylated liposome. The membrane wrapping process of 60% mol PEGylated
liposome as shown in Fig. A.25(B) is however different. Along with the aggregation of PEG
polymers at t = 280 µs, the lipids on the contact edge of the liposome start to protrude and
to assume a tubular shape. This protruding of the lipid might help releasing the increased
288

steric interaction caused by aggregation. Furthermore, with the formation of a tubular
shape, the space occupied by the water inside is decreased (at t = 1000 µs). Finally, the
60% mol PEGylated liposome is also trapped on the membrane. At 70% mol, the lipids
on the contact edge of the liposome protrude as well. Moreover, with the increase of PEG
polymer number, the tubular shape further reduces the space available to water, which in
turns produces a large osmotic pressure, ultimately leading to liposome rupture at t = 210
µs. Finally, the ruptured 70% mol PEGylated liposome deforms into a strip-like shape that

is trapped on the membrane.

Membrane wrapping process for PEGylated bicelle under the membrane tension
of 0.09kB T /r02
The membrane wrapping processes for the PEGylated bicelle with PEG molar ratios of
50% and 70% mol are given in Fig. A.26. The membrane tension for the two cases is
maintained at 0.09kB T /r02 . At 50% mol, the PEGylated bicelle is finally trapped on the
membrane and the bicelle keeps a disc-like shape during the whole membrane wrapping
process. The membrane wrapping process of the 40% mol PEGylated bicelle is similar to
that of the 50% mol PEGylated bicelle. At 70% mol, the PEGylated bicelle is also partially
wrapped. Interestingly, with the aggregation of PEG polymers in the wrapped region, the
bicelle deforms into a strip-like shape to release the increased steric force. The membrane
wrapping process of 60% mol PEGylated bicelle is similar to the that of 70% mol PEGylated
bicelle at the membrane tension of 0.09kB T /r02 .

289

t=0

(A)

t=236 𝜇𝑠

t=590 𝜇𝑠

t=1000 𝜇𝑠

t=224 𝜇𝑠

t=280 𝜇𝑠

t=1000 𝜇𝑠

t=210 𝜇𝑠

t=236 𝜇𝑠

t=1000 𝜇𝑠

50 % mol

t=59 𝜇𝑠

t=0

t=59 𝜇𝑠

60 % mol

(B)

t=0
t=200 𝜇𝑠

70 % mol

(C)

Figure A.25: Membrane wrapping process for PEGylated liposome under the membrane tension
of 0.09kB T /r02 . (A-C) Snapshots during membrane wrapping process for PEGylated liposomes with
PEG molar ratios of 50 %mol, 60 %mol, and 70 %mol.
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Figure A.26: Membrane wrapping process for the PEGylated bicelle under membrane tension
of 0.09kB T /r02 . (A-B) Snapshots taken during the membrane wrapping processes for PEGylated
liposomes with PEG molar ratios of 50% mol and 70% mol.
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Figure A.27: Projected PEG volume fraction distribution and end-to-end distance. Evolution of
the PEG volume fraction distribution of the (A) PEGylated liposome and (B) PEGylated bicelle.
Evolution of PEG polymers end-to-end distance for (C) PEGylated liposome and (D) PEGylated
bicelle. The PEG molar ratio for both liposome and bicelle is 50% mol; the membrane tension
is 0.09kB T /r02 for both liposome and bicelle. Because of the partially wrapped state at the end,
the PEG volume fraction remains highly inhomogeneous. Also, the end-to-end distance of PEG
polymers remains at a large value.
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Figure A.28: (A) Snapshots of bicelle deformation during the membrane wrapping process. The
configurations in the upper panel are cross cuttings of the bicelle at different times. The snapshots
in the lower panel are the corresponding top views of the same bicelles. (B) Evolution of the three
principal moments of the gyration tensor of the bicelle during the membrane wrapping process.
The corresponding snapshots of the membrane wrapping process are given in Fig.5.2 of Chapter 5.
The snapshots of cross cuttings in (A) show a flat surface plane for the bicelle during the entire
2
2
wrapping process. In (B), the in–plane principal moments rgz
and rgy
change dramatically during
2
the deformation of the bicelle, while the out–of–plane plane principal moment rgx
keeps almost
2
constant at a small value. The cross cutting of the bicelle in (A) and the principal moment rgx
suggest that the curvature of the bicelle barely changes during the membrane wrapping process.
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Figure A.29: Evolution of the three principle radii belonging to the fitted ellipsoids of the PEGylated bicelle. The corresponding snapshots of the membrane wrapping process are given in Fig.5.2
in the Chapter 5. Based on the data shown here, the three principle radii of the PEGylated bicelle
at the most deformed state around the critical wrapping fraction fc are R1 ≈ 19 r0 , R2 ≈ 10 r0 , and
R3 ≈ 4 r0 , respectively.
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Supplementary materials for Chapter 6

Interaction parameters
Table A.3: Interaction parameters, aij , between beads i and j, in the DPD simulation. S, H,
T, E and P represent solvent, lipid head, lipid tail, PEG and NP beads, respectively. LH and RH
denote ligand lipid head and receptor lipid head beads, respectively. LT and RT represent ligand
lipid tail and receptor lipid tail beads, respectively. aij − aii = 3.27χij , where χij is the FloryHuggins parameter. The Flory-Huggins parameters between PEG (E), lipid head (H) and lipid
tails (T) beads are taken from the work done by Groot and Rabone 226 , calibrated by experimental
studies. Specifically, the aSE = 26.3kB T /r0 , which can be used to correctly predict the properties of
polyethylene glycol (PEG) polymer, such as end-to-end distance and radius of gyration 72,123 , under
the bond and angle potentials given in Chapter 6. The nanoparticle (NP) core beads will experience
a big repulsion with all other types of beads, aPx = 100kB T /r0 , where x represents the PEG (E),
lipid head (H), lipid tails (T) and water (S) beads. The interaction parameters between the same
type of beads will be taken as 25kB T /r0 195 , except for the one between NP core beads.
aij (kB T /r0 )
S
H
T
E
P
LH
LT
RH
RT

S
25.0
25.0
100.0
26.3
100.0
25.0
100.0
25.0
100.0

H
25.0
25.0
100.0
26.3
100.0
25.0
100.0
25.0
100.0

T
100.0
100.0
25.0
100.0
100.0
100.0
25.0
100.0
25.0

E
26.3
26.3
100.0
25.0
100.0
26.3
100.0
26.3
100.0

P
100.0
100.0
100.0
100.0
0
100.0
100.0
100.0
100.0

LH
25.0
25.0
100.0
26.3
100.0
25.0
100.0
4.0
100.0

LT
100.0
100.0
25.0
100.0
100.0
100.0
25.0
100.0
25.0

RH
25.0
25.0
100.0
26.3
100.0
4.0
100.0
25.0
100.0

RT
100.0
100.0
25.0
100.0
100.0
100.0
25.0
100.0
25.0

Structural Analysis on CPLS NPs
Table A.4: Properties changes before and after the self-assembly process for the perfect encapsulated cases with polymerization degree N = 10. ’Before’ in the table means that the parameters
are calculated before the self-assembly process. While ’After’ indicates the situation after the selfassembly process. L = 2500 and L = 3000 represent the number of the free lipids in the simulation
box. σp is the grafting density of the PEG polymer on the NP core.
Before
σp

M

(chains/r2
0)

0.256
0.384
0.512
0.64

80
121
161
201

Vpolymer
(r03 )
5.111
3.585
2.877
2.439

Ree
(r0 )
2.345
2.324
2.382
2.433

Vpolymer
(r03 )
N/A
3.253
2.722
2.357

After
L=2500
Ree
(r0 )
N/A
2.472
2.508
2.568
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R
(r0 )
N/A
9.527
9.622
9.698

Vpolymer
(r03 )
5.495
3.678
2.812
2.440

After
L=3000
Ree
(r0 )
2.553
2.543
2.543
2.599

R
(r0 )
9.625
9.638
9.654
9.733

Table A.5: Properties changes before and after the self-assembly process for the perfect encapsulated cases with polymerization degree N = 40.
Before
σp

M

(chains/r2
0)

0.512
0.64
0.768

161
201
241

Vpolymer
(r03 )
8.486
7.438
6.579

Ree
(r0 )
5.335
5.967
6.352

Vpolymer
(r03 )
8.787
8.076
7.014

After
L=6500
Ree
(r0 )
7.173
7.793
7.953

R
(r0 )
11.235
11.503
11.585

Vpolymer
(r03 )
9.538
8.157
7.254

After
L=7500
Ree
(r0 )
7.668
7.824
8.165

R
(r0 )
11.392
11.523
11.655

To fully understand the properties of CPLS NPs, we further analyze the structure
properties of these NPs, by comparing the average volume Vpolymer and the average endto-end distance Ree for the polymer. Furthermore, we will estimate the radius of the
formed CPLS NPs, as listed in the tables below. The Vpolymer is calculated by Vpolymer =
3 )/3M , where M represent the number of the polymer chains
4π((Rthick + Rcore )3 − Rcore

tethered on the NP surface. Rthick is the polymer brush thickness, evaluated by Rthick =
R∞
R∞
415 . The ρ(r) here is the density of the polymer. The V
polymer
rcore ρ(r)rdr/ rcore ρ(r)dr
indicates the interactive chance between the individual PEG polymer. A larger value of the
Vpolymer suggests the less chance to interact with each other. While the average end-to-end
distance Ree of the PEG polymer reflects elasticity energy change for PEG polymers. Both
of them could be used to compute the free energy change according to the SCF theory
above. The radius of the CPLS NP R is calculated by R = Rcore + Rthick + Tbilayer , where
Rcore is the radius of the NP cores, Tbilayer is the thickness of the bilayer. The radius of the
CPLS NPs will be an important parameters for the potential use in the drug delivery. And
we speculate that being confined by the tethered PEG polymer, the radius of the CPLS
NPs will follow a uniform size distribution.
As given in Table A.4, the Vpolymer of the polymers will change after the self-assembly
according to the PEG grafting density. And the Ree will increase along with the formation of
the CPLS NPs. In this PEG polymerization degree N = 10, both of the Vpolymer and the Ree
will not change too much. In comparison, when N increases to 40 as given in the Table A.5,
the end-to-end distance Ree of PEG polymers will increase almost 50%. Correspondingly,
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the average volume for PEG polymers Vpolymer will decrease. The significant increment of
Ree indicates a growth of the elastic free energy from PEG polymers. And the decreasing
of Vpolymer means that the stretched polymers will leave more space between each other,
which will contribute to a reduction of the interaction free energy.
More importantly, we could find in these two tables that the radius of the CPLS NPs
will almost keep a constant value as long as the PEG polymerization degrees are given (at
least in the PEG density given in this paper). When N = 10, the variance in radius for all
of the CPLS NPs is only about 2%. Even in N = 40 cases, the variance in radius is only
3.4%. It might indicate that even under the high PEG molecular weight, the divergence
in the CPLS NPs’ radius is still small. These results confirm our speculation that we are
able to control the size of CPLS NPs by manipulating the PEG polymerization degree and
obtain the NPs with a uniform radius distribution.

Internalization of CPLS NPs
The details of the membrane wrapping process of the CPLS NPs and corresponding liposome
with 2500 lipids are revealed in this part. We could tell in Fig. A.30 that both of the
liposome and CPLS NP could be fully wrapped, conserving all the drug molecules inside
after the internalization. At t = 0, the CPLS NP and the liposome are placed above
the lipid membrane with 3r0 distance respectively. Under the thermal fluctuation, both
of the two NPs could easily adhere to the bilayer for the attractive interaction between
the ligands and receptors. The liposome and the CPLS NP will spread on the bilayer At
t = 1000τ . As time evolved, at the t = 3000τ , the majority of the liposome are wrapped
by the bilayer, deforming to a ellipse shape. For the CPLN, it would be wrapped with the
similar percentage at t = 2500τ . The following protruding process will happen at t = 4000τ
and t = 3000τ respectively for the liposome and the CPLS NP. At the end, both of then
could be fully wrapped by the bilayer. Interestingly the CPLS NP will be fully wrapped
about t = 500τ earlier than the liposome. And it might be highly related to the rigidity of
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A

t=0

t=

t=3

t=4

t=5.5

t=0

t=

t=2.5

t=3

t=5

B

Figure A.30: Lipid membrane wrapping process of (A) liposome and (B) CPLS NP, from time t = 0
to t = 5500τ . The liposome is formed by 2500 lipid molecules. The CPLS NP is self-assembled by
the PEGylated core with PEG polymerization degree N = 10, grafting density σp = 0.64 chains/r02
and 2500 free lipids. The NP core is colored in sliver. The PEG polymer is colored in yellow. The
lipid head and tails in the liposome and CPLS NP are colored in blue and cyan, respectively. The
lipid tails in the bilayer are colored in gray. And the lipids coated with receptors in the bilayer are
colored in tan, while the regular lipids heads are colored in purple. The drug molecules encapsulated
within liposome and CPLS NPs are colored in red. The water beads are not shown for clarity.

the NPs 45 .

Experimental Synthesis and characterization of CPLS NPs
Table A.6: Summary of particle size and charge measurements.
AgNP-PEG-DSPE

Diameter (nm)
Polydispersity
Surface Charge (mV)

202 ± 28
0.185 ± 0.0084
−25.04 ± 3.65

AgNP-PEG-DSPE-DOPE

399 ± 49
0.300 ± 0.065
−31.55 ± 8.23

AgNP-PEG-DSPE-DOPE+Dye

346 ± 19
0.300 ± 0.029
−41.11 ± 2.36

Table A.6 shows the relative size change between the PEGylated Si/Ag-PEG NP and
post lipid (DOPE) encapsulation. Particles loaded with dye (CF 633) are shown for comparison in the last column. All DLS and Zeta potential measurements were run on a Malvern
Zetasizer Nano ZS90. 5 measurements with 20 runs per measurement were recorded and
the standard deviation determined per sample condition. All TEM measurements were
acquired on a FEI Tecnai G2 Spirit BioTWIN Transmission Electron Microscope at the
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Figure A.31: Representative Dynamic Light Scattering (DLS) and Zeta measurements of the
CLPS NPs pre and post covalent linkage of the PEGylated lipid. The DLS of the crude synthesis
(unpurified) Si/AgNP-PEG-DSPE-DOPE NPs shows a broader size distribution and some smaller
materials (20-50 nm) in size which represent excess lipids which formed into micelles used in the self
assembly of the lipid bilayer. This is also observed in the corresponding TEM images of the DOPE
encapsulated Si/AgNP-PEG-DSPE NPs prior to size exclusion chromatography.
B
C
A

Figure A.32: TEM images pre and post addition of DOPE and lipid bilayer formation. Image A
shows PEGylated particles stained with uranyl acetate solution. Image B and zoomed in images C
show the staining of the particles post excess DOPE addition. Edges of DOPE micelles and surface
of encapsulated NPs are stained.

UCONN Bioscience Electron Microscopy Lab.
Dye encapsulation was performed prior to the addition of the second lipid (DOPE)
during the formation of the lipid bilayer. After the Si/Ag NPs were covalently functionalized
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Figure A.33: Schematic showing the stepwise encapsulation of a hydrophilic dye in the tethered
PEG layer, beneath the outer lipid bilayer of the CPLS NP.

with the lipidated PEG molecule (DSPE) , they were treated with a concentrated solution
of CF 633 dye (Sigma Aldrich). After adding the dye the particles were treated with DOPE
in chloroform, to which dye would have been driven in the hydrophilic PEG layer of the
CPLS. Any unincorporated dye was washed away during a multistep washing and drying
process. The final DOPE encapsulated particle washed of free dye was then subjected to
size exclusion chromatography (SEC).

Figure A.34: Green and Red channels depict laser excitation at 473 nm and 635 nm respectively.
The tubes correspond to size exclusion chromatography (SEC) elution fractions (1-8) off of a G-25
sephadex column (NAP-5, GE Healthcare). The top four tubes are fractions 1-4 and the bottom
are fractions 5-8. 500 µL was collected per fraction. The left image shows that the majority of the
CPLS NPs elute in fraction 3. The right image shows a significant amount of dye in fraction 3, but
also in fractions 4, 5, 6, and 7. This corresponds to the smaller size of the dye and that it would
be expected to elute later than the larger diameter NPs. The dye found in fraction 3 is attributed
to dye associated with the CPLS NPs. All fluorescent images were acquired on a GE Healthcare
Typhoon FLA7000 laser gel scanner.
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Figure A.35: Green and Red channels (473 nm and 635 nm overlay) for SEC fractions of particles
synthesized with and without dye. The image on the right shows that fraction 3 is the fraction in
which the CPLS NPs elute. The overlain images shows the presence of both the emission of the
FITC dye of the inorganic Si-Ag-NP core and the emission of the dye in fraction 3. Much of the
hydrophilic small molecule dye, CF633, is encapsulated in the CPLS. Free dye is shown to elute in
later fractions (4-7). All fluorescent images were acquired on a GE Healthcare Typhoon FLA7000
laser gel scanner.
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Model and methodology
Table A.7: Interaction parameters, aij , between beads i and j, in the DPD simulation. S, H,
T, E and P represent solvent (water), lipid head, lipid tail, PEG and NP (or substrate) beads,
respectively.

aij (kB T /r0 )
S
H
T
E
P

S
25.0
30.0
75.0
26.3
100.0

H
30.0
30.0
35.0
26.3
100.0

T
75.0
35.0
10.0
33.7
100.0

E
26.3
26.3
33.7
25.0
100.0

P
100.0
100.0
100.0
100.0
0

Model for nanoparticle core
The NP core is composed of 1575 beads with a radius 5r0 . These beads are arranged on
a FCC lattice with lattice parameter 0.8r0 . To get a smooth spherical surface, the core
is covered by a layer of spherical shell beads. These shell beads distribute evenly on the
surface. All of these produce a tight packing of the core with number density of 3 r0−3 . The
whole NP core moves like a rigid body during the simulation 255 to mimic the motion of a
hard metal core. Large repulsion between beads of NP core and other beads (aij = 100
kB T /r0 ) is applied to prevent the penetrations of water, polymer and lipid beads. The
interaction between NP core beads are turned off because of the adoption of rigid body.

Bilayer tension
Due to the fact in simulations that it is difficult to measure the tension of vesicle explicitly 90 ,
here, we try to estimate the bilayer tension by lipid area. To get the relation between bilayer
tension and lipid area, planar bilayers and PEG polymers tethered planar bilayers with area

302

A

B

z
x

z
y

x
6

C

Bilayer tension [kBT/r20]

Bilayer tension [kBT/r20]

6

y

4

2

0

-2
1.2

1.3

1.4

1.5

1.6

4

2

0

-2
1.2

2
0

D

Free
N=10
N=20
N=30
N=40
N=60

1.3

1.4

1.5

1.6

1.7

2
0

Lipid area [r ]

Lipid area [r ]

Figure A.36: Relationship between bilayer tension and lipid area. (A) Planar bilayer with free
lipids only. (B) PEG polymers (N = 60) tethered planar bilayer with grafting density equal to 1.0
chains/r02 .(C) The relationship between bilayer tension and lipid area for a pure lipid bilayer. (D)
The relationship between bilayer tension and lipid area for tethered lipid bilayer with different PEG
polymers. N represent PEG polymerization degree. ‘free’ here denotes the pure lipid bilayer for
comparison. Water beads are not shown for clarity in figures A and B.

of (50 × 50) r02 are built (cf. Fig. A.36.A and B). The grafting density of PEG polymers
are the same with the one of CPLS NPs in the main part of Chapter 7. In the progress, the
box size in x and y direction is varied simultaneously to change the bilayer area, the size
in z direction is correspondingly altered to ensure the constant bead density. To capture
the feature that the relative position of tethered points on NP core will keep unchanged for
CPLS NP under shear stress, the tethered points on the planer substrate is kept unmoved
during the box size variation. The tension of bilayers or PEG polymers tethered bilayer is
calculated according to the equation above, the forces in which are extracted in equilibrated
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states.

Stability

A
t=2900

t=2940

t=2970

t=9680

t=9700

t=9750

B

Figure A.37: Evolution process of pore formation in vesicles with different sizes. (A) The pore
formation process in a vesicle with radius R = 12.17r0 under shear rate of γ̇ = 0.045τ −1 . (B) The
pore formation process in a vesicle with radius R = 13.17r0 under shear rate of γ̇ = 0.04τ −1 .
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A

B

C

t=0

t=5190

t=5200

t=5230

t=5280

Figure A.38: Motion of CPLS NPs under shear flow. (A) CPLS NP (R = 11.43r0 ) under shear
rate of γ̇ = 0.625τ −1 (Same with the Fig.7.4 in Chapter 7). (B-C) Snapshots of the NP core, a
tethered polymer and marked lipid at different perspectives. For figures in (A-B), the directions of
x and z are within the plane of paper. And directions of y is perpendicular to the plane of paper
and point to it. For figures in (C), the directions of x and y are within the plane of paper. And
directions of z is perpendicular to the plane of paper and point to it.
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A
t=2680

t=2700
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t=6100

t=6120

t=5930

t=5960

t=6020

t=5700

t=5730
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C

D
t=5660

Figure A.39: Evolution process of pore formation in CPLS NPs of different sizes. (A) Snapshots
of CPLS NP (R = 10.28r0 ) with PEG polymers N = 10 under shear rate of γ̇ = 0.09τ −1 . (B)
Snapshots of CPLS NP (R = 12.51r0 ) with PEG polymers N = 30 under shear rate of γ̇ = 0.05τ −1 .
(C) Snapshots of CPLS NP (R = 13.44r0 ) with PEG polymers N = 40 under shear rate of γ̇ =
0.045τ −1 . (D) Snapshots of CPLS NP (R = 15.03r0 ) with PEG polymers N = 60 under shear rate
of γ̇ = 0.045τ −1 .
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t=0

,

t=6

t=56

t=140

t=260

Figure A.40: Self-assembly of TMLs at lp = 2.21,σg = 0.35 nm−2 , Nf = 8500. To investigate the
effect of free lipid number, we increased the free lipid number to 8500. All other conditions are the
same as the one in Figure 2 (B) in the main text. A partially encapsulated TML is also found when
the free lipid number is increased.

Characterization of CPLS NPs
The CPLS NPs observed in TEM images were counted and sorted into four categories
following these parameters: Perfectly Encapsulated is defined as having a thick white halo,
which can be slightly amorphous (i.e. not a rigid sphere); Budding is defined as a thick
white halo, including at least one contiguous bulge; Anchored Vesicles is defined as either a
thin or thick white halo around the inorganic core, but must include at least two small white
spheres non-contiguously or non-continuously arrayed around the core; No Encapsulation
is defined as a thin white shell which matches almost perfectly the core morphology, must
have zero white spheres arrayed around the core. Particles which contained multiple cores
per lipid shell were not counted. Particles which did not fit into the above parameters were
not counted. In instances where multiple cores could be observed sharing white spheres and
ownership could not be differentiated, all particles were declared Anchored Vesicles. The
following TEM images are representative of each 100%, 75%, 50%, and 0% grafting density
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Figure A.41: (A) Legend for scheme. (B) Schematic Representation of the synthesis of CPLS
NPs with variable amounts of SH-PEG-DSPE and polyT DNA backfill. The thiolated polymers
adsorb to the surface of the Au NP. To achieve the 100%, 75%, 50%, and 0% conditions, relative
concentrations of the SH-PEG-DSPE and the thiolated DNA oligonucleotide were controlled with
respect to the concentration of the 30 nm Au core, in a 10,000:1 molar ratio of the combined ligands
to the Au core. The free lipid DOPE was added to the PEGylated NPs through thin film hydration
in a 2, 500 : 1 molar ratio of DOPE to the Au core.

of SH-PEG-DSPE.
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Figure A.42: TEM images of the CPLS NPs with 100% PEGylated lipid. Samples were stained
with 0.5% uranyl acetate solution. All scale bars 100 nm.

Estimation of polymer persistence length
The persistence of a polymer is estimated based on the formula as bellows 416 :

hcos θi = exp(−L/lp )

(A.30)

where θ is defined as the angle between vectors v0 and vl . v0 is the vector that is tangent
to the polymer at the position 0. vl is the vector that is tangent to the polymer at a
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Figure A.43: TEM images of the CPLS NPs with 75% PEGylated lipid. Samples were stained
with 0.5% uranyl acetate solution. All scale bars 100 nm.

distance L away from position 0. The persistence length lp can be obtained by fitting the
hcos θi according to the formula. To evaluate the lp of a polymer under certain potential in
our simulation, we first relax a single polymer with monomer of 60 in the solvent. Then
the relaxed snapshots of the polymer is used to calculate the hcos θi along the polymer
length. As shown in Fig??, the hcos θi values of four different polymers are given along
with their corresponding fitting curves based on equation above. The persistence lengths
of the four different polymers are 4.93, 6.09, 35.09, and 64.08 with the unit of bond length
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Figure A.44: TEM images of the CPLS NPs with 50% PEGylated lipid. Samples were stained
with 0.5% uranyl acetate solution. All scale bars 100 nm.

b = 0.4125 nm. Their corresponding angular constants are Kθ2 = 0, 16.4946, 100 and 500
kB T , respectively. Their bending stiffnesses can be obtained based on the relation between
the persistence length and bending stiffness Bs 417 :

Bs = P kB T
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(A.31)

Figure A.45: TEM images of the CPLS NPs with 0% PEGylated lipid. Samples were stained with
0.5% uranyl acetate solution. All scale bars 100 nm. Note, uranyl acetate staining of DNA-Au NPs
can result in white halo effects due to electrostatic interactions between the stain and the DNA.

Therefore, the corresponding bending stiffnesses of the four different polymers in our simulation are 2.034, 2.512, 14.475 and 26.433 kB T ṅm, respectively.

Self-assembly process of planar polymer tethered lipid bilayer
To find out the critical grafting density σpc for a planar tethered lipid bilayer membrane, we
investigated its self-assembly process. As given in Figures A.50-A.53, polymers are grafted
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Figure A.46: Representative Dynamic Light Scattering (DLS) measurements of the CPLS NPs
with variable amounts of the PEGylated lipid with and without addition of the free lipid.

on the planar substrate surface. Similar to our TMLs, the free terminals of the grafted
polymers are linked with anchored lipids. The monomer for each polymer is 30. The size
of the substrate is (50 × 50) nm2 . The free lipid number added is 7000, which is obtained
according to the lipid area and substrate area. We investigated the selfassembly processes
at a series of different tethered polymer persistence lengths and grafting densities. Details
regarding the self-assembly process are given in Figures A.50-A.53. It is found that the
critical grafting density for the planar tethered lipid bilayer is much smaller than the one
found for TMLs in the main text. As shown in the figure, the critical grafting density for
the case of lp = 0.17 is around σpc = 0.04 nm−2 . More importantly, the critical grafting
densities for all 3 other cases of lp = 0.21, 1.21, 2.21 are the same with the value around
σpc = 0.06 nm−2 .
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Figure A.47: Representative Dynamic Light Scattering (DLS) measurements of the CPLS NPs as
a histogram of each individual condition. A. 100% PEG CPLS. B. 75% PEG CPLS. C. 50% PEG
CPLS. D. 0% PEG CPLS.
5. Estimation of lipid area
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Figure S9. The relationship between lipid area and the lipid bilayer tension. To
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Therefore, the lipid area is taken as ap = 0.7 nm2 for its zero bilayer tension.
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Figure A.49: Functions of hcos θi against the distance along with the polymer chain. The distance
here is plot with the unit of bond length b = 0.4125 nm
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(A)

(B)

Figure A.50: Self-assembly process of planar tethered lipid bilayers with polymer normalized
persistence length of lp = 0.17. As we can see in Figures (A) and (B), an intact planar lipid bilayer
can be assembled at the grafting density σpc = 0.04 nm−2 . However, at σpc = 0.03 nm−2 , an intact
bilayer cannot be formed. Therefore, the critical grafting density for lp = 0.17 is around σpc = 0.04
nm−2 .
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(A)

(B)

Figure A.51: Self-assembly process of planar tethered lipid bilayers with polymer normalized
persistence length of lp = 0.21. As we can see in Figures (A) and (B), an intact planar lipid bilayer
can be assembled at the grafting density σpc = 0.06 nm−2 . However, at σpc = 0.05 nm−2 , an intact
bilayer cannot be formed. Therefore, the critical grafting density for lp = 0.21, is around σpc = 0.06
nm−2 .
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(A)

(B)

Figure A.52: Self-assembly process of planar tethered lipid bilayers with polymer normalized
persistence length of lp = 1.21. As we can see in Figures (A) and (B), an intact planar lipid bilayer
can be assembled at the grafting density σpc = 0.06 nm−2 . However, at σpc = 0.05 nm−2 , an intact
bilayer cannot be formed. Therefore, the critical grafting density for lp = 1.21, is around σpc = 0.06
nm−2 .
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Figure A.53: Self-assembly process of a planar tethered lipid bilayer with polymer normalized
persistence length of lp = 2.21. At σpc = 0.05 nm−2 , an intact bilayer cannot be formed. As given
in the main text, an intact planar lipid bilayer can be assembled at the grafting density σpc = 0.06
nm−2 . Therefore, the critical grafting density for lp = 2.21 is around σpc = 0.06 nm−2
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Table A.8: Force field parameters according to Martini coarse-grained force field
bond1

non-bond

1

angle2

building block

type

building block

R0

kbond

Au

C5

S-(CH2 )4

0.445

1250

(CH2 )4 -(CH2 )4

0.470

1250

S

N0

(CH2 )4

C1

-NH+
3

Qda

-COOH

Qda

R0 in nm, kbond in kJmol−1 nm−2 .

t=0

2

θ0

kangle

S-(CH2 )4 -(CH2 )4

180

25

(CH2 )4 -(CH2 )4 -(CH2 )4

180

25

θ0 in degree, kangle in kJmol−1 rad−2 .

t=100 ns

t=200 ns

t=300 ns

t=400 ns

pH=2.0

pH=5.3

pH=8.0

Figure A.54: Evolution of configurations about 27 AuNPs in the simulation box at different pH
values.
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Figure A.55: (A) The convergence of potential of mean force (PMF) calculation over the simulation
time per window for two AuNPs at pH= 8.0. (B) The convergence of PMF calculation over the
simulation time per window for AuNPs penetration at pH= 2.0.
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Figure A.56: Evolution of maximum cluster for AuNPs at pH= 7.0 and pH= 8.0. As we can see,
the maximum cluster of AuNPs barely increases after the time of 200 ns. Moreover, after 300 ns,
the maximum cluster sizes do not change. It indicates that the AuNPs at pH= 7.0 and pH= 8.0
will not grow their size along with simulation time.
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Figure A.57: Comparisons of PMF profiles between AuNPs with free rotation and fixed rotation
during the umbrella sampling process at (A) pH= 7.0 and (B) pH= 8.0. The insets are the enlarged
figures at the distance between 4 nm and 6 nm. As we can see, the two PMF curves are slightly
different. With the fixed rotation, both AuNPs at pH= 7.0 and pH= 8.0 have larger maximum and
minimum values compared to the ones with free rotation. Furthermore, the ∆E1 values with fixed
rotation condition at pH= 7.0 and pH= 8.0 are 5.7 kcal/mol and 5.8 kcal/mol, respectively. Both
of them are larger than the ones of 4.6 kcal/mol and 4.8 kcal/mol at pH= 7.0 and pH= 8.0 with
free rotation. Moreover, the ∆E2 values with fixed rotation condition at pH= 7.0 and pH= 8.0 are
50.9 kcal/mol and 38.7 kcal/mol, respectively, which are smaller than the ones with free rotation.
All of these indicate that the orientation of AuNP will affect the PMF values during aggregation.
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Figure A.58: The transnational kinetic energy distribution of a single AuNP under the thermal
fluctuation during a simulation period of 300 ns. As we can see, the mean value of the transnational
kinetic energy is around 0.93 kcal/mol. The maximum transnational kinetic energy during the
testing time is 3.67 kcal/mol. This maximum value indicates that an energy barrier of 6.5 kcal/mol
is large enough to prevent the aggregation of AuNPs.
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Figure A.59: (A) Adhesion process of AuNP with only positive TMA ligands (all-TMA AuNP).
(B) Penetration process of AuNP with positive TMA ligands and alkane chain ligands (no-MUA
AuNP). Comparing with the pH-responsive AuNPs in the main text, the no-MUA AuNP replaces all
the MUA ligands by the pure hydrophobic alkane chains. The setting of no-MUA AuNP is similar
to the one in Ref 365 . As we can see, though the all-TMA AuNP has a larger positive surface charge
than the pH-responsive AuNP at pH=2.0, it still can not penetrate into the membrane. However, if
we change the MUA ligands on pH-responsive AuNPs to pure hydrophobic alkane chains as given for
the no-MUA AuNP, the AuNP without the MUA can quickly penetrate into the membrane within
1 µs.
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Figure A.60: (A) Configurations of AuNPs (all-TMA and no-MUA) and lipid bilayer during the
free energy analysis process. (B) Comparison of PMF profiles when directing an AuNP towards a
lipid bilayer. As we can see for the all-TMA AuNP, it adheres on the lipid bilayer surface at D = 4.0
nm. When the distance further decreases, the membrane starts to bend at D = 2.0 nm. And the
membrane wraps the majority part of AuNPs surface at D = 0.0 nm. During this entire process, the
alkane chains on the AuNPs surface do not have the chance to interact with the hydrophobic lipid
tail. In comparison, the alkane chains on no- MUA AuNP are easier to interact with the lipid tail.
And the no-MUA AuNPs finally penetrates into the lipid bilayer. Comparing the PMF values, we
can find that the PMF values of all-TMA AuNP is smaller than that of AuNPs at pH= 2.0, which
is caused by its larger positive surface density. Additionally, the no-MUA AuNP has the smallest
PMF values because of the hydrophobic interaction. Combining the results of pH-responsive AuNPs
and the AuNPs in Fig.A.59 and Fig.A.59, we can conclude that the penetration behavior of mixed
charged AuNPs is totally different from the ones with positive and pure hydrophobic ligands in
Ref. 365 .
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Figure A.61: (A) Snapshots of interaction process between multiple AuNPs and lipid bilayer. The
lipids extracted by AuNPs are highlighted in green. A pore opened in lipid bilayer is highlighted.
(B) Number of extracted lipids over simulation time. (C) Evolution of the lipid bilayer area. The
pH value in the system is 2.0. There are 36 NPs placed above the membrane at t = 0. And the
membrane size at t = 0 is (35 × 35) nm2 . The extracted lipid number can increase to 2500 during
the simulation time. Additionally, the membrane size also decreases with the amount around 100
nm2 .
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Figure A.62: (A) Snapshots of interaction process between multiple AuNPs and lipid bilayer. The
lipids extracted by AuNPs are highlighted in green. (B) Number of extracted lipids over simulation
time. (C) Evolution of the lipid bilayer area. The pH value in the system is 2.0. There are 25
NPs placed above the membrane at t = 0. And the membrane size at t = 0 is (35 × 35) nm2 .
The extracted lipid number can increase to 1500 during the simulation time. The membrane size
also decreases with the amount around 80 nm2 . Comparing with the one in Fig.A.61, an open
pore doses not appear, which might be related to the reduced area density of AuNPs. The results
in Fig.A.61 and Fig.A.62 suggest that the extraction of lipid and bilayer dehydration should be a
general phenomena for pH-responsive AuNPs with mixed charges.
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[291] A. Halperin, M. Kröger, and E. B. Zhulina, “Colloid-brush interactions: The effect of
solvent quality,” Macromolecules, vol. 44, no. 9, pp. 3622–3638, 2011.
[292] C. M. Wijmans and E. B. Zhulina, “Polymer brushes at curved surfaces,” Macromolecules, vol. 26, no. 26, pp. 7214–7224, 1993.
[293] G. M. Torrie and J. P. Valleau, “Nonphysical sampling distributions in monte carlo
free-energy estimation: Umbrella sampling,” J. Comput. Phys., vol. 23, no. 2, pp. 187–
199, 1977.
[294] S. Kumar, J. M. Rosenberg, D. Bouzida, R. H. Swendsen, and P. A. Kollman, “The
weighted histogram analysis method for free-energy calculations on biomolecules. i.
the method,” J. Comput. Chem., vol. 13, no. 8, pp. 1011–1021, 1992.
[295] R. Lipowsky, “Coupling of bending and stretching deformations in vesicle membranes,” Adv. Colloid Interface Sci., vol. 208, pp. 14–24, 2014.

361

[296] N. L. Rosi, D. A. Giljohann, C. S. Thaxton, A. K. Lytton-Jean, M. S. Han, and
C. A. Mirkin, “Oligonucleotide-modified gold nanoparticles for intracellular gene regulation,” Science, vol. 312, no. 5776, pp. 1027–1030, 2006.
[297] P. C. Ke, S. Lin, W. J. Parak, T. P. Davis, and F. Caruso, “A decade of the protein
corona,” ACS Nano, vol. 11, no. 12, pp. 11773–11776, 2017.
[298] B. S. Pattni, V. V. Chupin, and V. P. Torchilin, “New developments in liposomal
drug delivery,” Chem. Rev., vol. 115, no. 19, pp. 10938–10966, 2015.
[299] C.-H. Huang, “Phosphatidylcholine vesicles. formation and physical characteristics,”
Biochemistry (Mosc.), vol. 8, no. 1, pp. 344–352, 1969.
[300] R. Silva, H. Ferreira, C. Little, and A. Cavaco-Paulo, “Effect of ultrasound parameters
for unilamellar liposome preparation,” Ultrason. Sonochem., vol. 17, no. 3, pp. 628–
632, 2010.
[301] D. van Swaay and A. DeMello, “Microfluidic methods for forming liposomes,” Lab.
Chip, vol. 13, no. 5, pp. 752–767, 2013.
[302] H. Jousma, H. Talsma, F. Spies, J. Joosten, H. Junginger, and D. Crommelin, “Characterization of liposomes. the influence of extrusion of multilamellar vesicles through
polycarbonate membranes on particle size, particle size distribution and number of
bilayers,” Int. J. Pharm., vol. 35, no. 3, pp. 263–274, 1987.
[303] A. P. Costa, X. Xu, M. A. Khan, and D. J. Burgess, “Liposome formation using a
coaxial turbulent jet in co-flow,” Pharm. Res., vol. 33, no. 2, pp. 404–416, 2016.
[304] R. Tanasescu, M. A. Lanz, D. Mueller, S. Tassler, T. Ishikawa, R. Reiter, G. Brezesinski, and A. Zumbuehl, “Vesicle origami and the influence of cholesterol on lipid packing,” Langmuir, vol. 32, no. 19, pp. 4896–4903, 2016.

362

[305] R. Genc, M. Ortiz, and C. K. O’Sullivan, “Curvature-tuned preparation of nanoliposomes,” Langmuir, vol. 25, no. 21, pp. 12604–12613, 2009.
[306] Z. Shen, H. Ye, X. Yi, and Y. Li, “Membrane wrapping efficiency of elastic nanoparticles during endocytosis: Size and shape matter,” ACS Nano, vol. 13, no. 1, pp. 215–
228, 2018.
[307] Y. Yang, J. Wang, H. Shigematsu, W. Xu, W. M. Shih, J. E. Rothman, and C. Lin,
“Self-assembly of size-controlled liposomes on dna nanotemplates,” Nat. Chem., vol. 8,
no. 5, p. 476, 2016.
[308] J. I. Cutler, E. Auyeung, and C. A. Mirkin, “Spherical nucleic acids,” J. Am. Chem.
Soc., vol. 134, no. 3, pp. 1376–1391, 2012.
[309] S. A. Jensen, E. S. Day, C. H. Ko, L. A. Hurley, J. P. Luciano, F. M. Kouri, T. J.
Merkel, A. J. Luthi, P. C. Patel, J. I. Cutler, et al., “Spherical nucleic acid nanoparticle conjugates as an rnai-based therapy for glioblastoma,” Sci. Transl. Med., vol. 5,
no. 209, pp. 209ra152–209ra152, 2013.
[310] D. Zheng, D. A. Giljohann, D. L. Chen, M. D. Massich, X.-Q. Wang, H. Iordanov,
C. A. Mirkin, and A. S. Paller, “Topical delivery of sirna-based spherical nucleic acid
nanoparticle conjugates for gene regulation,” Proceedings of the National Academy of
Sciences, vol. 109, no. 30, pp. 11975–11980, 2012.
[311] D. A. Giljohann, D. S. Seferos, P. C. Patel, J. E. Millstone, N. L. Rosi, and C. A.
Mirkin, “Oligonucleotide loading determines cellular uptake of dna-modified gold
nanoparticles,” Nano Lett., vol. 7, no. 12, pp. 3818–3821, 2007.
[312] D. S. Seferos, A. E. Prigodich, D. A. Giljohann, P. C. Patel, and C. A. Mirkin,
“Polyvalent dna nanoparticle conjugates stabilize nucleic acids,” Nano Lett., vol. 9,
no. 1, pp. 308–311, 2009.

363

[313] M. D. Massich, D. A. Giljohann, D. S. Seferos, L. E. Ludlow, C. M. Horvath, and C. A.
Mirkin, “Regulating immune response using polyvalent nucleic acid- gold nanoparticle
conjugates,” Mol. Pharmaceutics, vol. 6, no. 6, pp. 1934–1940, 2009.
[314] C. H. Kapadia, J. R. Melamed, and E. S. Day, “Spherical nucleic acid nanoparticles:
Therapeutic potential,” BioDrugs, vol. 32, no. 4, pp. 297–309, 2018.
[315] A. B. Chinen, J. R. Ferrer, T. J. Merkel, and C. A. Mirkin, “Relationships between
poly (ethylene glycol) modifications on rna–spherical nucleic acid conjugates and cellular uptake and circulation time,” Bioconjugate Chem., vol. 27, no. 11, pp. 2715–2721,
2016.
[316] X. A. Wu, C. H. J. Choi, C. Zhang, L. Hao, and C. A. Mirkin, “Intracellular fate of
spherical nucleic acid nanoparticle conjugates,” J. Am. Chem. Soc., vol. 136, no. 21,
pp. 7726–7733, 2014.
[317] J. W. Zwanikken, P. Guo, C. A. Mirkin, and M. Olvera de la Cruz, “Local ionic environment around polyvalent nucleic acid-functionalized nanoparticles,” The Journal
of Physical Chemistry C, vol. 115, no. 33, pp. 16368–16373, 2011.
[318] T. I. Li, R. Sknepnek, R. J. Macfarlane, C. A. Mirkin, and M. Olvera de la Cruz,
“Modeling the crystallization of spherical nucleic acid nanoparticle conjugates with
molecular dynamics simulations,” Nano Lett., vol. 12, no. 5, pp. 2509–2514, 2012.
[319] L. Di Michele and E. Eiser, “Developments in understanding and controlling self
assembly of dna-functionalized colloids,” Phys. Chem. Chem. Phys., vol. 15, no. 9,
pp. 3115–3129, 2013.
[320] S. J. Hurst, A. K. Lytton-Jean, and C. A. Mirkin, “Maximizing dna loading on a
range of gold nanoparticle sizes,” Anal. Chem., vol. 78, no. 24, pp. 8313–8318, 2006.

364

[321] D. J. McGillivray, G. Valincius, D. J. Vanderah, W. Febo-Ayala, J. T. Woodward,
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